{"sentText": "Binding of hydroxyflutamide to m AR in LNCaP cells resulted in a concentrationdependent stimulation of PSA expression suggesting that hydroxyflutamide acted as an agonist of the m AR", "relationMentions": [{"em1Text": "hydroxyflutamide", "em2Text": "PSA", "label": "CPR:3"}, {"em1Text": "hydroxyflutamide", "em2Text": "AR", "label": "CPR:5"}]}
{"sentText": "Downregulation of prostatespecific antigen PSA expression an AR target gene by estramustine and bicalutamide was accompanied by the blockade of the mutated androgen receptor", "relationMentions": [{"em1Text": "prostatespecific antigen", "em2Text": "estramustine", "label": "CPR:4"}, {"em1Text": "PSA", "em2Text": "estramustine", "label": "CPR:4"}, {"em1Text": "AR", "em2Text": "estramustine", "label": "CPR:4"}, {"em1Text": "estramustine", "em2Text": "androgen receptor", "label": "CPR:4"}, {"em1Text": "prostatespecific antigen", "em2Text": "bicalutamide", "label": "CPR:4"}, {"em1Text": "PSA", "em2Text": "bicalutamide", "label": "CPR:4"}, {"em1Text": "AR", "em2Text": "bicalutamide", "label": "CPR:4"}, {"em1Text": "bicalutamide", "em2Text": "androgen receptor", "label": "CPR:4"}]}
{"sentText": "Downregulation of prostatespecific antigen PSA expression an AR target gene by estramustine and bicalutamide was accompanied by the blockade of the mutated androgen receptor", "relationMentions": [{"em1Text": "prostatespecific antigen", "em2Text": "estramustine", "label": "CPR:4"}, {"em1Text": "PSA", "em2Text": "estramustine", "label": "CPR:4"}, {"em1Text": "AR", "em2Text": "estramustine", "label": "CPR:4"}, {"em1Text": "estramustine", "em2Text": "androgen receptor", "label": "CPR:4"}, {"em1Text": "prostatespecific antigen", "em2Text": "bicalutamide", "label": "CPR:4"}, {"em1Text": "PSA", "em2Text": "bicalutamide", "label": "CPR:4"}, {"em1Text": "AR", "em2Text": "bicalutamide", "label": "CPR:4"}, {"em1Text": "bicalutamide", "em2Text": "androgen receptor", "label": "CPR:4"}]}
{"sentText": "Our data indicate that estramustine phosphate metabolites perform as androgen antagonists of AR an additional mechanism involved in the therapeutic effect of estramustine phosphate in patients with prostate cancer", "relationMentions": [{"em1Text": "estramustine phosphate", "em2Text": "AR", "label": "CPR:6"}, {"em1Text": "androgen", "em2Text": "AR", "label": "CPR:6"}]}
{"sentText": "Androgen antagonistic effect of estramustine phosphate EMP metabolites on wildtype and mutated androgen receptor", "relationMentions": [{"em1Text": "Androgen", "em2Text": "androgen receptor", "label": "CPR:6"}, {"em1Text": "estramustine phosphate", "em2Text": "androgen receptor", "label": "CPR:6"}, {"em1Text": "EMP", "em2Text": "androgen receptor", "label": "CPR:6"}]}
{"sentText": "RESULTS Administration of SC236 to cirrhotic animals did not produce significant renal effects whereas administration of the nonselective COX1 COX2 inhibitor ketorolac resulted in a marked reduction in urine volume urinary excretion of prostaglandins and glomerular filtration rate and in a significant impairment in renal water metabolism", "relationMentions": [{"em1Text": "COX1", "em2Text": "ketorolac", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "ketorolac", "label": "CPR:4"}, {"em1Text": "COX1", "em2Text": "prostaglandins", "label": "CPR:9"}, {"em1Text": "COX2", "em2Text": "prostaglandins", "label": "CPR:9"}]}
{"sentText": "RESULTS Administration of SC236 to cirrhotic animals did not produce significant renal effects whereas administration of the nonselective COX1 COX2 inhibitor ketorolac resulted in a marked reduction in urine volume urinary excretion of prostaglandins and glomerular filtration rate and in a significant impairment in renal water metabolism", "relationMentions": [{"em1Text": "COX1", "em2Text": "ketorolac", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "ketorolac", "label": "CPR:4"}, {"em1Text": "COX1", "em2Text": "prostaglandins", "label": "CPR:9"}, {"em1Text": "COX2", "em2Text": "prostaglandins", "label": "CPR:9"}]}
{"sentText": "We find that FP causes a decrease in stimulated eosinophil secretion of LTC4 that is regulated by phospholipase A2 PLA2", "relationMentions": [{"em1Text": "FP", "em2Text": "phospholipase A2", "label": "CPR:4"}, {"em1Text": "LTC4", "em2Text": "phospholipase A2", "label": "CPR:9"}, {"em1Text": "LTC4", "em2Text": "PLA2", "label": "CPR:9"}]}
{"sentText": "We find that FP causes a decrease in stimulated eosinophil secretion of LTC4 that is regulated by phospholipase A2 PLA2", "relationMentions": [{"em1Text": "FP", "em2Text": "phospholipase A2", "label": "CPR:4"}, {"em1Text": "LTC4", "em2Text": "phospholipase A2", "label": "CPR:9"}, {"em1Text": "LTC4", "em2Text": "PLA2", "label": "CPR:9"}]}
{"sentText": "The antidepressant desipramine has been shown to decrease synaptic membrane concentrations of the norepinephrine reuptake transporter NET in vivo and in vitro on both an acute and a chronic basis", "relationMentions": [{"em1Text": "desipramine", "em2Text": "NET", "label": "CPR:4"}, {"em1Text": "desipramine", "em2Text": "norepinephrine reuptake transporter", "label": "CPR:4"}]}
{"sentText": "The nonselective and irreversible MAO inhibitors phenelzine 310 mgkg tranylcypromine 13 mgkg and nialamide 30 mgkg decreased rates of responding maintained by ethanol reinforcement", "relationMentions": [{"em1Text": "MAO", "em2Text": "phenelzine", "label": "CPR:4"}, {"em1Text": "MAO", "em2Text": "tranylcypromine", "label": "CPR:4"}, {"em1Text": "MAO", "em2Text": "nialamide", "label": "CPR:4"}]}
{"sentText": "The irreversible MAOB inhibitors pargyline 30 mgkg and ldeprenyl 310 mgkg also decreased responding maintained by ethanol reinforcement these results are consistent with previous findings that both drugs decreased ethanol intake in mice", "relationMentions": [{"em1Text": "MAOB", "em2Text": "pargyline", "label": "CPR:4"}, {"em1Text": "MAOB", "em2Text": "ldeprenyl", "label": "CPR:4"}]}
{"sentText": "The reversible MAOA inhibitor befloxatone 033 mgkg and the irreversible MAOA inhibitor clorgyline 1030 mgkg also reduced ethanol selfadministration", "relationMentions": [{"em1Text": "MAOA", "em2Text": "befloxatone", "label": "CPR:4"}, {"em1Text": "MAOA", "em2Text": "clorgyline", "label": "CPR:4"}]}
{"sentText": "In 35SGTPgammaS binding protocols yohimbine exerts antagonist actions at halpha2AAR h5HT1B h5HT1D and hD2 sites yet partial agonist actions at h5HT1A sites", "relationMentions": [{"em1Text": "yohimbine", "em2Text": "h5HT1A", "label": "CPR:5"}, {"em1Text": "yohimbine", "em2Text": "halpha2AAR", "label": "CPR:6"}, {"em1Text": "yohimbine", "em2Text": "h5HT1B", "label": "CPR:6"}, {"em1Text": "yohimbine", "em2Text": "h5HT1D", "label": "CPR:6"}, {"em1Text": "yohimbine", "em2Text": "hD2", "label": "CPR:6"}]}
{"sentText": "In distinction to yohimbine fluparoxan shows only modest partial agonist actions at h5HT1A sites versus marked antagonist actions at halpha2ARs", "relationMentions": [{"em1Text": "yohimbine", "em2Text": "h5HT1A", "label": "CPR:5"}, {"em1Text": "fluparoxan", "em2Text": "h5HT1A", "label": "CPR:5"}, {"em1Text": "yohimbine", "em2Text": "halpha2ARs", "label": "CPR:6"}, {"em1Text": "fluparoxan", "em2Text": "halpha2ARs", "label": "CPR:6"}]}
{"sentText": "In distinction to yohimbine fluparoxan shows only modest partial agonist actions at h5HT1A sites versus marked antagonist actions at halpha2ARs", "relationMentions": [{"em1Text": "yohimbine", "em2Text": "h5HT1A", "label": "CPR:5"}, {"em1Text": "fluparoxan", "em2Text": "h5HT1A", "label": "CPR:5"}, {"em1Text": "yohimbine", "em2Text": "halpha2ARs", "label": "CPR:6"}, {"em1Text": "fluparoxan", "em2Text": "halpha2ARs", "label": "CPR:6"}]}
{"sentText": "Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha2adrenergic receptors ARs serotonin 5HT1A 5HT1B 5HT1D and dopamine D2 and D3 receptors", "relationMentions": [{"em1Text": "yohimbine", "em2Text": "ARs", "label": "CPR:5"}, {"em1Text": "yohimbine", "em2Text": "5HT1A", "label": "CPR:5"}, {"em1Text": "yohimbine", "em2Text": "5HT1B", "label": "CPR:5"}, {"em1Text": "yohimbine", "em2Text": "5HT1D", "label": "CPR:5"}, {"em1Text": "yohimbine", "em2Text": "alpha2adrenergic receptors", "label": "CPR:5"}, {"em1Text": "fluparoxan", "em2Text": "ARs", "label": "CPR:5"}, {"em1Text": "fluparoxan", "em2Text": "alpha2adrenergic receptors", "label": "CPR:5"}, {"em1Text": "yohimbine", "em2Text": "ARs", "label": "CPR:6"}, {"em1Text": "yohimbine", "em2Text": "5HT1A", "label": "CPR:6"}, {"em1Text": "yohimbine", "em2Text": "5HT1B", "label": "CPR:6"}, {"em1Text": "yohimbine", "em2Text": "5HT1D", "label": "CPR:6"}, {"em1Text": "yohimbine", "em2Text": "alpha2adrenergic receptors", "label": "CPR:6"}, {"em1Text": "fluparoxan", "em2Text": "ARs", "label": "CPR:6"}, {"em1Text": "fluparoxan", "em2Text": "alpha2adrenergic receptors", "label": "CPR:6"}]}
{"sentText": "Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha2adrenergic receptors ARs serotonin 5HT1A 5HT1B 5HT1D and dopamine D2 and D3 receptors", "relationMentions": [{"em1Text": "yohimbine", "em2Text": "ARs", "label": "CPR:5"}, {"em1Text": "yohimbine", "em2Text": "5HT1A", "label": "CPR:5"}, {"em1Text": "yohimbine", "em2Text": "5HT1B", "label": "CPR:5"}, {"em1Text": "yohimbine", "em2Text": "5HT1D", "label": "CPR:5"}, {"em1Text": "yohimbine", "em2Text": "alpha2adrenergic receptors", "label": "CPR:5"}, {"em1Text": "fluparoxan", "em2Text": "ARs", "label": "CPR:5"}, {"em1Text": "fluparoxan", "em2Text": "alpha2adrenergic receptors", "label": "CPR:5"}, {"em1Text": "yohimbine", "em2Text": "ARs", "label": "CPR:6"}, {"em1Text": "yohimbine", "em2Text": "5HT1A", "label": "CPR:6"}, {"em1Text": "yohimbine", "em2Text": "5HT1B", "label": "CPR:6"}, {"em1Text": "yohimbine", "em2Text": "5HT1D", "label": "CPR:6"}, {"em1Text": "yohimbine", "em2Text": "alpha2adrenergic receptors", "label": "CPR:6"}, {"em1Text": "fluparoxan", "em2Text": "ARs", "label": "CPR:6"}, {"em1Text": "fluparoxan", "em2Text": "alpha2adrenergic receptors", "label": "CPR:6"}]}
{"sentText": "Herein we evaluate the interaction of the alpha2AR antagonist yohimbine as compared to fluparoxan at multiple monoaminergic receptors and examine their roles in the modulation of adrenergic dopaminergic and serotonergic transmission in freelymoving rats", "relationMentions": [{"em1Text": "alpha2AR antagonist", "em2Text": "yohimbine", "label": "CPR:6"}, {"em1Text": "alpha2AR antagonist", "em2Text": "fluparoxan", "label": "CPR:6"}]}
{"sentText": "Parenteral administration of selective agonists of the deltaopioid receptor SB 227122 muopioid receptor codeine and hydrocodone and kappaopioid receptor BRL 52974 produced doserelated inhibition of citric acidinduced cough with ED50 values of 73 52 51 and 53 mgkg respectively", "relationMentions": [{"em1Text": "kappaopioid receptor", "em2Text": "BRL 52974", "label": "CPR:5"}, {"em1Text": "deltaopioid receptor", "em2Text": "SB 227122", "label": "CPR:5"}, {"em1Text": "muopioid receptor", "em2Text": "codeine", "label": "CPR:5"}, {"em1Text": "muopioid receptor", "em2Text": "hydrocodone", "label": "CPR:5"}]}
{"sentText": "attenuated the antitussive effects of codeine or SB 227122 indicating that the antitussive activity of both compounds is opioid receptor mediated", "relationMentions": [{"em1Text": "codeine", "em2Text": "opioid receptor", "label": "CPR:5"}, {"em1Text": "SB 227122", "em2Text": "opioid receptor", "label": "CPR:5"}]}
{"sentText": "New modes of therapy have recently been introduced and data on the cyclooxygenase2 COX2 specific inhibitors celecoxib and rofecoxib suggest that these agents will meet the need for safe and effective therapeutic alternatives to conventional NSAIDs", "relationMentions": [{"em1Text": "cyclooxygenase2", "em2Text": "celecoxib", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "celecoxib", "label": "CPR:4"}, {"em1Text": "cyclooxygenase2", "em2Text": "rofecoxib", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "rofecoxib", "label": "CPR:4"}]}
{"sentText": "New modes of therapy have recently been introduced and data on the cyclooxygenase2 COX2 specific inhibitors celecoxib and rofecoxib suggest that these agents will meet the need for safe and effective therapeutic alternatives to conventional NSAIDs", "relationMentions": [{"em1Text": "cyclooxygenase2", "em2Text": "celecoxib", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "celecoxib", "label": "CPR:4"}, {"em1Text": "cyclooxygenase2", "em2Text": "rofecoxib", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "rofecoxib", "label": "CPR:4"}]}
{"sentText": "Another inhibitor brequinar was previously reported to be a slowbinding inhibitor of the human dihydroorotate dehydrogenase W Knecht M Loffler Speciesrelated inhibition of human and rat dihyroorotate dehydrogenase by immunosuppressive isoxazol and cinchoninic acid derivatives Biochem", "relationMentions": [{"em1Text": "brequinar", "em2Text": "human dihydroorotate dehydrogenase", "label": "CPR:4"}, {"em1Text": "human and rat dihyroorotate dehydrogenase", "em2Text": "isoxazol", "label": "CPR:4"}, {"em1Text": "human and rat dihyroorotate dehydrogenase", "em2Text": "cinchoninic acid", "label": "CPR:4"}]}
{"sentText": "With respect to the substrate dihydroorotate atovaquone was an uncompetitive inhibitor of human dihydroorotate dehydrogenase Kiu = 116 microM and a noncompetitive inhibitor of the rat enzyme Kiu = 905 Kic = 1012 nM", "relationMentions": [{"em1Text": "dihydroorotate", "em2Text": "human dihydroorotate dehydrogenase", "label": "CPR:4"}, {"em1Text": "atovaquone", "em2Text": "human dihydroorotate dehydrogenase", "label": "CPR:4"}]}
{"sentText": "Kinetics of inhibition of human and rat dihydroorotate dehydrogenase by atovaquone lawsone derivatives brequinar sodium and polyporic acid", "relationMentions": [{"em1Text": "human and rat dihydroorotate dehydrogenase", "em2Text": "brequinar sodium", "label": "CPR:4"}, {"em1Text": "human and rat dihydroorotate dehydrogenase", "em2Text": "polyporic acid", "label": "CPR:4"}, {"em1Text": "human and rat dihydroorotate dehydrogenase", "em2Text": "atovaquone", "label": "CPR:4"}, {"em1Text": "human and rat dihydroorotate dehydrogenase", "em2Text": "lawsone", "label": "CPR:4"}]}
{"sentText": "With respect to the quinone cosubstrate of the dihydroorotate dehydrogenase atovaquone Kic = 27 microM and dichloroallylawsone Kic = 98 nM were shown to be competitive inhibitors of human dihydroorotate dehydrogenase", "relationMentions": [{"em1Text": "atovaquone", "em2Text": "human dihydroorotate dehydrogenase", "label": "CPR:4"}, {"em1Text": "dichloroallylawsone", "em2Text": "human dihydroorotate dehydrogenase", "label": "CPR:4"}, {"em1Text": "quinone", "em2Text": "dihydroorotate dehydrogenase", "label": "CPR:9"}]}
{"sentText": "Mitochondriallybound dihydroorotate dehydrogenase EC 139911 catalyzes the fourth sequential step in the de novo synthesis of uridine monophosphate", "relationMentions": [{"em1Text": "dihydroorotate dehydrogenase", "em2Text": "uridine monophosphate", "label": "CPR:9"}, {"em1Text": "EC 139911", "em2Text": "uridine monophosphate", "label": "CPR:9"}]}
{"sentText": "Mibefradil Ro 405967 belongs to a new chemical class of these molecules which differs from other Ca2 antagonists by its ability to potently block Ttype Ca2 channels", "relationMentions": [{"em1Text": "Mibefradil", "em2Text": "Ttype Ca2 channels", "label": "CPR:4"}, {"em1Text": "Ro 405967", "em2Text": "Ttype Ca2 channels", "label": "CPR:4"}]}
{"sentText": "Iontophoresis of propranolol whose serotonergic actions include antagonism and partial agonism at 5HT1 receptors also increased serotonin and decreased firing n=4", "relationMentions": [{"em1Text": "propranolol", "em2Text": "5HT1", "label": "CPR:5"}, {"em1Text": "propranolol", "em2Text": "5HT1", "label": "CPR:6"}]}
{"sentText": "Iontophoresis of propranolol whose serotonergic actions include antagonism and partial agonism at 5HT1 receptors also increased serotonin and decreased firing n=4", "relationMentions": [{"em1Text": "propranolol", "em2Text": "5HT1", "label": "CPR:5"}, {"em1Text": "propranolol", "em2Text": "5HT1", "label": "CPR:6"}]}
{"sentText": "Methiothepin intravenous 1 mgkg whose serotonergic actions include 5HT1 and 5HT2 antagonism typically raised serotonin levels four of five cells and always blocked inhibition by clomipramine n = 3", "relationMentions": [{"em1Text": "Methiothepin", "em2Text": "5HT1", "label": "CPR:6"}, {"em1Text": "Methiothepin", "em2Text": "5HT2", "label": "CPR:6"}]}
{"sentText": "Improper function of these proteins can be induced by selective disruption of their complexes with Hsp90 using the benzoquinonoid ansamycin geldanamycin", "relationMentions": [{"em1Text": "Hsp90", "em2Text": "benzoquinonoid ansamycin", "label": "CPR:4"}, {"em1Text": "Hsp90", "em2Text": "geldanamycin", "label": "CPR:4"}]}
{"sentText": "In this study we demonstrate that geldanamycin treatment blocks interleukin IL2 secretion IL2 receptor expression and proliferation of stimulated Tlymphocytes", "relationMentions": [{"em1Text": "geldanamycin", "em2Text": "interleukin IL2", "label": "CPR:4"}, {"em1Text": "geldanamycin", "em2Text": "IL2 receptor", "label": "CPR:4"}]}
{"sentText": "Moreover geldanamycin decreases the amount and phosphorylation of Lck and Raf1 kinases and prevents activation of the extracellular signal regulated kinase ERK2 kinase", "relationMentions": [{"em1Text": "geldanamycin", "em2Text": "Lck", "label": "CPR:4"}, {"em1Text": "geldanamycin", "em2Text": "Raf1", "label": "CPR:4"}, {"em1Text": "geldanamycin", "em2Text": "kinases", "label": "CPR:4"}, {"em1Text": "geldanamycin", "em2Text": "extracellular signal regulated kinase ERK2", "label": "CPR:4"}, {"em1Text": "geldanamycin", "em2Text": "kinase", "label": "CPR:4"}]}
{"sentText": "Geldanamycin also disrupts the Tcell receptor mediated activation of nuclear factor of activated Tcells NFAT", "relationMentions": [{"em1Text": "Geldanamycin", "em2Text": "Tcell receptor", "label": "CPR:4"}, {"em1Text": "Geldanamycin", "em2Text": "nuclear factor of activated Tcells", "label": "CPR:4"}, {"em1Text": "Geldanamycin", "em2Text": "NFAT", "label": "CPR:4"}]}
{"sentText": "gammaButyrobetaine hydroxylase catalyse the last step in carnitine biosynthesis the formation of Lcarnitine from gammabutyrobetaine a reaction dependent on Fe2 alphaketoglutarate ascorbate and oxygen", "relationMentions": [{"em1Text": "gammaButyrobetaine hydroxylase", "em2Text": "carnitine", "label": "CPR:9"}, {"em1Text": "gammaButyrobetaine hydroxylase", "em2Text": "Lcarnitine", "label": "CPR:9"}, {"em1Text": "gammaButyrobetaine hydroxylase", "em2Text": "gammabutyrobetaine", "label": "CPR:9"}]}
{"sentText": "Among the various enzymes dicoumarol inhibitable cytosolic NADPHquinone oxidoreductase1 NQO1 was shown to catalyse bioreductive activation of MMC leading to crosslinking of the DNA and cytotoxicity", "relationMentions": [{"em1Text": "dicoumarol", "em2Text": "NADPHquinone oxidoreductase1", "label": "CPR:4"}, {"em1Text": "dicoumarol", "em2Text": "NQO1", "label": "CPR:4"}, {"em1Text": "NADPHquinone oxidoreductase1", "em2Text": "MMC", "label": "CPR:9"}, {"em1Text": "NQO1", "em2Text": "MMC", "label": "CPR:9"}]}
{"sentText": "Among the various enzymes dicoumarol inhibitable cytosolic NADPHquinone oxidoreductase1 NQO1 was shown to catalyse bioreductive activation of MMC leading to crosslinking of the DNA and cytotoxicity", "relationMentions": [{"em1Text": "dicoumarol", "em2Text": "NADPHquinone oxidoreductase1", "label": "CPR:4"}, {"em1Text": "dicoumarol", "em2Text": "NQO1", "label": "CPR:4"}, {"em1Text": "NADPHquinone oxidoreductase1", "em2Text": "MMC", "label": "CPR:9"}, {"em1Text": "NQO1", "em2Text": "MMC", "label": "CPR:9"}]}
{"sentText": "In these tissues JTH601 prazosin a nonselective alpha1adrenoceptor antagonist and tamsulosin an alpha1Aadrenoceptor antagonist competitively antagonized contraction in a concentrationdependent manner", "relationMentions": [{"em1Text": "JTH601", "em2Text": "alpha1adrenoceptor", "label": "CPR:6"}, {"em1Text": "prazosin", "em2Text": "alpha1adrenoceptor", "label": "CPR:6"}, {"em1Text": "tamsulosin", "em2Text": "alpha1Aadrenoceptor", "label": "CPR:6"}]}
{"sentText": "We examined the effect of JTH601 3 inverted question mark N24hydroxy2isopropyl5methylphenoxyethylNmethylaminom ethyl inverted question mark 4methoxy256trimethylphenol hemifumarate a new alpha1Ladrenoceptor antagonist on prostatic function in isolated canine prostate and in anesthetized dogs", "relationMentions": [{"em1Text": "N24hydroxy2isopropyl5methylphenoxyethylNmethylaminom", "em2Text": "alpha1Ladrenoceptor", "label": "CPR:6"}, {"em1Text": "ethyl", "em2Text": "alpha1Ladrenoceptor", "label": "CPR:6"}, {"em1Text": "4methoxy256trimethylphenol hemifumarate", "em2Text": "alpha1Ladrenoceptor", "label": "CPR:6"}, {"em1Text": "JTH601", "em2Text": "alpha1Ladrenoceptor", "label": "CPR:6"}]}
{"sentText": "Treatment of lactating mice with a single injection of bezafibrate an activator of the peroxisome proliferatoractivated receptor PPAR raises UCP3 mRNA in skeletal muscle to levels similar to those in virgin mice", "relationMentions": [{"em1Text": "bezafibrate", "em2Text": "peroxisome proliferatoractivated receptor", "label": "CPR:3"}, {"em1Text": "bezafibrate", "em2Text": "PPAR", "label": "CPR:3"}, {"em1Text": "bezafibrate", "em2Text": "UCP3", "label": "CPR:3"}]}
{"sentText": "4chloro623xylidinepirimidinylthio acetic acid WY14643 a specific ligand of the PPARalpha subtype causes the most dramatic increase in UCP3 mRNA whereas troglitazone a specific activator of PPARgamma also significantly increases UCP3 mRNA abundance in skeletal muscle of lactating mice", "relationMentions": [{"em1Text": "4chloro623xylidinepirimidinylthio acetic acid", "em2Text": "UCP3", "label": "CPR:3"}, {"em1Text": "WY14643", "em2Text": "UCP3", "label": "CPR:3"}, {"em1Text": "troglitazone", "em2Text": "PPARgamma", "label": "CPR:3"}, {"em1Text": "UCP3", "em2Text": "troglitazone", "label": "CPR:3"}]}
{"sentText": "RESULTS NFkappaB Rel activity induced by tumor necrosis factor alpha 12Otetradecanoylphorbol13acetate or overexpression of NFkappaBinducing kinase IKKalpha IKKbeta or constitutively active IKKalpha and IKKbeta mutants was inhibited dose dependently by sulfasalazine", "relationMentions": [{"em1Text": "NFkappaB", "em2Text": "12Otetradecanoylphorbol13acetate", "label": "CPR:3"}, {"em1Text": "Rel", "em2Text": "12Otetradecanoylphorbol13acetate", "label": "CPR:3"}, {"em1Text": "NFkappaB", "em2Text": "sulfasalazine", "label": "CPR:4"}, {"em1Text": "Rel", "em2Text": "sulfasalazine", "label": "CPR:4"}, {"em1Text": "NFkappaBinducing kinase", "em2Text": "sulfasalazine", "label": "CPR:4"}, {"em1Text": "IKKalpha", "em2Text": "sulfasalazine", "label": "CPR:4"}, {"em1Text": "IKKbeta", "em2Text": "sulfasalazine", "label": "CPR:4"}]}
{"sentText": "RESULTS NFkappaB Rel activity induced by tumor necrosis factor alpha 12Otetradecanoylphorbol13acetate or overexpression of NFkappaBinducing kinase IKKalpha IKKbeta or constitutively active IKKalpha and IKKbeta mutants was inhibited dose dependently by sulfasalazine", "relationMentions": [{"em1Text": "NFkappaB", "em2Text": "12Otetradecanoylphorbol13acetate", "label": "CPR:3"}, {"em1Text": "Rel", "em2Text": "12Otetradecanoylphorbol13acetate", "label": "CPR:3"}, {"em1Text": "NFkappaB", "em2Text": "sulfasalazine", "label": "CPR:4"}, {"em1Text": "Rel", "em2Text": "sulfasalazine", "label": "CPR:4"}, {"em1Text": "NFkappaBinducing kinase", "em2Text": "sulfasalazine", "label": "CPR:4"}, {"em1Text": "IKKalpha", "em2Text": "sulfasalazine", "label": "CPR:4"}, {"em1Text": "IKKbeta", "em2Text": "sulfasalazine", "label": "CPR:4"}]}
{"sentText": "The suppression of NFkappaB activation by inhibition of the IKKs contributes to the wellknown antiinflammatory and immunosuppressive effects of sulfasalazine", "relationMentions": [{"em1Text": "NFkappaB", "em2Text": "sulfasalazine", "label": "CPR:4"}, {"em1Text": "IKKs", "em2Text": "sulfasalazine", "label": "CPR:4"}]}
{"sentText": "Sulfasalazine inhibited tumor necrosis factor alpha induced activation of endogenous IKK in Jurkat T cells and SW620 colon cells as well as the catalytic activity of purified IKKalpha and IKKbeta in vitro", "relationMentions": [{"em1Text": "Sulfasalazine", "em2Text": "tumor necrosis factor alpha", "label": "CPR:4"}, {"em1Text": "Sulfasalazine", "em2Text": "IKK", "label": "CPR:4"}, {"em1Text": "Sulfasalazine", "em2Text": "IKKalpha", "label": "CPR:4"}, {"em1Text": "Sulfasalazine", "em2Text": "IKKbeta", "label": "CPR:4"}]}
{"sentText": "In contrast aspirin like nonselective NSAIDs such as sulindac and indomethacin inhibit not only the enzymatic action of the highly inducible proinflammatory COX2 but the constitutively expressed cytoprotective COX1 as well", "relationMentions": [{"em1Text": "indomethacin", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "indomethacin", "em2Text": "COX1", "label": "CPR:4"}, {"em1Text": "aspirin", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "aspirin", "em2Text": "COX1", "label": "CPR:4"}, {"em1Text": "sulindac", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "sulindac", "em2Text": "COX1", "label": "CPR:4"}]}
{"sentText": "In contrast aspirin like nonselective NSAIDs such as sulindac and indomethacin inhibit not only the enzymatic action of the highly inducible proinflammatory COX2 but the constitutively expressed cytoprotective COX1 as well", "relationMentions": [{"em1Text": "indomethacin", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "indomethacin", "em2Text": "COX1", "label": "CPR:4"}, {"em1Text": "aspirin", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "aspirin", "em2Text": "COX1", "label": "CPR:4"}, {"em1Text": "sulindac", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "sulindac", "em2Text": "COX1", "label": "CPR:4"}]}
{"sentText": "Selective COX2 inhibitors such as meloxicam celecoxib SC58635 and rofecoxib MK0966 are NSAIDs that have been modified chemically to preferentially inhibit COX2 but not COX1", "relationMentions": [{"em1Text": "COX2", "em2Text": "meloxicam", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "celecoxib", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "SC58635", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "rofecoxib", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "MK0966", "label": "CPR:4"}]}
{"sentText": "To assess the feasibility of targeting these high AAAD levels for chemotherapy AAAD inhibitors carbidopa alphamethyldopahydrazine alphamonofluoromethyldopa MFMD and 3hydroxybenzylhydrazine NSD1015 were incubated 72 h with NCIH727 human lung carcinoid cells", "relationMentions": [{"em1Text": "AAAD", "em2Text": "carbidopa", "label": "CPR:4"}, {"em1Text": "AAAD", "em2Text": "alphamethyldopahydrazine", "label": "CPR:4"}, {"em1Text": "AAAD", "em2Text": "alphamonofluoromethyldopa", "label": "CPR:4"}, {"em1Text": "AAAD", "em2Text": "MFMD", "label": "CPR:4"}, {"em1Text": "AAAD", "em2Text": "3hydroxybenzylhydrazine", "label": "CPR:4"}, {"em1Text": "AAAD", "em2Text": "NSD1015", "label": "CPR:4"}]}
{"sentText": "Since this compound retains good AChE inhibitory activity and its hexahydrochromeno43bpyrrole moiety is reminiscent of the hexahydropyrrolo23bindole of physostigmine 3 we have designed and synthesized carbamates 46 and their biological evaluation has been assessed in vitro against human AChE and BChE", "relationMentions": [{"em1Text": "AChE", "em2Text": "hexahydrochromeno43bpyrrole", "label": "CPR:4"}, {"em1Text": "AChE", "em2Text": "hexahydropyrrolo23bindole of physostigmine", "label": "CPR:4"}]}
{"sentText": "In mice AS8112 10 30 mg kg1 sc potently inhibited hypothermia induced by the dopamine D3 receptor agonist R7OHDPAT R7hydroxy2NNdinpropylaminotetraline 03 mg kg1 sc", "relationMentions": [{"em1Text": "AS8112", "em2Text": "dopamine D3 receptor", "label": "CPR:4"}, {"em1Text": "dopamine D3 receptor", "em2Text": "R7OHDPAT", "label": "CPR:5"}, {"em1Text": "dopamine D3 receptor", "em2Text": "R7hydroxy2NNdinpropylaminotetraline", "label": "CPR:5"}]}
{"sentText": "In guineapig isolated colon AS8112 produced a rightward shift of the concentrationresponse curves of 2methyl5HT a 5HT3 receptor agonist pA2 value of 704", "relationMentions": [{"em1Text": "2methyl5HT", "em2Text": "5HT3 receptor", "label": "CPR:5"}, {"em1Text": "AS8112", "em2Text": "5HT3 receptor", "label": "CPR:6"}]}
{"sentText": "Other 5HT3 receptor antagonists also produced such a shift in the following antagonisticpotency order granisetron ondansetron = AS8112 metoclopramide", "relationMentions": [{"em1Text": "5HT3 receptor", "em2Text": "granisetron", "label": "CPR:6"}, {"em1Text": "5HT3 receptor", "em2Text": "ondansetron", "label": "CPR:6"}, {"em1Text": "5HT3 receptor", "em2Text": "AS8112", "label": "CPR:6"}, {"em1Text": "5HT3 receptor", "em2Text": "metoclopramide", "label": "CPR:6"}]}
{"sentText": "Fenofibrate and GW2331 induced expression of acylcoenzyme A CoA oxidase and enoylCoA hydratase and reduced apolipoprotein CIII and phosphoenolpyruvate carboxykinase mRNAs", "relationMentions": [{"em1Text": "Fenofibrate", "em2Text": "acylcoenzyme A CoA oxidase", "label": "CPR:3"}, {"em1Text": "Fenofibrate", "em2Text": "enoylCoA hydratase", "label": "CPR:3"}, {"em1Text": "GW2331", "em2Text": "acylcoenzyme A CoA oxidase", "label": "CPR:3"}, {"em1Text": "GW2331", "em2Text": "enoylCoA hydratase", "label": "CPR:3"}, {"em1Text": "Fenofibrate", "em2Text": "apolipoprotein CIII", "label": "CPR:4"}, {"em1Text": "Fenofibrate", "em2Text": "phosphoenolpyruvate carboxykinase", "label": "CPR:4"}, {"em1Text": "GW2331", "em2Text": "apolipoprotein CIII", "label": "CPR:4"}, {"em1Text": "GW2331", "em2Text": "phosphoenolpyruvate carboxykinase", "label": "CPR:4"}]}
{"sentText": "Fenofibrate and GW2331 induced expression of acylcoenzyme A CoA oxidase and enoylCoA hydratase and reduced apolipoprotein CIII and phosphoenolpyruvate carboxykinase mRNAs", "relationMentions": [{"em1Text": "Fenofibrate", "em2Text": "acylcoenzyme A CoA oxidase", "label": "CPR:3"}, {"em1Text": "Fenofibrate", "em2Text": "enoylCoA hydratase", "label": "CPR:3"}, {"em1Text": "GW2331", "em2Text": "acylcoenzyme A CoA oxidase", "label": "CPR:3"}, {"em1Text": "GW2331", "em2Text": "enoylCoA hydratase", "label": "CPR:3"}, {"em1Text": "Fenofibrate", "em2Text": "apolipoprotein CIII", "label": "CPR:4"}, {"em1Text": "Fenofibrate", "em2Text": "phosphoenolpyruvate carboxykinase", "label": "CPR:4"}, {"em1Text": "GW2331", "em2Text": "apolipoprotein CIII", "label": "CPR:4"}, {"em1Text": "GW2331", "em2Text": "phosphoenolpyruvate carboxykinase", "label": "CPR:4"}]}
{"sentText": "Rosiglitazone modestly increased apolipoprotein CIII mRNA and had no effect on expression of the other 2 genes in the liver but increased the expression of glucose transporter 4 and phosphoenolpyruvate carboxykinase in adipose tissue", "relationMentions": [{"em1Text": "Rosiglitazone", "em2Text": "glucose transporter 4", "label": "CPR:3"}, {"em1Text": "Rosiglitazone", "em2Text": "phosphoenolpyruvate carboxykinase", "label": "CPR:3"}, {"em1Text": "Rosiglitazone", "em2Text": "apolipoprotein CIII", "label": "CPR:3"}]}
{"sentText": "It showed high rat lymphoma growthinhibitory and lytic activity in vitro IC50 = 016 mM based specifically on inhibition of xc mediated cystine uptake in contrast to its colonic metabolites sulfapyridine and 5aminosalicylic acid", "relationMentions": [{"em1Text": "xc", "em2Text": "sulfapyridine", "label": "CPR:4"}, {"em1Text": "xc", "em2Text": "5aminosalicylic acid", "label": "CPR:4"}, {"em1Text": "xc", "em2Text": "cystine", "label": "CPR:9"}]}
{"sentText": "Like conventional ACE inhibitors omapatrilat causes extracellular volume reduction and vasodilatation moreover it increases levels of atrial and brain natriuretic peptides and bradykinin", "relationMentions": [{"em1Text": "omapatrilat", "em2Text": "atrial and brain natriuretic peptides", "label": "CPR:3"}, {"em1Text": "omapatrilat", "em2Text": "bradykinin", "label": "CPR:3"}, {"em1Text": "ACE", "em2Text": "omapatrilat", "label": "CPR:4"}]}
{"sentText": "Omapatrilat the prototypical vasopeptidase inhibitor inhibits not only ACE but also neutral endopeptidase", "relationMentions": [{"em1Text": "Omapatrilat", "em2Text": "vasopeptidase", "label": "CPR:4"}, {"em1Text": "Omapatrilat", "em2Text": "ACE", "label": "CPR:4"}, {"em1Text": "Omapatrilat", "em2Text": "neutral endopeptidase", "label": "CPR:4"}]}
{"sentText": "The transport amiloridesensitive mechanism that decreased the acidic intracellular pH change occurring in this medium would correspond to Na H exchange NHE1 isoform", "relationMentions": [{"em1Text": "Na", "em2Text": "NHE1", "label": "CPR:9"}, {"em1Text": "H", "em2Text": "NHE1", "label": "CPR:9"}]}
{"sentText": "Aspirin and salicylate bind to immunoglobulin heavy chain binding protein BiP and inhibit its ATPase activity in human fibroblasts", "relationMentions": [{"em1Text": "Aspirin", "em2Text": "ATPase", "label": "CPR:4"}, {"em1Text": "salicylate", "em2Text": "ATPase", "label": "CPR:4"}]}
{"sentText": "The specific activity of only ornithine aminotransferase OAT the ratelimiting enzyme in the conversion of ornithine to proline increased in 2 weeks of hypertrophy", "relationMentions": [{"em1Text": "ornithine", "em2Text": "ornithine aminotransferase", "label": "CPR:9"}, {"em1Text": "ornithine", "em2Text": "OAT", "label": "CPR:9"}, {"em1Text": "ornithine aminotransferase", "em2Text": "proline", "label": "CPR:9"}, {"em1Text": "OAT", "em2Text": "proline", "label": "CPR:9"}]}
{"sentText": "The specific activity of only ornithine aminotransferase OAT the ratelimiting enzyme in the conversion of ornithine to proline increased in 2 weeks of hypertrophy", "relationMentions": [{"em1Text": "ornithine", "em2Text": "ornithine aminotransferase", "label": "CPR:9"}, {"em1Text": "ornithine", "em2Text": "OAT", "label": "CPR:9"}, {"em1Text": "ornithine aminotransferase", "em2Text": "proline", "label": "CPR:9"}, {"em1Text": "OAT", "em2Text": "proline", "label": "CPR:9"}]}
{"sentText": "A series of studies is reviewed that assesses the relationship between cytokines released at the site of tissue injury and NSAID analgesia and the in vivo selectivity of a selective cyclooxygenase COX2 inhibitor celecoxib in comparison to a dual COX1 COX2 inhibitor ketorolac", "relationMentions": [{"em1Text": "cyclooxygenase COX2", "em2Text": "celecoxib", "label": "CPR:4"}, {"em1Text": "COX1", "em2Text": "ketorolac", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "ketorolac", "label": "CPR:4"}]}
{"sentText": "Celecoxib selectively suppressed PGE2 but not TxB2 at time points consistent with COX2 activity while producing analgesia", "relationMentions": [{"em1Text": "Celecoxib", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "PGE2", "em2Text": "COX2", "label": "CPR:9"}]}
{"sentText": "Three replicate studies in the oral surgery model of acute pain used submucosal microdialysis sample collection for the measurement of prostaglandin E2 PGE2 a product of both COX1 and COX2 and thromboxane B2 as a biomarker for COX1 activity with parallel assessments of pain", "relationMentions": [{"em1Text": "prostaglandin E2", "em2Text": "COX1", "label": "CPR:9"}, {"em1Text": "prostaglandin E2", "em2Text": "COX2", "label": "CPR:9"}, {"em1Text": "PGE2", "em2Text": "COX1", "label": "CPR:9"}, {"em1Text": "PGE2", "em2Text": "COX2", "label": "CPR:9"}]}
{"sentText": "Three replicate studies in the oral surgery model of acute pain used submucosal microdialysis sample collection for the measurement of prostaglandin E2 PGE2 a product of both COX1 and COX2 and thromboxane B2 as a biomarker for COX1 activity with parallel assessments of pain", "relationMentions": [{"em1Text": "prostaglandin E2", "em2Text": "COX1", "label": "CPR:9"}, {"em1Text": "prostaglandin E2", "em2Text": "COX2", "label": "CPR:9"}, {"em1Text": "PGE2", "em2Text": "COX1", "label": "CPR:9"}, {"em1Text": "PGE2", "em2Text": "COX2", "label": "CPR:9"}]}
{"sentText": "The time course of PGE2 production was consistent with early release due to COX1 activity followed by increased production 23 hours after surgery consistent with COX2 expression", "relationMentions": [{"em1Text": "PGE2", "em2Text": "COX1", "label": "CPR:9"}, {"em1Text": "PGE2", "em2Text": "COX2", "label": "CPR:9"}]}
{"sentText": "Acute and chronic PLZ administration increase brain GABA levels an effect due at least in part to an inhibition of the activity of the GABA metabolizing enzyme GABA transaminase GABAT", "relationMentions": [{"em1Text": "PLZ", "em2Text": "GABA transaminase", "label": "CPR:4"}, {"em1Text": "PLZ", "em2Text": "GABAT", "label": "CPR:4"}, {"em1Text": "GABA", "em2Text": "GABA transaminase", "label": "CPR:9"}, {"em1Text": "GABA", "em2Text": "GABAT", "label": "CPR:9"}]}
{"sentText": "Acute and chronic PLZ administration increase brain GABA levels an effect due at least in part to an inhibition of the activity of the GABA metabolizing enzyme GABA transaminase GABAT", "relationMentions": [{"em1Text": "PLZ", "em2Text": "GABA transaminase", "label": "CPR:4"}, {"em1Text": "PLZ", "em2Text": "GABAT", "label": "CPR:4"}, {"em1Text": "GABA", "em2Text": "GABA transaminase", "label": "CPR:9"}, {"em1Text": "GABA", "em2Text": "GABAT", "label": "CPR:9"}]}
{"sentText": "The elevation in brain alanine levels could be explained at least in part by a time and dosedependent inhibitory effect of PLZ on alanine transaminase ALAT although as with GABA the increases are higher than expected from the degree of enzyme inhibition produced", "relationMentions": [{"em1Text": "PLZ", "em2Text": "alanine transaminase", "label": "CPR:4"}, {"em1Text": "PLZ", "em2Text": "ALAT", "label": "CPR:4"}, {"em1Text": "alanine", "em2Text": "alanine transaminase", "label": "CPR:9"}, {"em1Text": "alanine", "em2Text": "ALAT", "label": "CPR:9"}]}
{"sentText": "The elevation in brain alanine levels could be explained at least in part by a time and dosedependent inhibitory effect of PLZ on alanine transaminase ALAT although as with GABA the increases are higher than expected from the degree of enzyme inhibition produced", "relationMentions": [{"em1Text": "PLZ", "em2Text": "alanine transaminase", "label": "CPR:4"}, {"em1Text": "PLZ", "em2Text": "ALAT", "label": "CPR:4"}, {"em1Text": "alanine", "em2Text": "alanine transaminase", "label": "CPR:9"}, {"em1Text": "alanine", "em2Text": "ALAT", "label": "CPR:9"}]}
{"sentText": "Cyclooxygenase1 COX1 inhibitors flurbiprofen ketoprofen and ketrolack attenuated the nicotineinduced contraction in a concentrationdependent manner and cyclooxygenase2 COX2 inhibitors at high concentrations nimesulide and NS389 slightly attenuated the contraction", "relationMentions": [{"em1Text": "Cyclooxygenase1", "em2Text": "flurbiprofen", "label": "CPR:4"}, {"em1Text": "COX1", "em2Text": "flurbiprofen", "label": "CPR:4"}, {"em1Text": "Cyclooxygenase1", "em2Text": "ketoprofen", "label": "CPR:4"}, {"em1Text": "COX1", "em2Text": "ketoprofen", "label": "CPR:4"}, {"em1Text": "Cyclooxygenase1", "em2Text": "ketrolack", "label": "CPR:4"}, {"em1Text": "COX1", "em2Text": "ketrolack", "label": "CPR:4"}, {"em1Text": "cyclooxygenase2", "em2Text": "nimesulide", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "nimesulide", "label": "CPR:4"}, {"em1Text": "cyclooxygenase2", "em2Text": "NS389", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "NS389", "label": "CPR:4"}]}
{"sentText": "Cyclooxygenase1 COX1 inhibitors flurbiprofen ketoprofen and ketrolack attenuated the nicotineinduced contraction in a concentrationdependent manner and cyclooxygenase2 COX2 inhibitors at high concentrations nimesulide and NS389 slightly attenuated the contraction", "relationMentions": [{"em1Text": "Cyclooxygenase1", "em2Text": "flurbiprofen", "label": "CPR:4"}, {"em1Text": "COX1", "em2Text": "flurbiprofen", "label": "CPR:4"}, {"em1Text": "Cyclooxygenase1", "em2Text": "ketoprofen", "label": "CPR:4"}, {"em1Text": "COX1", "em2Text": "ketoprofen", "label": "CPR:4"}, {"em1Text": "Cyclooxygenase1", "em2Text": "ketrolack", "label": "CPR:4"}, {"em1Text": "COX1", "em2Text": "ketrolack", "label": "CPR:4"}, {"em1Text": "cyclooxygenase2", "em2Text": "nimesulide", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "nimesulide", "label": "CPR:4"}, {"em1Text": "cyclooxygenase2", "em2Text": "NS389", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "NS389", "label": "CPR:4"}]}
{"sentText": "Accordingly docking of different COX inhibitors including selective and nonselective ligands rofecoxib ketoprofen suprofen carprofen zomepirac indomethacin diclofenac and meclofenamic acid were undertaken using the AMBER program", "relationMentions": [{"em1Text": "COX", "em2Text": "zomepirac", "label": "CPR:4"}, {"em1Text": "COX", "em2Text": "indomethacin", "label": "CPR:4"}, {"em1Text": "COX", "em2Text": "diclofenac", "label": "CPR:4"}, {"em1Text": "COX", "em2Text": "meclofenamic acid", "label": "CPR:4"}, {"em1Text": "COX", "em2Text": "rofecoxib", "label": "CPR:4"}, {"em1Text": "COX", "em2Text": "ketoprofen", "label": "CPR:4"}, {"em1Text": "COX", "em2Text": "suprofen", "label": "CPR:4"}, {"em1Text": "COX", "em2Text": "carprofen", "label": "CPR:4"}]}
{"sentText": "Non steroidal antiinflammatory drugs NSAIDs are competitive inhibitors of cyclooxygenase COX the enzyme that mediates biosynthesis of prostaglandins and thromboxanes from arachidonic acid", "relationMentions": [{"em1Text": "steroidal", "em2Text": "cyclooxygenase", "label": "CPR:4"}, {"em1Text": "steroidal", "em2Text": "COX", "label": "CPR:4"}, {"em1Text": "cyclooxygenase", "em2Text": "prostaglandins", "label": "CPR:9"}, {"em1Text": "COX", "em2Text": "prostaglandins", "label": "CPR:9"}, {"em1Text": "cyclooxygenase", "em2Text": "thromboxanes", "label": "CPR:9"}, {"em1Text": "COX", "em2Text": "thromboxanes", "label": "CPR:9"}, {"em1Text": "cyclooxygenase", "em2Text": "arachidonic acid", "label": "CPR:9"}, {"em1Text": "COX", "em2Text": "arachidonic acid", "label": "CPR:9"}]}
{"sentText": "Non steroidal antiinflammatory drugs NSAIDs are competitive inhibitors of cyclooxygenase COX the enzyme that mediates biosynthesis of prostaglandins and thromboxanes from arachidonic acid", "relationMentions": [{"em1Text": "steroidal", "em2Text": "cyclooxygenase", "label": "CPR:4"}, {"em1Text": "steroidal", "em2Text": "COX", "label": "CPR:4"}, {"em1Text": "cyclooxygenase", "em2Text": "prostaglandins", "label": "CPR:9"}, {"em1Text": "COX", "em2Text": "prostaglandins", "label": "CPR:9"}, {"em1Text": "cyclooxygenase", "em2Text": "thromboxanes", "label": "CPR:9"}, {"em1Text": "COX", "em2Text": "thromboxanes", "label": "CPR:9"}, {"em1Text": "cyclooxygenase", "em2Text": "arachidonic acid", "label": "CPR:9"}, {"em1Text": "COX", "em2Text": "arachidonic acid", "label": "CPR:9"}]}
{"sentText": "Olopatadine hydrochloride olopatadine 11Z3dimethylaminopropylidene611dihydrodibenzbeoxepin2acetic acid monohydrochloride is a novel antiallergic histamine H1receptor antagonistic drug that was synthesized and evaluated in our laboratories", "relationMentions": [{"em1Text": "olopatadine", "em2Text": "histamine H1receptor", "label": "CPR:6"}, {"em1Text": "11Z3dimethylaminopropylidene611dihydrodibenzbeoxepin2acetic acid monohydrochloride", "em2Text": "histamine H1receptor", "label": "CPR:6"}, {"em1Text": "Olopatadine hydrochloride", "em2Text": "histamine H1receptor", "label": "CPR:6"}]}
{"sentText": "Inhibition of human liver OATPs can explain the previously observed effects of rifamycin SV and rifampicin on hepatic organic anion elimination", "relationMentions": [{"em1Text": "human liver OATPs", "em2Text": "rifamycin SV", "label": "CPR:4"}, {"em1Text": "human liver OATPs", "em2Text": "rifampicin", "label": "CPR:4"}]}
{"sentText": "In complementary RNA cRNAinjected Xenopus laevis oocytes rifamycin SV 10 micromolL cisinhibited human organic anion transporting polypeptide C SLC21A6 OATPC human organic anion transporting polypeptide 8 SLC21A8 OATP8 human organic anion transporting polypeptide B SLC21A9 OATPB and human organic anion transporting polypeptide A SLC21A3 OATPA mediated BSP uptake by 69 79 89 and 57 respectively as compared with uptake into control oocytes", "relationMentions": [{"em1Text": "rifamycin SV", "em2Text": "human organic anion transporting polypeptide C", "label": "CPR:4"}, {"em1Text": "rifamycin SV", "em2Text": "SLC21A6", "label": "CPR:4"}, {"em1Text": "rifamycin SV", "em2Text": "OATPC", "label": "CPR:4"}, {"em1Text": "rifamycin SV", "em2Text": "human organic anion transporting polypeptide 8", "label": "CPR:4"}, {"em1Text": "rifamycin SV", "em2Text": "SLC21A8", "label": "CPR:4"}, {"em1Text": "rifamycin SV", "em2Text": "OATP8", "label": "CPR:4"}, {"em1Text": "rifamycin SV", "em2Text": "human organic anion transporting polypeptide B", "label": "CPR:4"}, {"em1Text": "rifamycin SV", "em2Text": "SLC21A9", "label": "CPR:4"}, {"em1Text": "rifamycin SV", "em2Text": "OATPB", "label": "CPR:4"}, {"em1Text": "rifamycin SV", "em2Text": "human organic anion transporting polypeptide A", "label": "CPR:4"}, {"em1Text": "rifamycin SV", "em2Text": "SLC21A3", "label": "CPR:4"}, {"em1Text": "rifamycin SV", "em2Text": "OATPA", "label": "CPR:4"}]}
{"sentText": "Rifampicin 10 micromolL inhibited OATP8 mediated BSP uptake by 50 whereas inhibition of OATPC OATPB and OATPA mediated BSP transport was below 15", "relationMentions": [{"em1Text": "Rifampicin", "em2Text": "OATP8", "label": "CPR:4"}, {"em1Text": "Rifampicin", "em2Text": "OATPC", "label": "CPR:4"}, {"em1Text": "Rifampicin", "em2Text": "OATPB", "label": "CPR:4"}, {"em1Text": "Rifampicin", "em2Text": "OATPA", "label": "CPR:4"}, {"em1Text": "OATP8", "em2Text": "BSP", "label": "CPR:9"}, {"em1Text": "BSP", "em2Text": "OATPC", "label": "CPR:9"}, {"em1Text": "BSP", "em2Text": "OATPB", "label": "CPR:9"}, {"em1Text": "BSP", "em2Text": "OATPA", "label": "CPR:9"}]}
{"sentText": "Rifampicin 10 micromolL inhibited OATP8 mediated BSP uptake by 50 whereas inhibition of OATPC OATPB and OATPA mediated BSP transport was below 15", "relationMentions": [{"em1Text": "Rifampicin", "em2Text": "OATP8", "label": "CPR:4"}, {"em1Text": "Rifampicin", "em2Text": "OATPC", "label": "CPR:4"}, {"em1Text": "Rifampicin", "em2Text": "OATPB", "label": "CPR:4"}, {"em1Text": "Rifampicin", "em2Text": "OATPA", "label": "CPR:4"}, {"em1Text": "OATP8", "em2Text": "BSP", "label": "CPR:9"}, {"em1Text": "BSP", "em2Text": "OATPC", "label": "CPR:9"}, {"em1Text": "BSP", "em2Text": "OATPB", "label": "CPR:9"}, {"em1Text": "BSP", "em2Text": "OATPA", "label": "CPR:9"}]}
{"sentText": "In rats rifamycin SV and rifampicin were shown to interfere with hepatic organic anion uptake by inhibition of the organic anion transporting polypeptides Oatp1 and Oatp2", "relationMentions": [{"em1Text": "rifamycin SV", "em2Text": "organic anion transporting polypeptides", "label": "CPR:4"}, {"em1Text": "rifamycin SV", "em2Text": "Oatp1", "label": "CPR:4"}, {"em1Text": "rifamycin SV", "em2Text": "Oatp2", "label": "CPR:4"}, {"em1Text": "rifampicin", "em2Text": "organic anion transporting polypeptides", "label": "CPR:4"}, {"em1Text": "rifampicin", "em2Text": "Oatp1", "label": "CPR:4"}, {"em1Text": "rifampicin", "em2Text": "Oatp2", "label": "CPR:4"}]}
{"sentText": "In rats rifamycin SV and rifampicin were shown to interfere with hepatic organic anion uptake by inhibition of the organic anion transporting polypeptides Oatp1 and Oatp2", "relationMentions": [{"em1Text": "rifamycin SV", "em2Text": "organic anion transporting polypeptides", "label": "CPR:4"}, {"em1Text": "rifamycin SV", "em2Text": "Oatp1", "label": "CPR:4"}, {"em1Text": "rifamycin SV", "em2Text": "Oatp2", "label": "CPR:4"}, {"em1Text": "rifampicin", "em2Text": "organic anion transporting polypeptides", "label": "CPR:4"}, {"em1Text": "rifampicin", "em2Text": "Oatp1", "label": "CPR:4"}, {"em1Text": "rifampicin", "em2Text": "Oatp2", "label": "CPR:4"}]}
{"sentText": "100 micromolL rifampicin inhibited OATPC and OATP8 OATPB and OATPA mediated BSP uptake by 66 96 25 and 49 respectively", "relationMentions": [{"em1Text": "rifampicin", "em2Text": "OATPC", "label": "CPR:4"}, {"em1Text": "rifampicin", "em2Text": "OATP8", "label": "CPR:4"}, {"em1Text": "rifampicin", "em2Text": "OATPB", "label": "CPR:4"}, {"em1Text": "rifampicin", "em2Text": "OATPA", "label": "CPR:4"}, {"em1Text": "OATPC", "em2Text": "BSP", "label": "CPR:9"}, {"em1Text": "OATP8", "em2Text": "BSP", "label": "CPR:9"}, {"em1Text": "OATPB", "em2Text": "BSP", "label": "CPR:9"}, {"em1Text": "OATPA", "em2Text": "BSP", "label": "CPR:9"}]}
{"sentText": "100 micromolL rifampicin inhibited OATPC and OATP8 OATPB and OATPA mediated BSP uptake by 66 96 25 and 49 respectively", "relationMentions": [{"em1Text": "rifampicin", "em2Text": "OATPC", "label": "CPR:4"}, {"em1Text": "rifampicin", "em2Text": "OATP8", "label": "CPR:4"}, {"em1Text": "rifampicin", "em2Text": "OATPB", "label": "CPR:4"}, {"em1Text": "rifampicin", "em2Text": "OATPA", "label": "CPR:4"}, {"em1Text": "OATPC", "em2Text": "BSP", "label": "CPR:9"}, {"em1Text": "OATP8", "em2Text": "BSP", "label": "CPR:9"}, {"em1Text": "OATPB", "em2Text": "BSP", "label": "CPR:9"}, {"em1Text": "OATPA", "em2Text": "BSP", "label": "CPR:9"}]}
{"sentText": "Direct transport of rifampicin could be shown for OATPC apparent Km value 13 micromolL and OATP8 23 micromolL", "relationMentions": [{"em1Text": "rifampicin", "em2Text": "OATPC", "label": "CPR:9"}, {"em1Text": "rifampicin", "em2Text": "OATP8", "label": "CPR:9"}]}
{"sentText": "Metformin treatment for 10 weeks significantly increased AMPK alpha2 activity in the skeletal muscle and this was associated with increased phosphorylation of AMPK on Thr172 and decreased acetylCoA carboxylase2 activity", "relationMentions": [{"em1Text": "Metformin", "em2Text": "AMPK alpha2", "label": "CPR:3"}, {"em1Text": "Metformin", "em2Text": "AMPK", "label": "CPR:3"}, {"em1Text": "Metformin", "em2Text": "acetylCoA carboxylase2", "label": "CPR:4"}]}
{"sentText": "AMPactivated protein kinase AMPK activity increases in response to depletion of cellular energy stores and this enzyme has been implicated in the stimulation of glucose uptake into skeletal muscle and the inhibition of liver gluconeogenesis", "relationMentions": [{"em1Text": "AMPactivated protein kinase", "em2Text": "glucose", "label": "CPR:9"}, {"em1Text": "AMPK", "em2Text": "glucose", "label": "CPR:9"}]}
{"sentText": "The PAO inhibitor MDL72527 only partially blocked oxidation of spermine while a previously reported PAO substrate N 1 n octanesulphonylspermine potently inhibited the reaction", "relationMentions": [{"em1Text": "PAO", "em2Text": "MDL72527", "label": "CPR:4"}, {"em1Text": "PAO", "em2Text": "N 1 n octanesulphonylspermine", "label": "CPR:9"}]}
{"sentText": "During polyamine catabolism spermine and spermidine are first acetylated by spermidinespermine N1acetyltransferase SSAT and subsequently oxidized by polyamine oxidase PAO to produce spermidine and putrescine respectively", "relationMentions": [{"em1Text": "spermidine", "em2Text": "polyamine oxidase", "label": "CPR:9"}, {"em1Text": "spermidine", "em2Text": "PAO", "label": "CPR:9"}, {"em1Text": "polyamine oxidase", "em2Text": "putrescine", "label": "CPR:9"}, {"em1Text": "PAO", "em2Text": "putrescine", "label": "CPR:9"}, {"em1Text": "spermine", "em2Text": "SSAT", "label": "CPR:9"}, {"em1Text": "spermine", "em2Text": "spermidinespermine N1acetyltransferase", "label": "CPR:9"}, {"em1Text": "spermidine", "em2Text": "SSAT", "label": "CPR:9"}, {"em1Text": "spermidine", "em2Text": "spermidinespermine N1acetyltransferase", "label": "CPR:9"}, {"em1Text": "polyamine", "em2Text": "SSAT", "label": "CPR:9"}, {"em1Text": "polyamine", "em2Text": "spermidinespermine N1acetyltransferase", "label": "CPR:9"}]}
{"sentText": "During polyamine catabolism spermine and spermidine are first acetylated by spermidinespermine N1acetyltransferase SSAT and subsequently oxidized by polyamine oxidase PAO to produce spermidine and putrescine respectively", "relationMentions": [{"em1Text": "spermidine", "em2Text": "polyamine oxidase", "label": "CPR:9"}, {"em1Text": "spermidine", "em2Text": "PAO", "label": "CPR:9"}, {"em1Text": "polyamine oxidase", "em2Text": "putrescine", "label": "CPR:9"}, {"em1Text": "PAO", "em2Text": "putrescine", "label": "CPR:9"}, {"em1Text": "spermine", "em2Text": "SSAT", "label": "CPR:9"}, {"em1Text": "spermine", "em2Text": "spermidinespermine N1acetyltransferase", "label": "CPR:9"}, {"em1Text": "spermidine", "em2Text": "SSAT", "label": "CPR:9"}, {"em1Text": "spermidine", "em2Text": "spermidinespermine N1acetyltransferase", "label": "CPR:9"}, {"em1Text": "polyamine", "em2Text": "SSAT", "label": "CPR:9"}, {"em1Text": "polyamine", "em2Text": "spermidinespermine N1acetyltransferase", "label": "CPR:9"}]}
{"sentText": "Substrate specificity using lysates of oxidasetransfected HEK293 cells revealed that the newly identified oxidase strongly favoured spermine over N 1acetylspermine and that it failed to act on N 1acetylspermidine spermidine or the preferred PAO substrate N 1 N 12diacetylspermine", "relationMentions": [{"em1Text": "oxidase", "em2Text": "spermine", "label": "CPR:9"}, {"em1Text": "oxidase", "em2Text": "N 1acetylspermine", "label": "CPR:9"}, {"em1Text": "PAO", "em2Text": "N 1 N 12diacetylspermine", "label": "CPR:9"}]}
{"sentText": "Most halogenated cysteine Sconjugates are metabolized by cysteine Sconjugate betalyases to pyruvate ammonia and an alphachloroenethiolate with DCVC or an alphadifluoroalkylthiolate with TFEC that may eliminate halide to give a thioacyl halide which reacts with epsilonamino groups of lysine residues in proteins", "relationMentions": [{"em1Text": "cysteine Sconjugates", "em2Text": "betalyases", "label": "CPR:9"}, {"em1Text": "betalyases", "em2Text": "pyruvate", "label": "CPR:9"}, {"em1Text": "betalyases", "em2Text": "ammonia", "label": "CPR:9"}, {"em1Text": "betalyases", "em2Text": "alphachloroenethiolate", "label": "CPR:9"}, {"em1Text": "betalyases", "em2Text": "DCVC", "label": "CPR:9"}, {"em1Text": "betalyases", "em2Text": "alphadifluoroalkylthiolate", "label": "CPR:9"}, {"em1Text": "betalyases", "em2Text": "TFEC", "label": "CPR:9"}]}
{"sentText": "The ensuing radioactive outflow from these cultures was enhanced by desipramine and reserpine but reduced in the presence of desipramine by the OCT3 inhibitors cyanine 863 oestradiol and corticosterone", "relationMentions": [{"em1Text": "OCT3", "em2Text": "oestradiol", "label": "CPR:4"}, {"em1Text": "OCT3", "em2Text": "corticosterone", "label": "CPR:4"}]}
{"sentText": "Amongst the three OCTs expressed in the SCG OCT3 best fits the profile of substrates and antagonists that cause transstimulation and transinhibition respectively of 3HMPP release", "relationMentions": [{"em1Text": "OCTs", "em2Text": "3HMPP", "label": "CPR:9"}, {"em1Text": "OCT3", "em2Text": "3HMPP", "label": "CPR:9"}]}
{"sentText": "Reuptake of extracellular noradrenaline NA into superior cervical ganglion SCG neurones is mediated by means of the noradrenaline transporter NAT uptake 1", "relationMentions": [{"em1Text": "noradrenaline", "em2Text": "noradrenaline transporter", "label": "CPR:9"}, {"em1Text": "noradrenaline", "em2Text": "NAT", "label": "CPR:9"}, {"em1Text": "NA", "em2Text": "noradrenaline transporter", "label": "CPR:9"}, {"em1Text": "NA", "em2Text": "NAT", "label": "CPR:9"}]}
{"sentText": "Reuptake of extracellular noradrenaline NA into superior cervical ganglion SCG neurones is mediated by means of the noradrenaline transporter NAT uptake 1", "relationMentions": [{"em1Text": "noradrenaline", "em2Text": "noradrenaline transporter", "label": "CPR:9"}, {"em1Text": "noradrenaline", "em2Text": "NAT", "label": "CPR:9"}, {"em1Text": "NA", "em2Text": "noradrenaline transporter", "label": "CPR:9"}, {"em1Text": "NA", "em2Text": "NAT", "label": "CPR:9"}]}
{"sentText": "The outflow of 3HMPP was significantly enhanced by MPP guanidine choline and amantadine as potential substrates for OCT related transmembrane transporters", "relationMentions": [{"em1Text": "3HMPP", "em2Text": "OCT", "label": "CPR:9"}, {"em1Text": "3HMPP", "em2Text": "transmembrane transporters", "label": "CPR:9"}, {"em1Text": "MPP", "em2Text": "OCT", "label": "CPR:9"}, {"em1Text": "MPP", "em2Text": "transmembrane transporters", "label": "CPR:9"}, {"em1Text": "guanidine", "em2Text": "OCT", "label": "CPR:9"}, {"em1Text": "guanidine", "em2Text": "transmembrane transporters", "label": "CPR:9"}, {"em1Text": "choline", "em2Text": "OCT", "label": "CPR:9"}, {"em1Text": "choline", "em2Text": "transmembrane transporters", "label": "CPR:9"}, {"em1Text": "amantadine", "em2Text": "OCT", "label": "CPR:9"}, {"em1Text": "amantadine", "em2Text": "transmembrane transporters", "label": "CPR:9"}]}
{"sentText": "The outflow of 3HMPP was significantly enhanced by MPP guanidine choline and amantadine as potential substrates for OCT related transmembrane transporters", "relationMentions": [{"em1Text": "3HMPP", "em2Text": "OCT", "label": "CPR:9"}, {"em1Text": "3HMPP", "em2Text": "transmembrane transporters", "label": "CPR:9"}, {"em1Text": "MPP", "em2Text": "OCT", "label": "CPR:9"}, {"em1Text": "MPP", "em2Text": "transmembrane transporters", "label": "CPR:9"}, {"em1Text": "guanidine", "em2Text": "OCT", "label": "CPR:9"}, {"em1Text": "guanidine", "em2Text": "transmembrane transporters", "label": "CPR:9"}, {"em1Text": "choline", "em2Text": "OCT", "label": "CPR:9"}, {"em1Text": "choline", "em2Text": "transmembrane transporters", "label": "CPR:9"}, {"em1Text": "amantadine", "em2Text": "OCT", "label": "CPR:9"}, {"em1Text": "amantadine", "em2Text": "transmembrane transporters", "label": "CPR:9"}]}
{"sentText": "Rasagiline prevented the PT in mitochondria directly and also indirectly through induction of antiapoptotic Bcl2 and a neurotrophic factor glial cell linederived neurotrophic factor GDNF", "relationMentions": [{"em1Text": "Rasagiline", "em2Text": "Bcl2", "label": "CPR:3"}, {"em1Text": "Rasagiline", "em2Text": "neurotrophic factor", "label": "CPR:3"}, {"em1Text": "Rasagiline", "em2Text": "glial cell linederived neurotrophic factor", "label": "CPR:3"}, {"em1Text": "Rasagiline", "em2Text": "GDNF", "label": "CPR:3"}]}
{"sentText": "Longterm administration of propargylamines to rats increased the activities of antioxidative enzymes superoxide dismutase SOD and catalase in the brain regions containing dopamine neurons", "relationMentions": [{"em1Text": "propargylamines", "em2Text": "superoxide dismutase", "label": "CPR:3"}, {"em1Text": "propargylamines", "em2Text": "SOD", "label": "CPR:3"}, {"em1Text": "propargylamines", "em2Text": "catalase", "label": "CPR:3"}]}
{"sentText": "An inhibitor of type B monoamine oxidase MAOB deprenyl selegiline was reported to have neuroprotective activity but clinical trials failed to confirm it", "relationMentions": [{"em1Text": "type B monoamine oxidase", "em2Text": "deprenyl", "label": "CPR:4"}, {"em1Text": "MAOB", "em2Text": "deprenyl", "label": "CPR:4"}, {"em1Text": "type B monoamine oxidase", "em2Text": "selegiline", "label": "CPR:4"}, {"em1Text": "MAOB", "em2Text": "selegiline", "label": "CPR:4"}]}
{"sentText": "An inhibitor of type B monoamine oxidase MAOB deprenyl selegiline was reported to have neuroprotective activity but clinical trials failed to confirm it", "relationMentions": [{"em1Text": "type B monoamine oxidase", "em2Text": "deprenyl", "label": "CPR:4"}, {"em1Text": "MAOB", "em2Text": "deprenyl", "label": "CPR:4"}, {"em1Text": "type B monoamine oxidase", "em2Text": "selegiline", "label": "CPR:4"}, {"em1Text": "MAOB", "em2Text": "selegiline", "label": "CPR:4"}]}
{"sentText": "These findings suggest that RhBG and RhCG may play important and cellspecific roles in ammonium transport and signaling in these regions of the kidney", "relationMentions": [{"em1Text": "RhBG", "em2Text": "ammonium", "label": "CPR:9"}, {"em1Text": "RhCG", "em2Text": "ammonium", "label": "CPR:9"}]}
{"sentText": "Sildenafil exhibits inhibitory potency against PDE5 and a 10fold lower doserelated inhibitory potency against rod outer segment PDE6 the predominant PDE in the phototransduction cascade in rods", "relationMentions": [{"em1Text": "Sildenafil", "em2Text": "PDE", "label": "CPR:4"}, {"em1Text": "Sildenafil", "em2Text": "PDE5", "label": "CPR:4"}, {"em1Text": "Sildenafil", "em2Text": "PDE6", "label": "CPR:4"}]}
{"sentText": "PDE5 is the predominant PDE in the corpus cavernosum and cGMP is its primary substrate", "relationMentions": [{"em1Text": "PDE5", "em2Text": "cGMP", "label": "CPR:9"}, {"em1Text": "PDE", "em2Text": "cGMP", "label": "CPR:9"}]}
{"sentText": "However when coapplied with 10 micro m GABA ivermectin potentiated the GABAevoked current of the GAB1 HG1A receptor but attenuated the GABA response of the GAB1 HG1E receptor", "relationMentions": [{"em1Text": "ivermectin", "em2Text": "GAB1", "label": "CPR:3"}, {"em1Text": "ivermectin", "em2Text": "HG1A", "label": "CPR:3"}, {"em1Text": "ivermectin", "em2Text": "GAB1", "label": "CPR:4"}, {"em1Text": "ivermectin", "em2Text": "HG1E", "label": "CPR:4"}]}
{"sentText": "However when coapplied with 10 micro m GABA ivermectin potentiated the GABAevoked current of the GAB1 HG1A receptor but attenuated the GABA response of the GAB1 HG1E receptor", "relationMentions": [{"em1Text": "ivermectin", "em2Text": "GAB1", "label": "CPR:3"}, {"em1Text": "ivermectin", "em2Text": "HG1A", "label": "CPR:3"}, {"em1Text": "ivermectin", "em2Text": "GAB1", "label": "CPR:4"}, {"em1Text": "ivermectin", "em2Text": "HG1E", "label": "CPR:4"}]}
{"sentText": "The immune response modifiers imiquimod and resiquimod are TLR7 agonists that induce type I interferon in numerous species including humans", "relationMentions": [{"em1Text": "imiquimod", "em2Text": "type I interferon", "label": "CPR:3"}, {"em1Text": "resiquimod", "em2Text": "type I interferon", "label": "CPR:3"}, {"em1Text": "imiquimod", "em2Text": "TLR7", "label": "CPR:5"}, {"em1Text": "resiquimod", "em2Text": "TLR7", "label": "CPR:5"}]}
{"sentText": "The immune response modifiers imiquimod and resiquimod are TLR7 agonists that induce type I interferon in numerous species including humans", "relationMentions": [{"em1Text": "imiquimod", "em2Text": "type I interferon", "label": "CPR:3"}, {"em1Text": "resiquimod", "em2Text": "type I interferon", "label": "CPR:3"}, {"em1Text": "imiquimod", "em2Text": "TLR7", "label": "CPR:5"}, {"em1Text": "resiquimod", "em2Text": "TLR7", "label": "CPR:5"}]}
{"sentText": "Results indicate that imiquimod and resiquimod induce IFNalpha and IFNomega from purified pDC and pDC are the principle IFNproducing cells in the blood", "relationMentions": [{"em1Text": "imiquimod", "em2Text": "IFNalpha", "label": "CPR:3"}, {"em1Text": "imiquimod", "em2Text": "IFNomega", "label": "CPR:3"}]}
{"sentText": "Resiquimod stimulated pDC also produce a number of other cytokines including TNFalpha and IP10", "relationMentions": [{"em1Text": "Resiquimod", "em2Text": "cytokines", "label": "CPR:3"}, {"em1Text": "Resiquimod", "em2Text": "TNFalpha", "label": "CPR:3"}, {"em1Text": "Resiquimod", "em2Text": "IP10", "label": "CPR:3"}]}
{"sentText": "Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists imiquimod and resiquimod", "relationMentions": [{"em1Text": "TLR7", "em2Text": "resiquimod", "label": "CPR:5"}, {"em1Text": "TLR7", "em2Text": "imiquimod", "label": "CPR:5"}]}
{"sentText": "Here we characterize the activation of human pDC with the TLR7 agonists imiquimod and resiquimod", "relationMentions": [{"em1Text": "TLR7", "em2Text": "imiquimod", "label": "CPR:5"}, {"em1Text": "TLR7", "em2Text": "resiquimod", "label": "CPR:5"}]}
{"sentText": "Induction of heat shock proteins HSPs by sodium arsenite in cultured astrocytes and reduction of hydrogen peroxideinduced cell death", "relationMentions": [{"em1Text": "heat shock proteins", "em2Text": "sodium arsenite", "label": "CPR:3"}, {"em1Text": "HSPs", "em2Text": "sodium arsenite", "label": "CPR:3"}]}
{"sentText": "Pretreatment with arsenite increased protein kinase B Akt and extracellular signal regulated kinase 12 ERK12 phosphorylation after H2O2", "relationMentions": [{"em1Text": "protein kinase B", "em2Text": "H2O2", "label": "CPR:3"}, {"em1Text": "Akt", "em2Text": "H2O2", "label": "CPR:3"}]}
{"sentText": "The results show that transient arsenite pretreatment induces Hsp72 HO1 and to a lesser extent Hsp27 it reduces H2O2 induced astrocyte death and it causes selective activation of Akt following H2O2", "relationMentions": [{"em1Text": "arsenite", "em2Text": "Hsp72", "label": "CPR:3"}, {"em1Text": "arsenite", "em2Text": "HO1", "label": "CPR:3"}, {"em1Text": "arsenite", "em2Text": "Hsp27", "label": "CPR:3"}, {"em1Text": "arsenite", "em2Text": "Akt", "label": "CPR:3"}, {"em1Text": "H2O2", "em2Text": "Akt", "label": "CPR:3"}]}
{"sentText": "The results show that transient arsenite pretreatment induces Hsp72 HO1 and to a lesser extent Hsp27 it reduces H2O2 induced astrocyte death and it causes selective activation of Akt following H2O2", "relationMentions": [{"em1Text": "arsenite", "em2Text": "Hsp72", "label": "CPR:3"}, {"em1Text": "arsenite", "em2Text": "HO1", "label": "CPR:3"}, {"em1Text": "arsenite", "em2Text": "Hsp27", "label": "CPR:3"}, {"em1Text": "arsenite", "em2Text": "Akt", "label": "CPR:3"}, {"em1Text": "H2O2", "em2Text": "Akt", "label": "CPR:3"}]}
{"sentText": "Arsenite triggered strong induction of HSPs which was prevented by 1 micro gmL cycloheximide CXH", "relationMentions": [{"em1Text": "Arsenite", "em2Text": "HSPs", "label": "CPR:3"}, {"em1Text": "HSPs", "em2Text": "cycloheximide", "label": "CPR:4"}, {"em1Text": "HSPs", "em2Text": "CXH", "label": "CPR:4"}]}
{"sentText": "GW660511X and omapatrilat increased the production of both BrBK18 and BrPhe5 but not that of BrBK48 and BrBK28", "relationMentions": [{"em1Text": "GW660511X", "em2Text": "BrBK18", "label": "CPR:3"}, {"em1Text": "GW660511X", "em2Text": "BrPhe5", "label": "CPR:3"}, {"em1Text": "omapatrilat", "em2Text": "BrBK18", "label": "CPR:3"}, {"em1Text": "omapatrilat", "em2Text": "BrPhe5", "label": "CPR:3"}]}
{"sentText": "GW660511X and omapatrilat increased the production of both BrBK18 and BrPhe5 but not that of BrBK48 and BrBK28", "relationMentions": [{"em1Text": "GW660511X", "em2Text": "BrBK18", "label": "CPR:3"}, {"em1Text": "GW660511X", "em2Text": "BrPhe5", "label": "CPR:3"}, {"em1Text": "omapatrilat", "em2Text": "BrBK18", "label": "CPR:3"}, {"em1Text": "omapatrilat", "em2Text": "BrPhe5", "label": "CPR:3"}]}
{"sentText": "GW660511X and omapatrilat reduced the production of BrBK15 and BrBK17 with more effect being observed with omapatrilat", "relationMentions": [{"em1Text": "GW660511X", "em2Text": "BrBK15", "label": "CPR:4"}, {"em1Text": "GW660511X", "em2Text": "BrBK17", "label": "CPR:4"}, {"em1Text": "omapatrilat", "em2Text": "BrBK15", "label": "CPR:4"}, {"em1Text": "omapatrilat", "em2Text": "BrBK17", "label": "CPR:4"}]}
{"sentText": "GW660511X and omapatrilat reduced the production of BrBK15 and BrBK17 with more effect being observed with omapatrilat", "relationMentions": [{"em1Text": "GW660511X", "em2Text": "BrBK15", "label": "CPR:4"}, {"em1Text": "GW660511X", "em2Text": "BrBK17", "label": "CPR:4"}, {"em1Text": "omapatrilat", "em2Text": "BrBK15", "label": "CPR:4"}, {"em1Text": "omapatrilat", "em2Text": "BrBK17", "label": "CPR:4"}]}
{"sentText": "This study shows that the potency of GW660511X in comparison with omapatrilat is more than 100fold lower in human but less than 10fold lower in rat plasma suggesting that rat may not be a suitable in vivo model for the evaluation of ACE NEP inhibition in relation to effects in humans", "relationMentions": [{"em1Text": "GW660511X", "em2Text": "ACE", "label": "CPR:4"}, {"em1Text": "GW660511X", "em2Text": "NEP", "label": "CPR:4"}, {"em1Text": "omapatrilat", "em2Text": "NEP", "label": "CPR:4"}]}
{"sentText": "This study shows that the potency of GW660511X in comparison with omapatrilat is more than 100fold lower in human but less than 10fold lower in rat plasma suggesting that rat may not be a suitable in vivo model for the evaluation of ACE NEP inhibition in relation to effects in humans", "relationMentions": [{"em1Text": "GW660511X", "em2Text": "ACE", "label": "CPR:4"}, {"em1Text": "GW660511X", "em2Text": "NEP", "label": "CPR:4"}, {"em1Text": "omapatrilat", "em2Text": "NEP", "label": "CPR:4"}]}
{"sentText": "In this work a novel approach combining HPLCUV online with oaTOFMS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled BK 7981 BrPhe5 BrBK in the presence of two new dual ACE NEP inhibitors GW660511X and omapatrilat currently under clinical trial", "relationMentions": [{"em1Text": "ACE", "em2Text": "GW660511X", "label": "CPR:4"}, {"em1Text": "NEP", "em2Text": "GW660511X", "label": "CPR:4"}, {"em1Text": "ACE", "em2Text": "omapatrilat", "label": "CPR:4"}, {"em1Text": "NEP", "em2Text": "omapatrilat", "label": "CPR:4"}]}
{"sentText": "In this work a novel approach combining HPLCUV online with oaTOFMS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled BK 7981 BrPhe5 BrBK in the presence of two new dual ACE NEP inhibitors GW660511X and omapatrilat currently under clinical trial", "relationMentions": [{"em1Text": "ACE", "em2Text": "GW660511X", "label": "CPR:4"}, {"em1Text": "NEP", "em2Text": "GW660511X", "label": "CPR:4"}, {"em1Text": "ACE", "em2Text": "omapatrilat", "label": "CPR:4"}, {"em1Text": "NEP", "em2Text": "omapatrilat", "label": "CPR:4"}]}
{"sentText": "Unlike GW660511X omapatrilat abolished the production of BrBK15 and BrBK17 suggesting a better ACE inhibition effect over GW660511X as no NEP activity was found", "relationMentions": [{"em1Text": "omapatrilat", "em2Text": "BrBK15", "label": "CPR:4"}, {"em1Text": "omapatrilat", "em2Text": "BrBK17", "label": "CPR:4"}, {"em1Text": "omapatrilat", "em2Text": "ACE", "label": "CPR:4"}, {"em1Text": "GW660511X", "em2Text": "ACE", "label": "CPR:4"}]}
{"sentText": "Unlike GW660511X omapatrilat abolished the production of BrBK15 and BrBK17 suggesting a better ACE inhibition effect over GW660511X as no NEP activity was found", "relationMentions": [{"em1Text": "omapatrilat", "em2Text": "BrBK15", "label": "CPR:4"}, {"em1Text": "omapatrilat", "em2Text": "BrBK17", "label": "CPR:4"}, {"em1Text": "omapatrilat", "em2Text": "ACE", "label": "CPR:4"}, {"em1Text": "GW660511X", "em2Text": "ACE", "label": "CPR:4"}]}
{"sentText": "Investigation of bradykinin metabolism in human and rat plasma in the presence of the dual ACE NEP inhibitors GW660511X and omapatrilat", "relationMentions": [{"em1Text": "ACE", "em2Text": "GW660511X", "label": "CPR:4"}, {"em1Text": "NEP", "em2Text": "GW660511X", "label": "CPR:4"}, {"em1Text": "ACE", "em2Text": "omapatrilat", "label": "CPR:4"}, {"em1Text": "NEP", "em2Text": "omapatrilat", "label": "CPR:4"}]}
{"sentText": "Investigation of bradykinin metabolism in human and rat plasma in the presence of the dual ACE NEP inhibitors GW660511X and omapatrilat", "relationMentions": [{"em1Text": "ACE", "em2Text": "GW660511X", "label": "CPR:4"}, {"em1Text": "NEP", "em2Text": "GW660511X", "label": "CPR:4"}, {"em1Text": "ACE", "em2Text": "omapatrilat", "label": "CPR:4"}, {"em1Text": "NEP", "em2Text": "omapatrilat", "label": "CPR:4"}]}
{"sentText": "Experimental evidence from the use of agents with enhanced selectivity for BuChE cymserine analogues MF8622 and the dual inhibitor of both AChE and BuChE rivastigmine indicates potential therapeutic benefits of inhibiting both AChE and BuChE in AD and related dementias", "relationMentions": [{"em1Text": "AChE", "em2Text": "rivastigmine", "label": "CPR:4"}, {"em1Text": "BuChE", "em2Text": "rivastigmine", "label": "CPR:4"}]}
{"sentText": "Acetylcholinesterase AChE predominates in the healthy brain with butyrylcholinesterase BuChE considered to play a minor role in regulating brain acetylcholine ACh levels", "relationMentions": [{"em1Text": "AChE", "em2Text": "acetylcholine", "label": "CPR:9"}, {"em1Text": "butyrylcholinesterase", "em2Text": "acetylcholine", "label": "CPR:9"}, {"em1Text": "BuChE", "em2Text": "acetylcholine", "label": "CPR:9"}, {"em1Text": "Acetylcholinesterase", "em2Text": "acetylcholine", "label": "CPR:9"}, {"em1Text": "ACh", "em2Text": "AChE", "label": "CPR:9"}, {"em1Text": "ACh", "em2Text": "butyrylcholinesterase", "label": "CPR:9"}, {"em1Text": "ACh", "em2Text": "BuChE", "label": "CPR:9"}, {"em1Text": "Acetylcholinesterase", "em2Text": "ACh", "label": "CPR:9"}]}
{"sentText": "Acetylcholinesterase AChE predominates in the healthy brain with butyrylcholinesterase BuChE considered to play a minor role in regulating brain acetylcholine ACh levels", "relationMentions": [{"em1Text": "AChE", "em2Text": "acetylcholine", "label": "CPR:9"}, {"em1Text": "butyrylcholinesterase", "em2Text": "acetylcholine", "label": "CPR:9"}, {"em1Text": "BuChE", "em2Text": "acetylcholine", "label": "CPR:9"}, {"em1Text": "Acetylcholinesterase", "em2Text": "acetylcholine", "label": "CPR:9"}, {"em1Text": "ACh", "em2Text": "AChE", "label": "CPR:9"}, {"em1Text": "ACh", "em2Text": "butyrylcholinesterase", "label": "CPR:9"}, {"em1Text": "ACh", "em2Text": "BuChE", "label": "CPR:9"}, {"em1Text": "Acetylcholinesterase", "em2Text": "ACh", "label": "CPR:9"}]}
{"sentText": "Agents which have recently been shown to block cyclin D1 translation by regulating calcium levels are the unsaturated essential fatty acid eicosapentaenoic acid EPA the antidiabetic thiazolidinediones and the antifungal agent clotrimazole", "relationMentions": [{"em1Text": "cyclin D1", "em2Text": "unsaturated essential fatty acid", "label": "CPR:4"}, {"em1Text": "cyclin D1", "em2Text": "eicosapentaenoic acid", "label": "CPR:4"}, {"em1Text": "cyclin D1", "em2Text": "EPA", "label": "CPR:4"}, {"em1Text": "cyclin D1", "em2Text": "thiazolidinediones", "label": "CPR:4"}, {"em1Text": "cyclin D1", "em2Text": "clotrimazole", "label": "CPR:4"}]}
{"sentText": "Inhibition corresponded to increased cAMP production caused by rolipram alone or rolipram plus salmeterol and blocked proportionately the phosphorylation and activation of gIVPLA2 in FMLPBactivated eosinophils", "relationMentions": [{"em1Text": "rolipram", "em2Text": "gIVPLA2", "label": "CPR:4"}, {"em1Text": "salmeterol", "em2Text": "gIVPLA2", "label": "CPR:4"}]}
{"sentText": "These effects were not mimicked by oral administration of the beta 2adrenoceptor agonist salbutamol even at high dose 52 mgkg diet and the effects of clenbuterol were not inhibited by addition of DLpropranolol 200 mgkg diet", "relationMentions": [{"em1Text": "beta 2adrenoceptor", "em2Text": "salbutamol", "label": "CPR:5"}, {"em1Text": "beta 2adrenoceptor", "em2Text": "clenbuterol", "label": "CPR:5"}]}
{"sentText": "In the hotplate test in mice the antinociceptive action of the alpha 2adrenoceptor agonist UK 14304 was abolished by the alpha 2adrenoceptor antagonist idazoxan the potent alpha 2Aadrenoceptor antagonist RX 821002 and the preferential alpha 2Aadrenoceptor antagonist BRL 44408", "relationMentions": [{"em1Text": "alpha 2adrenoceptor", "em2Text": "UK 14304", "label": "CPR:5"}, {"em1Text": "alpha 2adrenoceptor", "em2Text": "idazoxan", "label": "CPR:6"}, {"em1Text": "alpha 2Aadrenoceptor", "em2Text": "RX 821002", "label": "CPR:6"}, {"em1Text": "alpha 2Aadrenoceptor", "em2Text": "BRL 44408", "label": "CPR:6"}]}
{"sentText": "The preferential alpha 2Aadrenoceptor partial agonist guanfacine partially inhibited UK 14304 induced antinociception", "relationMentions": [{"em1Text": "alpha 2Aadrenoceptor", "em2Text": "guanfacine", "label": "CPR:5"}, {"em1Text": "alpha 2Aadrenoceptor", "em2Text": "UK 14304", "label": "CPR:5"}]}
{"sentText": "SDH Lserine dehydratase EC 43117 catalyzes the pyridoxal 5phosphate PLPdependent dehydration of Lserine to yield pyruvate and ammonia", "relationMentions": [{"em1Text": "SDH", "em2Text": "Lserine", "label": "CPR:9"}, {"em1Text": "Lserine", "em2Text": "EC 43117", "label": "CPR:9"}, {"em1Text": "Lserine", "em2Text": "Lserine dehydratase", "label": "CPR:9"}, {"em1Text": "SDH", "em2Text": "pyruvate", "label": "CPR:9"}, {"em1Text": "EC 43117", "em2Text": "pyruvate", "label": "CPR:9"}, {"em1Text": "Lserine dehydratase", "em2Text": "pyruvate", "label": "CPR:9"}, {"em1Text": "SDH", "em2Text": "ammonia", "label": "CPR:9"}, {"em1Text": "EC 43117", "em2Text": "ammonia", "label": "CPR:9"}, {"em1Text": "Lserine dehydratase", "em2Text": "ammonia", "label": "CPR:9"}]}
{"sentText": "SDH Lserine dehydratase EC 43117 catalyzes the pyridoxal 5phosphate PLPdependent dehydration of Lserine to yield pyruvate and ammonia", "relationMentions": [{"em1Text": "SDH", "em2Text": "Lserine", "label": "CPR:9"}, {"em1Text": "Lserine", "em2Text": "EC 43117", "label": "CPR:9"}, {"em1Text": "Lserine", "em2Text": "Lserine dehydratase", "label": "CPR:9"}, {"em1Text": "SDH", "em2Text": "pyruvate", "label": "CPR:9"}, {"em1Text": "EC 43117", "em2Text": "pyruvate", "label": "CPR:9"}, {"em1Text": "Lserine dehydratase", "em2Text": "pyruvate", "label": "CPR:9"}, {"em1Text": "SDH", "em2Text": "ammonia", "label": "CPR:9"}, {"em1Text": "EC 43117", "em2Text": "ammonia", "label": "CPR:9"}, {"em1Text": "Lserine dehydratase", "em2Text": "ammonia", "label": "CPR:9"}]}
{"sentText": "Blocking EGFR signaling with the EGFR HER2 kinase inhibitor KI GW572016 decreased the postradiation survival of irradiated Ras transformed cells and normal cells but had no effect on the survival of unirradiated cells", "relationMentions": [{"em1Text": "GW572016", "em2Text": "Ras", "label": "CPR:4"}, {"em1Text": "EGFR", "em2Text": "GW572016", "label": "CPR:4"}, {"em1Text": "HER2", "em2Text": "GW572016", "label": "CPR:4"}]}
{"sentText": "RasCM and TGFalpha also increase PI3K activity downstream of the EGFR and increase postradiation survival both of which are abrogated by GW572016", "relationMentions": [{"em1Text": "PI3K", "em2Text": "GW572016", "label": "CPR:4"}, {"em1Text": "EGFR", "em2Text": "GW572016", "label": "CPR:4"}]}
{"sentText": "Thus Ras utilizes autocrine signaling through EGFR to increase radioresistance and the EGFR KI GW572016 acts as a radiosensitizer", "relationMentions": [{"em1Text": "Ras", "em2Text": "GW572016", "label": "CPR:4"}, {"em1Text": "EGFR", "em2Text": "GW572016", "label": "CPR:4"}]}
{"sentText": "Isoprenaline and a nonconventional beta3adrenoceptor agonist 4311dimethylethylamino2hydroxypropoxy13dihydro2Hbenzimida zol2one hydrochloride CGP12177A induced concentrationdependent relaxation of phenylephrine 03 microM preconstricted spiral preparations", "relationMentions": [{"em1Text": "beta3adrenoceptor", "em2Text": "4311dimethylethylamino2hydroxypropoxy13dihydro2Hbenzimida zol2one hydrochloride", "label": "CPR:5"}, {"em1Text": "beta3adrenoceptor", "em2Text": "CGP12177A", "label": "CPR:5"}]}
{"sentText": "The aim of this study was therefore to provide comparative binding characteristics of agonists epinephrine norepinephrine isoproterenol fenoterol salbutamol salmeterol terbutalin formoterol broxaterol and antagonists propranolol alprenolol atenolol metoprolol bisoprolol carvedilol pindolol BRL 37344 CGP 20712 SR 59230A CGP 12177 ICI 118551 at all three subtypes of human betaadrenergic receptors in an identical cellular background", "relationMentions": [{"em1Text": "formoterol", "em2Text": "human betaadrenergic receptors", "label": "CPR:5"}, {"em1Text": "broxaterol", "em2Text": "human betaadrenergic receptors", "label": "CPR:5"}, {"em1Text": "epinephrine", "em2Text": "human betaadrenergic receptors", "label": "CPR:5"}, {"em1Text": "norepinephrine", "em2Text": "human betaadrenergic receptors", "label": "CPR:5"}, {"em1Text": "isoproterenol", "em2Text": "human betaadrenergic receptors", "label": "CPR:5"}, {"em1Text": "fenoterol", "em2Text": "human betaadrenergic receptors", "label": "CPR:5"}, {"em1Text": "salbutamol", "em2Text": "human betaadrenergic receptors", "label": "CPR:5"}, {"em1Text": "salmeterol", "em2Text": "human betaadrenergic receptors", "label": "CPR:5"}, {"em1Text": "terbutalin", "em2Text": "human betaadrenergic receptors", "label": "CPR:5"}, {"em1Text": "propranolol", "em2Text": "human betaadrenergic receptors", "label": "CPR:6"}, {"em1Text": "alprenolol", "em2Text": "human betaadrenergic receptors", "label": "CPR:6"}, {"em1Text": "atenolol", "em2Text": "human betaadrenergic receptors", "label": "CPR:6"}, {"em1Text": "metoprolol", "em2Text": "human betaadrenergic receptors", "label": "CPR:6"}, {"em1Text": "bisoprolol", "em2Text": "human betaadrenergic receptors", "label": "CPR:6"}, {"em1Text": "carvedilol", "em2Text": "human betaadrenergic receptors", "label": "CPR:6"}, {"em1Text": "pindolol", "em2Text": "human betaadrenergic receptors", "label": "CPR:6"}, {"em1Text": "BRL 37344", "em2Text": "human betaadrenergic receptors", "label": "CPR:6"}, {"em1Text": "CGP 20712", "em2Text": "human betaadrenergic receptors", "label": "CPR:6"}, {"em1Text": "SR 59230A", "em2Text": "human betaadrenergic receptors", "label": "CPR:6"}, {"em1Text": "CGP 12177", "em2Text": "human betaadrenergic receptors", "label": "CPR:6"}, {"em1Text": "ICI 118551", "em2Text": "human betaadrenergic receptors", "label": "CPR:6"}]}
{"sentText": "Effects of the EGFR HER2 kinase inhibitor GW572016 on EGFR and HER2 overexpressing breast cancer cell line proliferation radiosensitization and resistance", "relationMentions": [{"em1Text": "EGFR", "em2Text": "GW572016", "label": "CPR:4"}, {"em1Text": "HER2", "em2Text": "GW572016", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "GW572016", "label": "CPR:4"}]}
{"sentText": "CONCLUSION GW572016 potently inhibits receptor phosphorylation in either EGFR or HER2 overexpressing cell lines and has both antiproliferative and radiosensitizing effects", "relationMentions": [{"em1Text": "GW572016", "em2Text": "EGFR", "label": "CPR:4"}, {"em1Text": "GW572016", "em2Text": "HER2", "label": "CPR:4"}]}
{"sentText": "To gauge the potential clinical utility of targeting both EGFR and HER2 to control growth and radiosensitize human breast cancers we examined the effect of a dual EGFR HER2 inhibitor GW572016 on the proliferation and radiation response of either EGFR or HER2overexpressing human breast cancer cell lines", "relationMentions": [{"em1Text": "EGFR", "em2Text": "GW572016", "label": "CPR:4"}, {"em1Text": "HER2", "em2Text": "GW572016", "label": "CPR:4"}]}
{"sentText": "RESULTS GW572016 inhibited constitutive andor ligandinduced EGFR or HER2 tyrosine phosphorylation of all five cell lines which correlated with the antiproliferative response in all but one cell line", "relationMentions": [{"em1Text": "GW572016", "em2Text": "EGFR", "label": "CPR:4"}, {"em1Text": "GW572016", "em2Text": "HER2", "label": "CPR:4"}]}
{"sentText": "Incubation with metformin 021 mM activated AMPK in both human islets and MIN6 betacells in parallel with an inhibition of insulin secretion whereas leptin 10100 nM was without effect in MIN6 cells", "relationMentions": [{"em1Text": "metformin", "em2Text": "AMPK", "label": "CPR:3"}, {"em1Text": "metformin", "em2Text": "insulin", "label": "CPR:4"}]}
{"sentText": "Metformin a drug widely used in the treatment of type 2 diabetes has recently been shown to act on skeletal muscle and liver in part through the activation of AMPactivated protein kinase AMPK", "relationMentions": [{"em1Text": "Metformin", "em2Text": "AMPactivated protein kinase", "label": "CPR:3"}, {"em1Text": "Metformin", "em2Text": "AMPK", "label": "CPR:3"}]}
{"sentText": "RA is known to induce expression of the Burkitts lymphoma receptor 1 BLR1 gene which propels RA induced cell cycle arrest and differentiation of HL60 human myeloblastic leukemia cells motivating the present analysis of transcriptional regulation of blr1 expression by RA", "relationMentions": [{"em1Text": "RA", "em2Text": "blr1", "label": "CPR:3"}, {"em1Text": "RA", "em2Text": "Burkitts lymphoma receptor 1", "label": "CPR:3"}, {"em1Text": "RA", "em2Text": "BLR1", "label": "CPR:3"}]}
{"sentText": "Irbesartan may have antiatherosclerotic properties beyond those expected from blood pressure lowering per se this AT1 blocker decreases the vascular oxidative stress and prevents the procoagulant as well as the proinflammatory effects of angiotensin II", "relationMentions": [{"em1Text": "Irbesartan", "em2Text": "AT1", "label": "CPR:4"}, {"em1Text": "Irbesartan", "em2Text": "angiotensin II", "label": "CPR:4"}]}
{"sentText": "To verify the hypothesis that the nonconventional partial agonist CGP12177 binds at two beta1adrenoceptor sites human beta1adrenoceptors expressed in CHO cells were labelled with 3HCGP12177", "relationMentions": [{"em1Text": "CGP12177", "em2Text": "human beta1adrenoceptors", "label": "CPR:5"}, {"em1Text": "CGP12177", "em2Text": "beta1adrenoceptor", "label": "CPR:5"}]}
{"sentText": "Imiquimod IMQ an activator of Tolllike receptor7 TLR7 induces by several routes a profound antiviral and antitumor effect in vivo", "relationMentions": [{"em1Text": "Imiquimod", "em2Text": "Tolllike receptor7", "label": "CPR:3"}, {"em1Text": "Imiquimod", "em2Text": "TLR7", "label": "CPR:3"}, {"em1Text": "IMQ", "em2Text": "Tolllike receptor7", "label": "CPR:3"}, {"em1Text": "IMQ", "em2Text": "TLR7", "label": "CPR:3"}]}
{"sentText": "Imiquimod IMQ an activator of Tolllike receptor7 TLR7 induces by several routes a profound antiviral and antitumor effect in vivo", "relationMentions": [{"em1Text": "Imiquimod", "em2Text": "Tolllike receptor7", "label": "CPR:3"}, {"em1Text": "Imiquimod", "em2Text": "TLR7", "label": "CPR:3"}, {"em1Text": "IMQ", "em2Text": "Tolllike receptor7", "label": "CPR:3"}, {"em1Text": "IMQ", "em2Text": "TLR7", "label": "CPR:3"}]}
{"sentText": "Imiquimod a Tolllike receptor7 agonist induces perforin in cytotoxic T lymphocytes in vitro", "relationMentions": [{"em1Text": "Imiquimod", "em2Text": "perforin", "label": "CPR:3"}, {"em1Text": "Imiquimod", "em2Text": "Tolllike receptor7", "label": "CPR:5"}]}
{"sentText": "Ang II level in plasma and mesenteric arteries in imidapril group was significantly lower than that in irbesartan group P005", "relationMentions": [{"em1Text": "Ang II", "em2Text": "irbesartan", "label": "CPR:3"}, {"em1Text": "Ang II", "em2Text": "imidapril", "label": "CPR:4"}]}
{"sentText": "The cJun absorbed light value GAPDH absorbed light value of mesenteric arteries in the SHR group was 08500015 which was significantly higher than that in the WKY imidapril and irbesartan groups 05820013 07430012 and 07890013 respectively P001 and was significantly lower in imidapril group than in irbesartan group P005", "relationMentions": [{"em1Text": "cJun", "em2Text": "imidapril", "label": "CPR:3"}, {"em1Text": "GAPDH", "em2Text": "imidapril", "label": "CPR:3"}, {"em1Text": "cJun", "em2Text": "irbesartan", "label": "CPR:3"}, {"em1Text": "GAPDH", "em2Text": "irbesartan", "label": "CPR:3"}]}
{"sentText": "The cJun absorbed light value GAPDH absorbed light value of mesenteric arteries in the SHR group was 08500015 which was significantly higher than that in the WKY imidapril and irbesartan groups 05820013 07430012 and 07890013 respectively P001 and was significantly lower in imidapril group than in irbesartan group P005", "relationMentions": [{"em1Text": "cJun", "em2Text": "imidapril", "label": "CPR:3"}, {"em1Text": "GAPDH", "em2Text": "imidapril", "label": "CPR:3"}, {"em1Text": "cJun", "em2Text": "irbesartan", "label": "CPR:3"}, {"em1Text": "GAPDH", "em2Text": "irbesartan", "label": "CPR:3"}]}
{"sentText": "Ang II level in plasma and mesenteric arteries in SHR group was the same or lower than that in WKY group and was higher in irbesartan group and lower in imidapril group", "relationMentions": [{"em1Text": "Ang II", "em2Text": "irbesartan", "label": "CPR:3"}, {"em1Text": "Ang II", "em2Text": "imidapril", "label": "CPR:4"}]}
{"sentText": "The ratio of TGFbeta1 absorbed light value to GAPDH absorbed light value in the SHR group was 08870019 which was significantly higher than that in WKY group imidapril group and irbesartan group with the ratios of 07800018 08030005 and 08470017 respectively P001", "relationMentions": [{"em1Text": "TGFbeta1", "em2Text": "imidapril", "label": "CPR:3"}, {"em1Text": "GAPDH", "em2Text": "imidapril", "label": "CPR:3"}, {"em1Text": "TGFbeta1", "em2Text": "irbesartan", "label": "CPR:3"}, {"em1Text": "GAPDH", "em2Text": "irbesartan", "label": "CPR:3"}]}
{"sentText": "The ratio of TGFbeta1 absorbed light value to GAPDH absorbed light value in the SHR group was 08870019 which was significantly higher than that in WKY group imidapril group and irbesartan group with the ratios of 07800018 08030005 and 08470017 respectively P001", "relationMentions": [{"em1Text": "TGFbeta1", "em2Text": "imidapril", "label": "CPR:3"}, {"em1Text": "GAPDH", "em2Text": "imidapril", "label": "CPR:3"}, {"em1Text": "TGFbeta1", "em2Text": "irbesartan", "label": "CPR:3"}, {"em1Text": "GAPDH", "em2Text": "irbesartan", "label": "CPR:3"}]}
{"sentText": "CONCLUSION Imidapril and irbesartan cannot only control blood pressure but also inhibit mesenteric arteries remodeling and mRNA expression of TGFbeta1 cJun in SHR", "relationMentions": [{"em1Text": "Imidapril", "em2Text": "TGFbeta1", "label": "CPR:4"}, {"em1Text": "Imidapril", "em2Text": "cJun", "label": "CPR:4"}, {"em1Text": "irbesartan", "em2Text": "TGFbeta1", "label": "CPR:4"}, {"em1Text": "irbesartan", "em2Text": "cJun", "label": "CPR:4"}]}
{"sentText": "CONCLUSION Imidapril and irbesartan cannot only control blood pressure but also inhibit mesenteric arteries remodeling and mRNA expression of TGFbeta1 cJun in SHR", "relationMentions": [{"em1Text": "Imidapril", "em2Text": "TGFbeta1", "label": "CPR:4"}, {"em1Text": "Imidapril", "em2Text": "cJun", "label": "CPR:4"}, {"em1Text": "irbesartan", "em2Text": "TGFbeta1", "label": "CPR:4"}, {"em1Text": "irbesartan", "em2Text": "cJun", "label": "CPR:4"}]}
{"sentText": "BACKGROUND To assess the sensitivity of biochemical physiological and pharmacological markers of peripheral norepinephrine NE transporter NET function we chronically antagonized NET by a range of doses of duloxetine Nmethyl31naphthalenyloxy2 thiophenepropanamine which blocks the NE reuptake process", "relationMentions": [{"em1Text": "NET", "em2Text": "duloxetine", "label": "CPR:6"}, {"em1Text": "NET", "em2Text": "Nmethyl31naphthalenyloxy2 thiophenepropanamine", "label": "CPR:6"}, {"em1Text": "NE", "em2Text": "NET", "label": "CPR:9"}]}
{"sentText": "Auranofin an antirheumatic gold compound is an inhibitor of selenocysteine enzymes such as thioredoxin reductase and glutathione peroxidase", "relationMentions": [{"em1Text": "Auranofin", "em2Text": "glutathione peroxidase", "label": "CPR:4"}, {"em1Text": "Auranofin", "em2Text": "selenocysteine enzymes", "label": "CPR:4"}, {"em1Text": "Auranofin", "em2Text": "thioredoxin reductase", "label": "CPR:4"}]}
{"sentText": "However some experimental findings raise the question whether these effects resulting from the iron mimicking properties of gallium are solely responsible for its antineoplastic activity or whether additional mechanisms are involved such as antimitotic effects which result from its capability of inhibiting tubulin polymerization", "relationMentions": [{"em1Text": "iron", "em2Text": "tubulin", "label": "CPR:4"}, {"em1Text": "gallium", "em2Text": "tubulin", "label": "CPR:4"}]}
{"sentText": "Histamine H1receptor H1R antagonists or antihistamines often induce sedative side effects when used for the treatment of allergic disorders", "relationMentions": [{"em1Text": "Histamine H1receptor", "em2Text": "antihistamines", "label": "CPR:6"}, {"em1Text": "H1R", "em2Text": "antihistamines", "label": "CPR:6"}]}
{"sentText": "While fluoropyrimidine antimetabolites have other sites of action antifolates ZD1694 raltitrexed Tomudex and AG337 Thymitag are more specific and potent TS inhibitors", "relationMentions": [{"em1Text": "ZD1694", "em2Text": "TS", "label": "CPR:4"}, {"em1Text": "raltitrexed", "em2Text": "TS", "label": "CPR:4"}, {"em1Text": "Tomudex", "em2Text": "TS", "label": "CPR:4"}, {"em1Text": "AG337", "em2Text": "TS", "label": "CPR:4"}, {"em1Text": "Thymitag", "em2Text": "TS", "label": "CPR:4"}]}
{"sentText": "Thymidylate synthase TS continues to be a critical target for 5fluorouracil 5FU and its prodrugs UFTLV Orzel capecitabine Xeloda and S1 primarily because this enzyme is essential for the synthesis of 2deoxythymidine5monophosphate a precursor for DNA synthesis", "relationMentions": [{"em1Text": "Thymidylate synthase", "em2Text": "2deoxythymidine5monophosphate", "label": "CPR:9"}, {"em1Text": "TS", "em2Text": "2deoxythymidine5monophosphate", "label": "CPR:9"}]}
{"sentText": "Troglitazone bosentan and glibenclamide inhibit the bile salt export pump Bsep which transports taurocholate into bile", "relationMentions": [{"em1Text": "Troglitazone", "em2Text": "bile salt export pump", "label": "CPR:4"}, {"em1Text": "Troglitazone", "em2Text": "Bsep", "label": "CPR:4"}, {"em1Text": "bosentan", "em2Text": "bile salt export pump", "label": "CPR:4"}, {"em1Text": "bosentan", "em2Text": "Bsep", "label": "CPR:4"}, {"em1Text": "glibenclamide", "em2Text": "bile salt export pump", "label": "CPR:4"}, {"em1Text": "glibenclamide", "em2Text": "Bsep", "label": "CPR:4"}, {"em1Text": "bile salt export pump", "em2Text": "taurocholate", "label": "CPR:9"}, {"em1Text": "Bsep", "em2Text": "taurocholate", "label": "CPR:9"}]}
{"sentText": "Troglitazone bosentan and glibenclamide inhibit the bile salt export pump Bsep which transports taurocholate into bile", "relationMentions": [{"em1Text": "Troglitazone", "em2Text": "bile salt export pump", "label": "CPR:4"}, {"em1Text": "Troglitazone", "em2Text": "Bsep", "label": "CPR:4"}, {"em1Text": "bosentan", "em2Text": "bile salt export pump", "label": "CPR:4"}, {"em1Text": "bosentan", "em2Text": "Bsep", "label": "CPR:4"}, {"em1Text": "glibenclamide", "em2Text": "bile salt export pump", "label": "CPR:4"}, {"em1Text": "glibenclamide", "em2Text": "Bsep", "label": "CPR:4"}, {"em1Text": "bile salt export pump", "em2Text": "taurocholate", "label": "CPR:9"}, {"em1Text": "Bsep", "em2Text": "taurocholate", "label": "CPR:9"}]}
{"sentText": "Valdecoxib potently inhibits recombinant COX2 with an IC50 of 0005 microM this compares with IC values of 005 microM for celecoxib 05 microM for rofecoxib and 5 microM for etoricoxib", "relationMentions": [{"em1Text": "Valdecoxib", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "celecoxib", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "rofecoxib", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "etoricoxib", "label": "CPR:4"}]}
{"sentText": "Valdecoxib showed similar activity in the human wholeblood COX assay COX2 IC50 = 024 microM COX1 IC50 = 219 microM", "relationMentions": [{"em1Text": "Valdecoxib", "em2Text": "human wholeblood COX", "label": "CPR:4"}, {"em1Text": "Valdecoxib", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "Valdecoxib", "em2Text": "COX1", "label": "CPR:4"}]}
{"sentText": "An angiotensin II AT1 receptor antagonist telmisartan augments glucose uptake and GLUT4 protein expression in 3T3L1 adipocytes", "relationMentions": [{"em1Text": "telmisartan", "em2Text": "GLUT4", "label": "CPR:3"}, {"em1Text": "angiotensin II AT1 receptor", "em2Text": "telmisartan", "label": "CPR:6"}, {"em1Text": "glucose", "em2Text": "GLUT4", "label": "CPR:9"}]}
{"sentText": "Treatment of both differentiating adipocytes and fully differentiated adipocytes with telmisartan caused a dosedependent increase in mRNA levels for PPARgamma target genes such as aP2 and adiponectin", "relationMentions": [{"em1Text": "telmisartan", "em2Text": "PPARgamma", "label": "CPR:3"}, {"em1Text": "telmisartan", "em2Text": "aP2", "label": "CPR:3"}, {"em1Text": "telmisartan", "em2Text": "adiponectin", "label": "CPR:3"}]}
{"sentText": "Especially the compound 1 showed strong inhibition IC50=133 microM against the enzyme tyrosinase as compared to the standard tyrosinase inhibitors kojic acid IC50=1667 microM and Lmimosine IC50=368 microM indicating its potential used for the treatment of hyperpigmentation associated with the high production of melanocytes", "relationMentions": [{"em1Text": "tyrosinase", "em2Text": "kojic acid", "label": "CPR:4"}, {"em1Text": "tyrosinase", "em2Text": "Lmimosine", "label": "CPR:4"}]}
{"sentText": "In conclusion TT235 may inhibit the uterine response to oxytocin by decreasing oxytocin receptor numbers and oxytocin binding affinity which might explain the prolonged oxytocin antagonist activity of TT235", "relationMentions": [{"em1Text": "TT235", "em2Text": "oxytocin", "label": "CPR:4"}, {"em1Text": "TT235", "em2Text": "oxytocin receptor", "label": "CPR:4"}, {"em1Text": "TT235", "em2Text": "oxytocin", "label": "CPR:6"}]}
{"sentText": "In conclusion TT235 may inhibit the uterine response to oxytocin by decreasing oxytocin receptor numbers and oxytocin binding affinity which might explain the prolonged oxytocin antagonist activity of TT235", "relationMentions": [{"em1Text": "TT235", "em2Text": "oxytocin", "label": "CPR:4"}, {"em1Text": "TT235", "em2Text": "oxytocin receptor", "label": "CPR:4"}, {"em1Text": "TT235", "em2Text": "oxytocin", "label": "CPR:6"}]}
{"sentText": "In Experiment 1 Antag I Antag II and TT235 inhibited the integrated uterine response to oxytocin at 5 minutes by 76 77 and 80 respectively compared to controls p005", "relationMentions": [{"em1Text": "Antag I", "em2Text": "oxytocin", "label": "CPR:4"}, {"em1Text": "Antag II", "em2Text": "oxytocin", "label": "CPR:4"}, {"em1Text": "TT235", "em2Text": "oxytocin", "label": "CPR:4"}]}
{"sentText": "This manuscript presents the preclinical profile of lumiracoxib a novel cyclooxygenase2 COX2 selective inhibitor", "relationMentions": [{"em1Text": "lumiracoxib", "em2Text": "cyclooxygenase2", "label": "CPR:4"}, {"em1Text": "lumiracoxib", "em2Text": "COX2", "label": "CPR:4"}]}
{"sentText": "Ex vivo lumiracoxib inhibited COX1 derived thromboxane B2 TxB2 generation with an ID50 of 33 mg kg1 whereas COX2 derived production of prostaglandin E2 PGE2 in the lipopolysaccharidestimulated rat air pouch was inhibited with an ID50 value of 024 mg kg1", "relationMentions": [{"em1Text": "lumiracoxib", "em2Text": "COX1", "label": "CPR:4"}, {"em1Text": "COX1", "em2Text": "thromboxane B2", "label": "CPR:9"}, {"em1Text": "COX1", "em2Text": "TxB2", "label": "CPR:9"}, {"em1Text": "COX2", "em2Text": "prostaglandin E2", "label": "CPR:9"}, {"em1Text": "COX2", "em2Text": "PGE2", "label": "CPR:9"}]}
{"sentText": "However consistent with its low COX1 inhibitory activity lumiracoxib at a dose of 100 mg kg1 orally caused no ulcers and was significantly less ulcerogenic than diclofenac P005", "relationMentions": [{"em1Text": "COX1", "em2Text": "lumiracoxib", "label": "CPR:4"}, {"em1Text": "COX1", "em2Text": "diclofenac", "label": "CPR:4"}]}
{"sentText": "Lumiracoxib inhibited purified COX1 and COX2 with Ki values of 3 and 006 microM respectively", "relationMentions": [{"em1Text": "Lumiracoxib", "em2Text": "COX1", "label": "CPR:4"}, {"em1Text": "Lumiracoxib", "em2Text": "COX2", "label": "CPR:4"}]}
{"sentText": "In a human whole blood assay IC50 values for lumiracoxib were 013 microM for COX2 and 67 microM for COX1 COX1 COX2 selectivity ratio 515", "relationMentions": [{"em1Text": "lumiracoxib", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "lumiracoxib", "em2Text": "COX1", "label": "CPR:4"}]}
{"sentText": "As thiamine metabolism deficiencies have been seen in placental infarcts previously these indicate that PP20 hTPK may have a role in placental diseases", "relationMentions": [{"em1Text": "thiamine", "em2Text": "PP20", "label": "CPR:9"}, {"em1Text": "thiamine", "em2Text": "hTPK", "label": "CPR:9"}]}
{"sentText": "Denufosol tetrasodium INS37217 is a selective P2Y2 agonist that stimulates ciliary beat frequency and Cl secretion in normal and cystic fibrosis CF airway epithelia and is being investigated as an inhaled treatment for CF", "relationMentions": [{"em1Text": "Denufosol tetrasodium", "em2Text": "P2Y2", "label": "CPR:5"}, {"em1Text": "INS37217", "em2Text": "P2Y2", "label": "CPR:5"}]}
{"sentText": "Dimemorfan pretreatment also attenuated the KA induced increases in cfos cjun expression activator protein AP1 DNAbinding activity and loss of cells in the CA1 and CA3 fields of the hippocampus", "relationMentions": [{"em1Text": "KA", "em2Text": "cfos", "label": "CPR:3"}, {"em1Text": "KA", "em2Text": "cjun", "label": "CPR:3"}, {"em1Text": "KA", "em2Text": "activator protein AP1", "label": "CPR:3"}, {"em1Text": "Dimemorfan", "em2Text": "cfos", "label": "CPR:4"}, {"em1Text": "Dimemorfan", "em2Text": "cjun", "label": "CPR:4"}, {"em1Text": "Dimemorfan", "em2Text": "activator protein AP1", "label": "CPR:4"}]}
{"sentText": "Dimemorfan pretreatment also attenuated the KA induced increases in cfos cjun expression activator protein AP1 DNAbinding activity and loss of cells in the CA1 and CA3 fields of the hippocampus", "relationMentions": [{"em1Text": "KA", "em2Text": "cfos", "label": "CPR:3"}, {"em1Text": "KA", "em2Text": "cjun", "label": "CPR:3"}, {"em1Text": "KA", "em2Text": "activator protein AP1", "label": "CPR:3"}, {"em1Text": "Dimemorfan", "em2Text": "cfos", "label": "CPR:4"}, {"em1Text": "Dimemorfan", "em2Text": "cjun", "label": "CPR:4"}, {"em1Text": "Dimemorfan", "em2Text": "activator protein AP1", "label": "CPR:4"}]}
{"sentText": "The dextromethorphan analog dimemorfan attenuates kainateinduced seizures via sigma1 receptor activation comparison with the effects of dextromethorphan", "relationMentions": [{"em1Text": "dimemorfan", "em2Text": "sigma1 receptor", "label": "CPR:3"}, {"em1Text": "dextromethorphan", "em2Text": "sigma1 receptor", "label": "CPR:3"}]}
{"sentText": "We have analyzed binding domains of the oxytocin receptor for barusiban a highly selective oxytocin receptor antagonist in comparison to the combined vasopressin V1Aoxytocin receptor antagonist atosiban and the agonists oxytocin and carbetocin", "relationMentions": [{"em1Text": "oxytocin", "em2Text": "vasopressin V1Aoxytocin receptor", "label": "CPR:5"}, {"em1Text": "vasopressin V1Aoxytocin receptor", "em2Text": "carbetocin", "label": "CPR:5"}, {"em1Text": "vasopressin V1Aoxytocin receptor", "em2Text": "atosiban", "label": "CPR:6"}, {"em1Text": "oxytocin receptor", "em2Text": "barusiban", "label": "CPR:6"}]}
{"sentText": "Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin", "relationMentions": [{"em1Text": "oxytocin", "em2Text": "oxytocin receptor", "label": "CPR:5"}, {"em1Text": "oxytocin receptor", "em2Text": "carbetocin", "label": "CPR:5"}, {"em1Text": "oxytocin receptor", "em2Text": "barusiban", "label": "CPR:6"}]}
{"sentText": "The compounds 5azacytidine AZC and procainamide PCA belong to inhibitors of DNMT1 whose low activity correlates with increase in transcription of various genes", "relationMentions": [{"em1Text": "5azacytidine", "em2Text": "DNMT1", "label": "CPR:4"}, {"em1Text": "AZC", "em2Text": "DNMT1", "label": "CPR:4"}, {"em1Text": "procainamide", "em2Text": "DNMT1", "label": "CPR:4"}, {"em1Text": "PCA", "em2Text": "DNMT1", "label": "CPR:4"}]}
{"sentText": "However the flowcytometric analysis revealed that AZC and PCA decreased intracellular contents of CD3zeta chain in these cells in dose dependent manner", "relationMentions": [{"em1Text": "AZC", "em2Text": "CD3zeta chain", "label": "CPR:4"}, {"em1Text": "PCA", "em2Text": "CD3zeta chain", "label": "CPR:4"}]}
{"sentText": "These findings suggest that the mechanism of antiproliferative toxicity of capecitabine is at least partly due to TS inhibitory activity of its active metabolite 5fluoro2deoxyuridine monophosphate FdUMP", "relationMentions": [{"em1Text": "TS", "em2Text": "FdUMP", "label": "CPR:4"}, {"em1Text": "capecitabine", "em2Text": "TS", "label": "CPR:4"}, {"em1Text": "TS", "em2Text": "5fluoro2deoxyuridine monophosphate", "label": "CPR:4"}]}
{"sentText": "Clinical studies in cancer patients treated with the new fluoropyrimidine analogue capecitabine N4pentoxycarbonyl55fluorocytidine have shown that plasma 2deoxyuridine was significantly elevated after 1 week of treatment consistent with inhibition of thymidylate synthase TS", "relationMentions": [{"em1Text": "fluoropyrimidine", "em2Text": "thymidylate synthase", "label": "CPR:4"}, {"em1Text": "fluoropyrimidine", "em2Text": "TS", "label": "CPR:4"}, {"em1Text": "capecitabine", "em2Text": "thymidylate synthase", "label": "CPR:4"}, {"em1Text": "capecitabine", "em2Text": "TS", "label": "CPR:4"}, {"em1Text": "N4pentoxycarbonyl55fluorocytidine", "em2Text": "thymidylate synthase", "label": "CPR:4"}, {"em1Text": "N4pentoxycarbonyl55fluorocytidine", "em2Text": "TS", "label": "CPR:4"}, {"em1Text": "2deoxyuridine", "em2Text": "thymidylate synthase", "label": "CPR:4"}, {"em1Text": "2deoxyuridine", "em2Text": "TS", "label": "CPR:4"}]}
{"sentText": "Clinical studies in cancer patients treated with the new fluoropyrimidine analogue capecitabine N4pentoxycarbonyl55fluorocytidine have shown that plasma 2deoxyuridine was significantly elevated after 1 week of treatment consistent with inhibition of thymidylate synthase TS", "relationMentions": [{"em1Text": "fluoropyrimidine", "em2Text": "thymidylate synthase", "label": "CPR:4"}, {"em1Text": "fluoropyrimidine", "em2Text": "TS", "label": "CPR:4"}, {"em1Text": "capecitabine", "em2Text": "thymidylate synthase", "label": "CPR:4"}, {"em1Text": "capecitabine", "em2Text": "TS", "label": "CPR:4"}, {"em1Text": "N4pentoxycarbonyl55fluorocytidine", "em2Text": "thymidylate synthase", "label": "CPR:4"}, {"em1Text": "N4pentoxycarbonyl55fluorocytidine", "em2Text": "TS", "label": "CPR:4"}, {"em1Text": "2deoxyuridine", "em2Text": "thymidylate synthase", "label": "CPR:4"}, {"em1Text": "2deoxyuridine", "em2Text": "TS", "label": "CPR:4"}]}
{"sentText": "Inhibitors and neutralizing antibodies against heparinbinding epidermal growth factorlike growth factor HBEGF and to a lesser extent transforming growth factoralpha reduced imatinib mediated mitogen activated protein kinase MAPK activation", "relationMentions": [{"em1Text": "imatinib", "em2Text": "mitogen activated protein kinase", "label": "CPR:3"}, {"em1Text": "imatinib", "em2Text": "MAPK", "label": "CPR:3"}]}
{"sentText": "Imatinib stimulated the rapid release of soluble HBEGF and the subsequent induction of membranebound HBEGF which correlated with biphasic MAPK activation", "relationMentions": [{"em1Text": "Imatinib", "em2Text": "HBEGF", "label": "CPR:3"}, {"em1Text": "Imatinib", "em2Text": "MAPK", "label": "CPR:3"}]}
{"sentText": "Although imatinib primarily inhibits tyrosine kinases it also stimulates the activity of EGFR tyrosine kinase in head and neck squamous tumors", "relationMentions": [{"em1Text": "imatinib", "em2Text": "EGFR", "label": "CPR:3"}, {"em1Text": "imatinib", "em2Text": "tyrosine kinase", "label": "CPR:3"}, {"em1Text": "imatinib", "em2Text": "tyrosine kinases", "label": "CPR:4"}]}
{"sentText": "Treatment of head and neck squamous carcinoma cells with clinically relevant concentrations of imatinib induced changes in cell morphology and growth similar to changes associated with epidermal growth factor receptor EGFR activation", "relationMentions": [{"em1Text": "imatinib", "em2Text": "epidermal growth factor receptor", "label": "CPR:3"}, {"em1Text": "imatinib", "em2Text": "EGFR", "label": "CPR:3"}]}
{"sentText": "Imatinib mesylate is a tyrosine kinase inhibitor of the ABL plateletderived growth factor receptor PDGFR and ckit kinases", "relationMentions": [{"em1Text": "Imatinib mesylate", "em2Text": "PDGFR", "label": "CPR:4"}, {"em1Text": "Imatinib mesylate", "em2Text": "ckit", "label": "CPR:4"}, {"em1Text": "Imatinib mesylate", "em2Text": "kinases", "label": "CPR:4"}, {"em1Text": "Imatinib mesylate", "em2Text": "tyrosine kinase", "label": "CPR:4"}, {"em1Text": "Imatinib mesylate", "em2Text": "ABL", "label": "CPR:4"}, {"em1Text": "Imatinib mesylate", "em2Text": "plateletderived growth factor receptor", "label": "CPR:4"}]}
{"sentText": "The identity of the lung betaADHs was further demonstrated by their characteristic pHactivity profiles for ethanol oxidation Km values for NAD and ethanol and inhibition by 4methylpyrazole or 110phenanthroline", "relationMentions": [{"em1Text": "betaADHs", "em2Text": "4methylpyrazole", "label": "CPR:4"}, {"em1Text": "betaADHs", "em2Text": "110phenanthroline", "label": "CPR:4"}, {"em1Text": "betaADHs", "em2Text": "ethanol", "label": "CPR:9"}]}
{"sentText": "These findings indicate that human pulmonary ethanol metabolizing activities differ significantly with respect to genetic polymorphism at both the ADH2 and the ALDH2 loci", "relationMentions": [{"em1Text": "ethanol", "em2Text": "ADH2", "label": "CPR:9"}, {"em1Text": "ethanol", "em2Text": "ALDH2", "label": "CPR:9"}]}
{"sentText": "The results suggest that individuals with high Vmax beta 2ADH and deficient in lowKm mitochondrial ALDH2 accounting for approximately 45 of the Chinese population may end up with acetaldehyde accumulation during alcohol consumption rendering them vulnerable to tissue injury caused by this highly reactive and toxic metabolite", "relationMentions": [{"em1Text": "beta 2ADH", "em2Text": "acetaldehyde", "label": "CPR:9"}, {"em1Text": "ALDH2", "em2Text": "acetaldehyde", "label": "CPR:9"}, {"em1Text": "beta 2ADH", "em2Text": "alcohol", "label": "CPR:9"}, {"em1Text": "ALDH2", "em2Text": "alcohol", "label": "CPR:9"}]}
{"sentText": "The results suggest that individuals with high Vmax beta 2ADH and deficient in lowKm mitochondrial ALDH2 accounting for approximately 45 of the Chinese population may end up with acetaldehyde accumulation during alcohol consumption rendering them vulnerable to tissue injury caused by this highly reactive and toxic metabolite", "relationMentions": [{"em1Text": "beta 2ADH", "em2Text": "acetaldehyde", "label": "CPR:9"}, {"em1Text": "ALDH2", "em2Text": "acetaldehyde", "label": "CPR:9"}, {"em1Text": "beta 2ADH", "em2Text": "alcohol", "label": "CPR:9"}, {"em1Text": "ALDH2", "em2Text": "alcohol", "label": "CPR:9"}]}
{"sentText": "In the presence of IL18 simvastatin suppressed the expression of ICAM1 and CD40 as well as the production of IL12 TNFalpha and IFNgamma in PBMC contributing to the antiinflammatory effect of simvastatin", "relationMentions": [{"em1Text": "simvastatin", "em2Text": "IL12", "label": "CPR:3"}, {"em1Text": "simvastatin", "em2Text": "TNFalpha", "label": "CPR:3"}, {"em1Text": "simvastatin", "em2Text": "IFNgamma", "label": "CPR:3"}, {"em1Text": "simvastatin", "em2Text": "ICAM1", "label": "CPR:4"}, {"em1Text": "simvastatin", "em2Text": "CD40", "label": "CPR:4"}]}
{"sentText": "Simvastatin an HMGCoA reductase inhibitor with mild inhibition of LFA1 induced the production of interleukin IL18 tumor necrosis factor TNFalpha and interferon IFNgamma in human peripheral blood mononuclear cells PBMC", "relationMentions": [{"em1Text": "Simvastatin", "em2Text": "interleukin IL18", "label": "CPR:3"}, {"em1Text": "Simvastatin", "em2Text": "tumor necrosis factor TNFalpha", "label": "CPR:3"}, {"em1Text": "Simvastatin", "em2Text": "interferon IFNgamma", "label": "CPR:3"}, {"em1Text": "Simvastatin", "em2Text": "HMGCoA reductase", "label": "CPR:4"}, {"em1Text": "Simvastatin", "em2Text": "LFA1", "label": "CPR:4"}]}
{"sentText": "The IL18 production is located upstream of the cytokine cascade activated by simvastatin", "relationMentions": [{"em1Text": "IL18", "em2Text": "simvastatin", "label": "CPR:3"}, {"em1Text": "cytokine", "em2Text": "simvastatin", "label": "CPR:3"}]}
{"sentText": "Moreover simvastatin concentrationdependently inhibited the expression of ICAM1 and induced the expression of CD40 on monocytes", "relationMentions": [{"em1Text": "simvastatin", "em2Text": "CD40", "label": "CPR:3"}, {"em1Text": "simvastatin", "em2Text": "ICAM1", "label": "CPR:4"}]}
{"sentText": "However at IC80 phenylbutazone 1344 and flunixin 297 had greater COX2 selectivity than at IC50 and meloxicam 412 and carprofen 129 had lower COX2 selectivity than at IC50", "relationMentions": [{"em1Text": "COX2", "em2Text": "carprofen", "label": "CPR:4"}, {"em1Text": "phenylbutazone", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "flunixin", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "meloxicam", "label": "CPR:4"}]}
{"sentText": "However at IC80 phenylbutazone 1344 and flunixin 297 had greater COX2 selectivity than at IC50 and meloxicam 412 and carprofen 129 had lower COX2 selectivity than at IC50", "relationMentions": [{"em1Text": "COX2", "em2Text": "carprofen", "label": "CPR:4"}, {"em1Text": "phenylbutazone", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "flunixin", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "meloxicam", "label": "CPR:4"}]}
{"sentText": "We report on the inhibitory activity of the NSAIDs meloxicam carprofen phenylbutazone and flunixin on blood cyclooxygenases in the horse using in vitro enzymelinked assays", "relationMentions": [{"em1Text": "carprofen", "em2Text": "cyclooxygenases", "label": "CPR:4"}, {"em1Text": "phenylbutazone", "em2Text": "cyclooxygenases", "label": "CPR:4"}, {"em1Text": "flunixin", "em2Text": "cyclooxygenases", "label": "CPR:4"}, {"em1Text": "meloxicam", "em2Text": "cyclooxygenases", "label": "CPR:4"}]}
{"sentText": "COX1 and COX2 inhibition in horse blood by phenylbutazone flunixin carprofen and meloxicam an in vitro analysis", "relationMentions": [{"em1Text": "COX1", "em2Text": "phenylbutazone", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "phenylbutazone", "label": "CPR:4"}, {"em1Text": "COX1", "em2Text": "flunixin", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "flunixin", "label": "CPR:4"}, {"em1Text": "COX1", "em2Text": "carprofen", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "carprofen", "label": "CPR:4"}, {"em1Text": "COX1", "em2Text": "meloxicam", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "meloxicam", "label": "CPR:4"}]}
{"sentText": "COX1 and COX2 inhibition in horse blood by phenylbutazone flunixin carprofen and meloxicam an in vitro analysis", "relationMentions": [{"em1Text": "COX1", "em2Text": "phenylbutazone", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "phenylbutazone", "label": "CPR:4"}, {"em1Text": "COX1", "em2Text": "flunixin", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "flunixin", "label": "CPR:4"}, {"em1Text": "COX1", "em2Text": "carprofen", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "carprofen", "label": "CPR:4"}, {"em1Text": "COX1", "em2Text": "meloxicam", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "meloxicam", "label": "CPR:4"}]}
{"sentText": "As expected comparison of IC50 indicated that meloxicam and carprofen are more selective inhibitors of COX2 than phenylbutazone and flunixin meloxicam was the most advantageous for horses of four NSAIDs examined", "relationMentions": [{"em1Text": "meloxicam", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "carprofen", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "phenylbutazone", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "flunixin", "label": "CPR:4"}]}
{"sentText": "As expected comparison of IC50 indicated that meloxicam and carprofen are more selective inhibitors of COX2 than phenylbutazone and flunixin meloxicam was the most advantageous for horses of four NSAIDs examined", "relationMentions": [{"em1Text": "meloxicam", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "carprofen", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "phenylbutazone", "label": "CPR:4"}, {"em1Text": "COX2", "em2Text": "flunixin", "label": "CPR:4"}]}
{"sentText": "Treatment with carvedilol reversed both protein and mRNA of HIF1alpha VEGF BNP and NGFbeta to the baseline values", "relationMentions": [{"em1Text": "carvedilol", "em2Text": "NGFbeta", "label": "CPR:3"}, {"em1Text": "carvedilol", "em2Text": "HIF1alpha", "label": "CPR:4"}, {"em1Text": "carvedilol", "em2Text": "VEGF", "label": "CPR:4"}, {"em1Text": "carvedilol", "em2Text": "BNP", "label": "CPR:4"}]}
{"sentText": "Carvedilol prevents cardiac hypertrophy and overexpression of hypoxiainducible factor1alpha and vascular endothelial growth factor in pressureoverloaded rat heart", "relationMentions": [{"em1Text": "Carvedilol", "em2Text": "hypoxiainducible factor1alpha", "label": "CPR:4"}, {"em1Text": "Carvedilol", "em2Text": "vascular endothelial growth factor", "label": "CPR:4"}]}
{"sentText": "Increased immunohistochemical labeling of HIF1alpha VEGF and BNP in the ventricular myocardium was observed in the banding group and carvedilol again normalized the labeling", "relationMentions": [{"em1Text": "HIF1alpha", "em2Text": "carvedilol", "label": "CPR:4"}, {"em1Text": "VEGF", "em2Text": "carvedilol", "label": "CPR:4"}, {"em1Text": "BNP", "em2Text": "carvedilol", "label": "CPR:4"}]}
{"sentText": "Treatment with carvedilol is associated with a reversal of abnormal regulation of HIF1alpha VEGF BNP and NGFbeta in the hypertrophic myocardium", "relationMentions": [{"em1Text": "carvedilol", "em2Text": "HIF1alpha", "label": "CPR:4"}, {"em1Text": "carvedilol", "em2Text": "VEGF", "label": "CPR:4"}, {"em1Text": "carvedilol", "em2Text": "BNP", "label": "CPR:4"}]}
{"sentText": "Imatinib STI571 Gleevec Glivec Novartis Pharmaceuticals East Hanover NJ a selective inhibitor of KIT ABL BCR ABL PDGFRA and PDGFRB represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs", "relationMentions": [{"em1Text": "Imatinib", "em2Text": "KIT", "label": "CPR:4"}, {"em1Text": "Imatinib", "em2Text": "ABL", "label": "CPR:4"}, {"em1Text": "Imatinib", "em2Text": "BCR", "label": "CPR:4"}, {"em1Text": "Imatinib", "em2Text": "PDGFRA", "label": "CPR:4"}, {"em1Text": "Imatinib", "em2Text": "PDGFRB", "label": "CPR:4"}, {"em1Text": "STI571", "em2Text": "KIT", "label": "CPR:4"}, {"em1Text": "STI571", "em2Text": "ABL", "label": "CPR:4"}, {"em1Text": "STI571", "em2Text": "BCR", "label": "CPR:4"}, {"em1Text": "STI571", "em2Text": "PDGFRA", "label": "CPR:4"}, {"em1Text": "STI571", "em2Text": "PDGFRB", "label": "CPR:4"}, {"em1Text": "Gleevec", "em2Text": "KIT", "label": "CPR:4"}, {"em1Text": "Gleevec", "em2Text": "ABL", "label": "CPR:4"}, {"em1Text": "Gleevec", "em2Text": "BCR", "label": "CPR:4"}, {"em1Text": "Gleevec", "em2Text": "PDGFRA", "label": "CPR:4"}, {"em1Text": "Gleevec", "em2Text": "PDGFRB", "label": "CPR:4"}, {"em1Text": "Glivec", "em2Text": "KIT", "label": "CPR:4"}, {"em1Text": "Glivec", "em2Text": "ABL", "label": "CPR:4"}, {"em1Text": "Glivec", "em2Text": "BCR", "label": "CPR:4"}, {"em1Text": "Glivec", "em2Text": "PDGFRA", "label": "CPR:4"}, {"em1Text": "Glivec", "em2Text": "PDGFRB", "label": "CPR:4"}]}
{"sentText": "Imatinib STI571 Gleevec Glivec Novartis Pharmaceuticals East Hanover NJ a selective inhibitor of KIT ABL BCR ABL PDGFRA and PDGFRB represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs", "relationMentions": [{"em1Text": "Imatinib", "em2Text": "KIT", "label": "CPR:4"}, {"em1Text": "Imatinib", "em2Text": "ABL", "label": "CPR:4"}, {"em1Text": "Imatinib", "em2Text": "BCR", "label": "CPR:4"}, {"em1Text": "Imatinib", "em2Text": "PDGFRA", "label": "CPR:4"}, {"em1Text": "Imatinib", "em2Text": "PDGFRB", "label": "CPR:4"}, {"em1Text": "STI571", "em2Text": "KIT", "label": "CPR:4"}, {"em1Text": "STI571", "em2Text": "ABL", "label": "CPR:4"}, {"em1Text": "STI571", "em2Text": "BCR", "label": "CPR:4"}, {"em1Text": "STI571", "em2Text": "PDGFRA", "label": "CPR:4"}, {"em1Text": "STI571", "em2Text": "PDGFRB", "label": "CPR:4"}, {"em1Text": "Gleevec", "em2Text": "KIT", "label": "CPR:4"}, {"em1Text": "Gleevec", "em2Text": "ABL", "label": "CPR:4"}, {"em1Text": "Gleevec", "em2Text": "BCR", "label": "CPR:4"}, {"em1Text": "Gleevec", "em2Text": "PDGFRA", "label": "CPR:4"}, {"em1Text": "Gleevec", "em2Text": "PDGFRB", "label": "CPR:4"}, {"em1Text": "Glivec", "em2Text": "KIT", "label": "CPR:4"}, {"em1Text": "Glivec", "em2Text": "ABL", "label": "CPR:4"}, {"em1Text": "Glivec", "em2Text": "BCR", "label": "CPR:4"}, {"em1Text": "Glivec", "em2Text": "PDGFRA", "label": "CPR:4"}, {"em1Text": "Glivec", "em2Text": "PDGFRB", "label": "CPR:4"}]}
{"sentText": "Moreover 4methylhistamine potently activated the hH4R pEC50 = 74 01 alpha = 1 and this response was competitively antagonized by the selective H4R antagonist JNJ 7777120 15chloro1Hindol2ylcarbonyl4methylpiperazine pA2 = 78", "relationMentions": [{"em1Text": "4methylhistamine", "em2Text": "hH4R", "label": "CPR:3"}, {"em1Text": "H4R", "em2Text": "JNJ 7777120", "label": "CPR:6"}, {"em1Text": "H4R", "em2Text": "15chloro1Hindol2ylcarbonyl4methylpiperazine", "label": "CPR:6"}]}
{"sentText": "CPT11 and SN38 may also stimulate the production of proinflammatory cytokines and prostaglandins PGs thus inducing the secretion of Na and Cl", "relationMentions": [{"em1Text": "CPT11", "em2Text": "cytokines", "label": "CPR:3"}, {"em1Text": "SN38", "em2Text": "cytokines", "label": "CPR:3"}]}
{"sentText": "Irinotecan CPT11 7ethyl1041piperidino1piperidino carbonyloxycamptothecin has exhibited clinical activities against a broad spectrum of carcinomas by inhibiting DNA topoisomerase I Topo I", "relationMentions": [{"em1Text": "7ethyl1041piperidino1piperidino carbonyloxycamptothecin", "em2Text": "DNA topoisomerase I", "label": "CPR:4"}, {"em1Text": "7ethyl1041piperidino1piperidino carbonyloxycamptothecin", "em2Text": "Topo I", "label": "CPR:4"}, {"em1Text": "Irinotecan", "em2Text": "DNA topoisomerase I", "label": "CPR:4"}, {"em1Text": "Irinotecan", "em2Text": "Topo I", "label": "CPR:4"}, {"em1Text": "CPT11", "em2Text": "DNA topoisomerase I", "label": "CPR:4"}, {"em1Text": "CPT11", "em2Text": "Topo I", "label": "CPR:4"}]}
{"sentText": "Irinotecan CPT11 7ethyl1041piperidino1piperidino carbonyloxycamptothecin has exhibited clinical activities against a broad spectrum of carcinomas by inhibiting DNA topoisomerase I Topo I", "relationMentions": [{"em1Text": "7ethyl1041piperidino1piperidino carbonyloxycamptothecin", "em2Text": "DNA topoisomerase I", "label": "CPR:4"}, {"em1Text": "7ethyl1041piperidino1piperidino carbonyloxycamptothecin", "em2Text": "Topo I", "label": "CPR:4"}, {"em1Text": "Irinotecan", "em2Text": "DNA topoisomerase I", "label": "CPR:4"}, {"em1Text": "Irinotecan", "em2Text": "Topo I", "label": "CPR:4"}, {"em1Text": "CPT11", "em2Text": "DNA topoisomerase I", "label": "CPR:4"}, {"em1Text": "CPT11", "em2Text": "Topo I", "label": "CPR:4"}]}
{"sentText": "RRoscovitine CYC202 Seliciclib is a relatively selective inhibitor of cyclindependent kinases CDKs currently evaluated for the treatment of cancers neurodegenerative disorders renal diseases and several viral infections", "relationMentions": [{"em1Text": "RRoscovitine", "em2Text": "cyclindependent kinases", "label": "CPR:4"}, {"em1Text": "RRoscovitine", "em2Text": "CDKs", "label": "CPR:4"}, {"em1Text": "CYC202", "em2Text": "cyclindependent kinases", "label": "CPR:4"}, {"em1Text": "CYC202", "em2Text": "CDKs", "label": "CPR:4"}, {"em1Text": "Seliciclib", "em2Text": "cyclindependent kinases", "label": "CPR:4"}, {"em1Text": "Seliciclib", "em2Text": "CDKs", "label": "CPR:4"}]}
{"sentText": "RRoscovitine CYC202 Seliciclib is a relatively selective inhibitor of cyclindependent kinases CDKs currently evaluated for the treatment of cancers neurodegenerative disorders renal diseases and several viral infections", "relationMentions": [{"em1Text": "RRoscovitine", "em2Text": "cyclindependent kinases", "label": "CPR:4"}, {"em1Text": "RRoscovitine", "em2Text": "CDKs", "label": "CPR:4"}, {"em1Text": "CYC202", "em2Text": "cyclindependent kinases", "label": "CPR:4"}, {"em1Text": "CYC202", "em2Text": "CDKs", "label": "CPR:4"}, {"em1Text": "Seliciclib", "em2Text": "cyclindependent kinases", "label": "CPR:4"}, {"em1Text": "Seliciclib", "em2Text": "CDKs", "label": "CPR:4"}]}
{"sentText": "Pyridoxal kinase PDXK catalyzes the phosphorylation of pyridoxal pyridoxamine and pyridoxine in the presence of ATP and Zn2", "relationMentions": [{"em1Text": "Pyridoxal kinase", "em2Text": "pyridoxal", "label": "CPR:9"}, {"em1Text": "PDXK", "em2Text": "pyridoxal", "label": "CPR:9"}, {"em1Text": "Pyridoxal kinase", "em2Text": "pyridoxamine", "label": "CPR:9"}, {"em1Text": "PDXK", "em2Text": "pyridoxamine", "label": "CPR:9"}, {"em1Text": "Pyridoxal kinase", "em2Text": "pyridoxine", "label": "CPR:9"}, {"em1Text": "PDXK", "em2Text": "pyridoxine", "label": "CPR:9"}]}
{"sentText": "Pyridoxal kinase PDXK catalyzes the phosphorylation of pyridoxal pyridoxamine and pyridoxine in the presence of ATP and Zn2", "relationMentions": [{"em1Text": "Pyridoxal kinase", "em2Text": "pyridoxal", "label": "CPR:9"}, {"em1Text": "PDXK", "em2Text": "pyridoxal", "label": "CPR:9"}, {"em1Text": "Pyridoxal kinase", "em2Text": "pyridoxamine", "label": "CPR:9"}, {"em1Text": "PDXK", "em2Text": "pyridoxamine", "label": "CPR:9"}, {"em1Text": "Pyridoxal kinase", "em2Text": "pyridoxine", "label": "CPR:9"}, {"em1Text": "PDXK", "em2Text": "pyridoxine", "label": "CPR:9"}]}
{"sentText": "Both inhibitors moreover blunted the mucin secretory responses to betaadrenergic agonistgenerated second messenger cAMP as well as adenylate cyclase activator forskolin", "relationMentions": [{"em1Text": "adenylate cyclase", "em2Text": "forskolin", "label": "CPR:3"}, {"em1Text": "mucin", "em2Text": "forskolin", "label": "CPR:4"}, {"em1Text": "cAMP", "em2Text": "adenylate cyclase", "label": "CPR:9"}]}
{"sentText": "The gastric mucin secretory responses to isoproterenol furthermore were inhibited by PP2 a selective inhibitor of tyrosine kinase Src responsible for ligandindependent EGFR autophosphorylation but not by ERK inhibitor PD98059", "relationMentions": [{"em1Text": "PP2", "em2Text": "EGFR", "label": "CPR:3"}, {"em1Text": "gastric mucin", "em2Text": "PP2", "label": "CPR:4"}, {"em1Text": "PP2", "em2Text": "tyrosine kinase", "label": "CPR:4"}, {"em1Text": "PP2", "em2Text": "Src", "label": "CPR:4"}, {"em1Text": "ERK", "em2Text": "PD98059", "label": "CPR:4"}]}
{"sentText": "The inhibition of ERK moreover did not cause attenuation in mucin secretion in response to cAMP and forskolin", "relationMentions": [{"em1Text": "ERK", "em2Text": "cAMP", "label": "CPR:4"}, {"em1Text": "ERK", "em2Text": "forskolin", "label": "CPR:4"}]}
{"sentText": "Using 3Hglucosaminelabeled gastric mucosal cells we show that stimulatory effect of betaadrenergic agonist isoproterenol on mucin secretion was inhibited by EGFR kinase inhibitor PD153035 as well as wortmannin a specific inhibitor of PI3K", "relationMentions": [{"em1Text": "mucin", "em2Text": "PD153035", "label": "CPR:4"}, {"em1Text": "EGFR", "em2Text": "PD153035", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "PD153035", "label": "CPR:4"}, {"em1Text": "mucin", "em2Text": "wortmannin", "label": "CPR:4"}, {"em1Text": "wortmannin", "em2Text": "PI3K", "label": "CPR:4"}]}
{"sentText": "Using 3Hglucosaminelabeled gastric mucosal cells we show that stimulatory effect of betaadrenergic agonist isoproterenol on mucin secretion was inhibited by EGFR kinase inhibitor PD153035 as well as wortmannin a specific inhibitor of PI3K", "relationMentions": [{"em1Text": "mucin", "em2Text": "PD153035", "label": "CPR:4"}, {"em1Text": "EGFR", "em2Text": "PD153035", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "PD153035", "label": "CPR:4"}, {"em1Text": "mucin", "em2Text": "wortmannin", "label": "CPR:4"}, {"em1Text": "wortmannin", "em2Text": "PI3K", "label": "CPR:4"}]}
{"sentText": "Clinical experience in heart failure is growing and recent data suggest an improved survival with losartan versus captopril a drug from the angiotensinconvertingenzyme inhibitor class with proven benefit in this population", "relationMentions": [{"em1Text": "losartan", "em2Text": "angiotensinconvertingenzyme", "label": "CPR:4"}, {"em1Text": "captopril", "em2Text": "angiotensinconvertingenzyme", "label": "CPR:4"}]}
{"sentText": "Losartan COZAAR is the prototype of a new class of potent and selective angiotensin II AII type 1 AT1 receptor antagonists with the largest published preclinical and clinical data base", "relationMentions": [{"em1Text": "Losartan", "em2Text": "angiotensin II AII type 1 AT1 receptor", "label": "CPR:6"}, {"em1Text": "COZAAR", "em2Text": "angiotensin II AII type 1 AT1 receptor", "label": "CPR:6"}]}
{"sentText": "Abrupt removal of amrinone or pentoxifylline from the culture medium prior to LPS stimulation however caused significantly augmented TNF production", "relationMentions": [{"em1Text": "amrinone", "em2Text": "TNF", "label": "CPR:3"}, {"em1Text": "pentoxifylline", "em2Text": "TNF", "label": "CPR:3"}]}
{"sentText": "Combined application of dexamethasone and amrinone caused additive inhibition of TNF biosynthesis in vitro", "relationMentions": [{"em1Text": "dexamethasone", "em2Text": "TNF", "label": "CPR:4"}, {"em1Text": "amrinone", "em2Text": "TNF", "label": "CPR:4"}]}
{"sentText": "Therefore decreases of PLK and PNPO in the hippocampal CA1 region of aged brains may be involved in aging processes related with gammaaminobutyric acid GABA function", "relationMentions": [{"em1Text": "PLK", "em2Text": "gammaaminobutyric acid", "label": "CPR:4"}, {"em1Text": "PNPO", "em2Text": "gammaaminobutyric acid", "label": "CPR:4"}, {"em1Text": "PLK", "em2Text": "GABA", "label": "CPR:4"}, {"em1Text": "PNPO", "em2Text": "GABA", "label": "CPR:4"}]}
{"sentText": "Therefore decreases of PLK and PNPO in the hippocampal CA1 region of aged brains may be involved in aging processes related with gammaaminobutyric acid GABA function", "relationMentions": [{"em1Text": "PLK", "em2Text": "gammaaminobutyric acid", "label": "CPR:4"}, {"em1Text": "PNPO", "em2Text": "gammaaminobutyric acid", "label": "CPR:4"}, {"em1Text": "PLK", "em2Text": "GABA", "label": "CPR:4"}, {"em1Text": "PNPO", "em2Text": "GABA", "label": "CPR:4"}]}
{"sentText": "In the present study agerelated changes of pyridoxal 5phosphate PLP synthesizing enzymes pyridoxal kinase PLK and pyridoxine 5phosphate oxidase PNPO their protein contents and activities were examined in the gerbil hippocampus proper", "relationMentions": [{"em1Text": "pyridoxal 5phosphate", "em2Text": "PLK", "label": "CPR:9"}, {"em1Text": "pyridoxal 5phosphate", "em2Text": "pyridoxine 5phosphate oxidase", "label": "CPR:9"}, {"em1Text": "pyridoxal 5phosphate", "em2Text": "PNPO", "label": "CPR:9"}, {"em1Text": "pyridoxal 5phosphate", "em2Text": "pyridoxal kinase", "label": "CPR:9"}, {"em1Text": "PLP", "em2Text": "PLK", "label": "CPR:9"}, {"em1Text": "PLP", "em2Text": "pyridoxine 5phosphate oxidase", "label": "CPR:9"}, {"em1Text": "PLP", "em2Text": "PNPO", "label": "CPR:9"}, {"em1Text": "PLP", "em2Text": "pyridoxal kinase", "label": "CPR:9"}]}
{"sentText": "In the present study agerelated changes of pyridoxal 5phosphate PLP synthesizing enzymes pyridoxal kinase PLK and pyridoxine 5phosphate oxidase PNPO their protein contents and activities were examined in the gerbil hippocampus proper", "relationMentions": [{"em1Text": "pyridoxal 5phosphate", "em2Text": "PLK", "label": "CPR:9"}, {"em1Text": "pyridoxal 5phosphate", "em2Text": "pyridoxine 5phosphate oxidase", "label": "CPR:9"}, {"em1Text": "pyridoxal 5phosphate", "em2Text": "PNPO", "label": "CPR:9"}, {"em1Text": "pyridoxal 5phosphate", "em2Text": "pyridoxal kinase", "label": "CPR:9"}, {"em1Text": "PLP", "em2Text": "PLK", "label": "CPR:9"}, {"em1Text": "PLP", "em2Text": "pyridoxine 5phosphate oxidase", "label": "CPR:9"}, {"em1Text": "PLP", "em2Text": "PNPO", "label": "CPR:9"}, {"em1Text": "PLP", "em2Text": "pyridoxal kinase", "label": "CPR:9"}]}
{"sentText": "This process was reduced by a protonophore carbonylcyanide ptrifluoromethoxyphenylhydrazone and a typical monocarboxylate transporter MCT inhibitor alphacyano4hydroxycinnamic acid suggesting that nicotinate uptake by rat astrocytes is mediated by Hcoupled monocarboxylate transport system", "relationMentions": [{"em1Text": "monocarboxylate transporter", "em2Text": "alphacyano4hydroxycinnamic acid", "label": "CPR:4"}, {"em1Text": "MCT", "em2Text": "alphacyano4hydroxycinnamic acid", "label": "CPR:4"}, {"em1Text": "nicotinate", "em2Text": "monocarboxylate transport system", "label": "CPR:9"}]}
{"sentText": "Because llactate reduced to 67 of the nicotinate uptake even at 10mM it is unlikely that nicotinate uptake in rat astrocytes is mediated by MCT1 andor MCT2", "relationMentions": [{"em1Text": "nicotinate", "em2Text": "MCT1", "label": "CPR:9"}, {"em1Text": "nicotinate", "em2Text": "MCT2", "label": "CPR:9"}]}
{"sentText": "These results provide biochemical evidence of a Hcoupled and saturable transport system presumed to be a lowaffinity monocarboxylate transporter MCT4 or other unknown Hcoupled monocarboxylate transport system for nicotinate in rat cerebrocortical astrocytes", "relationMentions": [{"em1Text": "lowaffinity monocarboxylate transporter", "em2Text": "nicotinate", "label": "CPR:9"}, {"em1Text": "MCT4", "em2Text": "nicotinate", "label": "CPR:9"}, {"em1Text": "Hcoupled monocarboxylate transport system", "em2Text": "nicotinate", "label": "CPR:9"}]}
{"sentText": "Effects of granulocyte colonystimulating factor GCSF and neutrophil elastase inhibitor ONO5046 on acidinduced lung injury in rats", "relationMentions": [{"em1Text": "granulocyte colonystimulating factor", "em2Text": "ONO5046", "label": "CPR:4"}, {"em1Text": "GCSF", "em2Text": "ONO5046", "label": "CPR:4"}, {"em1Text": "neutrophil elastase", "em2Text": "ONO5046", "label": "CPR:4"}]}
{"sentText": "Miglustat an imino sugar that reversibly inhibits glucosylceramide synthase and reduces intracellular substrate burden is an oral treatment for patients with type 1 GD that was recently approved in the United States for symptomatic patients with mild to moderate clinical manifestations for whom ERT is not an option", "relationMentions": [{"em1Text": "Miglustat", "em2Text": "glucosylceramide synthase", "label": "CPR:4"}, {"em1Text": "imino sugar", "em2Text": "glucosylceramide synthase", "label": "CPR:4"}]}
{"sentText": "This effect was reverted in the presence of atropine ATR 01 microM which blocks the presynaptic muscarinic M2 receptor", "relationMentions": [{"em1Text": "atropine", "em2Text": "muscarinic M2 receptor", "label": "CPR:4"}, {"em1Text": "ATR", "em2Text": "muscarinic M2 receptor", "label": "CPR:4"}]}
{"sentText": "To test the role of nicotinic receptors in the drugs effects on 3HACh release mecamylamine MEC 100 microM was used to block such receptors", "relationMentions": [{"em1Text": "nicotinic receptors", "em2Text": "mecamylamine", "label": "CPR:4"}, {"em1Text": "nicotinic receptors", "em2Text": "MEC", "label": "CPR:4"}]}
{"sentText": "After that a wide range of concentrations of drugs concomitantly with ATR 01 microM was studied in the presence of haloperidol HAL 001 microM a dopamine D2 antagonist", "relationMentions": [{"em1Text": "haloperidol", "em2Text": "dopamine D2", "label": "CPR:6"}, {"em1Text": "HAL", "em2Text": "dopamine D2", "label": "CPR:6"}]}
{"sentText": "mRNA levels for RARalpha RARbeta and RARgamma the nuclear receptors for retinoic acid decreased during activation of freshly isolated HSC even with retinoid supplementation", "relationMentions": [{"em1Text": "RARalpha", "em2Text": "retinoid", "label": "CPR:4"}, {"em1Text": "RARbeta", "em2Text": "retinoid", "label": "CPR:4"}, {"em1Text": "RARgamma", "em2Text": "retinoid", "label": "CPR:4"}, {"em1Text": "nuclear receptors", "em2Text": "retinoid", "label": "CPR:4"}]}
{"sentText": "Preincubation with 1 microM of the protein kinase C PKC activator phorbol 12myristate 13acetate PMA caused a small but significant decrease in isoprenaline induced Emax indicating activated PKCmediated heterologous beta2adrenoceptor desensitization", "relationMentions": [{"em1Text": "protein kinase C", "em2Text": "PMA", "label": "CPR:3"}, {"em1Text": "PKC", "em2Text": "PMA", "label": "CPR:3"}, {"em1Text": "protein kinase C", "em2Text": "phorbol 12myristate 13acetate", "label": "CPR:3"}, {"em1Text": "PKC", "em2Text": "phorbol 12myristate 13acetate", "label": "CPR:3"}, {"em1Text": "PMA", "em2Text": "beta2adrenoceptor", "label": "CPR:4"}, {"em1Text": "phorbol 12myristate 13acetate", "em2Text": "beta2adrenoceptor", "label": "CPR:4"}, {"em1Text": "isoprenaline", "em2Text": "beta2adrenoceptor", "label": "CPR:5"}]}
{"sentText": "Preincubation with 1 microM of the protein kinase C PKC activator phorbol 12myristate 13acetate PMA caused a small but significant decrease in isoprenaline induced Emax indicating activated PKCmediated heterologous beta2adrenoceptor desensitization", "relationMentions": [{"em1Text": "protein kinase C", "em2Text": "PMA", "label": "CPR:3"}, {"em1Text": "PKC", "em2Text": "PMA", "label": "CPR:3"}, {"em1Text": "protein kinase C", "em2Text": "phorbol 12myristate 13acetate", "label": "CPR:3"}, {"em1Text": "PKC", "em2Text": "phorbol 12myristate 13acetate", "label": "CPR:3"}, {"em1Text": "PMA", "em2Text": "beta2adrenoceptor", "label": "CPR:4"}, {"em1Text": "phorbol 12myristate 13acetate", "em2Text": "beta2adrenoceptor", "label": "CPR:4"}, {"em1Text": "isoprenaline", "em2Text": "beta2adrenoceptor", "label": "CPR:5"}]}
{"sentText": "Moreover the specific PKC inhibitor 213dimethylaminopropyl1Hindol3yl31Hindol3yl maleimide GF 109203X markedly increased the potency and Emax of isoprenaline for all conditions used including control conditions and the synergistic effects of PMA and fenoterol were completely prevented", "relationMentions": [{"em1Text": "PKC", "em2Text": "213dimethylaminopropyl1Hindol3yl31Hindol3yl maleimide", "label": "CPR:4"}, {"em1Text": "PKC", "em2Text": "GF 109203X", "label": "CPR:4"}]}
{"sentText": "Preincubation 30 min of bovine tracheal smooth muscle with various concentrations 01 1 and 10 microM of fenoterol decreased isoprenaline induced maximal relaxation Emax of methacholinecontracted preparations in a concentration dependent fashion indicating desensitization of the beta2adrenoceptor", "relationMentions": [{"em1Text": "fenoterol", "em2Text": "beta2adrenoceptor", "label": "CPR:4"}, {"em1Text": "isoprenaline", "em2Text": "beta2adrenoceptor", "label": "CPR:5"}]}
{"sentText": "Tyrosine kinase inhibitors are quinazoline derived low molecular weight synthetic molecules that can block the intracellular tyrosine kinase domain of several receptors including EGFR Erb2 and vascular endothelial growth factor receptor and thereby inhibit ligandinduced receptor phosphorylation and abrogate the biologic effect of EGFR signaling", "relationMentions": [{"em1Text": "Tyrosine kinase", "em2Text": "quinazoline", "label": "CPR:4"}, {"em1Text": "quinazoline", "em2Text": "tyrosine kinase domain", "label": "CPR:4"}, {"em1Text": "quinazoline", "em2Text": "EGFR", "label": "CPR:4"}, {"em1Text": "quinazoline", "em2Text": "Erb2", "label": "CPR:4"}, {"em1Text": "quinazoline", "em2Text": "vascular endothelial growth factor receptor", "label": "CPR:4"}]}
{"sentText": "When expressed heterologously in a mammalian cell line rabbit PAT1 mediates pHdependent Naindependent uptake of proline glycine lalanine and alphamethylaminoisobutyric acid", "relationMentions": [{"em1Text": "rabbit PAT1", "em2Text": "proline", "label": "CPR:9"}, {"em1Text": "rabbit PAT1", "em2Text": "glycine", "label": "CPR:9"}, {"em1Text": "rabbit PAT1", "em2Text": "lalanine", "label": "CPR:9"}, {"em1Text": "rabbit PAT1", "em2Text": "alphamethylaminoisobutyric acid", "label": "CPR:9"}]}
{"sentText": "The functional characteristics of rabbit PAT1 in either mammalian cells or renal BBMV suggest that PAT1 is the lowaffinity transporter of proline glycine and hydroxyproline believed to be defective in patients with iminoglycinuria", "relationMentions": [{"em1Text": "PAT1", "em2Text": "proline", "label": "CPR:9"}, {"em1Text": "PAT1", "em2Text": "glycine", "label": "CPR:9"}, {"em1Text": "PAT1", "em2Text": "hydroxyproline", "label": "CPR:9"}]}
{"sentText": "Given the treatment with three doses of Captopril 15 approximately 45 mgkg markedly attenuated inhibition of vasodilator responses to ACh and eliminated the increased level of malondialdehyde the decreased level of NO activity of PON1 and SOD in serum by single intragastric gavaged Lmethionine", "relationMentions": [{"em1Text": "Captopril", "em2Text": "PON1", "label": "CPR:3"}, {"em1Text": "Captopril", "em2Text": "SOD", "label": "CPR:3"}]}
{"sentText": "These results suggested that Captopril can protect the vascular endothelium against the damages induced by Lmethionine in rats and the beneficial effects of Captopril may be related to attenuating the decrease in PON1 activity and NO levels", "relationMentions": [{"em1Text": "Captopril", "em2Text": "PON1", "label": "CPR:3"}, {"em1Text": "Lmethionine", "em2Text": "PON1", "label": "CPR:4"}]}
{"sentText": "We compared the effects of Captopril an ACE inhibitor with SH group enalapril an ACEinhibitor without SH group Nacetylcysteine only SH group not ACE inhibitor on endothelial dysfunction injured by methionineinduced hyperhomocysteinemia HHcy in rats", "relationMentions": [{"em1Text": "Captopril", "em2Text": "ACE", "label": "CPR:4"}, {"em1Text": "ACE", "em2Text": "SH", "label": "CPR:4"}, {"em1Text": "ACE", "em2Text": "enalapril", "label": "CPR:4"}]}
{"sentText": "Comparison of captopril and enalapril to study the role of the sulfhydryl group in improvement of endothelial dysfunction with ACE inhibitors in high dieted methionine mice", "relationMentions": [{"em1Text": "captopril", "em2Text": "ACE", "label": "CPR:4"}, {"em1Text": "enalapril", "em2Text": "ACE", "label": "CPR:4"}, {"em1Text": "sulfhydryl", "em2Text": "ACE", "label": "CPR:4"}]}
{"sentText": "It was found that a single intragastric gavage by Lmethionine resulted in inhibition of endotheliumdependent relaxation markedly increased the serum level of malondialdehyde and decreased the activity of PON1 and SOD similarly decreased the level of NO in the serum but had no effects on endotheliumindependent relaxation and angiotensinconverting enzyme activity compared with the control group", "relationMentions": [{"em1Text": "Lmethionine", "em2Text": "PON1", "label": "CPR:4"}, {"em1Text": "Lmethionine", "em2Text": "SOD", "label": "CPR:4"}]}
{"sentText": "In addition sorafenib demonstrated significant activity against several receptor tyrosine kinases involved in neovascularization and tumor progression including vascularendothelial growth factor VEGFR2 VEGFR3 plateletderived growth factor PDGFRbeta Flt3 and cKIT", "relationMentions": [{"em1Text": "sorafenib", "em2Text": "VEGFR3", "label": "CPR:3"}, {"em1Text": "sorafenib", "em2Text": "plateletderived growth factor PDGFRbeta", "label": "CPR:3"}, {"em1Text": "sorafenib", "em2Text": "Flt3", "label": "CPR:3"}, {"em1Text": "sorafenib", "em2Text": "cKIT", "label": "CPR:3"}, {"em1Text": "sorafenib", "em2Text": "receptor tyrosine kinases", "label": "CPR:3"}, {"em1Text": "sorafenib", "em2Text": "vascularendothelial growth factor VEGFR2", "label": "CPR:3"}]}
{"sentText": "Further characterization showed that sorafenib suppresses both wildtype and V599E mutant BRaf activity in vitro", "relationMentions": [{"em1Text": "sorafenib", "em2Text": "V599E", "label": "CPR:4"}, {"em1Text": "sorafenib", "em2Text": "BRaf", "label": "CPR:4"}]}
{"sentText": "Sorafenib which belongs chemically to a class that can be described as bisaryl ureas was selected for further pharmacologic characterization based on potent inhibition of Raf1 and its favorable kinase selectivity profile", "relationMentions": [{"em1Text": "Sorafenib", "em2Text": "Raf1", "label": "CPR:4"}, {"em1Text": "Sorafenib", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "bisaryl ureas", "em2Text": "Raf1", "label": "CPR:4"}, {"em1Text": "bisaryl ureas", "em2Text": "kinase", "label": "CPR:4"}]}
{"sentText": "Sorafenib which belongs chemically to a class that can be described as bisaryl ureas was selected for further pharmacologic characterization based on potent inhibition of Raf1 and its favorable kinase selectivity profile", "relationMentions": [{"em1Text": "Sorafenib", "em2Text": "Raf1", "label": "CPR:4"}, {"em1Text": "Sorafenib", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "bisaryl ureas", "em2Text": "Raf1", "label": "CPR:4"}, {"em1Text": "bisaryl ureas", "em2Text": "kinase", "label": "CPR:4"}]}
{"sentText": "Analysis of tumourconditioned medium indicated that bexarotene decreased the secretion of angiogenic factors and matrix metalloproteinases and increased the tissue inhibitor of matrix metalloproteinases", "relationMentions": [{"em1Text": "bexarotene", "em2Text": "matrix metalloproteinases", "label": "CPR:3"}, {"em1Text": "bexarotene", "em2Text": "matrix metalloproteinases", "label": "CPR:4"}]}
{"sentText": "Analysis of tumourconditioned medium indicated that bexarotene decreased the secretion of angiogenic factors and matrix metalloproteinases and increased the tissue inhibitor of matrix metalloproteinases", "relationMentions": [{"em1Text": "bexarotene", "em2Text": "matrix metalloproteinases", "label": "CPR:3"}, {"em1Text": "bexarotene", "em2Text": "matrix metalloproteinases", "label": "CPR:4"}]}
{"sentText": "A selective retinoid X receptor agonist bexarotene LGD1069 targretin inhibits angiogenesis and metastasis in solid tumours", "relationMentions": [{"em1Text": "retinoid X receptor", "em2Text": "bexarotene", "label": "CPR:5"}, {"em1Text": "retinoid X receptor", "em2Text": "LGD1069", "label": "CPR:5"}, {"em1Text": "retinoid X receptor", "em2Text": "targretin", "label": "CPR:5"}]}
{"sentText": "For some pharmacologic inhibitors are available including sorafenib for BRAF farnesyltransferase inhibitors for NRAS PD0325901 for mitogenactivated protein kinase extracellular signalregulated kinase kinase rapamycin analogues for mammalian target of rapamycin and agents that inhibit either vascular endothelial growth factor or its receptors", "relationMentions": [{"em1Text": "sorafenib", "em2Text": "BRAF", "label": "CPR:4"}, {"em1Text": "PD0325901", "em2Text": "mitogenactivated protein kinase", "label": "CPR:4"}, {"em1Text": "PD0325901", "em2Text": "extracellular signalregulated kinase kinase", "label": "CPR:4"}, {"em1Text": "rapamycin", "em2Text": "mammalian target of rapamycin", "label": "CPR:4"}]}
{"sentText": "Similar to the plasma membrane PS transporter Atp8a1 is activated only by the naturally occurring sn12glycerol isomer of PS and not the sn23glycerol stereoisomer", "relationMentions": [{"em1Text": "plasma membrane PS transporter", "em2Text": "sn12glycerol", "label": "CPR:3"}, {"em1Text": "Atp8a1", "em2Text": "sn12glycerol", "label": "CPR:3"}]}
{"sentText": "Weakly translocated lipids PE phosphatidylhydroxypropionate and phosphatidylhomoserine are also weak Atp8a1 activators", "relationMentions": [{"em1Text": "PE", "em2Text": "Atp8a1", "label": "CPR:3"}, {"em1Text": "phosphatidylhydroxypropionate", "em2Text": "Atp8a1", "label": "CPR:3"}, {"em1Text": "phosphatidylhomoserine", "em2Text": "Atp8a1", "label": "CPR:3"}]}
{"sentText": "These results indicate that the ATPase activity of the secretory granule Atp8a1 is activated by phospholipids binding to a specific site whose properties PS selectivity dependence upon glycerol but not serine stereochemistry and vanadate sensitivity are similar to but distinct from the properties of the substrate binding site of the plasma membrane flippase", "relationMentions": [{"em1Text": "ATPase", "em2Text": "PS", "label": "CPR:3"}, {"em1Text": "Atp8a1", "em2Text": "PS", "label": "CPR:3"}]}
{"sentText": "The purified Atp8a1 is inactive in detergent micelles or in micelles containing phosphatidylcholine phosphatidic acid or phosphatidylinositol is minimally activated by phosphatidylglycerol or phosphatidylethanolamine PE and is maximally activated by PS", "relationMentions": [{"em1Text": "Atp8a1", "em2Text": "phosphatidylglycerol", "label": "CPR:3"}, {"em1Text": "Atp8a1", "em2Text": "phosphatidylethanolamine", "label": "CPR:3"}, {"em1Text": "Atp8a1", "em2Text": "PE", "label": "CPR:3"}, {"em1Text": "Atp8a1", "em2Text": "PS", "label": "CPR:3"}]}
{"sentText": "Activation of Atp8a1 is also reduced by these modifications phosphatidylserineOmethyl ester lysophosphatidylserine glycerophosphoserine and phosphoserine which are not transported by the plasma membrane flippase do not activate Atp8a1", "relationMentions": [{"em1Text": "Atp8a1", "em2Text": "phosphatidylserineOmethyl ester", "label": "CPR:4"}, {"em1Text": "Atp8a1", "em2Text": "lysophosphatidylserine", "label": "CPR:4"}, {"em1Text": "Atp8a1", "em2Text": "glycerophosphoserine", "label": "CPR:4"}, {"em1Text": "Atp8a1", "em2Text": "phosphoserine", "label": "CPR:4"}]}
{"sentText": "Sorafenib BAY 439006 is a smallmolecule inhibitor that has been shown to target members of multiple classes of tyrosine kinases that are known to be involved in tumor cell proliferation and tumor angiogenesis", "relationMentions": [{"em1Text": "Sorafenib", "em2Text": "tyrosine kinases", "label": "CPR:4"}, {"em1Text": "BAY 439006", "em2Text": "tyrosine kinases", "label": "CPR:4"}]}
{"sentText": "Both H2S solution prepared by bubbling pure H2S gas and NaSH a H2S donor dose dependently induced HO1 expression through the activation of the extracellular signalregulated kinase ERK", "relationMentions": [{"em1Text": "H2S", "em2Text": "HO1", "label": "CPR:3"}, {"em1Text": "H2S", "em2Text": "extracellular signalregulated kinase", "label": "CPR:3"}, {"em1Text": "H2S", "em2Text": "ERK", "label": "CPR:3"}]}
{"sentText": "CO treatment also inhibited LPSinduced NO production and iNOS expression via its inactivation of NFkappaB", "relationMentions": [{"em1Text": "CO", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "CO", "em2Text": "NFkappaB", "label": "CPR:4"}, {"em1Text": "NO", "em2Text": "iNOS", "label": "CPR:9"}]}
{"sentText": "CO treatment also inhibited LPSinduced NO production and iNOS expression via its inactivation of NFkappaB", "relationMentions": [{"em1Text": "CO", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "CO", "em2Text": "NFkappaB", "label": "CPR:4"}, {"em1Text": "NO", "em2Text": "iNOS", "label": "CPR:9"}]}
{"sentText": "Here we show that at noncytotoxic concentrations H2S was able to inhibit NO production and inducible NO synthase iNOS expression via heme oxygenase HO1 expression in RAW2647 macrophages stimulated with lipopolysaccharide LPS", "relationMentions": [{"em1Text": "H2S", "em2Text": "inducible NO synthase", "label": "CPR:4"}, {"em1Text": "H2S", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "NO", "em2Text": "inducible NO synthase", "label": "CPR:9"}, {"em1Text": "NO", "em2Text": "iNOS", "label": "CPR:9"}]}
{"sentText": "Here we show that at noncytotoxic concentrations H2S was able to inhibit NO production and inducible NO synthase iNOS expression via heme oxygenase HO1 expression in RAW2647 macrophages stimulated with lipopolysaccharide LPS", "relationMentions": [{"em1Text": "H2S", "em2Text": "inducible NO synthase", "label": "CPR:4"}, {"em1Text": "H2S", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "NO", "em2Text": "inducible NO synthase", "label": "CPR:9"}, {"em1Text": "NO", "em2Text": "iNOS", "label": "CPR:9"}]}
{"sentText": "Pretreatment with H2S or NaHS significantly inhibited LPSinduced iNOS expression and NO production", "relationMentions": [{"em1Text": "H2S", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "NaHS", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "iNOS", "em2Text": "NO", "label": "CPR:9"}]}
{"sentText": "Moreover NO production in LPSstimulated macrophages that are expressing CSE mRNA was significantly reduced by the addition of LCys a substrate for H2S but enhanced by the selective CSE inhibitor betacyanoLalanine but not by the CBS inhibitor aminooxyacetic acid", "relationMentions": [{"em1Text": "CSE", "em2Text": "betacyanoLalanine", "label": "CPR:4"}, {"em1Text": "CBS", "em2Text": "aminooxyacetic acid", "label": "CPR:4"}, {"em1Text": "CSE", "em2Text": "LCys", "label": "CPR:9"}]}
{"sentText": "Hydrogen sulfide H2S a regulatory gaseous molecule that is endogenously synthesized by cystathionine gammalyase CSE andor cystathionine betasynthase CBS from Lcysteine LCys metabolism is a putative vasodilator and its role in nitric oxide NO production is unexplored", "relationMentions": [{"em1Text": "CSE", "em2Text": "Lcysteine", "label": "CPR:9"}, {"em1Text": "cystathionine betasynthase", "em2Text": "Lcysteine", "label": "CPR:9"}, {"em1Text": "CBS", "em2Text": "Lcysteine", "label": "CPR:9"}, {"em1Text": "cystathionine gammalyase", "em2Text": "Lcysteine", "label": "CPR:9"}, {"em1Text": "CSE", "em2Text": "LCys", "label": "CPR:9"}, {"em1Text": "cystathionine betasynthase", "em2Text": "LCys", "label": "CPR:9"}, {"em1Text": "CBS", "em2Text": "LCys", "label": "CPR:9"}, {"em1Text": "cystathionine gammalyase", "em2Text": "LCys", "label": "CPR:9"}, {"em1Text": "H2S", "em2Text": "CSE", "label": "CPR:9"}, {"em1Text": "H2S", "em2Text": "cystathionine betasynthase", "label": "CPR:9"}, {"em1Text": "H2S", "em2Text": "CBS", "label": "CPR:9"}, {"em1Text": "H2S", "em2Text": "cystathionine gammalyase", "label": "CPR:9"}, {"em1Text": "Hydrogen sulfide", "em2Text": "CSE", "label": "CPR:9"}, {"em1Text": "Hydrogen sulfide", "em2Text": "cystathionine betasynthase", "label": "CPR:9"}, {"em1Text": "Hydrogen sulfide", "em2Text": "CBS", "label": "CPR:9"}, {"em1Text": "Hydrogen sulfide", "em2Text": "cystathionine gammalyase", "label": "CPR:9"}]}
{"sentText": "Hydrogen sulfide H2S a regulatory gaseous molecule that is endogenously synthesized by cystathionine gammalyase CSE andor cystathionine betasynthase CBS from Lcysteine LCys metabolism is a putative vasodilator and its role in nitric oxide NO production is unexplored", "relationMentions": [{"em1Text": "CSE", "em2Text": "Lcysteine", "label": "CPR:9"}, {"em1Text": "cystathionine betasynthase", "em2Text": "Lcysteine", "label": "CPR:9"}, {"em1Text": "CBS", "em2Text": "Lcysteine", "label": "CPR:9"}, {"em1Text": "cystathionine gammalyase", "em2Text": "Lcysteine", "label": "CPR:9"}, {"em1Text": "CSE", "em2Text": "LCys", "label": "CPR:9"}, {"em1Text": "cystathionine betasynthase", "em2Text": "LCys", "label": "CPR:9"}, {"em1Text": "CBS", "em2Text": "LCys", "label": "CPR:9"}, {"em1Text": "cystathionine gammalyase", "em2Text": "LCys", "label": "CPR:9"}, {"em1Text": "H2S", "em2Text": "CSE", "label": "CPR:9"}, {"em1Text": "H2S", "em2Text": "cystathionine betasynthase", "label": "CPR:9"}, {"em1Text": "H2S", "em2Text": "CBS", "label": "CPR:9"}, {"em1Text": "H2S", "em2Text": "cystathionine gammalyase", "label": "CPR:9"}, {"em1Text": "Hydrogen sulfide", "em2Text": "CSE", "label": "CPR:9"}, {"em1Text": "Hydrogen sulfide", "em2Text": "cystathionine betasynthase", "label": "CPR:9"}, {"em1Text": "Hydrogen sulfide", "em2Text": "CBS", "label": "CPR:9"}, {"em1Text": "Hydrogen sulfide", "em2Text": "cystathionine gammalyase", "label": "CPR:9"}]}
{"sentText": "Larg is converted to urea by arginase I in the liver and arginase II in the kidney", "relationMentions": [{"em1Text": "Larg", "em2Text": "arginase I", "label": "CPR:9"}, {"em1Text": "Larg", "em2Text": "arginase II", "label": "CPR:9"}, {"em1Text": "urea", "em2Text": "arginase I", "label": "CPR:9"}, {"em1Text": "urea", "em2Text": "arginase II", "label": "CPR:9"}]}
{"sentText": "Larg is converted to urea by arginase I in the liver and arginase II in the kidney", "relationMentions": [{"em1Text": "Larg", "em2Text": "arginase I", "label": "CPR:9"}, {"em1Text": "Larg", "em2Text": "arginase II", "label": "CPR:9"}, {"em1Text": "urea", "em2Text": "arginase I", "label": "CPR:9"}, {"em1Text": "urea", "em2Text": "arginase II", "label": "CPR:9"}]}
{"sentText": "Sources of Larg include dietary proteins and endogenous synthesis by argininosuccinate synthetase and argininosuccinate lyase", "relationMentions": [{"em1Text": "Larg", "em2Text": "argininosuccinate synthetase", "label": "CPR:9"}, {"em1Text": "Larg", "em2Text": "argininosuccinate lyase", "label": "CPR:9"}]}
{"sentText": "However several promising nonpeptide vasopressin receptor antagonists have been described these agents are VPA985 lixivaptan YM087 conivaptan OPC41061 tolvaptan and SR121463", "relationMentions": [{"em1Text": "vasopressin receptor", "em2Text": "VPA985", "label": "CPR:6"}, {"em1Text": "vasopressin receptor", "em2Text": "lixivaptan", "label": "CPR:6"}, {"em1Text": "vasopressin receptor", "em2Text": "YM087", "label": "CPR:6"}, {"em1Text": "vasopressin receptor", "em2Text": "conivaptan", "label": "CPR:6"}, {"em1Text": "vasopressin receptor", "em2Text": "OPC41061", "label": "CPR:6"}, {"em1Text": "vasopressin receptor", "em2Text": "tolvaptan", "label": "CPR:6"}, {"em1Text": "vasopressin receptor", "em2Text": "SR121463", "label": "CPR:6"}]}
{"sentText": "Sedation and histamine H1receptor antagonism studies in man with the enantiomers of chlorpheniramine and dimethindene", "relationMentions": [{"em1Text": "histamine H1receptor", "em2Text": "dimethindene", "label": "CPR:6"}, {"em1Text": "histamine H1receptor", "em2Text": "chlorpheniramine", "label": "CPR:6"}]}
{"sentText": "BG also showed a protective effect in the presence of a DNA polymerase beta inhibitor cytosine arabinoside3phosphate AraC demonstrating that BG does not act through an antimutagenic mechanism of action involving DNA polymerase beta", "relationMentions": [{"em1Text": "DNA polymerase beta", "em2Text": "cytosine arabinoside3phosphate", "label": "CPR:4"}, {"em1Text": "DNA polymerase beta", "em2Text": "AraC", "label": "CPR:4"}]}
{"sentText": "Diacylglycerol DAG acts as an allosteric activator of protein kinase C PKC and is converted to phosphatidic acid by DAG kinase DGK", "relationMentions": [{"em1Text": "phosphatidic acid", "em2Text": "DAG kinase", "label": "CPR:9"}, {"em1Text": "phosphatidic acid", "em2Text": "DGK", "label": "CPR:9"}, {"em1Text": "Diacylglycerol", "em2Text": "DAG kinase", "label": "CPR:9"}, {"em1Text": "Diacylglycerol", "em2Text": "DGK", "label": "CPR:9"}, {"em1Text": "DAG", "em2Text": "DAG kinase", "label": "CPR:9"}, {"em1Text": "DAG", "em2Text": "DGK", "label": "CPR:9"}]}
{"sentText": "Diacylglycerol DAG acts as an allosteric activator of protein kinase C PKC and is converted to phosphatidic acid by DAG kinase DGK", "relationMentions": [{"em1Text": "phosphatidic acid", "em2Text": "DAG kinase", "label": "CPR:9"}, {"em1Text": "phosphatidic acid", "em2Text": "DGK", "label": "CPR:9"}, {"em1Text": "Diacylglycerol", "em2Text": "DAG kinase", "label": "CPR:9"}, {"em1Text": "Diacylglycerol", "em2Text": "DGK", "label": "CPR:9"}, {"em1Text": "DAG", "em2Text": "DAG kinase", "label": "CPR:9"}, {"em1Text": "DAG", "em2Text": "DGK", "label": "CPR:9"}]}
{"sentText": "It has been known for decades that lithium chloride LiCl leads to Dmyoinositol 1phosphate accumulation on GPCR activation by inhibiting inositol monophosphatase the final enzyme of the IP3 metabolic cascade", "relationMentions": [{"em1Text": "lithium chloride", "em2Text": "GPCR", "label": "CPR:3"}, {"em1Text": "LiCl", "em2Text": "GPCR", "label": "CPR:3"}, {"em1Text": "lithium chloride", "em2Text": "inositol monophosphatase", "label": "CPR:4"}, {"em1Text": "LiCl", "em2Text": "inositol monophosphatase", "label": "CPR:4"}, {"em1Text": "Dmyoinositol 1phosphate", "em2Text": "inositol monophosphatase", "label": "CPR:9"}, {"em1Text": "inositol monophosphatase", "em2Text": "IP3", "label": "CPR:9"}]}
{"sentText": "It has been known for decades that lithium chloride LiCl leads to Dmyoinositol 1phosphate accumulation on GPCR activation by inhibiting inositol monophosphatase the final enzyme of the IP3 metabolic cascade", "relationMentions": [{"em1Text": "lithium chloride", "em2Text": "GPCR", "label": "CPR:3"}, {"em1Text": "LiCl", "em2Text": "GPCR", "label": "CPR:3"}, {"em1Text": "lithium chloride", "em2Text": "inositol monophosphatase", "label": "CPR:4"}, {"em1Text": "LiCl", "em2Text": "inositol monophosphatase", "label": "CPR:4"}, {"em1Text": "Dmyoinositol 1phosphate", "em2Text": "inositol monophosphatase", "label": "CPR:9"}, {"em1Text": "inositol monophosphatase", "em2Text": "IP3", "label": "CPR:9"}]}
{"sentText": "Phospholipase C beta PLCbetacoupled G proteincoupled receptor GPCR activities traditionally are assessed by measuring Ca2 triggered by Dmyoinositol 145trisphosphate IP3 a PLCbeta hydrolysis product or by measuring the production of inositol phosphate using cumbersome radioactive assays", "relationMentions": [{"em1Text": "PLCbeta", "em2Text": "Dmyoinositol 145trisphosphate", "label": "CPR:9"}, {"em1Text": "PLCbeta", "em2Text": "IP3", "label": "CPR:9"}, {"em1Text": "PLCbeta", "em2Text": "inositol phosphate", "label": "CPR:9"}]}
{"sentText": "Once formed the molecule can be converted to glycine by alanineglyoxylate aminotransferase AGAT", "relationMentions": [{"em1Text": "glycine", "em2Text": "alanineglyoxylate aminotransferase", "label": "CPR:9"}, {"em1Text": "glycine", "em2Text": "AGAT", "label": "CPR:9"}]}
{"sentText": "inactivation of cortisol to cortisone to prevent activation of the mineralocorticoid receptor MR by cortisol", "relationMentions": [{"em1Text": "cortisol", "em2Text": "mineralocorticoid receptor", "label": "CPR:3"}, {"em1Text": "cortisol", "em2Text": "MR", "label": "CPR:3"}]}
{"sentText": "11BetaHSD1 activates cortisone to cortisol to facilitate glucocorticoid receptor GRmediated action", "relationMentions": [{"em1Text": "11BetaHSD1", "em2Text": "cortisone", "label": "CPR:9"}, {"em1Text": "11BetaHSD1", "em2Text": "cortisol", "label": "CPR:9"}]}
{"sentText": "ATRA regulates gene expression via the activation of the retinoic acid receptor RARalpha in human DCs and RARalpha acutely regulates CD1d expression", "relationMentions": [{"em1Text": "ATRA", "em2Text": "retinoic acid receptor RARalpha", "label": "CPR:3"}, {"em1Text": "ATRA", "em2Text": "RARalpha", "label": "CPR:3"}, {"em1Text": "ATRA", "em2Text": "CD1d", "label": "CPR:3"}]}
{"sentText": "Here we demonstrate that PPARgamma turns on retinoic acid synthesis by inducing the expression of retinol and retinal metabolizing enzymes such as retinol dehydrogenase 10 and retinaldehyde dehydrogenase type 2 RALDH2", "relationMentions": [{"em1Text": "retinoic acid", "em2Text": "retinol dehydrogenase 10", "label": "CPR:9"}, {"em1Text": "retinoic acid", "em2Text": "retinaldehyde dehydrogenase type 2", "label": "CPR:9"}, {"em1Text": "retinoic acid", "em2Text": "RALDH2", "label": "CPR:9"}, {"em1Text": "retinol", "em2Text": "retinol dehydrogenase 10", "label": "CPR:9"}, {"em1Text": "retinol", "em2Text": "retinaldehyde dehydrogenase type 2", "label": "CPR:9"}, {"em1Text": "retinol", "em2Text": "RALDH2", "label": "CPR:9"}, {"em1Text": "retinal", "em2Text": "retinol dehydrogenase 10", "label": "CPR:9"}, {"em1Text": "retinal", "em2Text": "retinaldehyde dehydrogenase type 2", "label": "CPR:9"}, {"em1Text": "retinal", "em2Text": "RALDH2", "label": "CPR:9"}]}
{"sentText": "Here we demonstrate that PPARgamma turns on retinoic acid synthesis by inducing the expression of retinol and retinal metabolizing enzymes such as retinol dehydrogenase 10 and retinaldehyde dehydrogenase type 2 RALDH2", "relationMentions": [{"em1Text": "retinoic acid", "em2Text": "retinol dehydrogenase 10", "label": "CPR:9"}, {"em1Text": "retinoic acid", "em2Text": "retinaldehyde dehydrogenase type 2", "label": "CPR:9"}, {"em1Text": "retinoic acid", "em2Text": "RALDH2", "label": "CPR:9"}, {"em1Text": "retinol", "em2Text": "retinol dehydrogenase 10", "label": "CPR:9"}, {"em1Text": "retinol", "em2Text": "retinaldehyde dehydrogenase type 2", "label": "CPR:9"}, {"em1Text": "retinol", "em2Text": "RALDH2", "label": "CPR:9"}, {"em1Text": "retinal", "em2Text": "retinol dehydrogenase 10", "label": "CPR:9"}, {"em1Text": "retinal", "em2Text": "retinaldehyde dehydrogenase type 2", "label": "CPR:9"}, {"em1Text": "retinal", "em2Text": "RALDH2", "label": "CPR:9"}]}
{"sentText": "CONTEXT Ramelteon is a novel MT1 and MT2 melatonin receptor selective agonist recently approved for insomnia treatment", "relationMentions": [{"em1Text": "Ramelteon", "em2Text": "MT1", "label": "CPR:5"}, {"em1Text": "Ramelteon", "em2Text": "MT2 melatonin receptor", "label": "CPR:5"}]}
{"sentText": "Late INa induced by the VGSC long QT mutant R1623Q was reduced by resveratrol and quercetin", "relationMentions": [{"em1Text": "VGSC", "em2Text": "resveratrol", "label": "CPR:4"}, {"em1Text": "R1623Q", "em2Text": "resveratrol", "label": "CPR:4"}, {"em1Text": "VGSC", "em2Text": "quercetin", "label": "CPR:4"}, {"em1Text": "R1623Q", "em2Text": "quercetin", "label": "CPR:4"}]}
{"sentText": "Late INa induced by the VGSC long QT mutant R1623Q was reduced by resveratrol and quercetin", "relationMentions": [{"em1Text": "VGSC", "em2Text": "resveratrol", "label": "CPR:4"}, {"em1Text": "R1623Q", "em2Text": "resveratrol", "label": "CPR:4"}, {"em1Text": "VGSC", "em2Text": "quercetin", "label": "CPR:4"}, {"em1Text": "R1623Q", "em2Text": "quercetin", "label": "CPR:4"}]}
{"sentText": "Enhancement of radiosensitivity by topoisomerase II inhibitor amrubicin and amrubicinol in human lung adenocarcinoma A549 cells and kinetics of apoptosis and necrosis induction", "relationMentions": [{"em1Text": "topoisomerase II", "em2Text": "amrubicin", "label": "CPR:4"}, {"em1Text": "topoisomerase II", "em2Text": "amrubicinol", "label": "CPR:4"}]}
{"sentText": "Similar to AMR and AMROH adriamycin and etoposide VP16 are DNA topoisomerase II inhibitors", "relationMentions": [{"em1Text": "AMR", "em2Text": "DNA topoisomerase II", "label": "CPR:4"}, {"em1Text": "AMROH", "em2Text": "DNA topoisomerase II", "label": "CPR:4"}, {"em1Text": "adriamycin", "em2Text": "DNA topoisomerase II", "label": "CPR:4"}, {"em1Text": "etoposide", "em2Text": "DNA topoisomerase II", "label": "CPR:4"}, {"em1Text": "VP16", "em2Text": "DNA topoisomerase II", "label": "CPR:4"}]}
{"sentText": "It was therefore proposed that H pylori may in fact antagonize aspirin induced delay of ulcer healing due to suppression of acid secretion by the enhancement in PGE2 possibly derived from COX2 expression and activity and to the overexpression of growth factors such as TGF alpha and VEGF", "relationMentions": [{"em1Text": "aspirin", "em2Text": "TGF alpha", "label": "CPR:3"}, {"em1Text": "aspirin", "em2Text": "VEGF", "label": "CPR:3"}, {"em1Text": "aspirin", "em2Text": "COX2", "label": "CPR:3"}, {"em1Text": "PGE2", "em2Text": "COX2", "label": "CPR:9"}]}
{"sentText": "It was therefore proposed that H pylori may in fact antagonize aspirin induced delay of ulcer healing due to suppression of acid secretion by the enhancement in PGE2 possibly derived from COX2 expression and activity and to the overexpression of growth factors such as TGF alpha and VEGF", "relationMentions": [{"em1Text": "aspirin", "em2Text": "TGF alpha", "label": "CPR:3"}, {"em1Text": "aspirin", "em2Text": "VEGF", "label": "CPR:3"}, {"em1Text": "aspirin", "em2Text": "COX2", "label": "CPR:3"}, {"em1Text": "PGE2", "em2Text": "COX2", "label": "CPR:9"}]}
{"sentText": "Methylthioadenosine phosphorylase MTAP salvages purines by releasing adenine from methylthioadenosine and is often deleted in mesothelioma", "relationMentions": [{"em1Text": "Methylthioadenosine phosphorylase", "em2Text": "adenine", "label": "CPR:9"}, {"em1Text": "MTAP", "em2Text": "adenine", "label": "CPR:9"}, {"em1Text": "Methylthioadenosine phosphorylase", "em2Text": "methylthioadenosine", "label": "CPR:9"}, {"em1Text": "MTAP", "em2Text": "methylthioadenosine", "label": "CPR:9"}]}
{"sentText": "Methylthioadenosine phosphorylase MTAP salvages purines by releasing adenine from methylthioadenosine and is often deleted in mesothelioma", "relationMentions": [{"em1Text": "Methylthioadenosine phosphorylase", "em2Text": "adenine", "label": "CPR:9"}, {"em1Text": "MTAP", "em2Text": "adenine", "label": "CPR:9"}, {"em1Text": "Methylthioadenosine phosphorylase", "em2Text": "methylthioadenosine", "label": "CPR:9"}, {"em1Text": "MTAP", "em2Text": "methylthioadenosine", "label": "CPR:9"}]}
{"sentText": "The most active of these compounds gliquidone is shown to be as potent as pioglitazone at inducing PPARgamma target gene expression", "relationMentions": [{"em1Text": "gliquidone", "em2Text": "PPARgamma", "label": "CPR:3"}, {"em1Text": "pioglitazone", "em2Text": "PPARgamma", "label": "CPR:3"}]}
{"sentText": "Most drugs currently employed in the treatment of type 2 diabetes either target the sulfonylurea receptor stimulating insulin release sulfonylureas glinides or target the peroxisome proliferatoractivated receptor PPARgamma improving insulin resistance thiazolidinediones", "relationMentions": [{"em1Text": "insulin", "em2Text": "sulfonylureas", "label": "CPR:3"}, {"em1Text": "insulin", "em2Text": "glinides", "label": "CPR:3"}]}
{"sentText": "Among the measured compounds gliquidone and glipizide two sulfonylureas as well as nateglinide a glinide exhibit PPARgamma agonistic activity at concentrations comparable with those reached under pharmacological treatment", "relationMentions": [{"em1Text": "gliquidone", "em2Text": "PPARgamma", "label": "CPR:5"}, {"em1Text": "glipizide", "em2Text": "PPARgamma", "label": "CPR:5"}, {"em1Text": "sulfonylureas", "em2Text": "PPARgamma", "label": "CPR:5"}, {"em1Text": "nateglinide", "em2Text": "PPARgamma", "label": "CPR:5"}, {"em1Text": "glinide", "em2Text": "PPARgamma", "label": "CPR:5"}]}
{"sentText": "Glinides sulfonylureas and other acidified sulfonamides may be promising leads in the development of new PPARgamma agonists", "relationMentions": [{"em1Text": "Glinides", "em2Text": "PPARgamma", "label": "CPR:5"}, {"em1Text": "sulfonylureas", "em2Text": "PPARgamma", "label": "CPR:5"}, {"em1Text": "acidified sulfonamides", "em2Text": "PPARgamma", "label": "CPR:5"}]}
{"sentText": "Our work shows that sulfonylureas and glinides additionally bind to PPARgamma and exhibit PPARgamma agonistic activity", "relationMentions": [{"em1Text": "sulfonylureas", "em2Text": "PPARgamma", "label": "CPR:5"}, {"em1Text": "glinides", "em2Text": "PPARgamma", "label": "CPR:5"}]}
{"sentText": "By using pharmacological and genetic manipulation of phosphodiesterases PDEs we demonstrate that compartmentalized PDE4B and PDE4D are responsible for selectively modulating the concentration of cAMP in individual subcellular compartments", "relationMentions": [{"em1Text": "PDE4B", "em2Text": "cAMP", "label": "CPR:9"}, {"em1Text": "PDE4D", "em2Text": "cAMP", "label": "CPR:9"}]}
{"sentText": "SKBr3 cells cultured in the presence of topoisomerase IIalpha TOP2A inhibitors doxorubicin and etopoxide VP16 demonstrated a 2 to 3fold increase in FAS promoter activity when compared with control cells growing in drugfree culture conditions", "relationMentions": [{"em1Text": "doxorubicin", "em2Text": "FAS promoter", "label": "CPR:3"}, {"em1Text": "etopoxide", "em2Text": "FAS promoter", "label": "CPR:3"}, {"em1Text": "VP16", "em2Text": "FAS promoter", "label": "CPR:3"}, {"em1Text": "topoisomerase IIalpha", "em2Text": "doxorubicin", "label": "CPR:4"}, {"em1Text": "TOP2A", "em2Text": "doxorubicin", "label": "CPR:4"}, {"em1Text": "topoisomerase IIalpha", "em2Text": "etopoxide", "label": "CPR:4"}, {"em1Text": "TOP2A", "em2Text": "etopoxide", "label": "CPR:4"}, {"em1Text": "topoisomerase IIalpha", "em2Text": "VP16", "label": "CPR:4"}, {"em1Text": "TOP2A", "em2Text": "VP16", "label": "CPR:4"}]}
{"sentText": "SKBr3 cells cultured in the presence of topoisomerase IIalpha TOP2A inhibitors doxorubicin and etopoxide VP16 demonstrated a 2 to 3fold increase in FAS promoter activity when compared with control cells growing in drugfree culture conditions", "relationMentions": [{"em1Text": "doxorubicin", "em2Text": "FAS promoter", "label": "CPR:3"}, {"em1Text": "etopoxide", "em2Text": "FAS promoter", "label": "CPR:3"}, {"em1Text": "VP16", "em2Text": "FAS promoter", "label": "CPR:3"}, {"em1Text": "topoisomerase IIalpha", "em2Text": "doxorubicin", "label": "CPR:4"}, {"em1Text": "TOP2A", "em2Text": "doxorubicin", "label": "CPR:4"}, {"em1Text": "topoisomerase IIalpha", "em2Text": "etopoxide", "label": "CPR:4"}, {"em1Text": "TOP2A", "em2Text": "etopoxide", "label": "CPR:4"}, {"em1Text": "topoisomerase IIalpha", "em2Text": "VP16", "label": "CPR:4"}, {"em1Text": "TOP2A", "em2Text": "VP16", "label": "CPR:4"}]}
{"sentText": "RESULTS The expression of endometrial ERalpha PRAB PRB and SRC1 was increased significantly after 1 week of mifepristone but the increase was no longer seen after 10 weeks", "relationMentions": [{"em1Text": "ERalpha", "em2Text": "mifepristone", "label": "CPR:3"}, {"em1Text": "PRAB", "em2Text": "mifepristone", "label": "CPR:3"}, {"em1Text": "PRB", "em2Text": "mifepristone", "label": "CPR:3"}, {"em1Text": "SRC1", "em2Text": "mifepristone", "label": "CPR:3"}]}
{"sentText": "CONCLUSIONS Shortterm exposure of mifepristone in new starters of DMPA increases the expression of endometrial ERalpha PRAB PRB and SRC1 and promotes cell proliferation", "relationMentions": [{"em1Text": "mifepristone", "em2Text": "ERalpha", "label": "CPR:3"}, {"em1Text": "mifepristone", "em2Text": "PRAB", "label": "CPR:3"}, {"em1Text": "mifepristone", "em2Text": "PRB", "label": "CPR:3"}, {"em1Text": "mifepristone", "em2Text": "SRC1", "label": "CPR:3"}]}
{"sentText": "Levels of mRNA encoding insulin 1 ICA512 and PC13 were increased in the pancreatic islets of GalN treated rats", "relationMentions": [{"em1Text": "insulin 1", "em2Text": "GalN", "label": "CPR:3"}, {"em1Text": "ICA512", "em2Text": "GalN", "label": "CPR:3"}]}
{"sentText": "This mRNA level elevation was not prevented by pretreatment with actinomycin D When the PTBbinding site in insulin 1 mRNA was incubated with the islet cytosolic fraction the RNAprotein complex level was increased in the cytosolic fraction obtained from GalN treated rats compared to the level in control rats", "relationMentions": [{"em1Text": "PTBbinding site", "em2Text": "GalN", "label": "CPR:3"}, {"em1Text": "insulin 1", "em2Text": "GalN", "label": "CPR:3"}]}
{"sentText": "Pranlukast ketamine and edaravone decreased NMDAinduced injury pranlukast 01 mgkg and ketamine inhibited the upregulated expression of the CysLT1 receptor", "relationMentions": [{"em1Text": "pranlukast", "em2Text": "CysLT1 receptor", "label": "CPR:4"}, {"em1Text": "ketamine", "em2Text": "CysLT1 receptor", "label": "CPR:4"}]}
{"sentText": "We have previously demonstrated that phosphorylation of Fasassociated death domaincontaining protein FADD at 194 serine through cjun NH2terminal kinase JNK activation sensitizes breast cancer cells to chemotherapy through accelerating cell cycle arrest at G2M and that Bcl2 phosphorylation downstream of JNKFADD plays an important role in cell growth suppression by paclitaxel", "relationMentions": [{"em1Text": "Fasassociated death domaincontaining protein", "em2Text": "paclitaxel", "label": "CPR:3"}, {"em1Text": "FADD", "em2Text": "paclitaxel", "label": "CPR:3"}, {"em1Text": "cjun NH2terminal kinase", "em2Text": "paclitaxel", "label": "CPR:3"}, {"em1Text": "JNK", "em2Text": "paclitaxel", "label": "CPR:3"}]}
{"sentText": "The vasopressor response to the calcium channel activator BAYK8644 which is mediated through the opening of voltage dependent calcium channels and the subsequent translocation of extracellular calcium was significantly inhibited by carvedilol 1 mgkg iv suggesting that carvedilol is also a calcium channel antagonist consistent with our previous in vitro studies", "relationMentions": [{"em1Text": "calcium channel", "em2Text": "BAYK8644", "label": "CPR:3"}, {"em1Text": "BAYK8644", "em2Text": "voltage dependent calcium channels", "label": "CPR:3"}, {"em1Text": "voltage dependent calcium channels", "em2Text": "carvedilol", "label": "CPR:4"}, {"em1Text": "calcium channel", "em2Text": "carvedilol", "label": "CPR:6"}, {"em1Text": "calcium", "em2Text": "voltage dependent calcium channels", "label": "CPR:9"}]}
{"sentText": "The vasopressor response to the calcium channel activator BAYK8644 which is mediated through the opening of voltage dependent calcium channels and the subsequent translocation of extracellular calcium was significantly inhibited by carvedilol 1 mgkg iv suggesting that carvedilol is also a calcium channel antagonist consistent with our previous in vitro studies", "relationMentions": [{"em1Text": "calcium channel", "em2Text": "BAYK8644", "label": "CPR:3"}, {"em1Text": "BAYK8644", "em2Text": "voltage dependent calcium channels", "label": "CPR:3"}, {"em1Text": "voltage dependent calcium channels", "em2Text": "carvedilol", "label": "CPR:4"}, {"em1Text": "calcium channel", "em2Text": "carvedilol", "label": "CPR:6"}, {"em1Text": "calcium", "em2Text": "voltage dependent calcium channels", "label": "CPR:9"}]}
{"sentText": "These results highlight the importance of PR activation of the Src MAPK signaling pathway for progesterone induced transcription of select target genes and cell cycle progression", "relationMentions": [{"em1Text": "PR", "em2Text": "progesterone", "label": "CPR:3"}, {"em1Text": "Src", "em2Text": "progesterone", "label": "CPR:3"}, {"em1Text": "MAPK", "em2Text": "progesterone", "label": "CPR:3"}]}
{"sentText": "Progestin activation of Src MAPK occurred outside the nucleus with the B isoform of PR that was distributed between the cytoplasm and nucleus but not with PRA that was predominantly nuclear", "relationMentions": [{"em1Text": "Progestin", "em2Text": "Src", "label": "CPR:3"}, {"em1Text": "Progestin", "em2Text": "MAPK", "label": "CPR:3"}]}
{"sentText": "Progestin induction of the cyclin D1 gene which lacks a progesterone response element was dependent on PR activation of the Src MAPK pathway whereas induction of the Sgk serum and glucocorticoid regulated kinase gene that contains a functional progesterone response element was unaffected by mutations that interfere with PR activation of Src", "relationMentions": [{"em1Text": "Progestin", "em2Text": "PR", "label": "CPR:3"}, {"em1Text": "Progestin", "em2Text": "Src", "label": "CPR:3"}, {"em1Text": "Progestin", "em2Text": "MAPK", "label": "CPR:3"}]}
{"sentText": "SecS required selenophosphate and Ophosphoseryl tRNASerSec as substrates to generate selenocysteyl tRNASerSec", "relationMentions": [{"em1Text": "SecS", "em2Text": "Ophosphoseryl", "label": "CPR:9"}, {"em1Text": "SecS", "em2Text": "selenocysteyl", "label": "CPR:9"}, {"em1Text": "SecS", "em2Text": "selenophosphate", "label": "CPR:9"}]}
{"sentText": "The GRIP1 reduction was inhibited by MK801 an Nmethyldaspartate NMDA receptor antagonist but not by 6cyano7nitroquinoxaline23dione CNQX an AMPA receptor antagonist", "relationMentions": [{"em1Text": "GRIP1", "em2Text": "MK801", "label": "CPR:3"}, {"em1Text": "MK801", "em2Text": "Nmethyldaspartate NMDA receptor", "label": "CPR:6"}, {"em1Text": "6cyano7nitroquinoxaline23dione", "em2Text": "AMPA receptor", "label": "CPR:6"}, {"em1Text": "CNQX", "em2Text": "AMPA receptor", "label": "CPR:6"}]}
{"sentText": "EGTA and 12bis2aminophenoxyethaneNNNNtetra acetic acid tetrakis BAPTA two Ca2 chelators but not nifedipine an Ltype Ca2 channel blocker prevented GRIP1 degradation", "relationMentions": [{"em1Text": "EGTA", "em2Text": "GRIP1", "label": "CPR:3"}, {"em1Text": "12bis2aminophenoxyethaneNNNNtetra acetic acid tetrakis", "em2Text": "GRIP1", "label": "CPR:3"}, {"em1Text": "BAPTA", "em2Text": "GRIP1", "label": "CPR:3"}, {"em1Text": "nifedipine", "em2Text": "Ltype Ca2 channel", "label": "CPR:4"}]}
{"sentText": "Downregulation of GRIP1 by glutamate was blocked by carbobenzoxylleucinylleucinylleucinal MG132 a proteasome inhibitor and by expression of K48Rubiquitin a dominant negative form of ubiquitin", "relationMentions": [{"em1Text": "MG132", "em2Text": "proteasome", "label": "CPR:4"}, {"em1Text": "GRIP1", "em2Text": "glutamate", "label": "CPR:4"}, {"em1Text": "carbobenzoxylleucinylleucinylleucinal", "em2Text": "proteasome", "label": "CPR:4"}]}
{"sentText": "RESULTS Leukotriene D4 upregulated MUC25AC gene expression and mucin secretion in a dose dependent pattern", "relationMentions": [{"em1Text": "Leukotriene D4", "em2Text": "MUC25AC", "label": "CPR:3"}, {"em1Text": "Leukotriene D4", "em2Text": "mucin", "label": "CPR:3"}]}
{"sentText": "The inhibitory effect of the leukotriene receptor antagonist on leukotriene D4 induced MUC25AC gene expression and mucin secretion in human airway epithelial cells", "relationMentions": [{"em1Text": "leukotriene D4", "em2Text": "mucin", "label": "CPR:3"}, {"em1Text": "leukotriene D4", "em2Text": "MUC25AC", "label": "CPR:3"}]}
{"sentText": "Pranlukast hydrate ONO1078 100 microM downregulated the leukotriene D4 induced MUC25AC gene expression and mucin secretion", "relationMentions": [{"em1Text": "leukotriene D4", "em2Text": "MUC25AC", "label": "CPR:3"}, {"em1Text": "leukotriene D4", "em2Text": "mucin", "label": "CPR:3"}, {"em1Text": "Pranlukast hydrate", "em2Text": "MUC25AC", "label": "CPR:4"}, {"em1Text": "Pranlukast hydrate", "em2Text": "mucin", "label": "CPR:4"}, {"em1Text": "ONO1078", "em2Text": "MUC25AC", "label": "CPR:4"}, {"em1Text": "ONO1078", "em2Text": "mucin", "label": "CPR:4"}]}
{"sentText": "Pranlukast hydrate ONO1078 100 microM downregulated the leukotriene D4 induced MUC25AC gene expression and mucin secretion", "relationMentions": [{"em1Text": "leukotriene D4", "em2Text": "MUC25AC", "label": "CPR:3"}, {"em1Text": "leukotriene D4", "em2Text": "mucin", "label": "CPR:3"}, {"em1Text": "Pranlukast hydrate", "em2Text": "MUC25AC", "label": "CPR:4"}, {"em1Text": "Pranlukast hydrate", "em2Text": "mucin", "label": "CPR:4"}, {"em1Text": "ONO1078", "em2Text": "MUC25AC", "label": "CPR:4"}, {"em1Text": "ONO1078", "em2Text": "mucin", "label": "CPR:4"}]}
{"sentText": "METHODS The effect of leukotriene D4 and the leukotriene receptor antagonist pranlukast hydrate ONO1078 on the regulation of MUC25AC gene expression and mucin secretion were observed in human airway NCIH292 epithelial cells", "relationMentions": [{"em1Text": "leukotriene receptor", "em2Text": "pranlukast hydrate", "label": "CPR:6"}, {"em1Text": "leukotriene receptor", "em2Text": "ONO1078", "label": "CPR:6"}]}
{"sentText": "However as a novel finding isoflavone treatment increased a subclass of highdensity lipoprotein the prebeta highdensity lipoprotein levels by 18 without affecting any other serum lipid concentrations", "relationMentions": [{"em1Text": "isoflavone", "em2Text": "highdensity lipoprotein", "label": "CPR:3"}, {"em1Text": "isoflavone", "em2Text": "prebeta highdensity lipoprotein", "label": "CPR:3"}]}
{"sentText": "We studied in a clinical trial whether isolated isoflavone treatment in postmenopausal women could affect reverse cholesterol transport as evaluated by adenosine triphosphatebinding cassette A1 ABCA1 dependent cholesterol efflux from macrophages", "relationMentions": [{"em1Text": "cholesterol", "em2Text": "adenosine triphosphatebinding cassette A1", "label": "CPR:9"}, {"em1Text": "cholesterol", "em2Text": "ABCA1", "label": "CPR:9"}]}
{"sentText": "We investigated the efficacy of sorafenib at inhibiting mutants of the receptor tyrosine kinases PDGFRbeta KIT and FLT3 which are implicated in the pathogenesis of myeloid malignancies", "relationMentions": [{"em1Text": "sorafenib", "em2Text": "receptor tyrosine kinases", "label": "CPR:4"}, {"em1Text": "sorafenib", "em2Text": "PDGFRbeta", "label": "CPR:4"}, {"em1Text": "sorafenib", "em2Text": "KIT", "label": "CPR:4"}, {"em1Text": "sorafenib", "em2Text": "FLT3", "label": "CPR:4"}]}
{"sentText": "The ability of sorafenib to inhibit oncogenic PDGFRbeta and FLT3 mutants and overcome resistance to other small molecule inhibitors", "relationMentions": [{"em1Text": "sorafenib", "em2Text": "PDGFRbeta", "label": "CPR:4"}, {"em1Text": "sorafenib", "em2Text": "FLT3", "label": "CPR:4"}]}
{"sentText": "RESULTS We show that sorafenib is a potent inhibitor of ETV6 PDGFRbeta and FLT3 mutants including some of the mutants that confer resistance to PKC412 and other FLT3 inhibitors", "relationMentions": [{"em1Text": "sorafenib", "em2Text": "ETV6", "label": "CPR:4"}, {"em1Text": "sorafenib", "em2Text": "PDGFRbeta", "label": "CPR:4"}, {"em1Text": "sorafenib", "em2Text": "FLT3", "label": "CPR:4"}]}
{"sentText": "Sorafenib BAY439006 Nexavar is a small molecule BRAF inhibitor that is used for the treatment of renal cell carcinoma and has been shown to have activity against receptor tyrosine kinases from the plateletderived growth factor receptor PDGFR and vascular endothelial growth factor receptor VEGFR families", "relationMentions": [{"em1Text": "Sorafenib", "em2Text": "BRAF", "label": "CPR:4"}, {"em1Text": "BAY439006", "em2Text": "BRAF", "label": "CPR:4"}, {"em1Text": "Nexavar", "em2Text": "BRAF", "label": "CPR:4"}]}
{"sentText": "INTERPRETATION AND CONCLUSIONS These results warrant further clinical studies of sorafenib for the treatment of myeloid malignancies expressing activated forms of PDGFRbeta and FLT3", "relationMentions": [{"em1Text": "sorafenib", "em2Text": "PDGFRbeta", "label": "CPR:4"}, {"em1Text": "sorafenib", "em2Text": "FLT3", "label": "CPR:4"}]}
{"sentText": "Oral aspirin as a representative of the salicylate family inhibited diabetesinduced increase in NFkappaB DNAbinding affinity in electrophoretic mobility shift assay and transcription factor array in nuclear extract isolated from whole retina", "relationMentions": [{"em1Text": "aspirin", "em2Text": "NFkappaB", "label": "CPR:4"}, {"em1Text": "salicylate", "em2Text": "NFkappaB", "label": "CPR:4"}]}
{"sentText": "All three salicylates inhibited the diabetesinduced translocation of p50 a subunit of NFkappaB into nuclei of retinal vascular endothelial cells of the isolated retinal vasculature as well as of p50 and p65 into nuclei of cells in the ganglion cell layer and inner nuclear layer on wholeretinal sections", "relationMentions": [{"em1Text": "salicylates", "em2Text": "p50", "label": "CPR:4"}, {"em1Text": "salicylates", "em2Text": "NFkappaB", "label": "CPR:4"}, {"em1Text": "salicylates", "em2Text": "p65", "label": "CPR:4"}]}
{"sentText": "Sulfasalazine also as a representative of the salicylates inhibited the diabetesinduced upregulation of several inflammatory gene products which are regulated by NFkappaB including vascular cell adhesion molecule intracellular adhesion molecule1 inducible nitric oxide synthase and cyclooxygenase2 in wholeretinal lysate", "relationMentions": [{"em1Text": "Sulfasalazine", "em2Text": "NFkappaB", "label": "CPR:4"}, {"em1Text": "Sulfasalazine", "em2Text": "intracellular adhesion molecule1", "label": "CPR:4"}, {"em1Text": "Sulfasalazine", "em2Text": "inducible nitric oxide synthase", "label": "CPR:4"}, {"em1Text": "Sulfasalazine", "em2Text": "cyclooxygenase2", "label": "CPR:4"}, {"em1Text": "salicylates", "em2Text": "NFkappaB", "label": "CPR:4"}]}
{"sentText": "Sulfasalazine also as a representative of the salicylates inhibited the diabetesinduced upregulation of several inflammatory gene products which are regulated by NFkappaB including vascular cell adhesion molecule intracellular adhesion molecule1 inducible nitric oxide synthase and cyclooxygenase2 in wholeretinal lysate", "relationMentions": [{"em1Text": "Sulfasalazine", "em2Text": "NFkappaB", "label": "CPR:4"}, {"em1Text": "Sulfasalazine", "em2Text": "intracellular adhesion molecule1", "label": "CPR:4"}, {"em1Text": "Sulfasalazine", "em2Text": "inducible nitric oxide synthase", "label": "CPR:4"}, {"em1Text": "Sulfasalazine", "em2Text": "cyclooxygenase2", "label": "CPR:4"}, {"em1Text": "salicylates", "em2Text": "NFkappaB", "label": "CPR:4"}]}
{"sentText": "In addition activation of protein kinase C and increases in intracellular cAMP also enhance cholinergic activity in T cells and lymphocyte function associated antigen1 LFA1 CD11a CD18 is an important mediator of leukocyte migration and T cell activation", "relationMentions": [{"em1Text": "cAMP", "em2Text": "lymphocyte function associated antigen1", "label": "CPR:3"}, {"em1Text": "cAMP", "em2Text": "LFA1", "label": "CPR:3"}, {"em1Text": "cAMP", "em2Text": "CD11a", "label": "CPR:3"}, {"em1Text": "cAMP", "em2Text": "CD18", "label": "CPR:3"}]}
{"sentText": "Lymphocytes possess the essential components of a cholinergic system including acetylcholine ACh choline acetyltransferase ChAT its synthesizing enzyme and both muscarinic and nicotinic ACh receptors mAChRs and nAChRs respectively", "relationMentions": [{"em1Text": "ACh", "em2Text": "choline acetyltransferase", "label": "CPR:9"}, {"em1Text": "ACh", "em2Text": "ChAT", "label": "CPR:9"}, {"em1Text": "acetylcholine", "em2Text": "choline acetyltransferase", "label": "CPR:9"}, {"em1Text": "acetylcholine", "em2Text": "ChAT", "label": "CPR:9"}]}
{"sentText": "Lymphocytes possess the essential components of a cholinergic system including acetylcholine ACh choline acetyltransferase ChAT its synthesizing enzyme and both muscarinic and nicotinic ACh receptors mAChRs and nAChRs respectively", "relationMentions": [{"em1Text": "ACh", "em2Text": "choline acetyltransferase", "label": "CPR:9"}, {"em1Text": "ACh", "em2Text": "ChAT", "label": "CPR:9"}, {"em1Text": "acetylcholine", "em2Text": "choline acetyltransferase", "label": "CPR:9"}, {"em1Text": "acetylcholine", "em2Text": "ChAT", "label": "CPR:9"}]}
{"sentText": "INTRODUCTION Medroxyprogesterone acetate MPA induces estrogen receptor ER positive and progesterone receptor PR positive ductal invasive mammary carcinomas in BALBc mice", "relationMentions": [{"em1Text": "MPA", "em2Text": "PR", "label": "CPR:3"}, {"em1Text": "MPA", "em2Text": "estrogen receptor", "label": "CPR:3"}, {"em1Text": "MPA", "em2Text": "ER", "label": "CPR:3"}, {"em1Text": "Medroxyprogesterone acetate", "em2Text": "PR", "label": "CPR:3"}, {"em1Text": "Medroxyprogesterone acetate", "em2Text": "estrogen receptor", "label": "CPR:3"}, {"em1Text": "Medroxyprogesterone acetate", "em2Text": "ER", "label": "CPR:3"}, {"em1Text": "Medroxyprogesterone acetate", "em2Text": "progesterone receptor", "label": "CPR:3"}]}
{"sentText": "INTRODUCTION Medroxyprogesterone acetate MPA induces estrogen receptor ER positive and progesterone receptor PR positive ductal invasive mammary carcinomas in BALBc mice", "relationMentions": [{"em1Text": "MPA", "em2Text": "PR", "label": "CPR:3"}, {"em1Text": "MPA", "em2Text": "estrogen receptor", "label": "CPR:3"}, {"em1Text": "MPA", "em2Text": "ER", "label": "CPR:3"}, {"em1Text": "Medroxyprogesterone acetate", "em2Text": "PR", "label": "CPR:3"}, {"em1Text": "Medroxyprogesterone acetate", "em2Text": "estrogen receptor", "label": "CPR:3"}, {"em1Text": "Medroxyprogesterone acetate", "em2Text": "ER", "label": "CPR:3"}, {"em1Text": "Medroxyprogesterone acetate", "em2Text": "progesterone receptor", "label": "CPR:3"}]}
{"sentText": "The expression of ERalpha and PR isoform A in virgin mice was surprisingly much higher in BALBc than in C57BL6 mammary glands and both receptors were downregulated in progestin treated BALBc mice P 005", "relationMentions": [{"em1Text": "ERalpha", "em2Text": "progestin", "label": "CPR:4"}, {"em1Text": "PR isoform A", "em2Text": "progestin", "label": "CPR:4"}]}
{"sentText": "Various genes controlled by estrogen including Xinactivespecific transcript anterior gradient2 trefoil factor1 CRPductin ghrelin and small prolinerich protein2A were dramatically overexpressed", "relationMentions": [{"em1Text": "estrogen", "em2Text": "Xinactivespecific transcript", "label": "CPR:3"}, {"em1Text": "estrogen", "em2Text": "anterior gradient2", "label": "CPR:3"}, {"em1Text": "estrogen", "em2Text": "trefoil factor1", "label": "CPR:3"}, {"em1Text": "estrogen", "em2Text": "CRPductin", "label": "CPR:3"}, {"em1Text": "estrogen", "em2Text": "ghrelin", "label": "CPR:3"}, {"em1Text": "estrogen", "em2Text": "small prolinerich protein2A", "label": "CPR:3"}]}
{"sentText": "Estrogen regulated genes including cytokeratin 119 and Cyp2a4 were overexpressed although Cyp3a25 was suppressed", "relationMentions": [{"em1Text": "Estrogen", "em2Text": "Cyp2a4", "label": "CPR:3"}, {"em1Text": "Estrogen", "em2Text": "cytokeratin 119", "label": "CPR:3"}, {"em1Text": "Estrogen", "em2Text": "Cyp3a25", "label": "CPR:4"}]}
{"sentText": "Several genes involved with steroid metabolism also showed remarkable expression changes including increased expression of 17betahydroxysteroid dehydrogenase7 HSD17beta7 involved in estradiol production and decreased expression of HSD17beta5 involved in testosterone production", "relationMentions": [{"em1Text": "17betahydroxysteroid dehydrogenase7", "em2Text": "estradiol", "label": "CPR:9"}, {"em1Text": "HSD17beta7", "em2Text": "estradiol", "label": "CPR:9"}, {"em1Text": "HSD17beta5", "em2Text": "testosterone", "label": "CPR:9"}]}
{"sentText": "The expression of key genes important in methionine metabolism such as methionine adenosyltransferase1a betainehomocysteine methyltransferase and thioether Smethyltransferase were suppressed", "relationMentions": [{"em1Text": "methionine", "em2Text": "methionine adenosyltransferase1a", "label": "CPR:9"}, {"em1Text": "methionine", "em2Text": "betainehomocysteine methyltransferase", "label": "CPR:9"}, {"em1Text": "methionine", "em2Text": "thioether Smethyltransferase", "label": "CPR:9"}]}
{"sentText": "In summary phenformin and metformin increase AMPK activity and phosphorylation in the isolated heart", "relationMentions": [{"em1Text": "phenformin", "em2Text": "AMPK", "label": "CPR:3"}, {"em1Text": "metformin", "em2Text": "AMPK", "label": "CPR:3"}]}
{"sentText": "Metformin and phenformin which are biguanides have been reported to increase AMPK activity without increasing AMPATP", "relationMentions": [{"em1Text": "Metformin", "em2Text": "AMPK", "label": "CPR:3"}, {"em1Text": "phenformin", "em2Text": "AMPK", "label": "CPR:3"}, {"em1Text": "biguanides", "em2Text": "AMPK", "label": "CPR:3"}]}
{"sentText": "In hearts treated with metformin AMP was increased at 50 min and AMPK activity phosphorylated AMPK and phosphorylated acetylCoA carboxylase were elevated at 61 min", "relationMentions": [{"em1Text": "metformin", "em2Text": "AMPK", "label": "CPR:3"}, {"em1Text": "metformin", "em2Text": "phosphorylated acetylCoA carboxylase", "label": "CPR:3"}]}
{"sentText": "Metformin and phenformin activate AMPactivated protein kinase in the heart by increasing cytosolic AMP concentration", "relationMentions": [{"em1Text": "Metformin", "em2Text": "AMPactivated protein kinase", "label": "CPR:3"}, {"em1Text": "phenformin", "em2Text": "AMPactivated protein kinase", "label": "CPR:3"}]}
{"sentText": "In the current project we found that the selective H1 antagonist pyrilamine also reversed the dizocilpine induced impairment in PPI of tactile startle with an auditory prepulse", "relationMentions": [{"em1Text": "H1", "em2Text": "dizocilpine", "label": "CPR:3"}, {"em1Text": "H1", "em2Text": "pyrilamine", "label": "CPR:6"}]}
{"sentText": "Furthermore the enzymatic activity of alanine aminotransferase ALT which converts the critical gluconeogenic amino acid alanine into pyruvate is decreased approximately 50 in KLF15 hepatocytes", "relationMentions": [{"em1Text": "alanine aminotransferase", "em2Text": "amino acid", "label": "CPR:9"}, {"em1Text": "ALT", "em2Text": "amino acid", "label": "CPR:9"}, {"em1Text": "alanine", "em2Text": "alanine aminotransferase", "label": "CPR:9"}, {"em1Text": "alanine", "em2Text": "ALT", "label": "CPR:9"}, {"em1Text": "alanine aminotransferase", "em2Text": "pyruvate", "label": "CPR:9"}, {"em1Text": "ALT", "em2Text": "pyruvate", "label": "CPR:9"}]}
{"sentText": "Furthermore the enzymatic activity of alanine aminotransferase ALT which converts the critical gluconeogenic amino acid alanine into pyruvate is decreased approximately 50 in KLF15 hepatocytes", "relationMentions": [{"em1Text": "alanine aminotransferase", "em2Text": "amino acid", "label": "CPR:9"}, {"em1Text": "ALT", "em2Text": "amino acid", "label": "CPR:9"}, {"em1Text": "alanine", "em2Text": "alanine aminotransferase", "label": "CPR:9"}, {"em1Text": "alanine", "em2Text": "ALT", "label": "CPR:9"}, {"em1Text": "alanine aminotransferase", "em2Text": "pyruvate", "label": "CPR:9"}, {"em1Text": "ALT", "em2Text": "pyruvate", "label": "CPR:9"}]}
{"sentText": "TGFbeta1 and high Dglucose increased hCAT1 mRNA expression approximately 8fold and maximal transport velocity Vmax L3Hcitrulline formation from L3Harginine index of NO synthesis and endothelial NO synthase eNOS protein abundance but did not alter eNOS phosphorylation", "relationMentions": [{"em1Text": "Dglucose", "em2Text": "hCAT1", "label": "CPR:3"}, {"em1Text": "NO", "em2Text": "endothelial NO synthase", "label": "CPR:9"}, {"em1Text": "NO", "em2Text": "eNOS", "label": "CPR:9"}]}
{"sentText": "High Dglucose increases Larginine transport and eNOS expression following TbetaRII activation by TGFbeta1 involving p4244mapk and Smad2 in HUVEC", "relationMentions": [{"em1Text": "Dglucose", "em2Text": "eNOS", "label": "CPR:3"}, {"em1Text": "Dglucose", "em2Text": "TbetaRII", "label": "CPR:3"}, {"em1Text": "Dglucose", "em2Text": "Smad2", "label": "CPR:3"}]}
{"sentText": "Elevated extracellular Dglucose increases transforming growth factor beta1 TGFbeta1 release from human umbilical vein endothelium HUVEC", "relationMentions": [{"em1Text": "Dglucose", "em2Text": "transforming growth factor beta1", "label": "CPR:3"}, {"em1Text": "Dglucose", "em2Text": "TGFbeta1", "label": "CPR:3"}]}
{"sentText": "We demonstrate that only treatment of HaCaT with GLA and EPA or a PPARgamma ligand roziglitazone induced COX2 expression protein and mRNA", "relationMentions": [{"em1Text": "GLA", "em2Text": "COX2", "label": "CPR:3"}, {"em1Text": "EPA", "em2Text": "COX2", "label": "CPR:3"}, {"em1Text": "roziglitazone", "em2Text": "COX2", "label": "CPR:3"}]}
{"sentText": "Moreover stimulation of COX2 promoter activity was increased by those PUFAs or rosiglitazone", "relationMentions": [{"em1Text": "COX2 promoter", "em2Text": "PUFAs", "label": "CPR:3"}, {"em1Text": "COX2 promoter", "em2Text": "rosiglitazone", "label": "CPR:3"}]}
{"sentText": "n3 and n6 polyunsaturated fatty acids induce the expression of COX2 via PPARgamma activation in human keratinocyte HaCaT cells", "relationMentions": [{"em1Text": "n3 and n6 polyunsaturated fatty acids", "em2Text": "COX2", "label": "CPR:3"}, {"em1Text": "n3 and n6 polyunsaturated fatty acids", "em2Text": "PPARgamma", "label": "CPR:3"}]}
{"sentText": "These findings demonstrate that n3 and n6 PUFA increased PPARgamma activity is necessary for the COX2 induction in HaCaT human keratinocyte cells", "relationMentions": [{"em1Text": "n3 and n6 PUFA", "em2Text": "PPARgamma", "label": "CPR:3"}, {"em1Text": "n3 and n6 PUFA", "em2Text": "COX2", "label": "CPR:3"}]}
{"sentText": "The inhibitory effects of GW9662 and T0070907 PPARgamma antagonists on COX2 expression and on stimulation of COX2 promoter activity by EPA and GLA suggest that PPARgamma is implicated in COX2 induction", "relationMentions": [{"em1Text": "GW9662", "em2Text": "PPARgamma", "label": "CPR:6"}, {"em1Text": "T0070907", "em2Text": "PPARgamma", "label": "CPR:6"}]}
{"sentText": "Acetylcoenzyme A carboxylase ACC enzymes exist as two isoforms ACC1 and ACC2 which play critical roles in fatty acid biosynthesis and oxidation", "relationMentions": [{"em1Text": "Acetylcoenzyme A carboxylase", "em2Text": "fatty acid", "label": "CPR:9"}, {"em1Text": "ACC", "em2Text": "fatty acid", "label": "CPR:9"}, {"em1Text": "ACC1", "em2Text": "fatty acid", "label": "CPR:9"}, {"em1Text": "ACC2", "em2Text": "fatty acid", "label": "CPR:9"}]}
{"sentText": "In contrast the RA catabolising enzymes Cyp26A1 and Cyp26B1 which are known to be RAresponsive were not expressed at all in the developing eye", "relationMentions": [{"em1Text": "RA", "em2Text": "Cyp26A1", "label": "CPR:9"}, {"em1Text": "RA", "em2Text": "Cyp26B1", "label": "CPR:9"}]}
{"sentText": "Npiperidin1yl54chlorophenyl4methyl1Hpyrazole3carboxyamide SR 141716A a selective cannabinoid CB1 receptor antagonist injected into the paraventricular nucleus of the hypothalamus PVN of male rats induces penile erection", "relationMentions": [{"em1Text": "SR 141716A", "em2Text": "cannabinoid CB1 receptor", "label": "CPR:6"}, {"em1Text": "Npiperidin1yl54chlorophenyl4methyl1Hpyrazole3carboxyamide", "em2Text": "cannabinoid CB1 receptor", "label": "CPR:6"}]}
{"sentText": "Modulation of the function of CD36 CD36 mice p38 MAPK SB203580 COX1 indomethacin and glycoprotein Ib alpha Nkprotease 6D1 antibody induced approximately 50 inhibition", "relationMentions": [{"em1Text": "p38", "em2Text": "SB203580", "label": "CPR:4"}, {"em1Text": "MAPK", "em2Text": "SB203580", "label": "CPR:4"}, {"em1Text": "COX1", "em2Text": "indomethacin", "label": "CPR:4"}]}
{"sentText": "In this study the neuromuscular blocking drug vecuronium and the controls gallamine and pancuronium slowed the rate of atropine induced 3HNmethylscopolamine dissociation from Chinese hamster ovary cells expressing recombinant human muscarinic M2 receptors Koff values min1 vecuronium 125 nM atropine 045007blocker 004002 gallamine 21 nM atropine 042005blocker 015004 pancuronium21 nM atropine 036003blocker 003001", "relationMentions": [{"em1Text": "vecuronium", "em2Text": "human muscarinic M2 receptors", "label": "CPR:4"}, {"em1Text": "gallamine", "em2Text": "human muscarinic M2 receptors", "label": "CPR:4"}, {"em1Text": "pancuronium", "em2Text": "human muscarinic M2 receptors", "label": "CPR:4"}]}
{"sentText": "The transcriptional activity of torafugu PPARalpha1 was enhanced 45 and 115fold by Wy14643 and 581114eicosatetraynoic acid ETYA each at 10 microM respectively whereas that of PPARalpha2 45 and 73fold at the same concentration of the respective ligands respectively", "relationMentions": [{"em1Text": "PPARalpha1", "em2Text": "Wy14643", "label": "CPR:3"}, {"em1Text": "Wy14643", "em2Text": "PPARalpha2", "label": "CPR:3"}, {"em1Text": "PPARalpha1", "em2Text": "581114eicosatetraynoic acid", "label": "CPR:3"}, {"em1Text": "581114eicosatetraynoic acid", "em2Text": "PPARalpha2", "label": "CPR:3"}, {"em1Text": "PPARalpha1", "em2Text": "ETYA", "label": "CPR:3"}, {"em1Text": "ETYA", "em2Text": "PPARalpha2", "label": "CPR:3"}]}
{"sentText": "The transcriptional activity of torafugu PPARalpha1 was enhanced 45 and 115fold by Wy14643 and 581114eicosatetraynoic acid ETYA each at 10 microM respectively whereas that of PPARalpha2 45 and 73fold at the same concentration of the respective ligands respectively", "relationMentions": [{"em1Text": "PPARalpha1", "em2Text": "Wy14643", "label": "CPR:3"}, {"em1Text": "Wy14643", "em2Text": "PPARalpha2", "label": "CPR:3"}, {"em1Text": "PPARalpha1", "em2Text": "581114eicosatetraynoic acid", "label": "CPR:3"}, {"em1Text": "581114eicosatetraynoic acid", "em2Text": "PPARalpha2", "label": "CPR:3"}, {"em1Text": "PPARalpha1", "em2Text": "ETYA", "label": "CPR:3"}, {"em1Text": "ETYA", "em2Text": "PPARalpha2", "label": "CPR:3"}]}
{"sentText": "Furthermore the activities of the two torafugu PPARalphas were enhanced 43 and 76fold by arachidonic acid 44 and 52fold by docosahexaenoic acid and 67 and 80fold by eicosapentaenoic acid each at 50 microM respectively", "relationMentions": [{"em1Text": "torafugu PPARalphas", "em2Text": "arachidonic acid", "label": "CPR:3"}, {"em1Text": "torafugu PPARalphas", "em2Text": "docosahexaenoic acid", "label": "CPR:3"}, {"em1Text": "torafugu PPARalphas", "em2Text": "eicosapentaenoic acid", "label": "CPR:3"}]}
{"sentText": "Combination chemotherapy with a substance P receptor antagonist aprepitant and melarsoprol in a mouse model of human African trypanosomiasis", "relationMentions": [{"em1Text": "substance P receptor", "em2Text": "aprepitant", "label": "CPR:6"}, {"em1Text": "substance P receptor", "em2Text": "melarsoprol", "label": "CPR:6"}]}
{"sentText": "In this study we investigated the effects of combination chemotherapy with melarsoprol and a humanised SP receptor antagonist aprepitant EMEND in this mouse model", "relationMentions": [{"em1Text": "humanised SP receptor", "em2Text": "aprepitant", "label": "CPR:6"}, {"em1Text": "humanised SP receptor", "em2Text": "EMEND", "label": "CPR:6"}]}
{"sentText": "Using this assay we found that both superoxide and nitric oxide inhibit renal cortical DDAH activity in vitro", "relationMentions": [{"em1Text": "superoxide", "em2Text": "DDAH", "label": "CPR:4"}, {"em1Text": "nitric oxide", "em2Text": "DDAH", "label": "CPR:4"}]}
{"sentText": "Dimethylarginine dimethylaminohydrolase DDAH metabolizes asymmetric dimethylarginine to generate Lcitrulline and is present in large quantities in the kidney", "relationMentions": [{"em1Text": "Dimethylarginine dimethylaminohydrolase", "em2Text": "Lcitrulline", "label": "CPR:9"}, {"em1Text": "DDAH", "em2Text": "Lcitrulline", "label": "CPR:9"}, {"em1Text": "Dimethylarginine dimethylaminohydrolase", "em2Text": "dimethylarginine", "label": "CPR:9"}, {"em1Text": "DDAH", "em2Text": "dimethylarginine", "label": "CPR:9"}]}
{"sentText": "Dimethylarginine dimethylaminohydrolase DDAH metabolizes asymmetric dimethylarginine to generate Lcitrulline and is present in large quantities in the kidney", "relationMentions": [{"em1Text": "Dimethylarginine dimethylaminohydrolase", "em2Text": "Lcitrulline", "label": "CPR:9"}, {"em1Text": "DDAH", "em2Text": "Lcitrulline", "label": "CPR:9"}, {"em1Text": "Dimethylarginine dimethylaminohydrolase", "em2Text": "dimethylarginine", "label": "CPR:9"}, {"em1Text": "DDAH", "em2Text": "dimethylarginine", "label": "CPR:9"}]}
{"sentText": "The next large phase III adjuvant trial for this subset of breast cancer is an international collaboration designed to evaluate the added or alternative benefit of an oral tyrosine kinase inhibitor targeting HER2 neu as well as the epidermal growth factor receptor EGFR lapatinib", "relationMentions": [{"em1Text": "HER2", "em2Text": "lapatinib", "label": "CPR:4"}, {"em1Text": "neu", "em2Text": "lapatinib", "label": "CPR:4"}, {"em1Text": "epidermal growth factor receptor", "em2Text": "lapatinib", "label": "CPR:4"}, {"em1Text": "EGFR", "em2Text": "lapatinib", "label": "CPR:4"}]}
{"sentText": "Exposure of Jurkat cells to either 5S10R5methyl1011dihydro5Hdibenzoabcyclohepten510imine MK 801 or D2amino5phosphonopentanoic acid DAP5 two selective NMDA receptor antagonists limited cell growth by inhibiting cell cycle progression and inducing apoptosis whereas lglutamate 1 microM and NMDA 10 microM significantly increased 1372220 P001 Jurkat T cell adhesion to fibronectin", "relationMentions": [{"em1Text": "5S10R5methyl1011dihydro5Hdibenzoabcyclohepten510imine", "em2Text": "NMDA receptor", "label": "CPR:6"}, {"em1Text": "MK 801", "em2Text": "NMDA receptor", "label": "CPR:6"}, {"em1Text": "D2amino5phosphonopentanoic acid", "em2Text": "NMDA receptor", "label": "CPR:6"}, {"em1Text": "DAP5", "em2Text": "NMDA receptor", "label": "CPR:6"}]}
{"sentText": "Using hNET in transfected human embryonic kidney293 cells this difference in potency for DVS at sites labeled by 3HNIS was found to distinguish DVS the DVS analog rac113chlorophenyl24methylpiperazin1ylethylcyclohexanol WY46824 methylphenidate and the cocaine analog 3beta4iodophenyltropane2betacarboxylic acid methyl ester RTI55 from other hNET antagonists such as NIS mazindol tricyclic antidepressants and cocaine", "relationMentions": [{"em1Text": "hNET", "em2Text": "DVS", "label": "CPR:6"}, {"em1Text": "hNET", "em2Text": "rac113chlorophenyl24methylpiperazin1ylethylcyclohexanol", "label": "CPR:6"}, {"em1Text": "hNET", "em2Text": "WY46824", "label": "CPR:6"}, {"em1Text": "hNET", "em2Text": "methylphenidate", "label": "CPR:6"}, {"em1Text": "hNET", "em2Text": "cocaine", "label": "CPR:6"}, {"em1Text": "hNET", "em2Text": "3beta4iodophenyltropane2betacarboxylic acid methyl ester", "label": "CPR:6"}, {"em1Text": "hNET", "em2Text": "RTI55", "label": "CPR:6"}, {"em1Text": "hNET", "em2Text": "NIS", "label": "CPR:6"}, {"em1Text": "hNET", "em2Text": "mazindol", "label": "CPR:6"}, {"em1Text": "hNET", "em2Text": "tricyclic", "label": "CPR:6"}]}
{"sentText": "Desvenlafaxine succinate DVS is a recently introduced antagonist of the human norepinephrine and serotonin transporters hNET and hSERT respectively currently in clinical development for use in the treatment of major depressive disorder and vasomotor symptoms associated with menopause", "relationMentions": [{"em1Text": "Desvenlafaxine succinate", "em2Text": "hNET", "label": "CPR:6"}, {"em1Text": "Desvenlafaxine succinate", "em2Text": "hSERT", "label": "CPR:6"}, {"em1Text": "DVS", "em2Text": "hNET", "label": "CPR:6"}, {"em1Text": "DVS", "em2Text": "hSERT", "label": "CPR:6"}]}
{"sentText": "Desvenlafaxine succinate DVS is a recently introduced antagonist of the human norepinephrine and serotonin transporters hNET and hSERT respectively currently in clinical development for use in the treatment of major depressive disorder and vasomotor symptoms associated with menopause", "relationMentions": [{"em1Text": "Desvenlafaxine succinate", "em2Text": "hNET", "label": "CPR:6"}, {"em1Text": "Desvenlafaxine succinate", "em2Text": "hSERT", "label": "CPR:6"}, {"em1Text": "DVS", "em2Text": "hNET", "label": "CPR:6"}, {"em1Text": "DVS", "em2Text": "hSERT", "label": "CPR:6"}]}
{"sentText": "Sorafenib and sunitinib are synthetic orally active agents shown to directly inhibit vascular endothelial growth factor receptors 2 and 3 VEGFR2 VEGFR3 and plateletderived growth factor receptor beta PDGFRbeta while temsirolimus is an mTOR inhibitor", "relationMentions": [{"em1Text": "Sorafenib", "em2Text": "VEGFR2", "label": "CPR:4"}, {"em1Text": "Sorafenib", "em2Text": "VEGFR3", "label": "CPR:4"}, {"em1Text": "Sorafenib", "em2Text": "plateletderived growth factor receptor beta", "label": "CPR:4"}, {"em1Text": "Sorafenib", "em2Text": "PDGFRbeta", "label": "CPR:4"}, {"em1Text": "sunitinib", "em2Text": "VEGFR2", "label": "CPR:4"}, {"em1Text": "sunitinib", "em2Text": "VEGFR3", "label": "CPR:4"}, {"em1Text": "sunitinib", "em2Text": "plateletderived growth factor receptor beta", "label": "CPR:4"}, {"em1Text": "sunitinib", "em2Text": "PDGFRbeta", "label": "CPR:4"}, {"em1Text": "temsirolimus", "em2Text": "mTOR", "label": "CPR:4"}]}
{"sentText": "Sorafenib and sunitinib are synthetic orally active agents shown to directly inhibit vascular endothelial growth factor receptors 2 and 3 VEGFR2 VEGFR3 and plateletderived growth factor receptor beta PDGFRbeta while temsirolimus is an mTOR inhibitor", "relationMentions": [{"em1Text": "Sorafenib", "em2Text": "VEGFR2", "label": "CPR:4"}, {"em1Text": "Sorafenib", "em2Text": "VEGFR3", "label": "CPR:4"}, {"em1Text": "Sorafenib", "em2Text": "plateletderived growth factor receptor beta", "label": "CPR:4"}, {"em1Text": "Sorafenib", "em2Text": "PDGFRbeta", "label": "CPR:4"}, {"em1Text": "sunitinib", "em2Text": "VEGFR2", "label": "CPR:4"}, {"em1Text": "sunitinib", "em2Text": "VEGFR3", "label": "CPR:4"}, {"em1Text": "sunitinib", "em2Text": "plateletderived growth factor receptor beta", "label": "CPR:4"}, {"em1Text": "sunitinib", "em2Text": "PDGFRbeta", "label": "CPR:4"}, {"em1Text": "temsirolimus", "em2Text": "mTOR", "label": "CPR:4"}]}
{"sentText": "Rasagiline NpropargyllRaminoindan is a secondgeneration propargylamine pharmacophore that selectively and irreversibly inhibits brain MAOB and is specifically designed for the treatment of Parkinsons disease PD", "relationMentions": [{"em1Text": "NpropargyllRaminoindan", "em2Text": "MAOB", "label": "CPR:4"}, {"em1Text": "propargylamine", "em2Text": "MAOB", "label": "CPR:4"}, {"em1Text": "Rasagiline", "em2Text": "MAOB", "label": "CPR:4"}]}
{"sentText": "This overview focuses on the indirect antithrombin dependent pentasaccharide derivatives of idraparinux and on the most advanced oral direct inhibitors to factor Xa rivaroxaban and apixaban and IIa dabigatran", "relationMentions": [{"em1Text": "factor Xa", "em2Text": "rivaroxaban", "label": "CPR:4"}, {"em1Text": "factor Xa", "em2Text": "apixaban", "label": "CPR:4"}]}
{"sentText": "Two imidazoquinoline molecules imiquimod and gardiquimod markedly activated both porcine TLR7 and TLR8 whereas only human TLR7 but not TLR8 was activated by the ligands", "relationMentions": [{"em1Text": "imidazoquinoline", "em2Text": "porcine TLR7", "label": "CPR:3"}, {"em1Text": "imidazoquinoline", "em2Text": "TLR8", "label": "CPR:3"}, {"em1Text": "imidazoquinoline", "em2Text": "human TLR7", "label": "CPR:3"}, {"em1Text": "imiquimod", "em2Text": "porcine TLR7", "label": "CPR:3"}, {"em1Text": "imiquimod", "em2Text": "TLR8", "label": "CPR:3"}, {"em1Text": "imiquimod", "em2Text": "human TLR7", "label": "CPR:3"}, {"em1Text": "gardiquimod", "em2Text": "porcine TLR7", "label": "CPR:3"}, {"em1Text": "gardiquimod", "em2Text": "TLR8", "label": "CPR:3"}, {"em1Text": "gardiquimod", "em2Text": "human TLR7", "label": "CPR:3"}]}
{"sentText": "Two imidazoquinoline molecules imiquimod and gardiquimod markedly activated both porcine TLR7 and TLR8 whereas only human TLR7 but not TLR8 was activated by the ligands", "relationMentions": [{"em1Text": "imidazoquinoline", "em2Text": "porcine TLR7", "label": "CPR:3"}, {"em1Text": "imidazoquinoline", "em2Text": "TLR8", "label": "CPR:3"}, {"em1Text": "imidazoquinoline", "em2Text": "human TLR7", "label": "CPR:3"}, {"em1Text": "imiquimod", "em2Text": "porcine TLR7", "label": "CPR:3"}, {"em1Text": "imiquimod", "em2Text": "TLR8", "label": "CPR:3"}, {"em1Text": "imiquimod", "em2Text": "human TLR7", "label": "CPR:3"}, {"em1Text": "gardiquimod", "em2Text": "porcine TLR7", "label": "CPR:3"}, {"em1Text": "gardiquimod", "em2Text": "TLR8", "label": "CPR:3"}, {"em1Text": "gardiquimod", "em2Text": "human TLR7", "label": "CPR:3"}]}
{"sentText": "Porcine TLR8 and TLR7 are both activated by a selective TLR7 ligand imiquimod", "relationMentions": [{"em1Text": "TLR7", "em2Text": "imiquimod", "label": "CPR:3"}, {"em1Text": "TLR8", "em2Text": "imiquimod", "label": "CPR:3"}]}
{"sentText": "Estimated affinities for the fastinactivated channel state were 81 nM 312 nM and 227 nM for 4iodopropofol 4bromopropofol and 4chloropropofol in NaV14 and 450 nM for 4chloropropofol in NaV12", "relationMentions": [{"em1Text": "4iodopropofol", "em2Text": "NaV14", "label": "CPR:4"}, {"em1Text": "4bromopropofol", "em2Text": "NaV14", "label": "CPR:4"}, {"em1Text": "4chloropropofol", "em2Text": "NaV14", "label": "CPR:4"}, {"em1Text": "4chloropropofol", "em2Text": "NaV12", "label": "CPR:4"}]}
{"sentText": "Estimated affinities for the fastinactivated channel state were 81 nM 312 nM and 227 nM for 4iodopropofol 4bromopropofol and 4chloropropofol in NaV14 and 450 nM for 4chloropropofol in NaV12", "relationMentions": [{"em1Text": "4iodopropofol", "em2Text": "NaV14", "label": "CPR:4"}, {"em1Text": "4bromopropofol", "em2Text": "NaV14", "label": "CPR:4"}, {"em1Text": "4chloropropofol", "em2Text": "NaV14", "label": "CPR:4"}, {"em1Text": "4chloropropofol", "em2Text": "NaV12", "label": "CPR:4"}]}
{"sentText": "Irbesartan Aprovel Avapro Irbetan Karvea an angiotensin II receptor type 1 antagonist is approved in many countries worldwide for the treatment of hypertension", "relationMentions": [{"em1Text": "Irbesartan", "em2Text": "angiotensin II receptor type 1", "label": "CPR:6"}, {"em1Text": "Aprovel", "em2Text": "angiotensin II receptor type 1", "label": "CPR:6"}, {"em1Text": "Avapro", "em2Text": "angiotensin II receptor type 1", "label": "CPR:6"}, {"em1Text": "Irbetan", "em2Text": "angiotensin II receptor type 1", "label": "CPR:6"}, {"em1Text": "Karvea", "em2Text": "angiotensin II receptor type 1", "label": "CPR:6"}]}
{"sentText": "RTX treatment also induced foci of RAD51 gammaH2AX phosphoChk1 and phosphoNBS1 although the extent of colocalization with RPA2 foci varied", "relationMentions": [{"em1Text": "RTX", "em2Text": "RAD51", "label": "CPR:3"}, {"em1Text": "RTX", "em2Text": "gammaH2AX", "label": "CPR:3"}, {"em1Text": "RTX", "em2Text": "phosphoChk1", "label": "CPR:3"}, {"em1Text": "RTX", "em2Text": "phosphoNBS1", "label": "CPR:3"}]}
{"sentText": "DNA damage is accepted as a consequence of thymidylate deprivation induced by chemotherapeutic inhibitors of thymidylate synthase TS but the types of damage and signaling responses remain incompletely understood", "relationMentions": [{"em1Text": "thymidylate", "em2Text": "thymidylate synthase", "label": "CPR:9"}, {"em1Text": "thymidylate", "em2Text": "TS", "label": "CPR:9"}]}
{"sentText": "Nicotinic acid NA a widely used drug to lower elevated plasma lipid levels induced NNMT enzyme activity in white adipose tissue of mice", "relationMentions": [{"em1Text": "NA", "em2Text": "NNMT", "label": "CPR:3"}, {"em1Text": "Nicotinic acid", "em2Text": "NNMT", "label": "CPR:3"}]}
{"sentText": "Nicotinamide Nmethyltransferase NNMT catalyses the conversion of nicotinamide to 1methylnicotinamide and plays an important role in hepatic detoxification reactions", "relationMentions": [{"em1Text": "Nicotinamide Nmethyltransferase", "em2Text": "1methylnicotinamide", "label": "CPR:9"}, {"em1Text": "NNMT", "em2Text": "1methylnicotinamide", "label": "CPR:9"}, {"em1Text": "Nicotinamide Nmethyltransferase", "em2Text": "nicotinamide", "label": "CPR:9"}, {"em1Text": "NNMT", "em2Text": "nicotinamide", "label": "CPR:9"}]}
{"sentText": "Nicotinamide Nmethyltransferase NNMT catalyses the conversion of nicotinamide to 1methylnicotinamide and plays an important role in hepatic detoxification reactions", "relationMentions": [{"em1Text": "Nicotinamide Nmethyltransferase", "em2Text": "1methylnicotinamide", "label": "CPR:9"}, {"em1Text": "NNMT", "em2Text": "1methylnicotinamide", "label": "CPR:9"}, {"em1Text": "Nicotinamide Nmethyltransferase", "em2Text": "nicotinamide", "label": "CPR:9"}, {"em1Text": "NNMT", "em2Text": "nicotinamide", "label": "CPR:9"}]}
{"sentText": "A comparison of bosutinib with dasatinib across the whole kinase panel revealed overlapping but distinct inhibition profiles", "relationMentions": [{"em1Text": "dasatinib", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "bosutinib", "em2Text": "kinase", "label": "CPR:4"}]}
{"sentText": "Finally bosutinib is the first kinase inhibitor shown to target CAMK2G recently implicated in myeloid leukemia cell proliferation", "relationMentions": [{"em1Text": "bosutinib", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "bosutinib", "em2Text": "CAMK2G", "label": "CPR:4"}]}
{"sentText": "Here we characterized the target profile of the dual SRC ABL inhibitor bosutinib employing a twotiered approach using chemical proteomics to identify natural binders in whole cell lysates of primary CML and K562 cells in parallel to in vitro kinase assays against a large recombinant kinase panel", "relationMentions": [{"em1Text": "SRC", "em2Text": "bosutinib", "label": "CPR:4"}, {"em1Text": "ABL", "em2Text": "bosutinib", "label": "CPR:4"}]}
{"sentText": "The affinity labeling nucleotide analog 5pfluorosulfonylbenzoyladenosine FSA inactivates the dehydrogenase and isomerase activities at similar rates in an irreversible manner which follows first order kinetics with respect to both time and alkylator concentration 0206 mM", "relationMentions": [{"em1Text": "nucleotide", "em2Text": "dehydrogenase", "label": "CPR:4"}, {"em1Text": "5pfluorosulfonylbenzoyladenosine", "em2Text": "dehydrogenase", "label": "CPR:4"}, {"em1Text": "FSA", "em2Text": "dehydrogenase", "label": "CPR:4"}]}
{"sentText": "Others kinase inhibitors used recently in cancer therapy include Dasatinib BMS354825 specific for ABL nonreceptor cytoplasmic kinase Gefitinib Iressa Erlotinib OSI774 Tarceva and Sunitinib SU 11248 Sutent specific for VEGF receptor kinase AMN107 Nilotinib and INNO406 NS187 specific for cKIT kinase", "relationMentions": [{"em1Text": "SU 11248", "em2Text": "VEGF receptor", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "SU 11248", "label": "CPR:4"}, {"em1Text": "Sutent", "em2Text": "VEGF receptor", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "Sutent", "label": "CPR:4"}, {"em1Text": "AMN107", "em2Text": "cKIT", "label": "CPR:4"}, {"em1Text": "Nilotinib", "em2Text": "cKIT", "label": "CPR:4"}, {"em1Text": "INNO406", "em2Text": "cKIT", "label": "CPR:4"}, {"em1Text": "NS187", "em2Text": "cKIT", "label": "CPR:4"}, {"em1Text": "Dasatinib", "em2Text": "ABL", "label": "CPR:4"}, {"em1Text": "Dasatinib", "em2Text": "nonreceptor cytoplasmic kinase", "label": "CPR:4"}, {"em1Text": "BMS354825", "em2Text": "ABL", "label": "CPR:4"}, {"em1Text": "Gefitinib", "em2Text": "VEGF receptor", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "Gefitinib", "label": "CPR:4"}, {"em1Text": "Iressa", "em2Text": "VEGF receptor", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "Iressa", "label": "CPR:4"}, {"em1Text": "Erlotinib", "em2Text": "VEGF receptor", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "Erlotinib", "label": "CPR:4"}, {"em1Text": "OSI774", "em2Text": "VEGF receptor", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "OSI774", "label": "CPR:4"}, {"em1Text": "Tarceva", "em2Text": "VEGF receptor", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "Tarceva", "label": "CPR:4"}, {"em1Text": "Sunitinib", "em2Text": "VEGF receptor", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "Sunitinib", "label": "CPR:4"}]}
{"sentText": "Others kinase inhibitors used recently in cancer therapy include Dasatinib BMS354825 specific for ABL nonreceptor cytoplasmic kinase Gefitinib Iressa Erlotinib OSI774 Tarceva and Sunitinib SU 11248 Sutent specific for VEGF receptor kinase AMN107 Nilotinib and INNO406 NS187 specific for cKIT kinase", "relationMentions": [{"em1Text": "SU 11248", "em2Text": "VEGF receptor", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "SU 11248", "label": "CPR:4"}, {"em1Text": "Sutent", "em2Text": "VEGF receptor", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "Sutent", "label": "CPR:4"}, {"em1Text": "AMN107", "em2Text": "cKIT", "label": "CPR:4"}, {"em1Text": "Nilotinib", "em2Text": "cKIT", "label": "CPR:4"}, {"em1Text": "INNO406", "em2Text": "cKIT", "label": "CPR:4"}, {"em1Text": "NS187", "em2Text": "cKIT", "label": "CPR:4"}, {"em1Text": "Dasatinib", "em2Text": "ABL", "label": "CPR:4"}, {"em1Text": "Dasatinib", "em2Text": "nonreceptor cytoplasmic kinase", "label": "CPR:4"}, {"em1Text": "BMS354825", "em2Text": "ABL", "label": "CPR:4"}, {"em1Text": "Gefitinib", "em2Text": "VEGF receptor", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "Gefitinib", "label": "CPR:4"}, {"em1Text": "Iressa", "em2Text": "VEGF receptor", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "Iressa", "label": "CPR:4"}, {"em1Text": "Erlotinib", "em2Text": "VEGF receptor", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "Erlotinib", "label": "CPR:4"}, {"em1Text": "OSI774", "em2Text": "VEGF receptor", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "OSI774", "label": "CPR:4"}, {"em1Text": "Tarceva", "em2Text": "VEGF receptor", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "Tarceva", "label": "CPR:4"}, {"em1Text": "Sunitinib", "em2Text": "VEGF receptor", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "Sunitinib", "label": "CPR:4"}]}
{"sentText": "The following TK blockers for treatment of various human tumors are in clinical development Lapatinib Lapatinib ditosylate Tykerb GW572016 Canertinib CI1033 Zactima ZD6474 Vatalanib PTK787 ZK 222584 Sorafenib Bay 439006 Nexavar and Leflunomide SU101 Arava", "relationMentions": [{"em1Text": "TK", "em2Text": "Lapatinib", "label": "CPR:4"}, {"em1Text": "TK", "em2Text": "Lapatinib ditosylate", "label": "CPR:4"}, {"em1Text": "TK", "em2Text": "Tykerb", "label": "CPR:4"}, {"em1Text": "TK", "em2Text": "GW572016", "label": "CPR:4"}, {"em1Text": "TK", "em2Text": "Canertinib", "label": "CPR:4"}, {"em1Text": "TK", "em2Text": "CI1033", "label": "CPR:4"}, {"em1Text": "TK", "em2Text": "Zactima", "label": "CPR:4"}, {"em1Text": "TK", "em2Text": "ZD6474", "label": "CPR:4"}, {"em1Text": "TK", "em2Text": "Vatalanib", "label": "CPR:4"}, {"em1Text": "TK", "em2Text": "PTK787", "label": "CPR:4"}, {"em1Text": "TK", "em2Text": "ZK 222584", "label": "CPR:4"}, {"em1Text": "TK", "em2Text": "Sorafenib", "label": "CPR:4"}, {"em1Text": "TK", "em2Text": "Bay 439006", "label": "CPR:4"}, {"em1Text": "TK", "em2Text": "Nexavar", "label": "CPR:4"}, {"em1Text": "TK", "em2Text": "Leflunomide", "label": "CPR:4"}, {"em1Text": "TK", "em2Text": "SU101", "label": "CPR:4"}, {"em1Text": "TK", "em2Text": "Arava", "label": "CPR:4"}]}
{"sentText": "The most successful example of kinase blockers is Imatinib Imatinib mesylate Gleevec STI571 the inhibitor of Bcr Abl oncoprotein which has become a firstline therapy for chronic myelogenous leukemia", "relationMentions": [{"em1Text": "kinase", "em2Text": "Imatinib", "label": "CPR:4"}, {"em1Text": "Imatinib", "em2Text": "Bcr", "label": "CPR:4"}, {"em1Text": "Imatinib", "em2Text": "Abl", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "Imatinib mesylate", "label": "CPR:4"}, {"em1Text": "Imatinib mesylate", "em2Text": "Bcr", "label": "CPR:4"}, {"em1Text": "Imatinib mesylate", "em2Text": "Abl", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "Gleevec", "label": "CPR:4"}, {"em1Text": "Gleevec", "em2Text": "Bcr", "label": "CPR:4"}, {"em1Text": "Gleevec", "em2Text": "Abl", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "STI571", "label": "CPR:4"}, {"em1Text": "STI571", "em2Text": "Bcr", "label": "CPR:4"}, {"em1Text": "STI571", "em2Text": "Abl", "label": "CPR:4"}]}
{"sentText": "The most successful example of kinase blockers is Imatinib Imatinib mesylate Gleevec STI571 the inhibitor of Bcr Abl oncoprotein which has become a firstline therapy for chronic myelogenous leukemia", "relationMentions": [{"em1Text": "kinase", "em2Text": "Imatinib", "label": "CPR:4"}, {"em1Text": "Imatinib", "em2Text": "Bcr", "label": "CPR:4"}, {"em1Text": "Imatinib", "em2Text": "Abl", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "Imatinib mesylate", "label": "CPR:4"}, {"em1Text": "Imatinib mesylate", "em2Text": "Bcr", "label": "CPR:4"}, {"em1Text": "Imatinib mesylate", "em2Text": "Abl", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "Gleevec", "label": "CPR:4"}, {"em1Text": "Gleevec", "em2Text": "Bcr", "label": "CPR:4"}, {"em1Text": "Gleevec", "em2Text": "Abl", "label": "CPR:4"}, {"em1Text": "kinase", "em2Text": "STI571", "label": "CPR:4"}, {"em1Text": "STI571", "em2Text": "Bcr", "label": "CPR:4"}, {"em1Text": "STI571", "em2Text": "Abl", "label": "CPR:4"}]}
{"sentText": "Currently the use of orally administered MAO inhibitor antidepressants eg phenelzine tranylcypromine is limited by the risk of tyramineprovoked events eg acute hypertension and headache also known as the cheese reaction when combined with dietary tyramine", "relationMentions": [{"em1Text": "MAO", "em2Text": "phenelzine", "label": "CPR:4"}, {"em1Text": "MAO", "em2Text": "tranylcypromine", "label": "CPR:4"}]}
{"sentText": "CYP2D6 inhibitors such as paroxetine are associated with changes in atomoxetine pharmacokinetics similar to those observed among poor CYP2D6 metabolizers", "relationMentions": [{"em1Text": "CYP2D6", "em2Text": "paroxetine", "label": "CPR:4"}, {"em1Text": "CYP2D6", "em2Text": "atomoxetine", "label": "CPR:9"}]}
{"sentText": "Subsequent studies demonstrated that wildtype and hyperinsulinemiahyperammonemia forms of GDH are inhibited by the green tea polyphenols epigallocatechin gallate and epicatechin gallate", "relationMentions": [{"em1Text": "GDH", "em2Text": "epigallocatechin gallate", "label": "CPR:4"}, {"em1Text": "GDH", "em2Text": "epicatechin gallate", "label": "CPR:4"}]}
{"sentText": "Mammalian glutamate dehydrogenase GDH is a homohexameric enzyme that catalyzes the reversible oxidative deamination of lglutamate to 2oxoglutarate using NADP as coenzyme", "relationMentions": [{"em1Text": "Mammalian glutamate dehydrogenase", "em2Text": "lglutamate", "label": "CPR:9"}, {"em1Text": "GDH", "em2Text": "lglutamate", "label": "CPR:9"}, {"em1Text": "Mammalian glutamate dehydrogenase", "em2Text": "2oxoglutarate", "label": "CPR:9"}, {"em1Text": "GDH", "em2Text": "2oxoglutarate", "label": "CPR:9"}]}
{"sentText": "Mammalian glutamate dehydrogenase GDH is a homohexameric enzyme that catalyzes the reversible oxidative deamination of lglutamate to 2oxoglutarate using NADP as coenzyme", "relationMentions": [{"em1Text": "Mammalian glutamate dehydrogenase", "em2Text": "lglutamate", "label": "CPR:9"}, {"em1Text": "GDH", "em2Text": "lglutamate", "label": "CPR:9"}, {"em1Text": "Mammalian glutamate dehydrogenase", "em2Text": "2oxoglutarate", "label": "CPR:9"}, {"em1Text": "GDH", "em2Text": "2oxoglutarate", "label": "CPR:9"}]}
{"sentText": "BACKGROUND Peripheral inflammatory pain is associated with an upregulation of spinal cord COX2 cyclooxygenase2 with a subsequent increase in central prostaglandin E2 PGE2 levels associated with the development of hyperalgesia", "relationMentions": [{"em1Text": "COX2", "em2Text": "prostaglandin E2", "label": "CPR:9"}, {"em1Text": "cyclooxygenase2", "em2Text": "prostaglandin E2", "label": "CPR:9"}, {"em1Text": "COX2", "em2Text": "PGE2", "label": "CPR:9"}, {"em1Text": "cyclooxygenase2", "em2Text": "PGE2", "label": "CPR:9"}]}
{"sentText": "BACKGROUND Peripheral inflammatory pain is associated with an upregulation of spinal cord COX2 cyclooxygenase2 with a subsequent increase in central prostaglandin E2 PGE2 levels associated with the development of hyperalgesia", "relationMentions": [{"em1Text": "COX2", "em2Text": "prostaglandin E2", "label": "CPR:9"}, {"em1Text": "cyclooxygenase2", "em2Text": "prostaglandin E2", "label": "CPR:9"}, {"em1Text": "COX2", "em2Text": "PGE2", "label": "CPR:9"}, {"em1Text": "cyclooxygenase2", "em2Text": "PGE2", "label": "CPR:9"}]}
{"sentText": "The Schild plots for the competitive antagonists WB4101 and 5methylurapidil against alpha 1aadrenoceptor selective agonist methoxamine induced contraction were linear and had slopes not significantly different from unity with a pA2 of 907 007 n = 5 for WB4101 and 909 005 n = 3 for 5methylurapidil", "relationMentions": [{"em1Text": "alpha 1aadrenoceptor", "em2Text": "methoxamine", "label": "CPR:5"}, {"em1Text": "WB4101", "em2Text": "alpha 1aadrenoceptor", "label": "CPR:6"}, {"em1Text": "5methylurapidil", "em2Text": "alpha 1aadrenoceptor", "label": "CPR:6"}]}
{"sentText": "Using the alpha 1adrenoceptor subtypeselective antagonists chlorethylclonidine CEC WB4101 and 5methylurapidil we have examined the possible heterogeneity in the alpha 1adrenoceptor populations in rabbit aorta", "relationMentions": [{"em1Text": "alpha 1adrenoceptor", "em2Text": "5methylurapidil", "label": "CPR:6"}, {"em1Text": "alpha 1adrenoceptor", "em2Text": "chlorethylclonidine", "label": "CPR:6"}, {"em1Text": "alpha 1adrenoceptor", "em2Text": "CEC", "label": "CPR:6"}, {"em1Text": "alpha 1adrenoceptor", "em2Text": "WB4101", "label": "CPR:6"}]}
{"sentText": "As discussed in this review various progestogens including dydrogesterone and its 20alphadihydroderivative medrogestone promegestone nomegestrol acetate and norelgestromin can reduce intratissular levels of estradiol in breast cancer by blocking sulfatase and 17betahydroxysteroiddehydrogenase type 1 activities", "relationMentions": [{"em1Text": "promegestone", "em2Text": "sulfatase", "label": "CPR:4"}, {"em1Text": "promegestone", "em2Text": "17betahydroxysteroiddehydrogenase type 1", "label": "CPR:4"}, {"em1Text": "nomegestrol acetate", "em2Text": "sulfatase", "label": "CPR:4"}, {"em1Text": "nomegestrol acetate", "em2Text": "17betahydroxysteroiddehydrogenase type 1", "label": "CPR:4"}, {"em1Text": "norelgestromin", "em2Text": "sulfatase", "label": "CPR:4"}, {"em1Text": "norelgestromin", "em2Text": "17betahydroxysteroiddehydrogenase type 1", "label": "CPR:4"}, {"em1Text": "progestogens", "em2Text": "sulfatase", "label": "CPR:4"}, {"em1Text": "progestogens", "em2Text": "17betahydroxysteroiddehydrogenase type 1", "label": "CPR:4"}, {"em1Text": "dydrogesterone", "em2Text": "sulfatase", "label": "CPR:4"}, {"em1Text": "dydrogesterone", "em2Text": "17betahydroxysteroiddehydrogenase type 1", "label": "CPR:4"}, {"em1Text": "medrogestone", "em2Text": "sulfatase", "label": "CPR:4"}, {"em1Text": "medrogestone", "em2Text": "17betahydroxysteroiddehydrogenase type 1", "label": "CPR:4"}, {"em1Text": "estradiol", "em2Text": "sulfatase", "label": "CPR:9"}, {"em1Text": "estradiol", "em2Text": "17betahydroxysteroiddehydrogenase type 1", "label": "CPR:9"}]}
{"sentText": "As discussed in this review various progestogens including dydrogesterone and its 20alphadihydroderivative medrogestone promegestone nomegestrol acetate and norelgestromin can reduce intratissular levels of estradiol in breast cancer by blocking sulfatase and 17betahydroxysteroiddehydrogenase type 1 activities", "relationMentions": [{"em1Text": "promegestone", "em2Text": "sulfatase", "label": "CPR:4"}, {"em1Text": "promegestone", "em2Text": "17betahydroxysteroiddehydrogenase type 1", "label": "CPR:4"}, {"em1Text": "nomegestrol acetate", "em2Text": "sulfatase", "label": "CPR:4"}, {"em1Text": "nomegestrol acetate", "em2Text": "17betahydroxysteroiddehydrogenase type 1", "label": "CPR:4"}, {"em1Text": "norelgestromin", "em2Text": "sulfatase", "label": "CPR:4"}, {"em1Text": "norelgestromin", "em2Text": "17betahydroxysteroiddehydrogenase type 1", "label": "CPR:4"}, {"em1Text": "progestogens", "em2Text": "sulfatase", "label": "CPR:4"}, {"em1Text": "progestogens", "em2Text": "17betahydroxysteroiddehydrogenase type 1", "label": "CPR:4"}, {"em1Text": "dydrogesterone", "em2Text": "sulfatase", "label": "CPR:4"}, {"em1Text": "dydrogesterone", "em2Text": "17betahydroxysteroiddehydrogenase type 1", "label": "CPR:4"}, {"em1Text": "medrogestone", "em2Text": "sulfatase", "label": "CPR:4"}, {"em1Text": "medrogestone", "em2Text": "17betahydroxysteroiddehydrogenase type 1", "label": "CPR:4"}, {"em1Text": "estradiol", "em2Text": "sulfatase", "label": "CPR:9"}, {"em1Text": "estradiol", "em2Text": "17betahydroxysteroiddehydrogenase type 1", "label": "CPR:9"}]}
{"sentText": "Mitiglinide reduced fasting plasma glucose and GA levels after 4 weeks and HbA1c levels after 8 weeks", "relationMentions": [{"em1Text": "Mitiglinide", "em2Text": "GA", "label": "CPR:4"}, {"em1Text": "Mitiglinide", "em2Text": "HbA1c", "label": "CPR:4"}]}
{"sentText": "In addition another study suggests that ibuprofen reduces generation of amyloidbeta42 peptide via inactivation of RhoA signaling although it may also regulate amyloidbeta42 formation by direct inhibition of the gammasecretase complex", "relationMentions": [{"em1Text": "ibuprofen", "em2Text": "amyloidbeta42", "label": "CPR:3"}, {"em1Text": "ibuprofen", "em2Text": "amyloidbeta42", "label": "CPR:4"}, {"em1Text": "ibuprofen", "em2Text": "RhoA", "label": "CPR:4"}, {"em1Text": "ibuprofen", "em2Text": "gammasecretase complex", "label": "CPR:4"}]}
{"sentText": "In addition another study suggests that ibuprofen reduces generation of amyloidbeta42 peptide via inactivation of RhoA signaling although it may also regulate amyloidbeta42 formation by direct inhibition of the gammasecretase complex", "relationMentions": [{"em1Text": "ibuprofen", "em2Text": "amyloidbeta42", "label": "CPR:3"}, {"em1Text": "ibuprofen", "em2Text": "amyloidbeta42", "label": "CPR:4"}, {"em1Text": "ibuprofen", "em2Text": "RhoA", "label": "CPR:4"}, {"em1Text": "ibuprofen", "em2Text": "gammasecretase complex", "label": "CPR:4"}]}
{"sentText": "We determined whether an angiotensinconverting enzyme ACE inhibitor captopril inhibits MMP2 activity in peritoneal effluents from patients on CAPD and simulated molecular models of the MMP2captopril complex", "relationMentions": [{"em1Text": "angiotensinconverting enzyme", "em2Text": "captopril", "label": "CPR:4"}, {"em1Text": "ACE", "em2Text": "captopril", "label": "CPR:4"}]}
{"sentText": "Phenformin but not metformin inhibits a number of variants of KATP including the cloned equivalents of currents present in vascular and nonvascular smooth muscle Kir61 SUR2B and Kir62SUR2B and pancreatic betacells Kir62 SUR1", "relationMentions": [{"em1Text": "Phenformin", "em2Text": "KATP", "label": "CPR:4"}, {"em1Text": "Phenformin", "em2Text": "Kir61", "label": "CPR:4"}, {"em1Text": "Phenformin", "em2Text": "SUR2B", "label": "CPR:4"}, {"em1Text": "Phenformin", "em2Text": "Kir62", "label": "CPR:4"}, {"em1Text": "Phenformin", "em2Text": "SUR1", "label": "CPR:4"}]}
{"sentText": "Phenformin reduced the open probability of Kir61 SUR2B channels by approximately 90 in insideout patches", "relationMentions": [{"em1Text": "Phenformin", "em2Text": "Kir61", "label": "CPR:4"}, {"em1Text": "Phenformin", "em2Text": "SUR2B", "label": "CPR:4"}]}
{"sentText": "In pig parathyroid cells paricalcitol and the active form of doxercalciferol induced VDR translocation from the cytoplasm into the nucleus suppressed PTH mRNA expression and inhibited cell proliferation in a similar manner although paricalcitol induced the expression of CaSR mRNA more effectively", "relationMentions": [{"em1Text": "paricalcitol", "em2Text": "CaSR", "label": "CPR:3"}, {"em1Text": "paricalcitol", "em2Text": "PTH", "label": "CPR:4"}, {"em1Text": "doxercalciferol", "em2Text": "PTH", "label": "CPR:4"}]}
{"sentText": "In pig parathyroid cells paricalcitol and the active form of doxercalciferol induced VDR translocation from the cytoplasm into the nucleus suppressed PTH mRNA expression and inhibited cell proliferation in a similar manner although paricalcitol induced the expression of CaSR mRNA more effectively", "relationMentions": [{"em1Text": "paricalcitol", "em2Text": "CaSR", "label": "CPR:3"}, {"em1Text": "paricalcitol", "em2Text": "PTH", "label": "CPR:4"}, {"em1Text": "doxercalciferol", "em2Text": "PTH", "label": "CPR:4"}]}
{"sentText": "Both drugs at the tested doses 0042033 mugkg suppressed PTH mRNA expression and serum PTH effectively in the 56 NX rats but paricalcitol was less potent in raising serum Ca than doxercalciferol", "relationMentions": [{"em1Text": "PTH", "em2Text": "paricalcitol", "label": "CPR:4"}, {"em1Text": "PTH", "em2Text": "doxercalciferol", "label": "CPR:4"}]}
{"sentText": "Recent studies indicate that tamoxifen initially acts as an antagonist but later functions as an ER agonist promoting tumor growth", "relationMentions": [{"em1Text": "tamoxifen", "em2Text": "ER", "label": "CPR:5"}, {"em1Text": "tamoxifen", "em2Text": "ER", "label": "CPR:6"}]}
{"sentText": "Recent studies indicate that tamoxifen initially acts as an antagonist but later functions as an ER agonist promoting tumor growth", "relationMentions": [{"em1Text": "tamoxifen", "em2Text": "ER", "label": "CPR:5"}, {"em1Text": "tamoxifen", "em2Text": "ER", "label": "CPR:6"}]}
{"sentText": "salmeterol and formoterol for the beta2adrenoceptor over the beta1 or beta3 while others eg", "relationMentions": [{"em1Text": "salmeterol", "em2Text": "beta2adrenoceptor", "label": "CPR:5"}, {"em1Text": "salmeterol", "em2Text": "beta1", "label": "CPR:5"}, {"em1Text": "formoterol", "em2Text": "beta2adrenoceptor", "label": "CPR:5"}, {"em1Text": "formoterol", "em2Text": "beta3", "label": "CPR:5"}]}
{"sentText": "salmeterol and formoterol for the beta2adrenoceptor over the beta1 or beta3 while others eg", "relationMentions": [{"em1Text": "salmeterol", "em2Text": "beta2adrenoceptor", "label": "CPR:5"}, {"em1Text": "salmeterol", "em2Text": "beta1", "label": "CPR:5"}, {"em1Text": "formoterol", "em2Text": "beta2adrenoceptor", "label": "CPR:5"}, {"em1Text": "formoterol", "em2Text": "beta3", "label": "CPR:5"}]}
{"sentText": "Rasagiline Npropargyl1Raminoindan is a novel highly potent irreversible monoamine oxidase MAOB inhibitor antiParkinsonian drug", "relationMentions": [{"em1Text": "Rasagiline", "em2Text": "monoamine oxidase MAOB", "label": "CPR:4"}, {"em1Text": "Npropargyl1Raminoindan", "em2Text": "monoamine oxidase MAOB", "label": "CPR:4"}]}
{"sentText": "METHODS We conducted a casecontrol study to measure the association between selective cox2 inhibitors particularly celecoxib rofecoxib valdecoxib and nonspecific NSAID subgroups and breast cancer risk", "relationMentions": [{"em1Text": "cox2", "em2Text": "celecoxib", "label": "CPR:4"}, {"em1Text": "cox2", "em2Text": "rofecoxib", "label": "CPR:4"}, {"em1Text": "cox2", "em2Text": "valdecoxib", "label": "CPR:4"}]}
{"sentText": "BACKGROUND Recent epidemiologic and laboratory studies have suggested that non steroidal antiinflammatory drugs NSAIDs may reduce the risk of breast cancer through inhibition of cyclooxygenase2 COX2", "relationMentions": [{"em1Text": "steroidal", "em2Text": "cyclooxygenase2", "label": "CPR:4"}, {"em1Text": "steroidal", "em2Text": "COX2", "label": "CPR:4"}]}
{"sentText": "The suppressive effect of ceruletide on barrel rotation could be partially countered by MK329 a selective peripheral CCK CCKA receptor antagonist", "relationMentions": [{"em1Text": "ceruletide", "em2Text": "CCK", "label": "CPR:4"}, {"em1Text": "ceruletide", "em2Text": "CCKA receptor", "label": "CPR:4"}, {"em1Text": "MK329", "em2Text": "CCK", "label": "CPR:6"}, {"em1Text": "MK329", "em2Text": "CCKA receptor", "label": "CPR:6"}]}
{"sentText": "The suppressive effect of ceruletide on barrel rotation could be partially countered by MK329 a selective peripheral CCK CCKA receptor antagonist", "relationMentions": [{"em1Text": "ceruletide", "em2Text": "CCK", "label": "CPR:4"}, {"em1Text": "ceruletide", "em2Text": "CCKA receptor", "label": "CPR:4"}, {"em1Text": "MK329", "em2Text": "CCK", "label": "CPR:6"}, {"em1Text": "MK329", "em2Text": "CCKA receptor", "label": "CPR:6"}]}
{"sentText": "Removing medium Ca2 blocking Ca2 channels with 50 mumoll verapamil or inhibiting calmodulin activation with 20 mumoll trifluoperazine 10 mumoll chlorpromazine or 10 mumoll pimozide almost completely blocked hyposmolarityinduced secretion", "relationMentions": [{"em1Text": "Ca2 channels", "em2Text": "verapamil", "label": "CPR:4"}, {"em1Text": "calmodulin", "em2Text": "trifluoperazine", "label": "CPR:4"}, {"em1Text": "calmodulin", "em2Text": "chlorpromazine", "label": "CPR:4"}, {"em1Text": "calmodulin", "em2Text": "pimozide", "label": "CPR:4"}]}
{"sentText": "An essential control in experiments using Gy mice is to demonstrate that the abnormal phenotypes exhibited by these mice are abolished by providing replacement spermine and this can be accomplished by breeding with CAG SMS mice that express SpmS from a ubiquitous promoter", "relationMentions": [{"em1Text": "spermine", "em2Text": "SMS", "label": "CPR:9"}, {"em1Text": "spermine", "em2Text": "SpmS", "label": "CPR:9"}]}
{"sentText": "Collectively these data suggest that cabozantinib is a promising agent for inhibiting tumor angiogenesis and metastasis in cancers with dysregulated MET and VEGFR signaling", "relationMentions": [{"em1Text": "cabozantinib", "em2Text": "MET", "label": "CPR:4"}, {"em1Text": "cabozantinib", "em2Text": "VEGFR", "label": "CPR:4"}]}
{"sentText": "Cabozantinib XL184 is a smallmolecule kinase inhibitor with potent activity toward MET and VEGF receptor 2 VEGFR2 as well as a number of other receptor tyrosine kinases that have also been implicated in tumor pathobiology including RET KIT AXL and FLT3", "relationMentions": [{"em1Text": "Cabozantinib", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "Cabozantinib", "em2Text": "MET", "label": "CPR:4"}, {"em1Text": "Cabozantinib", "em2Text": "VEGF receptor 2", "label": "CPR:4"}, {"em1Text": "Cabozantinib", "em2Text": "VEGFR2", "label": "CPR:4"}, {"em1Text": "Cabozantinib", "em2Text": "receptor tyrosine kinases", "label": "CPR:4"}, {"em1Text": "Cabozantinib", "em2Text": "RET", "label": "CPR:4"}, {"em1Text": "Cabozantinib", "em2Text": "KIT", "label": "CPR:4"}, {"em1Text": "Cabozantinib", "em2Text": "AXL", "label": "CPR:4"}, {"em1Text": "Cabozantinib", "em2Text": "FLT3", "label": "CPR:4"}, {"em1Text": "XL184", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "XL184", "em2Text": "MET", "label": "CPR:4"}, {"em1Text": "XL184", "em2Text": "VEGF receptor 2", "label": "CPR:4"}, {"em1Text": "XL184", "em2Text": "VEGFR2", "label": "CPR:4"}, {"em1Text": "XL184", "em2Text": "receptor tyrosine kinases", "label": "CPR:4"}, {"em1Text": "XL184", "em2Text": "RET", "label": "CPR:4"}, {"em1Text": "XL184", "em2Text": "KIT", "label": "CPR:4"}, {"em1Text": "XL184", "em2Text": "AXL", "label": "CPR:4"}, {"em1Text": "XL184", "em2Text": "FLT3", "label": "CPR:4"}]}
{"sentText": "Cabozantinib XL184 is a smallmolecule kinase inhibitor with potent activity toward MET and VEGF receptor 2 VEGFR2 as well as a number of other receptor tyrosine kinases that have also been implicated in tumor pathobiology including RET KIT AXL and FLT3", "relationMentions": [{"em1Text": "Cabozantinib", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "Cabozantinib", "em2Text": "MET", "label": "CPR:4"}, {"em1Text": "Cabozantinib", "em2Text": "VEGF receptor 2", "label": "CPR:4"}, {"em1Text": "Cabozantinib", "em2Text": "VEGFR2", "label": "CPR:4"}, {"em1Text": "Cabozantinib", "em2Text": "receptor tyrosine kinases", "label": "CPR:4"}, {"em1Text": "Cabozantinib", "em2Text": "RET", "label": "CPR:4"}, {"em1Text": "Cabozantinib", "em2Text": "KIT", "label": "CPR:4"}, {"em1Text": "Cabozantinib", "em2Text": "AXL", "label": "CPR:4"}, {"em1Text": "Cabozantinib", "em2Text": "FLT3", "label": "CPR:4"}, {"em1Text": "XL184", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "XL184", "em2Text": "MET", "label": "CPR:4"}, {"em1Text": "XL184", "em2Text": "VEGF receptor 2", "label": "CPR:4"}, {"em1Text": "XL184", "em2Text": "VEGFR2", "label": "CPR:4"}, {"em1Text": "XL184", "em2Text": "receptor tyrosine kinases", "label": "CPR:4"}, {"em1Text": "XL184", "em2Text": "RET", "label": "CPR:4"}, {"em1Text": "XL184", "em2Text": "KIT", "label": "CPR:4"}, {"em1Text": "XL184", "em2Text": "AXL", "label": "CPR:4"}, {"em1Text": "XL184", "em2Text": "FLT3", "label": "CPR:4"}]}
{"sentText": "Treatment with cabozantinib inhibited MET and VEGFR2 phosphorylation in vitro and in tumor models in vivo and led to significant reductions in cell invasion in vitro", "relationMentions": [{"em1Text": "cabozantinib", "em2Text": "MET", "label": "CPR:4"}, {"em1Text": "cabozantinib", "em2Text": "VEGFR2", "label": "CPR:4"}]}
{"sentText": "Cabozantinib XL184 a novel MET and VEGFR2 inhibitor simultaneously suppresses metastasis angiogenesis and tumor growth", "relationMentions": [{"em1Text": "Cabozantinib", "em2Text": "MET", "label": "CPR:4"}, {"em1Text": "Cabozantinib", "em2Text": "VEGFR2", "label": "CPR:4"}, {"em1Text": "XL184", "em2Text": "MET", "label": "CPR:4"}, {"em1Text": "XL184", "em2Text": "VEGFR2", "label": "CPR:4"}]}
{"sentText": "Cabozantinib XL184 a novel MET and VEGFR2 inhibitor simultaneously suppresses metastasis angiogenesis and tumor growth", "relationMentions": [{"em1Text": "Cabozantinib", "em2Text": "MET", "label": "CPR:4"}, {"em1Text": "Cabozantinib", "em2Text": "VEGFR2", "label": "CPR:4"}, {"em1Text": "XL184", "em2Text": "MET", "label": "CPR:4"}, {"em1Text": "XL184", "em2Text": "VEGFR2", "label": "CPR:4"}]}
{"sentText": "Inhibition of the NFkappaB pathway was responsible for this effect since the colchicoside inhibited RANKL induced NFkappaB activation activation of IkappaB kinase IKK and suppressed inhibitor of NFkappaBalpha IkappaBalpha phosphorylation and degradation an inhibitor of NFkappaB", "relationMentions": [{"em1Text": "NFkappaB", "em2Text": "colchicoside", "label": "CPR:4"}, {"em1Text": "colchicoside", "em2Text": "IkappaB kinase", "label": "CPR:4"}, {"em1Text": "colchicoside", "em2Text": "IKK", "label": "CPR:4"}, {"em1Text": "colchicoside", "em2Text": "NFkappaBalpha", "label": "CPR:4"}, {"em1Text": "colchicoside", "em2Text": "IkappaBalpha", "label": "CPR:4"}, {"em1Text": "colchicoside", "em2Text": "RANKL", "label": "CPR:4"}]}
{"sentText": "CONCLUSIONS AND IMPLICATIONS Together these data suggest that thiocolchicoside significantly suppressed osteoclastogenesis induced by RANKL and tumour cells via the NFkappaB signalling pathway", "relationMentions": [{"em1Text": "thiocolchicoside", "em2Text": "RANKL", "label": "CPR:4"}, {"em1Text": "thiocolchicoside", "em2Text": "NFkappaB", "label": "CPR:4"}]}
{"sentText": "Although genetic polymorphisms in the endothelial nitric oxide synthase eNOS gene may impair endogenous NO formation there is little information about how eNOS polymorphisms and haplotypes affect the responses to sildenafil", "relationMentions": [{"em1Text": "eNOS", "em2Text": "NO", "label": "CPR:9"}, {"em1Text": "endothelial nitric oxide synthase", "em2Text": "NO", "label": "CPR:9"}]}
{"sentText": "Here we report biochemical evidence that mercury alone induces NF\u03baB activation resulting in the induced expression of COX2 and iNOS", "relationMentions": [{"em1Text": "mercury", "em2Text": "NF\u03baB", "label": "CPR:3"}, {"em1Text": "mercury", "em2Text": "COX2", "label": "CPR:3"}, {"em1Text": "mercury", "em2Text": "iNOS", "label": "CPR:3"}]}
{"sentText": "Mercury induces the expression of cyclooxygenase2 and inducible nitric oxide synthase", "relationMentions": [{"em1Text": "Mercury", "em2Text": "cyclooxygenase2", "label": "CPR:3"}, {"em1Text": "Mercury", "em2Text": "inducible nitric oxide synthase", "label": "CPR:3"}]}
{"sentText": "We have examined the effectiveness of two novel Chk1 selective inhibitors AR323 and AR678 in a panel of melanoma cell lines and normal cell types", "relationMentions": [{"em1Text": "Chk1", "em2Text": "AR323", "label": "CPR:4"}, {"em1Text": "Chk1", "em2Text": "AR678", "label": "CPR:4"}]}
{"sentText": "Aspirin and metformin an activator of AMPK increased inhibition of mTOR and Akt as well as autophagy in CRC cells", "relationMentions": [{"em1Text": "metformin", "em2Text": "AMPK", "label": "CPR:3"}, {"em1Text": "Aspirin", "em2Text": "AMPK", "label": "CPR:3"}, {"em1Text": "metformin", "em2Text": "mTOR", "label": "CPR:4"}, {"em1Text": "metformin", "em2Text": "Akt", "label": "CPR:4"}, {"em1Text": "Aspirin", "em2Text": "mTOR", "label": "CPR:4"}, {"em1Text": "Aspirin", "em2Text": "Akt", "label": "CPR:4"}]}
{"sentText": "Aspirin and metformin an activator of AMPK increased inhibition of mTOR and Akt as well as autophagy in CRC cells", "relationMentions": [{"em1Text": "metformin", "em2Text": "AMPK", "label": "CPR:3"}, {"em1Text": "Aspirin", "em2Text": "AMPK", "label": "CPR:3"}, {"em1Text": "metformin", "em2Text": "mTOR", "label": "CPR:4"}, {"em1Text": "metformin", "em2Text": "Akt", "label": "CPR:4"}, {"em1Text": "Aspirin", "em2Text": "mTOR", "label": "CPR:4"}, {"em1Text": "Aspirin", "em2Text": "Akt", "label": "CPR:4"}]}
{"sentText": "CONCLUSIONS Aspirin is an inhibitor of mTOR and an activator of AMPK targeting regulators of intracellular energy homeostasis and metabolism", "relationMentions": [{"em1Text": "Aspirin", "em2Text": "AMPK", "label": "CPR:3"}, {"em1Text": "Aspirin", "em2Text": "mTOR", "label": "CPR:4"}]}
{"sentText": "Aspirin inhibits mTOR signaling activates AMPactivated protein kinase and induces autophagy in colorectal cancer cells", "relationMentions": [{"em1Text": "Aspirin", "em2Text": "AMPactivated protein kinase", "label": "CPR:3"}, {"em1Text": "Aspirin", "em2Text": "mTOR", "label": "CPR:4"}]}
{"sentText": "Rectal mucosal samples from patients given aspirin had reduced phosphorylation of S6 K1 and S6", "relationMentions": [{"em1Text": "aspirin", "em2Text": "S6 K1", "label": "CPR:4"}, {"em1Text": "aspirin", "em2Text": "S6", "label": "CPR:4"}]}
{"sentText": "RESULTS Aspirin reduced mTOR signaling in CRC cells by inhibiting the mTOR effectors S6K1 and 4EBP1", "relationMentions": [{"em1Text": "Aspirin", "em2Text": "mTOR", "label": "CPR:4"}, {"em1Text": "Aspirin", "em2Text": "S6K1", "label": "CPR:4"}, {"em1Text": "Aspirin", "em2Text": "4EBP1", "label": "CPR:4"}]}
{"sentText": "SB203580 a specific inhibitor of p38 kinase markedly suppressed the increased expression of collagen type I and \u03b1SMA in TGF\u03b21 induced NPDFs", "relationMentions": [{"em1Text": "SB203580", "em2Text": "collagen type I", "label": "CPR:4"}, {"em1Text": "SB203580", "em2Text": "\u03b1SMA", "label": "CPR:4"}, {"em1Text": "SB203580", "em2Text": "TGF\u03b21", "label": "CPR:4"}, {"em1Text": "SB203580", "em2Text": "p38", "label": "CPR:4"}, {"em1Text": "SB203580", "em2Text": "kinase", "label": "CPR:4"}]}
{"sentText": "In TGF\u03b21 induced NPDFs berberine significantly inhibited the expression of \u03b1SMA and collagen type I mRNA and reduced \u03b1SMA and collagen protein levels", "relationMentions": [{"em1Text": "TGF\u03b21", "em2Text": "berberine", "label": "CPR:4"}, {"em1Text": "berberine", "em2Text": "\u03b1SMA", "label": "CPR:4"}, {"em1Text": "berberine", "em2Text": "collagen type I", "label": "CPR:4"}, {"em1Text": "berberine", "em2Text": "collagen", "label": "CPR:4"}]}
{"sentText": "CRBN mediated antiproliferative activities of lenalidomide and pomalidomide in myeloma cells as well as lenalidomide and pomalidomide induced cytokine production in T cells", "relationMentions": [{"em1Text": "lenalidomide", "em2Text": "cytokine", "label": "CPR:3"}, {"em1Text": "pomalidomide", "em2Text": "cytokine", "label": "CPR:3"}]}
{"sentText": "Overexpression of CRBN wildtype protein but not CRBNYWAA mutant protein in KMS12 myeloma cells amplified pomalidomide mediated reductions in cmyc and IRF4 expression and increases in p21 WAF1 expression", "relationMentions": [{"em1Text": "pomalidomide", "em2Text": "WAF1", "label": "CPR:3"}, {"em1Text": "pomalidomide", "em2Text": "p21", "label": "CPR:3"}, {"em1Text": "pomalidomide", "em2Text": "cmyc", "label": "CPR:4"}, {"em1Text": "pomalidomide", "em2Text": "IRF4", "label": "CPR:4"}]}
{"sentText": "Lenalidomide and pomalidomide inhibited autoubiquitination of CRBN in HEK293T cells expressing thalidomidebinding competent wildtype CRBN but not thalidomidebinding defective CRBNYWAA", "relationMentions": [{"em1Text": "Lenalidomide", "em2Text": "CRBN", "label": "CPR:4"}, {"em1Text": "pomalidomide", "em2Text": "CRBN", "label": "CPR:4"}]}
{"sentText": "Crizotinib is an oral tyrosine kinase inhibitor TKI which silences the protein product of the ALK fusion gene and has recently been approved for the treatment of NSCLC aberrantly expressing ALK", "relationMentions": [{"em1Text": "Crizotinib", "em2Text": "tyrosine kinase", "label": "CPR:4"}, {"em1Text": "Crizotinib", "em2Text": "ALK", "label": "CPR:4"}]}
{"sentText": "Enprofylline a weak adenosine antagonist but potent inhibitor of cyclic AMP phosphodiesterase did not alter ethanols motor incoordination further supporting involvement of brain adenosine receptor mechanisms in ethanoladenosine interactions", "relationMentions": [{"em1Text": "Enprofylline", "em2Text": "cyclic AMP phosphodiesterase", "label": "CPR:4"}, {"em1Text": "Enprofylline", "em2Text": "adenosine", "label": "CPR:6"}]}
{"sentText": "adenosine agonists N6Rphenylisopropyl adenosine RPIA N6Sphenylisopropyl adenosine 5Ncyclopropylcarboxamido adenosine antagonists theophylline and 8psulfophenyltheophylline as well as enprofylline on ethanolip", "relationMentions": [{"em1Text": "adenosine", "em2Text": "RPIA", "label": "CPR:5"}, {"em1Text": "adenosine", "em2Text": "theophylline", "label": "CPR:6"}, {"em1Text": "adenosine", "em2Text": "8psulfophenyltheophylline", "label": "CPR:6"}, {"em1Text": "adenosine", "em2Text": "enprofylline", "label": "CPR:6"}]}
{"sentText": "Celastrol a TAK1 inhibitor and antiinflammatory compound used in traditional Chinese medicine also decreased TGF\u03b21induced phosphorylation of TAK1 and RELA and suppressed basal TGF\u03b21 and tumor necrosis factoralpha TNF\u03b1induced NF\u03baB reporter gene activity", "relationMentions": [{"em1Text": "Celastrol", "em2Text": "TAK1", "label": "CPR:4"}, {"em1Text": "Celastrol", "em2Text": "TGF\u03b21", "label": "CPR:4"}, {"em1Text": "Celastrol", "em2Text": "RELA", "label": "CPR:4"}, {"em1Text": "Celastrol", "em2Text": "tumor necrosis factoralpha", "label": "CPR:4"}, {"em1Text": "Celastrol", "em2Text": "NF\u03baB", "label": "CPR:4"}]}
{"sentText": "When combined mianserin antagonized the effects of the full kappaopioid receptor agonists in 35SGTPgammaS assays and reduced the stimulation of p38 MAPK and ERK12 phosphorylation by dynorphin A", "relationMentions": [{"em1Text": "p38", "em2Text": "dynorphin A", "label": "CPR:3"}, {"em1Text": "MAPK", "em2Text": "dynorphin A", "label": "CPR:3"}, {"em1Text": "mianserin", "em2Text": "p38", "label": "CPR:4"}, {"em1Text": "mianserin", "em2Text": "MAPK", "label": "CPR:4"}, {"em1Text": "mianserin", "em2Text": "kappaopioid receptor", "label": "CPR:6"}]}
{"sentText": "When combined mianserin antagonized the effects of the full kappaopioid receptor agonists in 35SGTPgammaS assays and reduced the stimulation of p38 MAPK and ERK12 phosphorylation by dynorphin A", "relationMentions": [{"em1Text": "p38", "em2Text": "dynorphin A", "label": "CPR:3"}, {"em1Text": "MAPK", "em2Text": "dynorphin A", "label": "CPR:3"}, {"em1Text": "mianserin", "em2Text": "p38", "label": "CPR:4"}, {"em1Text": "mianserin", "em2Text": "MAPK", "label": "CPR:4"}, {"em1Text": "mianserin", "em2Text": "kappaopioid receptor", "label": "CPR:6"}]}
{"sentText": "CONCLUSIONS AND IMPLICATIONS In different cell systems mianserin directly activates kappaopioid receptors displaying partial agonist activity at brain receptors", "relationMentions": [{"em1Text": "mianserin", "em2Text": "kappaopioid receptors", "label": "CPR:3"}, {"em1Text": "mianserin", "em2Text": "kappaopioid receptors", "label": "CPR:5"}]}
{"sentText": "CONCLUSIONS AND IMPLICATIONS In different cell systems mianserin directly activates kappaopioid receptors displaying partial agonist activity at brain receptors", "relationMentions": [{"em1Text": "mianserin", "em2Text": "kappaopioid receptors", "label": "CPR:3"}, {"em1Text": "mianserin", "em2Text": "kappaopioid receptors", "label": "CPR:5"}]}
{"sentText": "The agonist activity was antagonized by the selective kappaopioid blocker norbinaltorphimine norBNI", "relationMentions": [{"em1Text": "kappaopioid", "em2Text": "norbinaltorphimine", "label": "CPR:4"}, {"em1Text": "kappaopioid", "em2Text": "norBNI", "label": "CPR:4"}, {"em1Text": "kappaopioid", "em2Text": "norbinaltorphimine", "label": "CPR:6"}, {"em1Text": "kappaopioid", "em2Text": "norBNI", "label": "CPR:6"}]}
{"sentText": "The agonist activity was antagonized by the selective kappaopioid blocker norbinaltorphimine norBNI", "relationMentions": [{"em1Text": "kappaopioid", "em2Text": "norbinaltorphimine", "label": "CPR:4"}, {"em1Text": "kappaopioid", "em2Text": "norBNI", "label": "CPR:4"}, {"em1Text": "kappaopioid", "em2Text": "norbinaltorphimine", "label": "CPR:6"}, {"em1Text": "kappaopioid", "em2Text": "norBNI", "label": "CPR:6"}]}
{"sentText": "The mianserin analogue mirtazapine also displayed kappaopioid agonist activity", "relationMentions": [{"em1Text": "mianserin", "em2Text": "kappaopioid", "label": "CPR:5"}, {"em1Text": "mirtazapine", "em2Text": "kappaopioid", "label": "CPR:5"}]}
{"sentText": "In rat striatum and nucleus accumbens mianserin stimulated 35SGTPgammaS binding in a norBNIsensitive manner with maximal effects lower than those of the full kappaopioid agonists U50488 and dynorphin A", "relationMentions": [{"em1Text": "kappaopioid", "em2Text": "U50488", "label": "CPR:5"}, {"em1Text": "kappaopioid", "em2Text": "dynorphin A", "label": "CPR:5"}]}
{"sentText": "CBDP irreversibly inhibits butyrylcholinesterase BChE in human plasma by forming adducts on the active site serine Ser198", "relationMentions": [{"em1Text": "CBDP", "em2Text": "butyrylcholinesterase", "label": "CPR:4"}, {"em1Text": "CBDP", "em2Text": "BChE", "label": "CPR:4"}]}
{"sentText": "Galantamine is a reversible competitive acetylcholinesterase AChE inhibitor and allosteric potentiating ligand of nicotinic acetylcholine receptors nAChRAPL that shares many common structural elements with morphinanbased opioids", "relationMentions": [{"em1Text": "Galantamine", "em2Text": "acetylcholinesterase", "label": "CPR:4"}, {"em1Text": "Galantamine", "em2Text": "AChE", "label": "CPR:4"}]}
{"sentText": "Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of oestradiol a selective ER\u03b1 agonist PPT 444\u20334propyl1Hpyrazole135triyltrisphenol a selective ER\u03b2 agonist DPN 23bis4hydroxyphenylpropionitrile a selective ER\u03b1 antagonist MPP 13bis4hydroxyphenyl4methyl542piperidinylethoxyphenol 1Hpyrazole dihydrochloride or a selective ER\u03b2 antagonist PHTPP 42phenyl57bistrifluoromethylpyrazolo15apyrimidin3ylphenol", "relationMentions": [{"em1Text": "ER\u03b2", "em2Text": "DPN", "label": "CPR:5"}, {"em1Text": "ER\u03b2", "em2Text": "23bis4hydroxyphenylpropionitrile", "label": "CPR:5"}, {"em1Text": "ER\u03b1", "em2Text": "PPT", "label": "CPR:5"}, {"em1Text": "ER\u03b1", "em2Text": "444\u20334propyl1Hpyrazole135triyltrisphenol", "label": "CPR:5"}, {"em1Text": "ER\u03b1", "em2Text": "MPP", "label": "CPR:6"}, {"em1Text": "ER\u03b1", "em2Text": "13bis4hydroxyphenyl4methyl542piperidinylethoxyphenol", "label": "CPR:6"}, {"em1Text": "ER\u03b1", "em2Text": "1Hpyrazole dihydrochloride", "label": "CPR:6"}, {"em1Text": "ER\u03b2", "em2Text": "PHTPP", "label": "CPR:6"}, {"em1Text": "ER\u03b2", "em2Text": "42phenyl57bistrifluoromethylpyrazolo15apyrimidin3ylphenol", "label": "CPR:6"}]}
{"sentText": "Furthermore salubrinal a specific eIF2\u03b1 phosphorylationinducing agent increased CHOP and DR5 expression in the presence of VA", "relationMentions": [{"em1Text": "salubrinal", "em2Text": "eIF2\u03b1", "label": "CPR:3"}, {"em1Text": "salubrinal", "em2Text": "CHOP", "label": "CPR:3"}, {"em1Text": "salubrinal", "em2Text": "DR5", "label": "CPR:3"}]}
{"sentText": "Verrucarin A sensitizes TRAILinduced apoptosis via the upregulation of DR5 in an eIF2\u03b1 CHOP dependent manner", "relationMentions": [{"em1Text": "Verrucarin A", "em2Text": "DR5", "label": "CPR:3"}, {"em1Text": "Verrucarin A", "em2Text": "eIF2\u03b1", "label": "CPR:3"}, {"em1Text": "Verrucarin A", "em2Text": "CHOP", "label": "CPR:3"}]}
{"sentText": "Disruption of microtubule prevented insulininduced actin remodeling and distal insulin signal transduction with reduction in surface glucose transporter isoform 4 GLUT4 and glucose uptake", "relationMentions": [{"em1Text": "glucose", "em2Text": "glucose transporter isoform 4", "label": "CPR:9"}, {"em1Text": "glucose", "em2Text": "GLUT4", "label": "CPR:9"}]}
{"sentText": "By contrast 112diamino369triazadodecane SpmTrien a chargedeficient spermine analog was an extremely poor substrate of human recombinant SSAT2 and was metabolized by SSAT1 in HEPG2 cells and in wildtype primary hepatocytes", "relationMentions": [{"em1Text": "112diamino369triazadodecane", "em2Text": "SSAT1", "label": "CPR:9"}, {"em1Text": "112diamino369triazadodecane", "em2Text": "human recombinant SSAT2", "label": "CPR:9"}, {"em1Text": "SpmTrien", "em2Text": "SSAT1", "label": "CPR:9"}, {"em1Text": "SpmTrien", "em2Text": "human recombinant SSAT2", "label": "CPR:9"}, {"em1Text": "spermine", "em2Text": "SSAT1", "label": "CPR:9"}, {"em1Text": "spermine", "em2Text": "human recombinant SSAT2", "label": "CPR:9"}]}
{"sentText": "By contrast 112diamino369triazadodecane SpmTrien a chargedeficient spermine analog was an extremely poor substrate of human recombinant SSAT2 and was metabolized by SSAT1 in HEPG2 cells and in wildtype primary hepatocytes", "relationMentions": [{"em1Text": "112diamino369triazadodecane", "em2Text": "SSAT1", "label": "CPR:9"}, {"em1Text": "112diamino369triazadodecane", "em2Text": "human recombinant SSAT2", "label": "CPR:9"}, {"em1Text": "SpmTrien", "em2Text": "SSAT1", "label": "CPR:9"}, {"em1Text": "SpmTrien", "em2Text": "human recombinant SSAT2", "label": "CPR:9"}, {"em1Text": "spermine", "em2Text": "SSAT1", "label": "CPR:9"}, {"em1Text": "spermine", "em2Text": "human recombinant SSAT2", "label": "CPR:9"}]}
{"sentText": "Metabolism of triethylenetetramine and 112diamino369triazadodecane by the spermidinespermineN1acetyltransferase and thialysine acetyltransferase", "relationMentions": [{"em1Text": "triethylenetetramine", "em2Text": "thialysine acetyltransferase", "label": "CPR:9"}, {"em1Text": "triethylenetetramine", "em2Text": "spermidinespermineN1acetyltransferase", "label": "CPR:9"}, {"em1Text": "112diamino369triazadodecane", "em2Text": "thialysine acetyltransferase", "label": "CPR:9"}, {"em1Text": "112diamino369triazadodecane", "em2Text": "spermidinespermineN1acetyltransferase", "label": "CPR:9"}]}
{"sentText": "Metabolism of triethylenetetramine and 112diamino369triazadodecane by the spermidinespermineN1acetyltransferase and thialysine acetyltransferase", "relationMentions": [{"em1Text": "triethylenetetramine", "em2Text": "thialysine acetyltransferase", "label": "CPR:9"}, {"em1Text": "triethylenetetramine", "em2Text": "spermidinespermineN1acetyltransferase", "label": "CPR:9"}, {"em1Text": "112diamino369triazadodecane", "em2Text": "thialysine acetyltransferase", "label": "CPR:9"}, {"em1Text": "112diamino369triazadodecane", "em2Text": "spermidinespermineN1acetyltransferase", "label": "CPR:9"}]}
{"sentText": "We recently showed that TETA is metabolized in vitro by polyamine catabolic enzyme spermidinespermineN1acetyltransferase SSAT1 and by thialysine acetyltransferase SSAT2 to its monoacetylated derivative MAT", "relationMentions": [{"em1Text": "TETA", "em2Text": "spermidinespermineN1acetyltransferase", "label": "CPR:9"}, {"em1Text": "TETA", "em2Text": "SSAT1", "label": "CPR:9"}, {"em1Text": "TETA", "em2Text": "thialysine acetyltransferase", "label": "CPR:9"}, {"em1Text": "TETA", "em2Text": "SSAT2", "label": "CPR:9"}, {"em1Text": "polyamine", "em2Text": "spermidinespermineN1acetyltransferase", "label": "CPR:9"}, {"em1Text": "polyamine", "em2Text": "SSAT1", "label": "CPR:9"}]}
{"sentText": "We recently showed that TETA is metabolized in vitro by polyamine catabolic enzyme spermidinespermineN1acetyltransferase SSAT1 and by thialysine acetyltransferase SSAT2 to its monoacetylated derivative MAT", "relationMentions": [{"em1Text": "TETA", "em2Text": "spermidinespermineN1acetyltransferase", "label": "CPR:9"}, {"em1Text": "TETA", "em2Text": "SSAT1", "label": "CPR:9"}, {"em1Text": "TETA", "em2Text": "thialysine acetyltransferase", "label": "CPR:9"}, {"em1Text": "TETA", "em2Text": "SSAT2", "label": "CPR:9"}, {"em1Text": "polyamine", "em2Text": "spermidinespermineN1acetyltransferase", "label": "CPR:9"}, {"em1Text": "polyamine", "em2Text": "SSAT1", "label": "CPR:9"}]}
{"sentText": "The signaling of both Sox9 and Runx2 key regulators of chondrogenesis was downregulated by VPA", "relationMentions": [{"em1Text": "Sox9", "em2Text": "VPA", "label": "CPR:4"}, {"em1Text": "Runx2", "em2Text": "VPA", "label": "CPR:4"}]}
{"sentText": "In utero exposure to valproic acid VPA a histone deacetylase HDAC inhibitor causes neural tube heart and limb defects", "relationMentions": [{"em1Text": "valproic acid", "em2Text": "histone deacetylase", "label": "CPR:4"}, {"em1Text": "valproic acid", "em2Text": "HDAC", "label": "CPR:4"}, {"em1Text": "VPA", "em2Text": "histone deacetylase", "label": "CPR:4"}, {"em1Text": "VPA", "em2Text": "HDAC", "label": "CPR:4"}]}
{"sentText": "In utero exposure to valproic acid VPA a histone deacetylase HDAC inhibitor causes neural tube heart and limb defects", "relationMentions": [{"em1Text": "valproic acid", "em2Text": "histone deacetylase", "label": "CPR:4"}, {"em1Text": "valproic acid", "em2Text": "HDAC", "label": "CPR:4"}, {"em1Text": "VPA", "em2Text": "histone deacetylase", "label": "CPR:4"}, {"em1Text": "VPA", "em2Text": "HDAC", "label": "CPR:4"}]}
{"sentText": "Human serum butyrylcholinesterase HuBChE is currently the most suitable bioscavenger for the prophylaxis of highly toxic organophosphate OP nerve agents", "relationMentions": [{"em1Text": "HuBChE", "em2Text": "organophosphate", "label": "CPR:9"}, {"em1Text": "Human serum butyrylcholinesterase", "em2Text": "organophosphate", "label": "CPR:9"}]}
{"sentText": "Results showed that DMF increased nuclear levels of Nrf2 and both DMF and adenovirusmediated overexpression of Nrf2 AdNrf2 decreased PAI1 alphasmooth muscle actin alphaSMA fibronectin and type 1 collagen expression in TGFbetatreated rat mesangial cells RMCs and renal fibroblast cells NRK49F", "relationMentions": [{"em1Text": "DMF", "em2Text": "Nrf2", "label": "CPR:3"}, {"em1Text": "DMF", "em2Text": "PAI1", "label": "CPR:4"}, {"em1Text": "DMF", "em2Text": "alphasmooth muscle actin", "label": "CPR:4"}, {"em1Text": "DMF", "em2Text": "alphaSMA", "label": "CPR:4"}, {"em1Text": "DMF", "em2Text": "fibronectin", "label": "CPR:4"}, {"em1Text": "DMF", "em2Text": "type 1 collagen", "label": "CPR:4"}]}
{"sentText": "Finally DMF suppressed unilateral ureteral obstruction UUOinduced renal fibrosis and alphaSMA fibronectin and type 1 collagen expression in the obstructed kidneys from UUO mice along with increased and decreased expression of Nrf2 and phosphoSmad3 respectively", "relationMentions": [{"em1Text": "DMF", "em2Text": "Nrf2", "label": "CPR:3"}, {"em1Text": "DMF", "em2Text": "alphaSMA", "label": "CPR:4"}, {"em1Text": "DMF", "em2Text": "fibronectin", "label": "CPR:4"}, {"em1Text": "DMF", "em2Text": "type 1 collagen", "label": "CPR:4"}, {"em1Text": "DMF", "em2Text": "phosphoSmad3", "label": "CPR:4"}]}
{"sentText": "Additionally DMF and AdNrf2 repressed TGFbeta stimulated Smad3 activity by inhibiting Smad3 phosphorylation which was restored by siRNAmediated knockdown of Nrf2 expression", "relationMentions": [{"em1Text": "DMF", "em2Text": "TGFbeta", "label": "CPR:4"}, {"em1Text": "DMF", "em2Text": "Smad3", "label": "CPR:4"}]}
{"sentText": "Dimethylfumarate attenuates renal fibrosis via NFE2related factor 2mediated inhibition of transforming growth factorbeta Smad signaling", "relationMentions": [{"em1Text": "Dimethylfumarate", "em2Text": "Smad", "label": "CPR:4"}, {"em1Text": "Dimethylfumarate", "em2Text": "transforming growth factorbeta", "label": "CPR:4"}]}
{"sentText": "In summary DMF attenuated renal fibrosis via the Nrf2mediated inhibition of TGFbeta Smad3 signaling in an AREindependent manner suggesting that DMF could be used to treat renal fibrosis", "relationMentions": [{"em1Text": "DMF", "em2Text": "TGFbeta", "label": "CPR:4"}, {"em1Text": "DMF", "em2Text": "Smad3", "label": "CPR:4"}]}
{"sentText": "The expression of the osteoblast markers runtrelated transcription factor 2 RUNX2 and periostin was decreased while osteocalcin OCN was augmented in CCL3 and Met RANTEStreated mice", "relationMentions": [{"em1Text": "osteocalcin", "em2Text": "Met", "label": "CPR:3"}, {"em1Text": "OCN", "em2Text": "Met", "label": "CPR:3"}, {"em1Text": "RUNX2", "em2Text": "Met", "label": "CPR:4"}, {"em1Text": "periostin", "em2Text": "Met", "label": "CPR:4"}, {"em1Text": "runtrelated transcription factor 2", "em2Text": "Met", "label": "CPR:4"}]}
{"sentText": "mRNA levels of receptor activator of nuclear factor kappaB RANK its ligand RANKL tumor necrosis factor alpha TNF\u03b1 and RANKL osteoprotegerin OPG ratio were diminished in the periodontium of CCL3 mice and in the group treated with Met RANTES", "relationMentions": [{"em1Text": "receptor activator of nuclear factor kappaB", "em2Text": "Met", "label": "CPR:4"}, {"em1Text": "RANK", "em2Text": "Met", "label": "CPR:4"}, {"em1Text": "RANKL", "em2Text": "Met", "label": "CPR:4"}, {"em1Text": "tumor necrosis factor alpha", "em2Text": "Met", "label": "CPR:4"}, {"em1Text": "TNF\u03b1", "em2Text": "Met", "label": "CPR:4"}, {"em1Text": "osteoprotegerin", "em2Text": "Met", "label": "CPR:4"}, {"em1Text": "OPG", "em2Text": "Met", "label": "CPR:4"}]}
{"sentText": "Met RANTES treatment also reduced the levels of cathepsin K and metalloproteinase 13 MMP13", "relationMentions": [{"em1Text": "Met", "em2Text": "cathepsin K", "label": "CPR:4"}, {"em1Text": "Met", "em2Text": "metalloproteinase 13", "label": "CPR:4"}, {"em1Text": "Met", "em2Text": "MMP13", "label": "CPR:4"}]}
{"sentText": "The quinolizidine alkaloids natural products such as oxymatrine sophoridine sophocarpine and matrine carry the common molecular structure of O=C=NCCCN that possessed positive ionotropic effect and hERG blocking activity", "relationMentions": [{"em1Text": "matrine", "em2Text": "hERG", "label": "CPR:4"}, {"em1Text": "O=C=NCCCN", "em2Text": "hERG", "label": "CPR:4"}, {"em1Text": "quinolizidine alkaloids", "em2Text": "hERG", "label": "CPR:4"}, {"em1Text": "oxymatrine", "em2Text": "hERG", "label": "CPR:4"}, {"em1Text": "sophoridine", "em2Text": "hERG", "label": "CPR:4"}, {"em1Text": "sophocarpine", "em2Text": "hERG", "label": "CPR:4"}]}
{"sentText": "Several effects of polyphenols are useful in this scenario including a reduction in the activities of cytokines and modulation of cellular metabolism through histone deacetylase inhibitors AMPK activators calorierestriction mimetics or epigenetic regulators", "relationMentions": [{"em1Text": "polyphenols", "em2Text": "AMPK", "label": "CPR:3"}, {"em1Text": "polyphenols", "em2Text": "cytokines", "label": "CPR:4"}, {"em1Text": "polyphenols", "em2Text": "histone deacetylase", "label": "CPR:4"}]}
{"sentText": "Furthermore the EGF R inhibitor AG1478 inhibited EGF induced MMP9 expression cell migration and invasion as well as the activation of PI3KAkt suggesting that PI3K Akt activation occur downstream of EGF R activation", "relationMentions": [{"em1Text": "AG1478", "em2Text": "PI3K", "label": "CPR:4"}, {"em1Text": "AG1478", "em2Text": "Akt", "label": "CPR:4"}, {"em1Text": "EGF", "em2Text": "AG1478", "label": "CPR:4"}, {"em1Text": "AG1478", "em2Text": "MMP9", "label": "CPR:4"}]}
{"sentText": "Inhibition of EGF EGFR activation with naphtho12bfuran45dione blocks migration and invasion of MDAMB231 cells", "relationMentions": [{"em1Text": "EGF", "em2Text": "naphtho12bfuran45dione", "label": "CPR:4"}, {"em1Text": "EGFR", "em2Text": "naphtho12bfuran45dione", "label": "CPR:4"}]}
{"sentText": "These findings suggest that NFD inhibited the EGF induced invasion and migration of MDAMB231 cells via EGFR dependent PI3K Akt signaling leading to the downregulation of MMP9 expression", "relationMentions": [{"em1Text": "NFD", "em2Text": "EGF", "label": "CPR:4"}, {"em1Text": "NFD", "em2Text": "EGFR", "label": "CPR:4"}, {"em1Text": "NFD", "em2Text": "PI3K", "label": "CPR:4"}, {"em1Text": "NFD", "em2Text": "Akt", "label": "CPR:4"}, {"em1Text": "NFD", "em2Text": "MMP9", "label": "CPR:4"}]}
{"sentText": "NFD suppressed EGF mediated protein levels of cJun and cFos and reduced MMP9 expression and activity concomitantly with a marked inhibition on cell migration and invasion without obvious cellular cytotoxicity", "relationMentions": [{"em1Text": "NFD", "em2Text": "EGF", "label": "CPR:4"}, {"em1Text": "NFD", "em2Text": "cJun", "label": "CPR:4"}, {"em1Text": "NFD", "em2Text": "cFos", "label": "CPR:4"}, {"em1Text": "NFD", "em2Text": "MMP9", "label": "CPR:4"}]}
{"sentText": "NFD abrogated EGFinduced phosphorylation of EGF receptor EGFR and phosphatidylinositol 3kinase PI3K Akt", "relationMentions": [{"em1Text": "NFD", "em2Text": "EGF", "label": "CPR:4"}, {"em1Text": "NFD", "em2Text": "EGF receptor", "label": "CPR:4"}, {"em1Text": "NFD", "em2Text": "EGFR", "label": "CPR:4"}, {"em1Text": "NFD", "em2Text": "phosphatidylinositol 3kinase", "label": "CPR:4"}, {"em1Text": "NFD", "em2Text": "PI3K", "label": "CPR:4"}, {"em1Text": "NFD", "em2Text": "Akt", "label": "CPR:4"}]}
{"sentText": "Herein we report the identification and characterization of 35tertbutylisoxazol3yl23chlorophenylhydrazono3oxopropionitrile ESI09 a novel noncyclic nucleotide EPAC antagonist that is capable of specifically blocking intracellular EPACmediated Rap1 activation and Akt phosphorylation as well as EPACmediated insulin secretion in pancreatic \u03b2 cells", "relationMentions": [{"em1Text": "35tertbutylisoxazol3yl23chlorophenylhydrazono3oxopropionitrile", "em2Text": "EPAC", "label": "CPR:4"}, {"em1Text": "35tertbutylisoxazol3yl23chlorophenylhydrazono3oxopropionitrile", "em2Text": "Rap1", "label": "CPR:4"}, {"em1Text": "35tertbutylisoxazol3yl23chlorophenylhydrazono3oxopropionitrile", "em2Text": "Akt", "label": "CPR:4"}, {"em1Text": "35tertbutylisoxazol3yl23chlorophenylhydrazono3oxopropionitrile", "em2Text": "insulin", "label": "CPR:4"}, {"em1Text": "ESI09", "em2Text": "EPAC", "label": "CPR:4"}, {"em1Text": "ESI09", "em2Text": "Rap1", "label": "CPR:4"}, {"em1Text": "ESI09", "em2Text": "Akt", "label": "CPR:4"}, {"em1Text": "ESI09", "em2Text": "insulin", "label": "CPR:4"}, {"em1Text": "nucleotide", "em2Text": "EPAC", "label": "CPR:4"}, {"em1Text": "nucleotide", "em2Text": "Rap1", "label": "CPR:4"}, {"em1Text": "nucleotide", "em2Text": "Akt", "label": "CPR:4"}, {"em1Text": "nucleotide", "em2Text": "insulin", "label": "CPR:4"}, {"em1Text": "35tertbutylisoxazol3yl23chlorophenylhydrazono3oxopropionitrile", "em2Text": "EPAC", "label": "CPR:6"}, {"em1Text": "ESI09", "em2Text": "EPAC", "label": "CPR:6"}, {"em1Text": "nucleotide", "em2Text": "EPAC", "label": "CPR:6"}]}
{"sentText": "Herein we report the identification and characterization of 35tertbutylisoxazol3yl23chlorophenylhydrazono3oxopropionitrile ESI09 a novel noncyclic nucleotide EPAC antagonist that is capable of specifically blocking intracellular EPACmediated Rap1 activation and Akt phosphorylation as well as EPACmediated insulin secretion in pancreatic \u03b2 cells", "relationMentions": [{"em1Text": "35tertbutylisoxazol3yl23chlorophenylhydrazono3oxopropionitrile", "em2Text": "EPAC", "label": "CPR:4"}, {"em1Text": "35tertbutylisoxazol3yl23chlorophenylhydrazono3oxopropionitrile", "em2Text": "Rap1", "label": "CPR:4"}, {"em1Text": "35tertbutylisoxazol3yl23chlorophenylhydrazono3oxopropionitrile", "em2Text": "Akt", "label": "CPR:4"}, {"em1Text": "35tertbutylisoxazol3yl23chlorophenylhydrazono3oxopropionitrile", "em2Text": "insulin", "label": "CPR:4"}, {"em1Text": "ESI09", "em2Text": "EPAC", "label": "CPR:4"}, {"em1Text": "ESI09", "em2Text": "Rap1", "label": "CPR:4"}, {"em1Text": "ESI09", "em2Text": "Akt", "label": "CPR:4"}, {"em1Text": "ESI09", "em2Text": "insulin", "label": "CPR:4"}, {"em1Text": "nucleotide", "em2Text": "EPAC", "label": "CPR:4"}, {"em1Text": "nucleotide", "em2Text": "Rap1", "label": "CPR:4"}, {"em1Text": "nucleotide", "em2Text": "Akt", "label": "CPR:4"}, {"em1Text": "nucleotide", "em2Text": "insulin", "label": "CPR:4"}, {"em1Text": "35tertbutylisoxazol3yl23chlorophenylhydrazono3oxopropionitrile", "em2Text": "EPAC", "label": "CPR:6"}, {"em1Text": "ESI09", "em2Text": "EPAC", "label": "CPR:6"}, {"em1Text": "nucleotide", "em2Text": "EPAC", "label": "CPR:6"}]}
{"sentText": "Metformin significantly reduced ghrelin secretion and proghrelin mRNA production and both these effects were blocked by coincubation with the AMPK inhibitor compound C Furthermore the AMPK activator 5amino1\u03b2Dribofuranosylimidazole4carboxamide AICAR significantly inhibited ghrelin secretion", "relationMentions": [{"em1Text": "ghrelin", "em2Text": "compound C", "label": "CPR:3"}, {"em1Text": "proghrelin", "em2Text": "compound C", "label": "CPR:3"}, {"em1Text": "AMPK", "em2Text": "5amino1\u03b2Dribofuranosylimidazole4carboxamide", "label": "CPR:3"}, {"em1Text": "AMPK", "em2Text": "AICAR", "label": "CPR:3"}, {"em1Text": "Metformin", "em2Text": "ghrelin", "label": "CPR:4"}, {"em1Text": "Metformin", "em2Text": "proghrelin", "label": "CPR:4"}, {"em1Text": "AMPK", "em2Text": "compound C", "label": "CPR:4"}, {"em1Text": "ghrelin", "em2Text": "AICAR", "label": "CPR:4"}]}
{"sentText": "Metformin significantly reduced ghrelin secretion and proghrelin mRNA production and both these effects were blocked by coincubation with the AMPK inhibitor compound C Furthermore the AMPK activator 5amino1\u03b2Dribofuranosylimidazole4carboxamide AICAR significantly inhibited ghrelin secretion", "relationMentions": [{"em1Text": "ghrelin", "em2Text": "compound C", "label": "CPR:3"}, {"em1Text": "proghrelin", "em2Text": "compound C", "label": "CPR:3"}, {"em1Text": "AMPK", "em2Text": "5amino1\u03b2Dribofuranosylimidazole4carboxamide", "label": "CPR:3"}, {"em1Text": "AMPK", "em2Text": "AICAR", "label": "CPR:3"}, {"em1Text": "Metformin", "em2Text": "ghrelin", "label": "CPR:4"}, {"em1Text": "Metformin", "em2Text": "proghrelin", "label": "CPR:4"}, {"em1Text": "AMPK", "em2Text": "compound C", "label": "CPR:4"}, {"em1Text": "ghrelin", "em2Text": "AICAR", "label": "CPR:4"}]}
{"sentText": "Metformin treatment is also associated with lower circulating levels of the orexigenic hormone ghrelin", "relationMentions": [{"em1Text": "Metformin", "em2Text": "orexigenic hormone", "label": "CPR:4"}, {"em1Text": "Metformin", "em2Text": "ghrelin", "label": "CPR:4"}]}
{"sentText": "Fungicide prochloraz and environmental pollutant dioxin induce the ABCG2 transporter in bovine mammary epithelial cells by the arylhydrocarbon receptor signaling pathway", "relationMentions": [{"em1Text": "prochloraz", "em2Text": "ABCG2", "label": "CPR:3"}, {"em1Text": "dioxin", "em2Text": "ABCG2", "label": "CPR:3"}]}
{"sentText": "Induction of AhR by TCDD and prochloraz resulted in a time and dosedependent increase of ABCG2 gene expression and transporter protein levels", "relationMentions": [{"em1Text": "AhR", "em2Text": "TCDD", "label": "CPR:3"}, {"em1Text": "TCDD", "em2Text": "ABCG2", "label": "CPR:3"}, {"em1Text": "AhR", "em2Text": "prochloraz", "label": "CPR:3"}, {"em1Text": "prochloraz", "em2Text": "ABCG2", "label": "CPR:3"}]}
{"sentText": "Induction of AhR by TCDD and prochloraz resulted in a time and dosedependent increase of ABCG2 gene expression and transporter protein levels", "relationMentions": [{"em1Text": "AhR", "em2Text": "TCDD", "label": "CPR:3"}, {"em1Text": "TCDD", "em2Text": "ABCG2", "label": "CPR:3"}, {"em1Text": "AhR", "em2Text": "prochloraz", "label": "CPR:3"}, {"em1Text": "prochloraz", "em2Text": "ABCG2", "label": "CPR:3"}]}
{"sentText": "As these regulatory motifs mediate regulation of target genes by AhR agonists including TCDD and prochloraz we have systematically investigated the effect of both contaminants on functional ABCG2 transport activity in primary bovine mammary epithelial cells", "relationMentions": [{"em1Text": "AhR", "em2Text": "TCDD", "label": "CPR:5"}, {"em1Text": "AhR", "em2Text": "prochloraz", "label": "CPR:5"}]}
{"sentText": "We observed similar effects of Ag NPs on inflammatory mediator expression in vitro and in vivo with increase of interleukin8 IL8 macrophage inflammatory protein 2 IL1RI and tumor necrosis factor\u03b1 expression in both models and increased IL8 protein release in vitro", "relationMentions": [{"em1Text": "Ag", "em2Text": "interleukin8", "label": "CPR:3"}, {"em1Text": "Ag", "em2Text": "IL8", "label": "CPR:3"}, {"em1Text": "Ag", "em2Text": "macrophage inflammatory protein 2", "label": "CPR:3"}, {"em1Text": "Ag", "em2Text": "IL1RI", "label": "CPR:3"}, {"em1Text": "Ag", "em2Text": "tumor necrosis factor\u03b1", "label": "CPR:3"}]}
{"sentText": "Blood pressure was increased in rats exposed to IH and treatment with the PDK1 inhibitor OSU03012 2aminoN452phenanthrenyl3trifluoromethyl1Hpyrazol1ylphenylacetamide 33 mgday lowered blood pressure in IH but not sham group rats", "relationMentions": [{"em1Text": "PDK1", "em2Text": "OSU03012", "label": "CPR:4"}, {"em1Text": "PDK1", "em2Text": "2aminoN452phenanthrenyl3trifluoromethyl1Hpyrazol1ylphenylacetamide", "label": "CPR:4"}]}
{"sentText": "Following CdCl\u2082 treatment ICAM2 was found to be upregulated during restructuring of the seminiferous epithelium with round spermatids becoming increasingly immunoreactive for ICAM2 by 616 h Interestingly there was a loss in the binding of ICAM2 to actin during CdCl\u2082induced germ cell loss suggesting that a loss of ICAM2actin interactions might have facilitated junction restructuring", "relationMentions": [{"em1Text": "CdCl\u2082", "em2Text": "ICAM2", "label": "CPR:3"}, {"em1Text": "CdCl\u2082", "em2Text": "actin", "label": "CPR:4"}]}
{"sentText": "The reaction was inhibited by the specific CYP2D inhibitors quinine and fluoxetine", "relationMentions": [{"em1Text": "CYP2D", "em2Text": "quinine", "label": "CPR:4"}, {"em1Text": "CYP2D", "em2Text": "fluoxetine", "label": "CPR:4"}]}
{"sentText": "Of the rat CYP isoforms studied CYP2D isoforms were the most efficient in catalyzing the O demethylation of 5methoxytryptamine to serotonin but they were less effective than the human isoform CYP2D6", "relationMentions": [{"em1Text": "O", "em2Text": "CYP2D", "label": "CPR:9"}, {"em1Text": "O", "em2Text": "human isoform CYP2D6", "label": "CPR:9"}, {"em1Text": "CYP2D", "em2Text": "5methoxytryptamine", "label": "CPR:9"}, {"em1Text": "5methoxytryptamine", "em2Text": "human isoform CYP2D6", "label": "CPR:9"}, {"em1Text": "CYP2D", "em2Text": "serotonin", "label": "CPR:9"}, {"em1Text": "serotonin", "em2Text": "human isoform CYP2D6", "label": "CPR:9"}]}
{"sentText": "Of the rat CYP isoforms studied CYP2D isoforms were the most efficient in catalyzing the O demethylation of 5methoxytryptamine to serotonin but they were less effective than the human isoform CYP2D6", "relationMentions": [{"em1Text": "O", "em2Text": "CYP2D", "label": "CPR:9"}, {"em1Text": "O", "em2Text": "human isoform CYP2D6", "label": "CPR:9"}, {"em1Text": "CYP2D", "em2Text": "5methoxytryptamine", "label": "CPR:9"}, {"em1Text": "5methoxytryptamine", "em2Text": "human isoform CYP2D6", "label": "CPR:9"}, {"em1Text": "CYP2D", "em2Text": "serotonin", "label": "CPR:9"}, {"em1Text": "serotonin", "em2Text": "human isoform CYP2D6", "label": "CPR:9"}]}
{"sentText": "The catalytic competence of cytochrome P450 in the synthesis of serotonin from 5methoxytryptamine in the brain an in vitro study", "relationMentions": [{"em1Text": "cytochrome P450", "em2Text": "serotonin", "label": "CPR:9"}, {"em1Text": "cytochrome P450", "em2Text": "5methoxytryptamine", "label": "CPR:9"}]}
{"sentText": "Human liver microsomes of the wildtype CYP2D6 metabolized 5methoxytryptamine to serotonin more effectively than did the defective CYP2D6 44 ones", "relationMentions": [{"em1Text": "CYP2D6", "em2Text": "5methoxytryptamine", "label": "CPR:9"}, {"em1Text": "CYP2D6", "em2Text": "serotonin", "label": "CPR:9"}]}
{"sentText": "The obtained results indicate that rat brain CYP2D isoforms catalyze the formation of serotonin from 5methoxytryptamine and that the deficit or genetic defect of CYP2D may affect serotonin metabolism in the brain", "relationMentions": [{"em1Text": "rat brain CYP2D", "em2Text": "serotonin", "label": "CPR:9"}, {"em1Text": "rat brain CYP2D", "em2Text": "5methoxytryptamine", "label": "CPR:9"}, {"em1Text": "CYP2D", "em2Text": "serotonin", "label": "CPR:9"}]}
{"sentText": "The obtained results indicate that rat brain CYP2D isoforms catalyze the formation of serotonin from 5methoxytryptamine and that the deficit or genetic defect of CYP2D may affect serotonin metabolism in the brain", "relationMentions": [{"em1Text": "rat brain CYP2D", "em2Text": "serotonin", "label": "CPR:9"}, {"em1Text": "rat brain CYP2D", "em2Text": "5methoxytryptamine", "label": "CPR:9"}, {"em1Text": "CYP2D", "em2Text": "serotonin", "label": "CPR:9"}]}
{"sentText": "Western blot analysis indicated that TSN inhibits the CDC42 MEKK1 JNK pathway", "relationMentions": [{"em1Text": "TSN", "em2Text": "CDC42", "label": "CPR:4"}, {"em1Text": "TSN", "em2Text": "MEKK1", "label": "CPR:4"}, {"em1Text": "TSN", "em2Text": "JNK", "label": "CPR:4"}]}
{"sentText": "The MCAOinduced decrease in insulin receptor levels in the liver and skeletal muscle on day 1 was recovered to control levels by orexinA and this effect of orexinA was reversed by the administration of SB334867 as well as by hypothalamic BDNF knockdown", "relationMentions": [{"em1Text": "insulin receptor", "em2Text": "SB334867", "label": "CPR:4"}, {"em1Text": "orexinA", "em2Text": "SB334867", "label": "CPR:4"}]}
{"sentText": "Small interfering RNA directed BDNF orexinA and SB334867 N2methyl6benzoxazolylN15naphthyridin4yl urea a specific orexin1 receptor antagonist were administered directly into the hypothalamus", "relationMentions": [{"em1Text": "SB334867", "em2Text": "orexin1 receptor", "label": "CPR:6"}, {"em1Text": "N2methyl6benzoxazolylN15naphthyridin4yl urea", "em2Text": "orexin1 receptor", "label": "CPR:6"}]}
{"sentText": "Moreover 5ASA treatment restored membranous expression of adhesion molecules Ecadherin and \u03b2catenin", "relationMentions": [{"em1Text": "5ASA", "em2Text": "Ecadherin", "label": "CPR:3"}, {"em1Text": "5ASA", "em2Text": "\u03b2catenin", "label": "CPR:3"}]}
{"sentText": "In contrast EGCG markedly downregulated major bile acid transporters Asbt and Ost\u03b1 and regulatory molecules Shp and Fgf15 in the ileum", "relationMentions": [{"em1Text": "EGCG", "em2Text": "bile acid transporters", "label": "CPR:4"}, {"em1Text": "EGCG", "em2Text": "Asbt", "label": "CPR:4"}, {"em1Text": "EGCG", "em2Text": "Ost\u03b1", "label": "CPR:4"}, {"em1Text": "EGCG", "em2Text": "Shp", "label": "CPR:4"}, {"em1Text": "EGCG", "em2Text": "Fgf15", "label": "CPR:4"}]}
{"sentText": "In addition our exploration further revealed that the suppressive action of catalpol on inflammation was mediated via inhibiting nuclear factor\u03baB NF\u03baB activation", "relationMentions": [{"em1Text": "catalpol", "em2Text": "NF\u03baB", "label": "CPR:4"}, {"em1Text": "catalpol", "em2Text": "nuclear factor\u03baB", "label": "CPR:4"}]}
{"sentText": "Data at transcriptional level also demonstrated that catalpol potently attenuated gene expressions involved in inflammation such as iNOS COX2 and TLR4", "relationMentions": [{"em1Text": "catalpol", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "catalpol", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "catalpol", "em2Text": "TLR4", "label": "CPR:4"}]}
{"sentText": "Protein tyrosine phosphatase 1B inhibitory effect by dammarane type triterpenes from hydrolyzate of total Gynostemma pentaphyllum saponins", "relationMentions": [{"em1Text": "Protein tyrosine phosphatase 1B", "em2Text": "saponins", "label": "CPR:4"}, {"em1Text": "Protein tyrosine phosphatase 1B", "em2Text": "dammarane", "label": "CPR:4"}, {"em1Text": "Protein tyrosine phosphatase 1B", "em2Text": "triterpenes", "label": "CPR:4"}]}
{"sentText": "Therefore the present results show that the earlier cerebellar responses to PhTe2 include disruption of cytoskeletal homeostasis that could be related with MAPK and PKA activation and reactive astrogliosis", "relationMentions": [{"em1Text": "PhTe2", "em2Text": "MAPK", "label": "CPR:3"}, {"em1Text": "PhTe2", "em2Text": "PKA", "label": "CPR:3"}]}
{"sentText": "Fluorescence of the reporter dye is turned on by rapid removal of the quinone quencher an event that immediately occurs only after highly selective twoelectron reduction of the sterically and conformationally restricted quinone substrate by the cancerassociated human NADPHquinone oxidoreductase isozyme 1 hNQO1", "relationMentions": [{"em1Text": "quinone", "em2Text": "human NADPHquinone oxidoreductase isozyme 1", "label": "CPR:9"}, {"em1Text": "quinone", "em2Text": "hNQO1", "label": "CPR:9"}]}
{"sentText": "Within the TPBP scaffold either electronic or steric perturbations to the central piperidine ring led to a loss of selective M1 allosteric agonism and afforded pan mAChR antagonism which was demonstrated to be mediated via the orthosteric site", "relationMentions": [{"em1Text": "TPBP", "em2Text": "mAChR", "label": "CPR:6"}, {"em1Text": "piperidine", "em2Text": "mAChR", "label": "CPR:6"}]}
{"sentText": "The objective of this article is to examine the effects of single and repeated administrations of silymarin on pharmacokinetics of a Pgp substrate risperidone and its major metabolite 9hydroxyrisperidone in rats", "relationMentions": [{"em1Text": "Pgp", "em2Text": "risperidone", "label": "CPR:9"}, {"em1Text": "Pgp", "em2Text": "9hydroxyrisperidone", "label": "CPR:9"}]}
{"sentText": "Liver X Receptor LXR \u03b1 and LXR \u03b2 are nuclear receptors activated by oxysterols oxidized derivatives of cholesterol", "relationMentions": [{"em1Text": "Liver X Receptor LXR \u03b1", "em2Text": "oxysterols", "label": "CPR:3"}, {"em1Text": "LXR \u03b2", "em2Text": "oxysterols", "label": "CPR:3"}]}
{"sentText": "The aim of the present work was to evaluate the effectiveness of such an antidote by testing whether doxorubicin DOX a known Pgp inducer could efficiently protect Caco2 cells against PQ cytotoxicity 6 h after the incubation with the herbicide reflecting a reallife intoxication scenario", "relationMentions": [{"em1Text": "doxorubicin", "em2Text": "Pgp", "label": "CPR:3"}, {"em1Text": "DOX", "em2Text": "Pgp", "label": "CPR:3"}]}
{"sentText": "The selective SYK inhibitor P50515 PRT062607 inhibits B cell signaling and function in vitro and in vivo and augments the activity of fludarabine in chronic lymphocytic leukemia", "relationMentions": [{"em1Text": "SYK", "em2Text": "P50515", "label": "CPR:4"}, {"em1Text": "SYK", "em2Text": "PRT062607", "label": "CPR:4"}]}
{"sentText": "P50515 also known as PRT062607 is a novel highly selective and orally bioavailable small molecule SYK inhibitor SYK IC50 = 1 nM with antiSYK activity that is at least 80fold greater than its affinity for other kinases", "relationMentions": [{"em1Text": "P50515", "em2Text": "SYK", "label": "CPR:4"}, {"em1Text": "PRT062607", "em2Text": "SYK", "label": "CPR:4"}]}
{"sentText": "P50515 successfully inhibited SYK mediated Bcell receptor signaling and decreased cell viability in NHL and CLL", "relationMentions": [{"em1Text": "P50515", "em2Text": "SYK", "label": "CPR:4"}, {"em1Text": "P50515", "em2Text": "Bcell receptor", "label": "CPR:4"}]}
{"sentText": "17Allylamino17demethoxygeldanamycin 17AAG an Hsp90 inhibitor is currently under evaluation for its anticancer activity in clinical trials", "relationMentions": [{"em1Text": "17Allylamino17demethoxygeldanamycin", "em2Text": "Hsp90", "label": "CPR:4"}, {"em1Text": "17AAG", "em2Text": "Hsp90", "label": "CPR:4"}]}
{"sentText": "In addition 17AAG treatment reduced cell viability CDK2 CDK4 cyclin E cyclin D1 and phosphorylated Rb levels in AhRexpressing lung AD cells", "relationMentions": [{"em1Text": "17AAG", "em2Text": "CDK2", "label": "CPR:4"}, {"em1Text": "17AAG", "em2Text": "CDK4", "label": "CPR:4"}, {"em1Text": "17AAG", "em2Text": "cyclin E", "label": "CPR:4"}, {"em1Text": "17AAG", "em2Text": "cyclin D1", "label": "CPR:4"}, {"em1Text": "17AAG", "em2Text": "phosphorylated Rb", "label": "CPR:4"}]}
{"sentText": "Wildtype enzymes and variants of CDA Lys27Gln and Ala70Thr and DCK Ile24Val Ala119Gly and Pro122Ser were expressed in and purified from Escherichia coli and enzyme kinetic parameters were estimated for cytarabine AraC dFdC and its metabolite 22difluorodeoxyuridine dFdU as substrates", "relationMentions": [{"em1Text": "CDA", "em2Text": "AraC", "label": "CPR:9"}, {"em1Text": "Lys27Gln", "em2Text": "AraC", "label": "CPR:9"}, {"em1Text": "Ala70Thr", "em2Text": "AraC", "label": "CPR:9"}, {"em1Text": "DCK", "em2Text": "AraC", "label": "CPR:9"}, {"em1Text": "Ile24Val", "em2Text": "AraC", "label": "CPR:9"}, {"em1Text": "Ala119Gly", "em2Text": "AraC", "label": "CPR:9"}, {"em1Text": "Pro122Ser", "em2Text": "AraC", "label": "CPR:9"}, {"em1Text": "CDA", "em2Text": "dFdC", "label": "CPR:9"}, {"em1Text": "Lys27Gln", "em2Text": "dFdC", "label": "CPR:9"}, {"em1Text": "Ala70Thr", "em2Text": "dFdC", "label": "CPR:9"}, {"em1Text": "DCK", "em2Text": "dFdC", "label": "CPR:9"}, {"em1Text": "Ile24Val", "em2Text": "dFdC", "label": "CPR:9"}, {"em1Text": "Ala119Gly", "em2Text": "dFdC", "label": "CPR:9"}, {"em1Text": "Pro122Ser", "em2Text": "dFdC", "label": "CPR:9"}, {"em1Text": "CDA", "em2Text": "22difluorodeoxyuridine", "label": "CPR:9"}, {"em1Text": "Lys27Gln", "em2Text": "22difluorodeoxyuridine", "label": "CPR:9"}, {"em1Text": "Ala70Thr", "em2Text": "22difluorodeoxyuridine", "label": "CPR:9"}, {"em1Text": "DCK", "em2Text": "22difluorodeoxyuridine", "label": "CPR:9"}, {"em1Text": "Ile24Val", "em2Text": "22difluorodeoxyuridine", "label": "CPR:9"}, {"em1Text": "Ala119Gly", "em2Text": "22difluorodeoxyuridine", "label": "CPR:9"}, {"em1Text": "Pro122Ser", "em2Text": "22difluorodeoxyuridine", "label": "CPR:9"}, {"em1Text": "CDA", "em2Text": "dFdU", "label": "CPR:9"}, {"em1Text": "CDA", "em2Text": "cytarabine", "label": "CPR:9"}, {"em1Text": "Lys27Gln", "em2Text": "cytarabine", "label": "CPR:9"}, {"em1Text": "Ala70Thr", "em2Text": "cytarabine", "label": "CPR:9"}, {"em1Text": "DCK", "em2Text": "cytarabine", "label": "CPR:9"}, {"em1Text": "Ile24Val", "em2Text": "cytarabine", "label": "CPR:9"}, {"em1Text": "Ala119Gly", "em2Text": "cytarabine", "label": "CPR:9"}, {"em1Text": "Pro122Ser", "em2Text": "cytarabine", "label": "CPR:9"}]}
{"sentText": "Wildtype enzymes and variants of CDA Lys27Gln and Ala70Thr and DCK Ile24Val Ala119Gly and Pro122Ser were expressed in and purified from Escherichia coli and enzyme kinetic parameters were estimated for cytarabine AraC dFdC and its metabolite 22difluorodeoxyuridine dFdU as substrates", "relationMentions": [{"em1Text": "CDA", "em2Text": "AraC", "label": "CPR:9"}, {"em1Text": "Lys27Gln", "em2Text": "AraC", "label": "CPR:9"}, {"em1Text": "Ala70Thr", "em2Text": "AraC", "label": "CPR:9"}, {"em1Text": "DCK", "em2Text": "AraC", "label": "CPR:9"}, {"em1Text": "Ile24Val", "em2Text": "AraC", "label": "CPR:9"}, {"em1Text": "Ala119Gly", "em2Text": "AraC", "label": "CPR:9"}, {"em1Text": "Pro122Ser", "em2Text": "AraC", "label": "CPR:9"}, {"em1Text": "CDA", "em2Text": "dFdC", "label": "CPR:9"}, {"em1Text": "Lys27Gln", "em2Text": "dFdC", "label": "CPR:9"}, {"em1Text": "Ala70Thr", "em2Text": "dFdC", "label": "CPR:9"}, {"em1Text": "DCK", "em2Text": "dFdC", "label": "CPR:9"}, {"em1Text": "Ile24Val", "em2Text": "dFdC", "label": "CPR:9"}, {"em1Text": "Ala119Gly", "em2Text": "dFdC", "label": "CPR:9"}, {"em1Text": "Pro122Ser", "em2Text": "dFdC", "label": "CPR:9"}, {"em1Text": "CDA", "em2Text": "22difluorodeoxyuridine", "label": "CPR:9"}, {"em1Text": "Lys27Gln", "em2Text": "22difluorodeoxyuridine", "label": "CPR:9"}, {"em1Text": "Ala70Thr", "em2Text": "22difluorodeoxyuridine", "label": "CPR:9"}, {"em1Text": "DCK", "em2Text": "22difluorodeoxyuridine", "label": "CPR:9"}, {"em1Text": "Ile24Val", "em2Text": "22difluorodeoxyuridine", "label": "CPR:9"}, {"em1Text": "Ala119Gly", "em2Text": "22difluorodeoxyuridine", "label": "CPR:9"}, {"em1Text": "Pro122Ser", "em2Text": "22difluorodeoxyuridine", "label": "CPR:9"}, {"em1Text": "CDA", "em2Text": "dFdU", "label": "CPR:9"}, {"em1Text": "CDA", "em2Text": "cytarabine", "label": "CPR:9"}, {"em1Text": "Lys27Gln", "em2Text": "cytarabine", "label": "CPR:9"}, {"em1Text": "Ala70Thr", "em2Text": "cytarabine", "label": "CPR:9"}, {"em1Text": "DCK", "em2Text": "cytarabine", "label": "CPR:9"}, {"em1Text": "Ile24Val", "em2Text": "cytarabine", "label": "CPR:9"}, {"em1Text": "Ala119Gly", "em2Text": "cytarabine", "label": "CPR:9"}, {"em1Text": "Pro122Ser", "em2Text": "cytarabine", "label": "CPR:9"}]}
{"sentText": "All three CDA proteins showed similar Km and Vmax for AraC and dFdC deamination except for CDA 70Thr which had a 25fold lower Km and 6fold lower Vmax for AraC deamination", "relationMentions": [{"em1Text": "CDA", "em2Text": "AraC", "label": "CPR:9"}, {"em1Text": "CDA", "em2Text": "dFdC", "label": "CPR:9"}]}
{"sentText": "All four DCK proteins yielded comparable metabolic activity for AraC and dFdC monophosphorylation except for DCK24Val which demonstrated an approximately 2fold increase P 005 in the intrinsic clearance of dFdC monophosphorylation due to a 40 decrease in Km P 005", "relationMentions": [{"em1Text": "DCK", "em2Text": "AraC", "label": "CPR:9"}, {"em1Text": "DCK", "em2Text": "dFdC", "label": "CPR:9"}]}
{"sentText": "Gemcitabine dFdC 22difluorodeoxycytidine is metabolized by cytidine deaminase CDA and deoxycytidine kinase DCK but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear", "relationMentions": [{"em1Text": "Gemcitabine", "em2Text": "DCK", "label": "CPR:9"}, {"em1Text": "Gemcitabine", "em2Text": "cytidine deaminase", "label": "CPR:9"}, {"em1Text": "Gemcitabine", "em2Text": "CDA", "label": "CPR:9"}, {"em1Text": "Gemcitabine", "em2Text": "deoxycytidine kinase", "label": "CPR:9"}, {"em1Text": "dFdC", "em2Text": "DCK", "label": "CPR:9"}, {"em1Text": "dFdC", "em2Text": "cytidine deaminase", "label": "CPR:9"}, {"em1Text": "dFdC", "em2Text": "CDA", "label": "CPR:9"}, {"em1Text": "dFdC", "em2Text": "deoxycytidine kinase", "label": "CPR:9"}, {"em1Text": "22difluorodeoxycytidine", "em2Text": "DCK", "label": "CPR:9"}, {"em1Text": "22difluorodeoxycytidine", "em2Text": "cytidine deaminase", "label": "CPR:9"}, {"em1Text": "22difluorodeoxycytidine", "em2Text": "CDA", "label": "CPR:9"}, {"em1Text": "22difluorodeoxycytidine", "em2Text": "deoxycytidine kinase", "label": "CPR:9"}]}
{"sentText": "Gemcitabine dFdC 22difluorodeoxycytidine is metabolized by cytidine deaminase CDA and deoxycytidine kinase DCK but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear", "relationMentions": [{"em1Text": "Gemcitabine", "em2Text": "DCK", "label": "CPR:9"}, {"em1Text": "Gemcitabine", "em2Text": "cytidine deaminase", "label": "CPR:9"}, {"em1Text": "Gemcitabine", "em2Text": "CDA", "label": "CPR:9"}, {"em1Text": "Gemcitabine", "em2Text": "deoxycytidine kinase", "label": "CPR:9"}, {"em1Text": "dFdC", "em2Text": "DCK", "label": "CPR:9"}, {"em1Text": "dFdC", "em2Text": "cytidine deaminase", "label": "CPR:9"}, {"em1Text": "dFdC", "em2Text": "CDA", "label": "CPR:9"}, {"em1Text": "dFdC", "em2Text": "deoxycytidine kinase", "label": "CPR:9"}, {"em1Text": "22difluorodeoxycytidine", "em2Text": "DCK", "label": "CPR:9"}, {"em1Text": "22difluorodeoxycytidine", "em2Text": "cytidine deaminase", "label": "CPR:9"}, {"em1Text": "22difluorodeoxycytidine", "em2Text": "CDA", "label": "CPR:9"}, {"em1Text": "22difluorodeoxycytidine", "em2Text": "deoxycytidine kinase", "label": "CPR:9"}]}
{"sentText": "In conclusion the Lys27Gln substitution does not significantly modulate CDA activity toward dFdC and therefore would not contribute to interindividual variability in response to gemcitabine", "relationMentions": [{"em1Text": "Lys27Gln", "em2Text": "dFdC", "label": "CPR:9"}, {"em1Text": "CDA", "em2Text": "dFdC", "label": "CPR:9"}]}
{"sentText": "A series of compounds based on a 4phenyl2phenylaminopyridine scaffold that are potent and selective inhibitors of Traf2 and Nckinteracting kinase TNIK activity are described", "relationMentions": [{"em1Text": "4phenyl2phenylaminopyridine", "em2Text": "Traf2 and Nckinteracting kinase", "label": "CPR:4"}, {"em1Text": "4phenyl2phenylaminopyridine", "em2Text": "TNIK", "label": "CPR:4"}]}
{"sentText": "Here we present boronic and borinic acid derivatives as a new class of potent and nontoxic APT inhibitors", "relationMentions": [{"em1Text": "boronic", "em2Text": "APT", "label": "CPR:4"}, {"em1Text": "borinic acid", "em2Text": "APT", "label": "CPR:4"}]}
{"sentText": "Genistein also reduced the formation of stress fibers by thrombin and suppressed thrombininduced phosphorylation of myosin light chain MLC on Ser19Thr18 in endothelial cells ECs", "relationMentions": [{"em1Text": "Genistein", "em2Text": "thrombin", "label": "CPR:4"}, {"em1Text": "Genistein", "em2Text": "myosin light chain", "label": "CPR:4"}, {"em1Text": "Genistein", "em2Text": "MLC", "label": "CPR:4"}]}
{"sentText": "In vitro GSK1292263 demonstrated littleweak inhibition IC50 values 30 \u03bcM towards CYPs CYP1A2 2C9 2C19 2D6 3A4 Pgp OATP1B3 or OCT2", "relationMentions": [{"em1Text": "GSK1292263", "em2Text": "CYPs", "label": "CPR:4"}, {"em1Text": "GSK1292263", "em2Text": "CYP1A2", "label": "CPR:4"}, {"em1Text": "GSK1292263", "em2Text": "2C9", "label": "CPR:4"}, {"em1Text": "GSK1292263", "em2Text": "2C19", "label": "CPR:4"}, {"em1Text": "GSK1292263", "em2Text": "2D6", "label": "CPR:4"}, {"em1Text": "GSK1292263", "em2Text": "3A4", "label": "CPR:4"}, {"em1Text": "GSK1292263", "em2Text": "Pgp", "label": "CPR:4"}, {"em1Text": "GSK1292263", "em2Text": "OATP1B3", "label": "CPR:4"}, {"em1Text": "GSK1292263", "em2Text": "OCT2", "label": "CPR:4"}]}
{"sentText": "However GSK1292263 inhibited BCRP and OATP1B1 which are transporters involved in statin disposition", "relationMentions": [{"em1Text": "GSK1292263", "em2Text": "BCRP", "label": "CPR:4"}, {"em1Text": "GSK1292263", "em2Text": "OATP1B1", "label": "CPR:4"}]}
{"sentText": "In the clinical study small increases in the AUC0inf of simvastatin mean ratio 90 CI of 134 122 148 and rosuvastatin mean ratio 90 CI of 139 130 149 were observed when coadministered with GSK1292263 which is consistent with an inhibitory effect on intestinal BCRP and CYP3A4", "relationMentions": [{"em1Text": "GSK1292263", "em2Text": "CYP3A4", "label": "CPR:4"}, {"em1Text": "GSK1292263", "em2Text": "BCRP", "label": "CPR:4"}]}
{"sentText": "This work investigated the drug interaction potential of GSK1292263 a novel GPR119 agonist with the HMGcoA reductase inhibitors simvastatin and rosuvastatin", "relationMentions": [{"em1Text": "HMGcoA reductase", "em2Text": "simvastatin", "label": "CPR:4"}, {"em1Text": "HMGcoA reductase", "em2Text": "rosuvastatin", "label": "CPR:4"}, {"em1Text": "GSK1292263", "em2Text": "GPR119", "label": "CPR:5"}]}
{"sentText": "In vitro experiments assessed the inhibition of transporters and CYP enzymes by GSK1292263 and a clinical drug interaction study investigated the effect of GSK1292263 300 mg BID on the pharmacokinetic profile of simvastatin 40 mg single dose and rosuvastatin 10 mg single dose", "relationMentions": [{"em1Text": "transporters", "em2Text": "GSK1292263", "label": "CPR:4"}, {"em1Text": "CYP", "em2Text": "GSK1292263", "label": "CPR:4"}]}
{"sentText": "Inhibition of Th1Th17 responses via suppression of STAT1 and STAT3 activation contributes to the amelioration of murine experimental colitis by a natural flavonoid glucoside icariin", "relationMentions": [{"em1Text": "STAT1", "em2Text": "icariin", "label": "CPR:4"}, {"em1Text": "STAT3", "em2Text": "icariin", "label": "CPR:4"}, {"em1Text": "STAT1", "em2Text": "flavonoid", "label": "CPR:4"}, {"em1Text": "STAT3", "em2Text": "flavonoid", "label": "CPR:4"}]}
{"sentText": "Inhibition of Th1Th17 responses via suppression of STAT1 and STAT3 activation contributes to the amelioration of murine experimental colitis by a natural flavonoid glucoside icariin", "relationMentions": [{"em1Text": "STAT1", "em2Text": "icariin", "label": "CPR:4"}, {"em1Text": "STAT3", "em2Text": "icariin", "label": "CPR:4"}, {"em1Text": "STAT1", "em2Text": "flavonoid", "label": "CPR:4"}, {"em1Text": "STAT3", "em2Text": "flavonoid", "label": "CPR:4"}]}
{"sentText": "Moreover icariin treatment inhibited the phosphorylations of STAT1 and STAT3 in CD4 T cells which were the crucial transcription factors for Th1 and Th17 respectively", "relationMentions": [{"em1Text": "icariin", "em2Text": "STAT1", "label": "CPR:4"}, {"em1Text": "icariin", "em2Text": "STAT3", "label": "CPR:4"}]}
{"sentText": "Furthermore insulin stimulated TI cell proliferation and the expression of cell cycle regulatory proteins CDK4 CCND3 and PCNA were also blocked by rapamycin", "relationMentions": [{"em1Text": "insulin", "em2Text": "rapamycin", "label": "CPR:4"}, {"em1Text": "cell cycle regulatory proteins", "em2Text": "rapamycin", "label": "CPR:4"}, {"em1Text": "CDK4", "em2Text": "rapamycin", "label": "CPR:4"}, {"em1Text": "CCND3", "em2Text": "rapamycin", "label": "CPR:4"}, {"em1Text": "PCNA", "em2Text": "rapamycin", "label": "CPR:4"}]}
{"sentText": "Pharmacological inhibition of MTORC1 with rapamycin abrogated the insulin induced phosphorylation of EIF4EBP1 RPS6 KB1 and its downstream effector RPS6", "relationMentions": [{"em1Text": "MTORC1", "em2Text": "rapamycin", "label": "CPR:4"}, {"em1Text": "rapamycin", "em2Text": "insulin", "label": "CPR:4"}, {"em1Text": "rapamycin", "em2Text": "EIF4EBP1", "label": "CPR:4"}, {"em1Text": "rapamycin", "em2Text": "RPS6", "label": "CPR:4"}]}
{"sentText": "We report the discovery of novel series of highly potent TLR7 agonists based on 8oxoadenines 1 and 2 by introducing and optimizing various tertiary amines onto the N 9position of the adenine moiety", "relationMentions": [{"em1Text": "TLR7", "em2Text": "tertiary amines", "label": "CPR:5"}, {"em1Text": "TLR7", "em2Text": "N", "label": "CPR:5"}, {"em1Text": "TLR7", "em2Text": "adenine", "label": "CPR:5"}, {"em1Text": "TLR7", "em2Text": "8oxoadenines", "label": "CPR:5"}]}
{"sentText": "Inhibitors based on a benzofused spirocyclic oxazepine scaffold were discovered for stearoylcoenzyme A CoA desaturase 1 SCD1 and subsequently optimized to potent compounds with favorable pharmacokinetic profiles and in vivo efficacy in reducing the desaturation index in a mouse model", "relationMentions": [{"em1Text": "benzofused spirocyclic oxazepine", "em2Text": "SCD1", "label": "CPR:4"}, {"em1Text": "benzofused spirocyclic oxazepine", "em2Text": "stearoylcoenzyme A CoA desaturase 1", "label": "CPR:4"}]}
{"sentText": "Apocynin and raisanberine alleviate intermittent hypoxia induced abnormal StAR and 3\u03b2HSD and low testosterone by suppressing endoplasmic reticulum stress and activated p66Shc in rat testes", "relationMentions": [{"em1Text": "Apocynin", "em2Text": "p66Shc", "label": "CPR:4"}, {"em1Text": "raisanberine", "em2Text": "p66Shc", "label": "CPR:4"}, {"em1Text": "raisanberine", "em2Text": "3\u03b2HSD", "label": "CPR:9"}]}
{"sentText": "Apocynin and raisanberine alleviate intermittent hypoxia induced abnormal StAR and 3\u03b2HSD and low testosterone by suppressing endoplasmic reticulum stress and activated p66Shc in rat testes", "relationMentions": [{"em1Text": "Apocynin", "em2Text": "p66Shc", "label": "CPR:4"}, {"em1Text": "raisanberine", "em2Text": "p66Shc", "label": "CPR:4"}, {"em1Text": "raisanberine", "em2Text": "3\u03b2HSD", "label": "CPR:9"}]}
{"sentText": "We hypothesized that hypoxia induced testicular damage is mediated by an activated NADPH oxidase NOX therefore APO apocynin an inhibitor of NOX and raisanberine RS a calcium influx inhibitor were tested if they could attenuate hypoxic toxicity to the testis", "relationMentions": [{"em1Text": "NOX", "em2Text": "APO", "label": "CPR:4"}, {"em1Text": "NOX", "em2Text": "apocynin", "label": "CPR:4"}]}
{"sentText": "Furthermore we found that arsenic trioxide activates the Pirh2 promoter and consequently induces Pirh2 expression", "relationMentions": [{"em1Text": "arsenic trioxide", "em2Text": "Pirh2 promoter", "label": "CPR:3"}, {"em1Text": "arsenic trioxide", "em2Text": "Pirh2", "label": "CPR:3"}]}
{"sentText": "Additional mechanistic studies revealed that jaceosidin treatment resulted in an increase in phosphorylation of Cdc25C and ATM Chk12", "relationMentions": [{"em1Text": "jaceosidin", "em2Text": "Cdc25C", "label": "CPR:3"}, {"em1Text": "jaceosidin", "em2Text": "ATM", "label": "CPR:3"}]}
{"sentText": "Jaceosidin isolated from dietary mugwort Artemisia princeps induces G2M cell cycle arrest by inactivating cdc25C cdc2 via ATM Chk12 activation", "relationMentions": [{"em1Text": "Jaceosidin", "em2Text": "ATM", "label": "CPR:3"}, {"em1Text": "Jaceosidin", "em2Text": "cdc25C", "label": "CPR:4"}, {"em1Text": "Jaceosidin", "em2Text": "cdc2", "label": "CPR:4"}]}
{"sentText": "These data suggest that jaceosidin isolated from Japanese mugwort modulates the ERKATMChk12 pathway leading to inactivation of the Cdc2 cyclin B1 complex followed by G2M cell cycle arrest in endometrial cancer cells", "relationMentions": [{"em1Text": "jaceosidin", "em2Text": "Cdc2", "label": "CPR:4"}, {"em1Text": "jaceosidin", "em2Text": "cyclin B1", "label": "CPR:4"}]}
{"sentText": "Electrical stimulation ATP and insulin each increased fluorescent 2NBDGlucose 2NBDG uptake in primary myotubes but only electrical stimulation and ATPdependent 2NBDG uptake were inhibited by adenosinephosphate phosphatase and by purinergic receptor blockade suramin", "relationMentions": [{"em1Text": "adenosinephosphate phosphatase", "em2Text": "suramin", "label": "CPR:4"}, {"em1Text": "purinergic receptor", "em2Text": "suramin", "label": "CPR:4"}]}
{"sentText": "ATPdependent 2NBDG uptake was also inhibited by the G protein \u03b2\u03b3 subunitinteracting peptide \u03b2arkct and by the phosphatidylinositol 3kinase\u03b3 PI3K\u03b3 inhibitor AS605240", "relationMentions": [{"em1Text": "phosphatidylinositol 3kinase\u03b3", "em2Text": "AS605240", "label": "CPR:4"}, {"em1Text": "PI3K\u03b3", "em2Text": "AS605240", "label": "CPR:4"}]}
{"sentText": "In conclusion this study provides the first evidence implicating that TSA inhibits TGF\u03b2 induced ROS accumulation and myofibroblast differentiation via enhanced Nrf2 ARE signaling", "relationMentions": [{"em1Text": "TSA", "em2Text": "Nrf2", "label": "CPR:3"}, {"em1Text": "TSA", "em2Text": "ARE", "label": "CPR:3"}, {"em1Text": "TSA", "em2Text": "TGF\u03b2", "label": "CPR:4"}]}
{"sentText": "Human immortalized corneal fibroblasts were treated with TGF\u03b2 in the presence of TSA the NADPH oxidase inhibitor diphenyleneiodonium DPI the antioxidant Nacetylcysteine NAC the NFE2related factor 2 antioxidant response element Nrf2 ARE activator sulforaphane or small interfering RNA", "relationMentions": [{"em1Text": "NFE2related factor 2", "em2Text": "sulforaphane", "label": "CPR:3"}, {"em1Text": "antioxidant response element", "em2Text": "sulforaphane", "label": "CPR:3"}, {"em1Text": "Nrf2", "em2Text": "sulforaphane", "label": "CPR:3"}, {"em1Text": "ARE", "em2Text": "sulforaphane", "label": "CPR:3"}, {"em1Text": "NADPH oxidase", "em2Text": "diphenyleneiodonium", "label": "CPR:4"}, {"em1Text": "NADPH oxidase", "em2Text": "DPI", "label": "CPR:4"}]}
{"sentText": "Human immortalized corneal fibroblasts were treated with TGF\u03b2 in the presence of TSA the NADPH oxidase inhibitor diphenyleneiodonium DPI the antioxidant Nacetylcysteine NAC the NFE2related factor 2 antioxidant response element Nrf2 ARE activator sulforaphane or small interfering RNA", "relationMentions": [{"em1Text": "NFE2related factor 2", "em2Text": "sulforaphane", "label": "CPR:3"}, {"em1Text": "antioxidant response element", "em2Text": "sulforaphane", "label": "CPR:3"}, {"em1Text": "Nrf2", "em2Text": "sulforaphane", "label": "CPR:3"}, {"em1Text": "ARE", "em2Text": "sulforaphane", "label": "CPR:3"}, {"em1Text": "NADPH oxidase", "em2Text": "diphenyleneiodonium", "label": "CPR:4"}, {"em1Text": "NADPH oxidase", "em2Text": "DPI", "label": "CPR:4"}]}
{"sentText": "Trichostatin A inhibits transforming growth factor\u03b2 induced reactive oxygen species accumulation and myofibroblast differentiation via enhanced NFE2related factor 2 antioxidant response element signaling", "relationMentions": [{"em1Text": "Trichostatin A", "em2Text": "NFE2related factor 2", "label": "CPR:3"}, {"em1Text": "Trichostatin A", "em2Text": "antioxidant response element", "label": "CPR:3"}, {"em1Text": "Trichostatin A", "em2Text": "transforming growth factor\u03b2", "label": "CPR:4"}]}
{"sentText": "In addition TSA induced Nrf2 nuclear translocation and upregulated the expression of Nrf2 ARE downstream antioxidant genes whereas Nrf2 knockdown by RNA interference blocked the inhibition of TSA on myofibroblast differentiation", "relationMentions": [{"em1Text": "TSA", "em2Text": "Nrf2", "label": "CPR:3"}, {"em1Text": "TSA", "em2Text": "ARE", "label": "CPR:3"}]}
{"sentText": "Results indicate that AM4054 serves as an effective CB1 discriminative stimulus with an onset and time course of action comparable with that of the CB1 agonist \u03949tetrahydrocannabinol and that the inverse agonist rimonabant and the neutral antagonist AM4113 produce doserelated rightward shifts in the AM4054 doseeffect curve indicating that both drugs surmountably antagonize the discriminative stimulus effects of AM4054", "relationMentions": [{"em1Text": "AM4054", "em2Text": "CB1", "label": "CPR:3"}, {"em1Text": "CB1", "em2Text": "\u03949tetrahydrocannabinol", "label": "CPR:5"}, {"em1Text": "CB1", "em2Text": "rimonabant", "label": "CPR:5"}, {"em1Text": "AM4054", "em2Text": "CB1", "label": "CPR:5"}, {"em1Text": "CB1", "em2Text": "AM4113", "label": "CPR:6"}]}
{"sentText": "Results indicate that AM4054 serves as an effective CB1 discriminative stimulus with an onset and time course of action comparable with that of the CB1 agonist \u03949tetrahydrocannabinol and that the inverse agonist rimonabant and the neutral antagonist AM4113 produce doserelated rightward shifts in the AM4054 doseeffect curve indicating that both drugs surmountably antagonize the discriminative stimulus effects of AM4054", "relationMentions": [{"em1Text": "AM4054", "em2Text": "CB1", "label": "CPR:3"}, {"em1Text": "CB1", "em2Text": "\u03949tetrahydrocannabinol", "label": "CPR:5"}, {"em1Text": "CB1", "em2Text": "rimonabant", "label": "CPR:5"}, {"em1Text": "AM4054", "em2Text": "CB1", "label": "CPR:5"}, {"em1Text": "CB1", "em2Text": "AM4113", "label": "CPR:6"}]}
{"sentText": "In the present studies the CB1 inverse agonist SR141716A rimonabant and the CB1 neutral antagonist AM4113 were compared for their ability to modify CB1 receptormediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel CB1 full agonist AM4054", "relationMentions": [{"em1Text": "CB1", "em2Text": "AM4054", "label": "CPR:5"}, {"em1Text": "CB1", "em2Text": "SR141716A", "label": "CPR:5"}, {"em1Text": "CB1", "em2Text": "rimonabant", "label": "CPR:5"}, {"em1Text": "CB1", "em2Text": "AM4113", "label": "CPR:6"}]}
{"sentText": "Cannabinoid receptor 1 CB1 inverse agonists eg rimonabant have been reported to produce adverse effects including nausea emesis and anhedonia that limit their clinical applications", "relationMentions": [{"em1Text": "Cannabinoid receptor 1", "em2Text": "rimonabant", "label": "CPR:5"}, {"em1Text": "CB1", "em2Text": "rimonabant", "label": "CPR:5"}]}
{"sentText": "Dabigatran has an advantage over the indirect thrombin inhibitors unfractionated heparin and lowmolecularweight heparin in that it inhibits free and fibrin bound thrombin", "relationMentions": [{"em1Text": "Dabigatran", "em2Text": "thrombin", "label": "CPR:4"}, {"em1Text": "Dabigatran", "em2Text": "fibrin", "label": "CPR:4"}]}
{"sentText": "rivaroxaban and apixaban are potent oral direct inhibitors of prothrombinase bound clotassociated or free FXa", "relationMentions": [{"em1Text": "rivaroxaban", "em2Text": "prothrombinase", "label": "CPR:4"}, {"em1Text": "rivaroxaban", "em2Text": "FXa", "label": "CPR:4"}, {"em1Text": "apixaban", "em2Text": "prothrombinase", "label": "CPR:4"}, {"em1Text": "apixaban", "em2Text": "FXa", "label": "CPR:4"}]}
{"sentText": "rivaroxaban and apixaban are potent oral direct inhibitors of prothrombinase bound clotassociated or free FXa", "relationMentions": [{"em1Text": "rivaroxaban", "em2Text": "prothrombinase", "label": "CPR:4"}, {"em1Text": "rivaroxaban", "em2Text": "FXa", "label": "CPR:4"}, {"em1Text": "apixaban", "em2Text": "prothrombinase", "label": "CPR:4"}, {"em1Text": "apixaban", "em2Text": "FXa", "label": "CPR:4"}]}
{"sentText": "Although parenteral oral direct thrombin inhibitors DTIs such as argatroban and bivalirudin have been on the market for years DTIs such as dabigatran are novel synthetic thrombin antagonists", "relationMentions": [{"em1Text": "thrombin", "em2Text": "argatroban", "label": "CPR:4"}, {"em1Text": "thrombin", "em2Text": "dabigatran", "label": "CPR:6"}]}
{"sentText": "Aldehyde dehydrogenase 1 ALDH1A1 catalyzes the oxidation of toxic aldehydes to carboxylic acids", "relationMentions": [{"em1Text": "Aldehyde dehydrogenase 1", "em2Text": "aldehydes", "label": "CPR:9"}, {"em1Text": "ALDH1A1", "em2Text": "aldehydes", "label": "CPR:9"}, {"em1Text": "Aldehyde dehydrogenase 1", "em2Text": "carboxylic acids", "label": "CPR:9"}, {"em1Text": "ALDH1A1", "em2Text": "carboxylic acids", "label": "CPR:9"}]}
{"sentText": "Aldehyde dehydrogenase 1 ALDH1A1 catalyzes the oxidation of toxic aldehydes to carboxylic acids", "relationMentions": [{"em1Text": "Aldehyde dehydrogenase 1", "em2Text": "aldehydes", "label": "CPR:9"}, {"em1Text": "ALDH1A1", "em2Text": "aldehydes", "label": "CPR:9"}, {"em1Text": "Aldehyde dehydrogenase 1", "em2Text": "carboxylic acids", "label": "CPR:9"}, {"em1Text": "ALDH1A1", "em2Text": "carboxylic acids", "label": "CPR:9"}]}
{"sentText": "Moreover Acrolein resulted in activation of astrocytes upregulation of BACE1 in cortex and downregulation of ADAM10 in hippocampus and cortex", "relationMentions": [{"em1Text": "Acrolein", "em2Text": "BACE1", "label": "CPR:3"}, {"em1Text": "Acrolein", "em2Text": "ADAM10", "label": "CPR:4"}]}
{"sentText": "Interestingly Acrolein increased proteins levels of amyloid precursor protein APP \u03b2secretase BACE1 and the amyloid \u03b2peptide transporter receptor for advanced glycation end products and decreased Adisintegrin and metalloprotease ADAM 10 levels", "relationMentions": [{"em1Text": "Acrolein", "em2Text": "amyloid precursor protein", "label": "CPR:3"}, {"em1Text": "Acrolein", "em2Text": "\u03b2secretase", "label": "CPR:3"}, {"em1Text": "Acrolein", "em2Text": "BACE1", "label": "CPR:3"}, {"em1Text": "Acrolein", "em2Text": "amyloid \u03b2peptide transporter", "label": "CPR:3"}, {"em1Text": "Acrolein", "em2Text": "receptor for advanced glycation end products", "label": "CPR:3"}, {"em1Text": "Acrolein", "em2Text": "Adisintegrin and metalloprotease ADAM 10", "label": "CPR:4"}]}
{"sentText": "Regulation of sexual reproduction by estradiol involves the activation of estrogen receptors ERs in the hypothalamus", "relationMentions": [{"em1Text": "estradiol", "em2Text": "estrogen receptors", "label": "CPR:3"}, {"em1Text": "estradiol", "em2Text": "ERs", "label": "CPR:3"}]}
{"sentText": "Insertion of ER\u03b1 was blocked by the ER antagonist ICI 182780 or with the protein kinase C PKC pathway inhibitor bisindolylmaleimide BIS", "relationMentions": [{"em1Text": "ER\u03b1", "em2Text": "ICI 182780", "label": "CPR:4"}, {"em1Text": "ER\u03b1", "em2Text": "bisindolylmaleimide", "label": "CPR:4"}, {"em1Text": "protein kinase C", "em2Text": "bisindolylmaleimide", "label": "CPR:4"}, {"em1Text": "PKC", "em2Text": "bisindolylmaleimide", "label": "CPR:4"}, {"em1Text": "ER\u03b1", "em2Text": "BIS", "label": "CPR:4"}, {"em1Text": "protein kinase C", "em2Text": "BIS", "label": "CPR:4"}, {"em1Text": "PKC", "em2Text": "BIS", "label": "CPR:4"}, {"em1Text": "ER", "em2Text": "ICI 182780", "label": "CPR:6"}]}
{"sentText": "Insertion of ER\u03b1 was blocked by the ER antagonist ICI 182780 or with the protein kinase C PKC pathway inhibitor bisindolylmaleimide BIS", "relationMentions": [{"em1Text": "ER\u03b1", "em2Text": "ICI 182780", "label": "CPR:4"}, {"em1Text": "ER\u03b1", "em2Text": "bisindolylmaleimide", "label": "CPR:4"}, {"em1Text": "protein kinase C", "em2Text": "bisindolylmaleimide", "label": "CPR:4"}, {"em1Text": "PKC", "em2Text": "bisindolylmaleimide", "label": "CPR:4"}, {"em1Text": "ER\u03b1", "em2Text": "BIS", "label": "CPR:4"}, {"em1Text": "protein kinase C", "em2Text": "BIS", "label": "CPR:4"}, {"em1Text": "PKC", "em2Text": "BIS", "label": "CPR:4"}, {"em1Text": "ER", "em2Text": "ICI 182780", "label": "CPR:6"}]}
{"sentText": "Additionally in SHSY5Y cells MPP induced demethylation of phosphoprotein phosphatase 2A PP2A the master regulator of the cellular phosphoregulatory network and cytotoxicity were ameliorated by EHT", "relationMentions": [{"em1Text": "phosphoprotein phosphatase 2A", "em2Text": "EHT", "label": "CPR:3"}, {"em1Text": "PP2A", "em2Text": "EHT", "label": "CPR:3"}, {"em1Text": "MPP", "em2Text": "phosphoprotein phosphatase 2A", "label": "CPR:4"}, {"em1Text": "MPP", "em2Text": "PP2A", "label": "CPR:4"}]}
{"sentText": "Additionally in SHSY5Y cells MPP induced demethylation of phosphoprotein phosphatase 2A PP2A the master regulator of the cellular phosphoregulatory network and cytotoxicity were ameliorated by EHT", "relationMentions": [{"em1Text": "phosphoprotein phosphatase 2A", "em2Text": "EHT", "label": "CPR:3"}, {"em1Text": "PP2A", "em2Text": "EHT", "label": "CPR:3"}, {"em1Text": "MPP", "em2Text": "phosphoprotein phosphatase 2A", "label": "CPR:4"}, {"em1Text": "MPP", "em2Text": "PP2A", "label": "CPR:4"}]}
{"sentText": "In cultured primary microglia and astrocytes EHT had a direct antiinflammatory effect demonstrated by repression of lipopolysaccharideinduced NF\u03baB activation iNOS induction and nitric oxide production", "relationMentions": [{"em1Text": "EHT", "em2Text": "NF\u03baB", "label": "CPR:4"}, {"em1Text": "EHT", "em2Text": "iNOS", "label": "CPR:4"}]}
{"sentText": "Induction of HO1 through p38 MAPK Nrf2 signaling pathway by ethanol extract of Inula helenium L reduces inflammation in LPSactivated RAW 2647 cells and CLPinduced septic mice", "relationMentions": [{"em1Text": "HO1", "em2Text": "ethanol", "label": "CPR:3"}, {"em1Text": "p38", "em2Text": "ethanol", "label": "CPR:3"}, {"em1Text": "MAPK", "em2Text": "ethanol", "label": "CPR:3"}]}
{"sentText": "FMO3 expression is induced by dietary bile acids by a mechanism that involves the farnesoid X receptor FXR a bile acid activated nuclear receptor", "relationMentions": [{"em1Text": "FMO3", "em2Text": "bile acids", "label": "CPR:3"}, {"em1Text": "bile acid", "em2Text": "farnesoid X receptor", "label": "CPR:3"}, {"em1Text": "bile acid", "em2Text": "FXR", "label": "CPR:3"}]}
{"sentText": "We demonstrate that two flavin monooxygenase family members FMO1 and FMO3 oxidize trimethylamine TMA derived from gut flora metabolism of choline to TMAO", "relationMentions": [{"em1Text": "flavin monooxygenase", "em2Text": "trimethylamine", "label": "CPR:9"}, {"em1Text": "FMO1", "em2Text": "trimethylamine", "label": "CPR:9"}, {"em1Text": "FMO3", "em2Text": "trimethylamine", "label": "CPR:9"}, {"em1Text": "flavin monooxygenase", "em2Text": "TMA", "label": "CPR:9"}, {"em1Text": "FMO1", "em2Text": "TMA", "label": "CPR:9"}, {"em1Text": "FMO3", "em2Text": "TMA", "label": "CPR:9"}, {"em1Text": "flavin monooxygenase", "em2Text": "choline", "label": "CPR:9"}, {"em1Text": "FMO1", "em2Text": "choline", "label": "CPR:9"}, {"em1Text": "FMO3", "em2Text": "choline", "label": "CPR:9"}, {"em1Text": "flavin monooxygenase", "em2Text": "TMAO", "label": "CPR:9"}, {"em1Text": "FMO1", "em2Text": "TMAO", "label": "CPR:9"}, {"em1Text": "FMO3", "em2Text": "TMAO", "label": "CPR:9"}]}
{"sentText": "We demonstrate that two flavin monooxygenase family members FMO1 and FMO3 oxidize trimethylamine TMA derived from gut flora metabolism of choline to TMAO", "relationMentions": [{"em1Text": "flavin monooxygenase", "em2Text": "trimethylamine", "label": "CPR:9"}, {"em1Text": "FMO1", "em2Text": "trimethylamine", "label": "CPR:9"}, {"em1Text": "FMO3", "em2Text": "trimethylamine", "label": "CPR:9"}, {"em1Text": "flavin monooxygenase", "em2Text": "TMA", "label": "CPR:9"}, {"em1Text": "FMO1", "em2Text": "TMA", "label": "CPR:9"}, {"em1Text": "FMO3", "em2Text": "TMA", "label": "CPR:9"}, {"em1Text": "flavin monooxygenase", "em2Text": "choline", "label": "CPR:9"}, {"em1Text": "FMO1", "em2Text": "choline", "label": "CPR:9"}, {"em1Text": "FMO3", "em2Text": "choline", "label": "CPR:9"}, {"em1Text": "flavin monooxygenase", "em2Text": "TMAO", "label": "CPR:9"}, {"em1Text": "FMO1", "em2Text": "TMAO", "label": "CPR:9"}, {"em1Text": "FMO3", "em2Text": "TMAO", "label": "CPR:9"}]}
{"sentText": "Phosphodiesterase type 5 PDE5 mediates the degradation of cGMP in a variety of tissues including brain", "relationMentions": [{"em1Text": "PDE5", "em2Text": "cGMP", "label": "CPR:9"}, {"em1Text": "Phosphodiesterase type 5", "em2Text": "cGMP", "label": "CPR:9"}]}
{"sentText": "Peginesatide a polyethylene glycol PEG ylated peptidebased erythropoiesisstimulating agent stimulates the erythropoietin receptor dimer that governs erythropoiesis", "relationMentions": [{"em1Text": "Peginesatide", "em2Text": "erythropoietin receptor", "label": "CPR:3"}, {"em1Text": "polyethylene glycol", "em2Text": "erythropoietin receptor", "label": "CPR:3"}, {"em1Text": "PEG", "em2Text": "erythropoietin receptor", "label": "CPR:3"}]}
{"sentText": "Bile acids are signaling molecules that activate nuclear receptors such as farnesoid X receptor pregnane X receptor constitutive androstane receptor and vitamin D receptor and play a critical role in the regulation of lipid glucose energy and drug metabolism", "relationMentions": [{"em1Text": "Bile acids", "em2Text": "constitutive androstane receptor", "label": "CPR:3"}, {"em1Text": "Bile acids", "em2Text": "vitamin D receptor", "label": "CPR:3"}, {"em1Text": "Bile acids", "em2Text": "nuclear receptors", "label": "CPR:3"}, {"em1Text": "Bile acids", "em2Text": "farnesoid X receptor", "label": "CPR:3"}, {"em1Text": "Bile acids", "em2Text": "pregnane X receptor", "label": "CPR:3"}]}
{"sentText": "The peptide YR11 YLEIEFSLKHR obtained by direct substitution of cysteine with a serine residue in the template sequence significantly p005 inhibited RANKRANKL binding and RANKL induced TRAP activity and formation of multinucleated osteoclasts without any cytotoxicity", "relationMentions": [{"em1Text": "YR11", "em2Text": "RANKL", "label": "CPR:4"}, {"em1Text": "YR11", "em2Text": "TRAP", "label": "CPR:4"}, {"em1Text": "cysteine", "em2Text": "RANKL", "label": "CPR:4"}, {"em1Text": "cysteine", "em2Text": "TRAP", "label": "CPR:4"}, {"em1Text": "serine", "em2Text": "RANKL", "label": "CPR:4"}, {"em1Text": "serine", "em2Text": "TRAP", "label": "CPR:4"}]}
{"sentText": "The peptide YR11 YLEIEFSLKHR obtained by direct substitution of cysteine with a serine residue in the template sequence significantly p005 inhibited RANKRANKL binding and RANKL induced TRAP activity and formation of multinucleated osteoclasts without any cytotoxicity", "relationMentions": [{"em1Text": "YR11", "em2Text": "RANKL", "label": "CPR:4"}, {"em1Text": "YR11", "em2Text": "TRAP", "label": "CPR:4"}, {"em1Text": "cysteine", "em2Text": "RANKL", "label": "CPR:4"}, {"em1Text": "cysteine", "em2Text": "TRAP", "label": "CPR:4"}, {"em1Text": "serine", "em2Text": "RANKL", "label": "CPR:4"}, {"em1Text": "serine", "em2Text": "TRAP", "label": "CPR:4"}]}
{"sentText": "Results confirmed that YR11 peptide inhibited proinflammatory cytokines in the sera and hind paw tissues of AIA rats through its suppressive effect on RANKL induced nuclear translocation of NF\u03baB", "relationMentions": [{"em1Text": "YR11", "em2Text": "cytokines", "label": "CPR:4"}, {"em1Text": "YR11", "em2Text": "RANKL", "label": "CPR:4"}, {"em1Text": "YR11", "em2Text": "NF\u03baB", "label": "CPR:4"}]}
{"sentText": "Additionally these effects of ATO on \u03b3 H2AX Chk1 Chk2 p53 and p21 waf1 cip1 were reduced by an ATM inhibitor", "relationMentions": [{"em1Text": "ATO", "em2Text": "Chk1", "label": "CPR:3"}, {"em1Text": "ATO", "em2Text": "Chk2", "label": "CPR:3"}, {"em1Text": "ATO", "em2Text": "p53", "label": "CPR:3"}, {"em1Text": "ATO", "em2Text": "p21", "label": "CPR:3"}, {"em1Text": "ATO", "em2Text": "waf1", "label": "CPR:3"}, {"em1Text": "ATO", "em2Text": "cip1", "label": "CPR:3"}, {"em1Text": "ATO", "em2Text": "ATM", "label": "CPR:3"}, {"em1Text": "ATO", "em2Text": "H2AX", "label": "CPR:3"}]}
{"sentText": "In monocytes both EPA and DHA increased interleukin IL10 without affecting tumor necrosis factor TNF\u03b1 and IL6", "relationMentions": [{"em1Text": "EPA", "em2Text": "interleukin IL10", "label": "CPR:3"}, {"em1Text": "DHA", "em2Text": "interleukin IL10", "label": "CPR:3"}]}
{"sentText": "Both fatty acids but DHA to a lesser extent compared with EPA selectively and dosedependently reduced the percentage of cytokine expressing Th cells in a peroxisome proliferatoractivated receptor PPAR\u03b3dependent fashion whereas the expression of the cell surface marker CD69 was unaltered on activated T cells", "relationMentions": [{"em1Text": "fatty acids", "em2Text": "cytokine", "label": "CPR:4"}, {"em1Text": "DHA", "em2Text": "cytokine", "label": "CPR:4"}, {"em1Text": "EPA", "em2Text": "cytokine", "label": "CPR:4"}]}
{"sentText": "In the in vitro model we observed high permeability of imperatorin and isoimperatorin with the Pgp mediated efflux ratios of 053 and 006 as well as medium permeability of cnidilin with 082", "relationMentions": [{"em1Text": "imperatorin", "em2Text": "Pgp", "label": "CPR:9"}, {"em1Text": "isoimperatorin", "em2Text": "Pgp", "label": "CPR:9"}, {"em1Text": "Pgp", "em2Text": "cnidilin", "label": "CPR:9"}]}
{"sentText": "Through immunoblotting analysis it was found that AdOx was capable of indirectly diminishing the phosphorylation of oncogenic Src and its kinase activity", "relationMentions": [{"em1Text": "AdOx", "em2Text": "Src", "label": "CPR:4"}, {"em1Text": "AdOx", "em2Text": "kinase", "label": "CPR:4"}]}
{"sentText": "Interestingly AdOx disrupted actin cytoskeleton structures leading to morphological changes and suppressed the formation of a signaling complex composed of Src and p85 PI3K which is linked to various tumorigenic responses", "relationMentions": [{"em1Text": "AdOx", "em2Text": "actin", "label": "CPR:4"}, {"em1Text": "AdOx", "em2Text": "Src", "label": "CPR:4"}, {"em1Text": "AdOx", "em2Text": "p85", "label": "CPR:4"}, {"em1Text": "AdOx", "em2Text": "PI3K", "label": "CPR:4"}]}
{"sentText": "In agreement with these data the exogenous treatment of SAH or inhibition of SAHH by specific siRNA or another type of inhibitor 3deazaadenosine DAZA similarly resulted in antitumorigenic responses suppressive activity on Src the alteration of actin cytoskeleton and a change of the colocalization pattern between actin and Src", "relationMentions": [{"em1Text": "SAH", "em2Text": "Src", "label": "CPR:4"}, {"em1Text": "SAHH", "em2Text": "3deazaadenosine", "label": "CPR:4"}, {"em1Text": "SAHH", "em2Text": "DAZA", "label": "CPR:4"}]}
{"sentText": "Treatment with adenosine dialdehyde AdOx an inhibitor of transmethylationsuppressive adenosylhomocysteine SAH hydrolase SAHH enhanced the level of SAH and effectively blocked the proliferation migration and invasion of cancer cells the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dosedependent manner", "relationMentions": [{"em1Text": "adenosine dialdehyde", "em2Text": "adenosylhomocysteine SAH hydrolase", "label": "CPR:4"}, {"em1Text": "adenosine dialdehyde", "em2Text": "SAHH", "label": "CPR:4"}, {"em1Text": "AdOx", "em2Text": "adenosylhomocysteine SAH hydrolase", "label": "CPR:4"}, {"em1Text": "AdOx", "em2Text": "SAHH", "label": "CPR:4"}, {"em1Text": "adenosylhomocysteine SAH hydrolase", "em2Text": "SAH", "label": "CPR:9"}, {"em1Text": "SAH", "em2Text": "SAHH", "label": "CPR:9"}]}
{"sentText": "Treatment with adenosine dialdehyde AdOx an inhibitor of transmethylationsuppressive adenosylhomocysteine SAH hydrolase SAHH enhanced the level of SAH and effectively blocked the proliferation migration and invasion of cancer cells the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dosedependent manner", "relationMentions": [{"em1Text": "adenosine dialdehyde", "em2Text": "adenosylhomocysteine SAH hydrolase", "label": "CPR:4"}, {"em1Text": "adenosine dialdehyde", "em2Text": "SAHH", "label": "CPR:4"}, {"em1Text": "AdOx", "em2Text": "adenosylhomocysteine SAH hydrolase", "label": "CPR:4"}, {"em1Text": "AdOx", "em2Text": "SAHH", "label": "CPR:4"}, {"em1Text": "adenosylhomocysteine SAH hydrolase", "em2Text": "SAH", "label": "CPR:9"}, {"em1Text": "SAH", "em2Text": "SAHH", "label": "CPR:9"}]}
{"sentText": "Synthesis of derivatives of methyl rosmarinate and their inhibitory activities against matrix metalloproteinase1 MMP1", "relationMentions": [{"em1Text": "methyl rosmarinate", "em2Text": "MMP1", "label": "CPR:4"}, {"em1Text": "methyl rosmarinate", "em2Text": "matrix metalloproteinase1", "label": "CPR:4"}]}
{"sentText": "All the compounds were evaluated for their antitumor activity against MCF7 A549 and B16F10 tumor cell lines as well as cyclooxygenase2 COX2 derived prostaglandin E2 PGE2 inhibitory activity of murine macrophage RAW 2647 cell line", "relationMentions": [{"em1Text": "cyclooxygenase2", "em2Text": "prostaglandin E2", "label": "CPR:9"}, {"em1Text": "COX2", "em2Text": "prostaglandin E2", "label": "CPR:9"}, {"em1Text": "cyclooxygenase2", "em2Text": "PGE2", "label": "CPR:9"}, {"em1Text": "COX2", "em2Text": "PGE2", "label": "CPR:9"}]}
{"sentText": "All the compounds were evaluated for their antitumor activity against MCF7 A549 and B16F10 tumor cell lines as well as cyclooxygenase2 COX2 derived prostaglandin E2 PGE2 inhibitory activity of murine macrophage RAW 2647 cell line", "relationMentions": [{"em1Text": "cyclooxygenase2", "em2Text": "prostaglandin E2", "label": "CPR:9"}, {"em1Text": "COX2", "em2Text": "prostaglandin E2", "label": "CPR:9"}, {"em1Text": "cyclooxygenase2", "em2Text": "PGE2", "label": "CPR:9"}, {"em1Text": "COX2", "em2Text": "PGE2", "label": "CPR:9"}]}
{"sentText": "Its headspace aroma displayed new volatile phytomolecules and also had higher levels of green volatiles from the lipoxygenase LOX pathway one having as precursors the polyunsaturated fatty acids containing a ciscis14pentadiene system", "relationMentions": [{"em1Text": "lipoxygenase", "em2Text": "polyunsaturated fatty acids", "label": "CPR:9"}, {"em1Text": "LOX", "em2Text": "polyunsaturated fatty acids", "label": "CPR:9"}, {"em1Text": "lipoxygenase", "em2Text": "ciscis14pentadiene", "label": "CPR:9"}, {"em1Text": "LOX", "em2Text": "ciscis14pentadiene", "label": "CPR:9"}]}
{"sentText": "Its headspace aroma displayed new volatile phytomolecules and also had higher levels of green volatiles from the lipoxygenase LOX pathway one having as precursors the polyunsaturated fatty acids containing a ciscis14pentadiene system", "relationMentions": [{"em1Text": "lipoxygenase", "em2Text": "polyunsaturated fatty acids", "label": "CPR:9"}, {"em1Text": "LOX", "em2Text": "polyunsaturated fatty acids", "label": "CPR:9"}, {"em1Text": "lipoxygenase", "em2Text": "ciscis14pentadiene", "label": "CPR:9"}, {"em1Text": "LOX", "em2Text": "ciscis14pentadiene", "label": "CPR:9"}]}
{"sentText": "The recent identification of zinc permeability of the lysosomal ion channel TRPML1 transient receptor potential mucolipin 1 and the evidence of abnormal zinc levels in cells deficient in TRPML1 suggested a role for TRPML1 in zinc transport", "relationMentions": [{"em1Text": "zinc", "em2Text": "TRPML1", "label": "CPR:9"}, {"em1Text": "zinc", "em2Text": "transient receptor potential mucolipin 1", "label": "CPR:9"}]}
{"sentText": "Cellular zinc is controlled by zincchelating proteins and by zinc transporters", "relationMentions": [{"em1Text": "zinc", "em2Text": "zincchelating proteins", "label": "CPR:9"}, {"em1Text": "zinc", "em2Text": "zinc transporters", "label": "CPR:9"}]}
{"sentText": "Furthermore they suggest that TRPML1 works in concert with ZnT4 to regulate zinc translocation between the cytoplasm and lysosomes", "relationMentions": [{"em1Text": "TRPML1", "em2Text": "zinc", "label": "CPR:9"}, {"em1Text": "ZnT4", "em2Text": "zinc", "label": "CPR:9"}]}
{"sentText": "Importantly expression of the acutephase reactant serum amyloid A SAA significantly increased after ritodrine injection with values indicating the largest foldchange", "relationMentions": [{"em1Text": "serum amyloid A", "em2Text": "ritodrine", "label": "CPR:3"}, {"em1Text": "SAA", "em2Text": "ritodrine", "label": "CPR:3"}]}
{"sentText": "Pharmacodynamic data suggest that ceftazidime avibactam is rapidly bactericidal versus \u03b2lactamase producing Gramnegative bacilli that are not inhibited by ceftazidime aloneClinical trials to date have reported that ceftazidimeavibactam is as effective as standard carbapenem therapy in complicated intraabdominal infection and complicated urinary tract infection including infection caused by cephalosporinresistant Gramnegative isolates", "relationMentions": [{"em1Text": "ceftazidime", "em2Text": "\u03b2lactamase", "label": "CPR:4"}, {"em1Text": "avibactam", "em2Text": "\u03b2lactamase", "label": "CPR:4"}]}
{"sentText": "Avibactam formerly NXL104 AVE1330A is a synthetic non\u03b2lactam \u03b2lactamase inhibitor that inhibits the activities of Ambler class A and C \u03b2lactamases and some Ambler class D enzymes", "relationMentions": [{"em1Text": "NXL104", "em2Text": "Ambler class D", "label": "CPR:4"}, {"em1Text": "NXL104", "em2Text": "\u03b2lactamase", "label": "CPR:4"}, {"em1Text": "Avibactam", "em2Text": "Ambler class D", "label": "CPR:4"}, {"em1Text": "Avibactam", "em2Text": "\u03b2lactamase", "label": "CPR:4"}, {"em1Text": "AVE1330A", "em2Text": "Ambler class D", "label": "CPR:4"}, {"em1Text": "AVE1330A", "em2Text": "\u03b2lactamase", "label": "CPR:4"}]}
{"sentText": "Avibactam formerly NXL104 AVE1330A is a synthetic non\u03b2lactam \u03b2lactamase inhibitor that inhibits the activities of Ambler class A and C \u03b2lactamases and some Ambler class D enzymes", "relationMentions": [{"em1Text": "NXL104", "em2Text": "Ambler class D", "label": "CPR:4"}, {"em1Text": "NXL104", "em2Text": "\u03b2lactamase", "label": "CPR:4"}, {"em1Text": "Avibactam", "em2Text": "Ambler class D", "label": "CPR:4"}, {"em1Text": "Avibactam", "em2Text": "\u03b2lactamase", "label": "CPR:4"}, {"em1Text": "AVE1330A", "em2Text": "Ambler class D", "label": "CPR:4"}, {"em1Text": "AVE1330A", "em2Text": "\u03b2lactamase", "label": "CPR:4"}]}
{"sentText": "Ceftazidimeavibactam appears to be well tolerated in healthy subjects and hospitalized patients with few serious drugrelated treatmentemergent adverse events reported to dateIn conclusion avibactam serves to broaden the spectrum of ceftazidime versus \u00dflactamase producing Gramnegative bacilli", "relationMentions": [{"em1Text": "avibactam", "em2Text": "\u00dflactamase", "label": "CPR:4"}, {"em1Text": "ceftazidime", "em2Text": "\u00dflactamase", "label": "CPR:4"}]}
{"sentText": "The addition of avibactam greatly 41024fold minimum inhibitory concentration MIC reduction improves the activity of ceftazidime versus most species of Enterobacteriaceae depending on the presence or absence of \u03b2lactamase enzymes", "relationMentions": [{"em1Text": "avibactam", "em2Text": "\u03b2lactamase", "label": "CPR:4"}, {"em1Text": "ceftazidime", "em2Text": "\u03b2lactamase", "label": "CPR:4"}]}
{"sentText": "Ceftazidime avibactam a novel cephalosporin \u03b2lactamase inhibitor combination", "relationMentions": [{"em1Text": "Ceftazidime", "em2Text": "\u03b2lactamase", "label": "CPR:4"}, {"em1Text": "avibactam", "em2Text": "\u03b2lactamase", "label": "CPR:4"}]}
{"sentText": "Upamostat Mesupron \u00ae is a new small molecule serine protease inhibitor", "relationMentions": [{"em1Text": "Upamostat", "em2Text": "serine protease", "label": "CPR:4"}, {"em1Text": "Mesupron", "em2Text": "serine protease", "label": "CPR:4"}]}
{"sentText": "Interestingly GPx1a was the most sensitive to selenium availability in non stressful conditions whereas GPx1b1 and GPx1b2 were highly induced by exposure to selenium levels that had some toxic effects on the cells", "relationMentions": [{"em1Text": "selenium", "em2Text": "GPx1b1", "label": "CPR:3"}, {"em1Text": "selenium", "em2Text": "GPx1b2", "label": "CPR:3"}]}
{"sentText": "These findings are the first to show that longterm exposure to Mn during a critical period of neurodevelopment causes motor coordination dysfunction with parallel increment in oxidative stress markers p38 MAPK phosphorylation and caspase activity in the striatum", "relationMentions": [{"em1Text": "Mn", "em2Text": "p38", "label": "CPR:3"}, {"em1Text": "Mn", "em2Text": "MAPK", "label": "CPR:3"}, {"em1Text": "Mn", "em2Text": "caspase", "label": "CPR:3"}]}
{"sentText": "Mn exposure 20 mgkg increased p38 MAPK and Akt phosphorylation but decreased DARPP32 Thr34 phosphorylation", "relationMentions": [{"em1Text": "Mn", "em2Text": "p38", "label": "CPR:3"}, {"em1Text": "Mn", "em2Text": "MAPK", "label": "CPR:3"}, {"em1Text": "Mn", "em2Text": "Akt", "label": "CPR:3"}, {"em1Text": "Mn", "em2Text": "DARPP32", "label": "CPR:4"}]}
{"sentText": "Notably the antioxidant Trolox \u2122 reversed the Mn 20 mgkgdependent augmentation in p38 MAPK phosphorylation and reduced the Mn 20 mgkginduced caspase activity and F2isoprostane production", "relationMentions": [{"em1Text": "Mn", "em2Text": "p38", "label": "CPR:3"}, {"em1Text": "Mn", "em2Text": "MAPK", "label": "CPR:3"}, {"em1Text": "Mn", "em2Text": "caspase", "label": "CPR:3"}, {"em1Text": "Trolox", "em2Text": "p38", "label": "CPR:4"}, {"em1Text": "Trolox", "em2Text": "MAPK", "label": "CPR:4"}, {"em1Text": "Trolox", "em2Text": "caspase", "label": "CPR:4"}]}
{"sentText": "Notably the antioxidant Trolox \u2122 reversed the Mn 20 mgkgdependent augmentation in p38 MAPK phosphorylation and reduced the Mn 20 mgkginduced caspase activity and F2isoprostane production", "relationMentions": [{"em1Text": "Mn", "em2Text": "p38", "label": "CPR:3"}, {"em1Text": "Mn", "em2Text": "MAPK", "label": "CPR:3"}, {"em1Text": "Mn", "em2Text": "caspase", "label": "CPR:3"}, {"em1Text": "Trolox", "em2Text": "p38", "label": "CPR:4"}, {"em1Text": "Trolox", "em2Text": "MAPK", "label": "CPR:4"}, {"em1Text": "Trolox", "em2Text": "caspase", "label": "CPR:4"}]}
{"sentText": "Nocapyrone H 1 reduced the proinflammatory factor such as nitric oxide NO prostaglandin E2 PGE2 and interleukin1\u03b2 IL1\u03b2", "relationMentions": [{"em1Text": "Nocapyrone H", "em2Text": "interleukin1\u03b2", "label": "CPR:4"}, {"em1Text": "Nocapyrone H", "em2Text": "IL1\u03b2", "label": "CPR:4"}]}
{"sentText": "The fecal elimination IC and systemic clearance of apixaban were increased upon AC administration in both BDC rats and dogs and were decreased in BDC rats dosed with GF120918 a dual BCRP and Pgp inhibitor", "relationMentions": [{"em1Text": "GF120918", "em2Text": "BCRP", "label": "CPR:4"}, {"em1Text": "GF120918", "em2Text": "Pgp", "label": "CPR:4"}]}
{"sentText": "A large number of aromaticheterocyclic sulfonamides and some 5mercapto134thiadiazoles were investigated as TcCA inhibitors", "relationMentions": [{"em1Text": "aromaticheterocyclic sulfonamides", "em2Text": "TcCA", "label": "CPR:4"}, {"em1Text": "5mercapto134thiadiazoles", "em2Text": "TcCA", "label": "CPR:4"}]}
{"sentText": "Cloning Characterization and Sulfonamide and Thiol Inhibition Studies of an \u03b1Carbonic Anhydrase from Trypanosoma cruzi the Causative Agent of Chagas Disease", "relationMentions": [{"em1Text": "Sulfonamide", "em2Text": "\u03b1Carbonic Anhydrase", "label": "CPR:4"}, {"em1Text": "Thiol", "em2Text": "\u03b1Carbonic Anhydrase", "label": "CPR:4"}]}
{"sentText": "The mRNA level for nestin Nes biomarker for stem Leydig cells was significantly increased in the control testis on day 4 post EDS but not in the DEHP treated testes suggesting that these nestin positive stem cells were differentiated into progenitor Leydig cells in the DEHPtreated testes", "relationMentions": [{"em1Text": "nestin", "em2Text": "EDS", "label": "CPR:3"}, {"em1Text": "Nes", "em2Text": "EDS", "label": "CPR:3"}]}
{"sentText": "A dominant negative PKA DNPKA reduced GnRH stimulated pCREB and markedly decreased GnRH stimulation of FSH\u03b2 mRNA and FSH\u03b2LUC activity but had little effect on LH\u03b2LUC activity indicating relative specificity of this pathway", "relationMentions": [{"em1Text": "GnRH", "em2Text": "pCREB", "label": "CPR:3"}, {"em1Text": "GnRH", "em2Text": "FSH\u03b2", "label": "CPR:3"}]}
{"sentText": "GnRH pulse frequencydependent stimulation of FSH\u03b2 transcription is mediated via activation of PKA and CREB", "relationMentions": [{"em1Text": "GnRH", "em2Text": "CREB", "label": "CPR:3"}, {"em1Text": "GnRH", "em2Text": "FSH\u03b2", "label": "CPR:3"}, {"em1Text": "GnRH", "em2Text": "PKA", "label": "CPR:3"}]}
{"sentText": "Correlating with FSH\u03b2 activation both PKA activity and levels of pCREB were increased to a greater extent by low compared with high GnRH pulse frequencies and the induction of pCREB was also attenuated by overexpression of DNPKA at both low and high pulse frequencies", "relationMentions": [{"em1Text": "FSH\u03b2", "em2Text": "GnRH", "label": "CPR:3"}, {"em1Text": "PKA", "em2Text": "GnRH", "label": "CPR:3"}, {"em1Text": "pCREB", "em2Text": "GnRH", "label": "CPR:3"}]}
{"sentText": "Taken together these data indicate that a PKAmediated signaling pathway mediates GnRH activation of CREB at lowpulse frequencies playing a significant role in the decoding of the hypothalamic GnRH signal to result in frequencydependent FSH\u03b2 activation", "relationMentions": [{"em1Text": "GnRH", "em2Text": "CREB", "label": "CPR:3"}, {"em1Text": "GnRH", "em2Text": "FSH\u03b2", "label": "CPR:3"}]}
{"sentText": "GnRH stimulation of CREB phosphorylation pCREB in the gonadotropederived L\u03b2T2 cell line was attenuated by a protein kinase A PKA inhibitor H89", "relationMentions": [{"em1Text": "GnRH", "em2Text": "CREB", "label": "CPR:3"}, {"em1Text": "GnRH", "em2Text": "pCREB", "label": "CPR:3"}, {"em1Text": "CREB", "em2Text": "H89", "label": "CPR:4"}, {"em1Text": "pCREB", "em2Text": "H89", "label": "CPR:4"}, {"em1Text": "protein kinase A", "em2Text": "H89", "label": "CPR:4"}, {"em1Text": "PKA", "em2Text": "H89", "label": "CPR:4"}]}
{"sentText": "GnRH stimulation of CREB phosphorylation pCREB in the gonadotropederived L\u03b2T2 cell line was attenuated by a protein kinase A PKA inhibitor H89", "relationMentions": [{"em1Text": "GnRH", "em2Text": "CREB", "label": "CPR:3"}, {"em1Text": "GnRH", "em2Text": "pCREB", "label": "CPR:3"}, {"em1Text": "CREB", "em2Text": "H89", "label": "CPR:4"}, {"em1Text": "pCREB", "em2Text": "H89", "label": "CPR:4"}, {"em1Text": "protein kinase A", "em2Text": "H89", "label": "CPR:4"}, {"em1Text": "PKA", "em2Text": "H89", "label": "CPR:4"}]}
{"sentText": "Moreover compared with the model group sophocarpine could significantly increase PAMPK\u03b1 582fold AMPK\u03b1 129fold and ACC 327fold protein expressions and reduce PACC 030fold and HNF4\u03b1 020fold protein expression", "relationMentions": [{"em1Text": "sophocarpine", "em2Text": "ACC", "label": "CPR:3"}, {"em1Text": "sophocarpine", "em2Text": "PAMPK\u03b1", "label": "CPR:3"}, {"em1Text": "sophocarpine", "em2Text": "AMPK\u03b1", "label": "CPR:3"}, {"em1Text": "sophocarpine", "em2Text": "PACC", "label": "CPR:4"}, {"em1Text": "sophocarpine", "em2Text": "HNF4\u03b1", "label": "CPR:4"}]}
{"sentText": "While sophocarpine treatment resulted in significant improvement of steatosis 50 decrease decrease of leptin expression 057fold and increase of adiponectin expression 148fold", "relationMentions": [{"em1Text": "sophocarpine", "em2Text": "adiponectin", "label": "CPR:3"}, {"em1Text": "sophocarpine", "em2Text": "leptin", "label": "CPR:4"}]}
{"sentText": "The involvement of Pgp in the absorption of darunavir was clearly shown by coperfusion of darunavir with the Pgp inhibitor zosuquidar", "relationMentions": [{"em1Text": "Pgp", "em2Text": "zosuquidar", "label": "CPR:4"}, {"em1Text": "Pgp", "em2Text": "darunavir", "label": "CPR:9"}]}
{"sentText": "Upon studying the drugdrug interaction of darunavir with ketoconazole data were indicative for an inhibitory effect of ketoconazole on Pgp as the main mechanism for the increased transport of darunavir across the small intestine", "relationMentions": [{"em1Text": "ketoconazole", "em2Text": "Pgp", "label": "CPR:4"}, {"em1Text": "darunavir", "em2Text": "Pgp", "label": "CPR:9"}]}
{"sentText": "To evaluate to what extent the regional differences in expression of Pgp and P450 enzymes affect the absorption of a dual substrate we investigated the transport of darunavir across different small intestinal segments duodenum proximal jejunum and ileum", "relationMentions": [{"em1Text": "Pgp", "em2Text": "darunavir", "label": "CPR:9"}, {"em1Text": "P450 enzymes", "em2Text": "darunavir", "label": "CPR:9"}]}
{"sentText": "In another experiment topical application of CFB CFE or CLS prior to UVB irradiation 200mJcm2 on BALBc mice inhibited the UVBelevated protein levels of COX2 iNOS and TNF\u03b1", "relationMentions": [{"em1Text": "CLS", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "CLS", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "CLS", "em2Text": "TNF\u03b1", "label": "CPR:4"}]}
{"sentText": "In HaCaT cells buthanol and ethylacetate fractions of 80 methanol C fragile extract CFB or CFE and a single compound clerosterol CLS isolated from CFE attenuated UVB 60mJcm2induced cytotoxicity and reduced expression of proinflammatory proteins including cyclooxygenase2 COX2 inducible nitric oxide synthase iNOS and tumor necrosis factor\u03b1 TNF \u03b1", "relationMentions": [{"em1Text": "buthanol", "em2Text": "cyclooxygenase2", "label": "CPR:4"}, {"em1Text": "buthanol", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "buthanol", "em2Text": "inducible nitric oxide synthase", "label": "CPR:4"}, {"em1Text": "buthanol", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "buthanol", "em2Text": "tumor necrosis factor\u03b1", "label": "CPR:4"}, {"em1Text": "buthanol", "em2Text": "TNF \u03b1", "label": "CPR:4"}, {"em1Text": "ethylacetate", "em2Text": "cyclooxygenase2", "label": "CPR:4"}, {"em1Text": "ethylacetate", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "ethylacetate", "em2Text": "inducible nitric oxide synthase", "label": "CPR:4"}, {"em1Text": "ethylacetate", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "ethylacetate", "em2Text": "tumor necrosis factor\u03b1", "label": "CPR:4"}, {"em1Text": "ethylacetate", "em2Text": "TNF \u03b1", "label": "CPR:4"}, {"em1Text": "methanol", "em2Text": "cyclooxygenase2", "label": "CPR:4"}, {"em1Text": "methanol", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "methanol", "em2Text": "inducible nitric oxide synthase", "label": "CPR:4"}, {"em1Text": "methanol", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "methanol", "em2Text": "tumor necrosis factor\u03b1", "label": "CPR:4"}, {"em1Text": "methanol", "em2Text": "TNF \u03b1", "label": "CPR:4"}, {"em1Text": "clerosterol", "em2Text": "cyclooxygenase2", "label": "CPR:4"}, {"em1Text": "clerosterol", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "clerosterol", "em2Text": "inducible nitric oxide synthase", "label": "CPR:4"}, {"em1Text": "clerosterol", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "clerosterol", "em2Text": "tumor necrosis factor\u03b1", "label": "CPR:4"}, {"em1Text": "clerosterol", "em2Text": "TNF \u03b1", "label": "CPR:4"}, {"em1Text": "CLS", "em2Text": "cyclooxygenase2", "label": "CPR:4"}, {"em1Text": "CLS", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "CLS", "em2Text": "inducible nitric oxide synthase", "label": "CPR:4"}, {"em1Text": "CLS", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "CLS", "em2Text": "tumor necrosis factor\u03b1", "label": "CPR:4"}, {"em1Text": "CLS", "em2Text": "TNF \u03b1", "label": "CPR:4"}]}
{"sentText": "In HaCaT cells buthanol and ethylacetate fractions of 80 methanol C fragile extract CFB or CFE and a single compound clerosterol CLS isolated from CFE attenuated UVB 60mJcm2induced cytotoxicity and reduced expression of proinflammatory proteins including cyclooxygenase2 COX2 inducible nitric oxide synthase iNOS and tumor necrosis factor\u03b1 TNF \u03b1", "relationMentions": [{"em1Text": "buthanol", "em2Text": "cyclooxygenase2", "label": "CPR:4"}, {"em1Text": "buthanol", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "buthanol", "em2Text": "inducible nitric oxide synthase", "label": "CPR:4"}, {"em1Text": "buthanol", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "buthanol", "em2Text": "tumor necrosis factor\u03b1", "label": "CPR:4"}, {"em1Text": "buthanol", "em2Text": "TNF \u03b1", "label": "CPR:4"}, {"em1Text": "ethylacetate", "em2Text": "cyclooxygenase2", "label": "CPR:4"}, {"em1Text": "ethylacetate", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "ethylacetate", "em2Text": "inducible nitric oxide synthase", "label": "CPR:4"}, {"em1Text": "ethylacetate", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "ethylacetate", "em2Text": "tumor necrosis factor\u03b1", "label": "CPR:4"}, {"em1Text": "ethylacetate", "em2Text": "TNF \u03b1", "label": "CPR:4"}, {"em1Text": "methanol", "em2Text": "cyclooxygenase2", "label": "CPR:4"}, {"em1Text": "methanol", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "methanol", "em2Text": "inducible nitric oxide synthase", "label": "CPR:4"}, {"em1Text": "methanol", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "methanol", "em2Text": "tumor necrosis factor\u03b1", "label": "CPR:4"}, {"em1Text": "methanol", "em2Text": "TNF \u03b1", "label": "CPR:4"}, {"em1Text": "clerosterol", "em2Text": "cyclooxygenase2", "label": "CPR:4"}, {"em1Text": "clerosterol", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "clerosterol", "em2Text": "inducible nitric oxide synthase", "label": "CPR:4"}, {"em1Text": "clerosterol", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "clerosterol", "em2Text": "tumor necrosis factor\u03b1", "label": "CPR:4"}, {"em1Text": "clerosterol", "em2Text": "TNF \u03b1", "label": "CPR:4"}, {"em1Text": "CLS", "em2Text": "cyclooxygenase2", "label": "CPR:4"}, {"em1Text": "CLS", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "CLS", "em2Text": "inducible nitric oxide synthase", "label": "CPR:4"}, {"em1Text": "CLS", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "CLS", "em2Text": "tumor necrosis factor\u03b1", "label": "CPR:4"}, {"em1Text": "CLS", "em2Text": "TNF \u03b1", "label": "CPR:4"}]}
{"sentText": "In overexpressing cell lines OATP1B1 and OATP1B3 mediated estradiol17\u03b2glucuronide uptake and OATP2B1 mediated estrone3sulfate uptake were inhibited by most of the silymarin flavonolignans investigated", "relationMentions": [{"em1Text": "OATP1B1", "em2Text": "flavonolignans", "label": "CPR:4"}, {"em1Text": "OATP1B3", "em2Text": "flavonolignans", "label": "CPR:4"}, {"em1Text": "OATP2B1", "em2Text": "flavonolignans", "label": "CPR:4"}, {"em1Text": "OATP1B1", "em2Text": "estradiol17\u03b2glucuronide", "label": "CPR:9"}, {"em1Text": "OATP1B3", "em2Text": "estradiol17\u03b2glucuronide", "label": "CPR:9"}, {"em1Text": "OATP2B1", "em2Text": "estrone3sulfate", "label": "CPR:9"}]}
{"sentText": "In overexpressing cell lines OATP1B1 and OATP1B3 mediated estradiol17\u03b2glucuronide uptake and OATP2B1 mediated estrone3sulfate uptake were inhibited by most of the silymarin flavonolignans investigated", "relationMentions": [{"em1Text": "OATP1B1", "em2Text": "flavonolignans", "label": "CPR:4"}, {"em1Text": "OATP1B3", "em2Text": "flavonolignans", "label": "CPR:4"}, {"em1Text": "OATP2B1", "em2Text": "flavonolignans", "label": "CPR:4"}, {"em1Text": "OATP1B1", "em2Text": "estradiol17\u03b2glucuronide", "label": "CPR:9"}, {"em1Text": "OATP1B3", "em2Text": "estradiol17\u03b2glucuronide", "label": "CPR:9"}, {"em1Text": "OATP2B1", "em2Text": "estrone3sulfate", "label": "CPR:9"}]}
{"sentText": "OATP1B1 OATP1B3 and OATP2B1 mediated substrate transport was inhibited efficiently by silymarin IC50 values of 13 22 and 03 \u00b5M respectively silybin A IC50 values of 97 27 and 45 \u00b5M respectively silybin B IC50 values of 85 50 and 08 \u00b5M respectively and silychristin IC50 values of 90 364 and 36 \u00b5M respectively", "relationMentions": [{"em1Text": "OATP1B1", "em2Text": "silybin A", "label": "CPR:4"}, {"em1Text": "OATP1B3", "em2Text": "silybin A", "label": "CPR:4"}, {"em1Text": "OATP2B1", "em2Text": "silybin A", "label": "CPR:4"}, {"em1Text": "OATP1B1", "em2Text": "silybin B", "label": "CPR:4"}, {"em1Text": "OATP1B3", "em2Text": "silybin B", "label": "CPR:4"}, {"em1Text": "OATP2B1", "em2Text": "silybin B", "label": "CPR:4"}, {"em1Text": "OATP1B1", "em2Text": "silychristin", "label": "CPR:4"}, {"em1Text": "OATP1B3", "em2Text": "silychristin", "label": "CPR:4"}, {"em1Text": "OATP2B1", "em2Text": "silychristin", "label": "CPR:4"}]}
{"sentText": "OATP1B1 OATP1B3 and OATP2B1 mediated substrate transport was inhibited efficiently by silymarin IC50 values of 13 22 and 03 \u00b5M respectively silybin A IC50 values of 97 27 and 45 \u00b5M respectively silybin B IC50 values of 85 50 and 08 \u00b5M respectively and silychristin IC50 values of 90 364 and 36 \u00b5M respectively", "relationMentions": [{"em1Text": "OATP1B1", "em2Text": "silybin A", "label": "CPR:4"}, {"em1Text": "OATP1B3", "em2Text": "silybin A", "label": "CPR:4"}, {"em1Text": "OATP2B1", "em2Text": "silybin A", "label": "CPR:4"}, {"em1Text": "OATP1B1", "em2Text": "silybin B", "label": "CPR:4"}, {"em1Text": "OATP1B3", "em2Text": "silybin B", "label": "CPR:4"}, {"em1Text": "OATP2B1", "em2Text": "silybin B", "label": "CPR:4"}, {"em1Text": "OATP1B1", "em2Text": "silychristin", "label": "CPR:4"}, {"em1Text": "OATP1B3", "em2Text": "silychristin", "label": "CPR:4"}, {"em1Text": "OATP2B1", "em2Text": "silychristin", "label": "CPR:4"}]}
{"sentText": "Furthermore silymarin silybin A and silybin B 100 \u00b5M significantly inhibited OATP mediated estradiol17\u03b2glucuronide and rosuvastatin uptake into human hepatocytes", "relationMentions": [{"em1Text": "silybin A", "em2Text": "OATP", "label": "CPR:4"}, {"em1Text": "silybin B", "em2Text": "OATP", "label": "CPR:4"}, {"em1Text": "OATP", "em2Text": "estradiol17\u03b2glucuronide", "label": "CPR:9"}, {"em1Text": "OATP", "em2Text": "rosuvastatin", "label": "CPR:9"}]}
{"sentText": "Furthermore silymarin silybin A and silybin B 100 \u00b5M significantly inhibited OATP mediated estradiol17\u03b2glucuronide and rosuvastatin uptake into human hepatocytes", "relationMentions": [{"em1Text": "silybin A", "em2Text": "OATP", "label": "CPR:4"}, {"em1Text": "silybin B", "em2Text": "OATP", "label": "CPR:4"}, {"em1Text": "OATP", "em2Text": "estradiol17\u03b2glucuronide", "label": "CPR:9"}, {"em1Text": "OATP", "em2Text": "rosuvastatin", "label": "CPR:9"}]}
{"sentText": "Further investigation demonstrated that 8k reduced H2O2 induced activation of mitochondrial apoptosis by inhibiting the expression of Bax and elevating the expression of Bcl2", "relationMentions": [{"em1Text": "H2O2", "em2Text": "Bax", "label": "CPR:3"}, {"em1Text": "H2O2", "em2Text": "Bcl2", "label": "CPR:4"}]}
{"sentText": "Three variables of cardiac vagal effects the root mean square of successive differences rMSSD in the interbeat interval of the heart rate IBI heartrate variability HRV caused by peakvalley respiratory sinus arrhythmia pvRSA and highfrequency power HF and heart rate HR were obtained at seven time points during the clamps characterised by increasing levels of insulin achieved by administering insulin plus glucose glucose only glucose and GLP1 and glucose and GLP1 combined with arginine", "relationMentions": [{"em1Text": "insulin", "em2Text": "glucose", "label": "CPR:3"}, {"em1Text": "insulin", "em2Text": "arginine", "label": "CPR:3"}]}
{"sentText": "The monoacylglycerol lipase MAGL inhibitor JZL184 produces antinociceptive and antiinflammatory effects", "relationMentions": [{"em1Text": "MAGL", "em2Text": "JZL184", "label": "CPR:4"}, {"em1Text": "monoacylglycerol lipase", "em2Text": "JZL184", "label": "CPR:4"}]}
{"sentText": "Bicyclic pyrazinone and pyrimidinone amides were designed and synthesized as potent TF FVIIa inhibitors", "relationMentions": [{"em1Text": "Bicyclic pyrazinone and pyrimidinone amides", "em2Text": "FVIIa", "label": "CPR:4"}, {"em1Text": "Bicyclic pyrazinone and pyrimidinone amides", "em2Text": "TF", "label": "CPR:4"}]}
{"sentText": "Design and synthesis of bicyclic pyrazinone and pyrimidinone amides as potent TF FVIIa inhibitors", "relationMentions": [{"em1Text": "bicyclic pyrazinone and pyrimidinone amides", "em2Text": "TF", "label": "CPR:4"}, {"em1Text": "bicyclic pyrazinone and pyrimidinone amides", "em2Text": "FVIIa", "label": "CPR:4"}]}
{"sentText": "The most potent compound 5 HJC0123 has demonstrated to inhibit STAT3 promoter activity downregulate phosphorylation of STAT3 increase the expression of cleaved caspase3 inhibit cell cycle progression and promote apoptosis in breast and pancreatic cancer cells with low micromolar to nanomolar IC50 values", "relationMentions": [{"em1Text": "HJC0123", "em2Text": "caspase3", "label": "CPR:3"}, {"em1Text": "HJC0123", "em2Text": "STAT3 promoter", "label": "CPR:4"}, {"em1Text": "HJC0123", "em2Text": "STAT3", "label": "CPR:4"}]}
{"sentText": "for 15 days or along with a peroxisome proliferatoractivated receptor alpha agonist bezafibrate Bzf 30 \u03bcg100 g BW oral and were found to improve in the Bzf cotreated condition", "relationMentions": [{"em1Text": "peroxisome proliferatoractivated receptor alpha", "em2Text": "bezafibrate", "label": "CPR:5"}, {"em1Text": "peroxisome proliferatoractivated receptor alpha", "em2Text": "Bzf", "label": "CPR:5"}]}
{"sentText": "Moreover the effects of the DRD3 agonist 7hydroxyNNdipropyl2aminotetralin 7OHDPAT induced locomotor hypoactivity were significantly increased when DRD3 proteins were abundant", "relationMentions": [{"em1Text": "DRD3", "em2Text": "7hydroxyNNdipropyl2aminotetralin", "label": "CPR:5"}, {"em1Text": "DRD3", "em2Text": "7OHDPAT", "label": "CPR:5"}]}
{"sentText": "2RIKM159 locks the GluA2 in an open form consistent with a pharmacological action as competitive antagonist of AMPA receptors", "relationMentions": [{"em1Text": "2RIKM159", "em2Text": "GluA2", "label": "CPR:4"}, {"em1Text": "2RIKM159", "em2Text": "AMPA receptors", "label": "CPR:6"}]}
{"sentText": "IKM159 was developed and identified as a member of a new class of heterotricyclic glutamate analogues that act as AMPA receptor selective antagonists", "relationMentions": [{"em1Text": "IKM159", "em2Text": "AMPA receptor", "label": "CPR:6"}, {"em1Text": "glutamate", "em2Text": "AMPA receptor", "label": "CPR:6"}]}
{"sentText": "Coumarin 7hydroxylation catalyzed by P450 2A13 was strongly inhibited by 2methoxy57dihydroxyflavone 2ethynylnaphthalene 2methoxyflavone 2naphththalene propargyl ether acenaphthene acenaphthylene naphthalene 1acetylpyrene flavanone chrysin 3ethynylphenanthrene flavone and 7hydroxyflavone these chemicals induced Type I spectral changes with low Ks values", "relationMentions": [{"em1Text": "P450 2A13", "em2Text": "flavanone", "label": "CPR:4"}, {"em1Text": "P450 2A13", "em2Text": "2methoxy57dihydroxyflavone", "label": "CPR:4"}, {"em1Text": "P450 2A13", "em2Text": "2ethynylnaphthalene", "label": "CPR:4"}, {"em1Text": "P450 2A13", "em2Text": "2methoxyflavone", "label": "CPR:4"}, {"em1Text": "P450 2A13", "em2Text": "2naphththalene propargyl ether", "label": "CPR:4"}, {"em1Text": "P450 2A13", "em2Text": "acenaphthene", "label": "CPR:4"}, {"em1Text": "P450 2A13", "em2Text": "chrysin", "label": "CPR:4"}, {"em1Text": "P450 2A13", "em2Text": "acenaphthylene", "label": "CPR:4"}, {"em1Text": "P450 2A13", "em2Text": "naphthalene", "label": "CPR:4"}, {"em1Text": "P450 2A13", "em2Text": "1acetylpyrene", "label": "CPR:4"}, {"em1Text": "P450 2A13", "em2Text": "3ethynylphenanthrene", "label": "CPR:4"}, {"em1Text": "P450 2A13", "em2Text": "flavone", "label": "CPR:4"}, {"em1Text": "P450 2A13", "em2Text": "7hydroxyflavone", "label": "CPR:4"}, {"em1Text": "Coumarin", "em2Text": "P450 2A13", "label": "CPR:9"}]}
{"sentText": "The pleiotropic effects of vitamin A are exerted mainly by one active metabolite alltrans retinoic acid atRA which regulates the expression of a battery of target genes through several families of nuclear receptors RARs RXRs and PPAR\u03b2\u03b4 polymorphic retinoic acid RA response elements and multiple coregulators", "relationMentions": [{"em1Text": "alltrans retinoic acid", "em2Text": "nuclear receptors", "label": "CPR:3"}, {"em1Text": "alltrans retinoic acid", "em2Text": "RARs", "label": "CPR:3"}, {"em1Text": "alltrans retinoic acid", "em2Text": "RXRs", "label": "CPR:3"}, {"em1Text": "alltrans retinoic acid", "em2Text": "polymorphic retinoic acid RA response elements", "label": "CPR:3"}, {"em1Text": "atRA", "em2Text": "nuclear receptors", "label": "CPR:3"}, {"em1Text": "atRA", "em2Text": "RARs", "label": "CPR:3"}, {"em1Text": "atRA", "em2Text": "RXRs", "label": "CPR:3"}, {"em1Text": "atRA", "em2Text": "polymorphic retinoic acid RA response elements", "label": "CPR:3"}]}
{"sentText": "The pleiotropic effects of vitamin A are exerted mainly by one active metabolite alltrans retinoic acid atRA which regulates the expression of a battery of target genes through several families of nuclear receptors RARs RXRs and PPAR\u03b2\u03b4 polymorphic retinoic acid RA response elements and multiple coregulators", "relationMentions": [{"em1Text": "alltrans retinoic acid", "em2Text": "nuclear receptors", "label": "CPR:3"}, {"em1Text": "alltrans retinoic acid", "em2Text": "RARs", "label": "CPR:3"}, {"em1Text": "alltrans retinoic acid", "em2Text": "RXRs", "label": "CPR:3"}, {"em1Text": "alltrans retinoic acid", "em2Text": "polymorphic retinoic acid RA response elements", "label": "CPR:3"}, {"em1Text": "atRA", "em2Text": "nuclear receptors", "label": "CPR:3"}, {"em1Text": "atRA", "em2Text": "RARs", "label": "CPR:3"}, {"em1Text": "atRA", "em2Text": "RXRs", "label": "CPR:3"}, {"em1Text": "atRA", "em2Text": "polymorphic retinoic acid RA response elements", "label": "CPR:3"}]}
{"sentText": "Interestingly miR21 expression positively correlated with urine albumin creatine ratio ACR TIMP1 collagen IV ColIV and fibronectin FN while negatively correlated with creatine clearance ratio Ccr and MMP9 protein", "relationMentions": [{"em1Text": "miR21", "em2Text": "creatine", "label": "CPR:3"}, {"em1Text": "miR21", "em2Text": "creatine", "label": "CPR:4"}]}
{"sentText": "Interestingly miR21 expression positively correlated with urine albumin creatine ratio ACR TIMP1 collagen IV ColIV and fibronectin FN while negatively correlated with creatine clearance ratio Ccr and MMP9 protein", "relationMentions": [{"em1Text": "miR21", "em2Text": "creatine", "label": "CPR:3"}, {"em1Text": "miR21", "em2Text": "creatine", "label": "CPR:4"}]}
{"sentText": "Studies on the kinetics of the hSULT2A1 catalyzed sulfation of dehydroepiandrosterone DHEA showed the effects of disulfide bond formation on the substrate inhibition characteristics of the enzyme", "relationMentions": [{"em1Text": "hSULT2A1", "em2Text": "dehydroepiandrosterone", "label": "CPR:9"}, {"em1Text": "hSULT2A1", "em2Text": "DHEA", "label": "CPR:9"}]}
{"sentText": "The human cytosolic sulfotransferase hSULT2A1 catalyzes the sulfation of a broad range of xenobiotics as well as endogenous hydroxysteroids and bile acids", "relationMentions": [{"em1Text": "human cytosolic sulfotransferase hSULT2A1", "em2Text": "hydroxysteroids", "label": "CPR:9"}, {"em1Text": "human cytosolic sulfotransferase hSULT2A1", "em2Text": "bile acids", "label": "CPR:9"}]}
{"sentText": "7Methoxy644methyl13thiazol2yl1Himidazol5yl13benzothiazole 11 TASP0382088 was synthesized and evaluated as transforming growth factor\u03b2 TGF\u03b2 type I receptor also known as activin receptorlike kinase 5 or ALK5 inhibitor", "relationMentions": [{"em1Text": "7Methoxy644methyl13thiazol2yl1Himidazol5yl13benzothiazole", "em2Text": "activin receptorlike kinase 5", "label": "CPR:4"}, {"em1Text": "7Methoxy644methyl13thiazol2yl1Himidazol5yl13benzothiazole", "em2Text": "ALK5", "label": "CPR:4"}, {"em1Text": "7Methoxy644methyl13thiazol2yl1Himidazol5yl13benzothiazole", "em2Text": "transforming growth factor\u03b2 TGF\u03b2 type I receptor", "label": "CPR:4"}, {"em1Text": "TASP0382088", "em2Text": "activin receptorlike kinase 5", "label": "CPR:4"}, {"em1Text": "TASP0382088", "em2Text": "ALK5", "label": "CPR:4"}, {"em1Text": "TASP0382088", "em2Text": "transforming growth factor\u03b2 TGF\u03b2 type I receptor", "label": "CPR:4"}]}
{"sentText": "7Methoxy644methyl13thiazol2yl1Himidazol5yl13benzothiazole 11 TASP0382088 was synthesized and evaluated as transforming growth factor\u03b2 TGF\u03b2 type I receptor also known as activin receptorlike kinase 5 or ALK5 inhibitor", "relationMentions": [{"em1Text": "7Methoxy644methyl13thiazol2yl1Himidazol5yl13benzothiazole", "em2Text": "activin receptorlike kinase 5", "label": "CPR:4"}, {"em1Text": "7Methoxy644methyl13thiazol2yl1Himidazol5yl13benzothiazole", "em2Text": "ALK5", "label": "CPR:4"}, {"em1Text": "7Methoxy644methyl13thiazol2yl1Himidazol5yl13benzothiazole", "em2Text": "transforming growth factor\u03b2 TGF\u03b2 type I receptor", "label": "CPR:4"}, {"em1Text": "TASP0382088", "em2Text": "activin receptorlike kinase 5", "label": "CPR:4"}, {"em1Text": "TASP0382088", "em2Text": "ALK5", "label": "CPR:4"}, {"em1Text": "TASP0382088", "em2Text": "transforming growth factor\u03b2 TGF\u03b2 type I receptor", "label": "CPR:4"}]}
{"sentText": "Discovery of 7methoxy644methyl13thiazol2yl1Himidazol5yl13benzothiazole TASP0382088 a potent and selective transforming growth factor\u03b2 type I receptor inhibitor as a topical drug for alopecia", "relationMentions": [{"em1Text": "7methoxy644methyl13thiazol2yl1Himidazol5yl13benzothiazole", "em2Text": "transforming growth factor\u03b2 type I receptor", "label": "CPR:4"}, {"em1Text": "TASP0382088", "em2Text": "transforming growth factor\u03b2 type I receptor", "label": "CPR:4"}]}
{"sentText": "In lymphocytes the NTPDase and ADA activities were increased in all groups treated with caffeic acid when compared to control P005", "relationMentions": [{"em1Text": "ADA", "em2Text": "caffeic acid", "label": "CPR:3"}, {"em1Text": "NTPDase", "em2Text": "caffeic acid", "label": "CPR:3"}]}
{"sentText": "The procedure was to reduce liver AOX activity by providing tungsten or hydralazine in the drinking water or to use the AOXdeficient DBA2 mouse strain", "relationMentions": [{"em1Text": "AOX", "em2Text": "tungsten", "label": "CPR:4"}, {"em1Text": "AOX", "em2Text": "hydralazine", "label": "CPR:4"}]}
{"sentText": "Liver AOX activity was reduced by 45 with tungsten and 61 with hydralazine and 81 in AOXdeficient mice relative to controls", "relationMentions": [{"em1Text": "AOX", "em2Text": "tungsten", "label": "CPR:4"}, {"em1Text": "AOX", "em2Text": "hydralazine", "label": "CPR:4"}]}
{"sentText": "When mice were treated ip with the major neonicotinoid imidacloprid IMI metabolism by CYP oxidation reactions was not appreciably affected whereas the AOX generated nitrosoguanidine metabolite was decreased by 30 with tungsten and 56 with hydralazine and 86 in the AOXdeficient mice", "relationMentions": [{"em1Text": "AOX", "em2Text": "tungsten", "label": "CPR:4"}, {"em1Text": "AOX", "em2Text": "hydralazine", "label": "CPR:4"}, {"em1Text": "AOX", "em2Text": "nitrosoguanidine", "label": "CPR:9"}]}
{"sentText": "Currently the most important insecticides are neonicotinoids which are metabolized in vitro by AOX on reduction of the nitroimino group and by CYPs via oxidation reactions", "relationMentions": [{"em1Text": "neonicotinoids", "em2Text": "AOX", "label": "CPR:9"}, {"em1Text": "neonicotinoids", "em2Text": "CYPs", "label": "CPR:9"}, {"em1Text": "AOX", "em2Text": "nitroimino", "label": "CPR:9"}]}
{"sentText": "Of the compounds active in the present assay system the most potent compound 7 platyphyllonol5O\u03b2dxylopyranoside significantly suppressed the induction of peroxisome proliferator activated receptor \u03b3 PPAR\u03b3 and CCAATenhancer binding protein \u03b1 CEBP\u03b1 protein expression and inhibited adipocyte differentiation induced by troglitazone a PPAR\u03b3 agonist", "relationMentions": [{"em1Text": "platyphyllonol5O\u03b2dxylopyranoside", "em2Text": "CCAATenhancer binding protein \u03b1", "label": "CPR:4"}, {"em1Text": "platyphyllonol5O\u03b2dxylopyranoside", "em2Text": "CEBP\u03b1", "label": "CPR:4"}, {"em1Text": "platyphyllonol5O\u03b2dxylopyranoside", "em2Text": "peroxisome proliferator activated receptor \u03b3", "label": "CPR:4"}, {"em1Text": "platyphyllonol5O\u03b2dxylopyranoside", "em2Text": "PPAR\u03b3", "label": "CPR:4"}, {"em1Text": "PPAR\u03b3", "em2Text": "troglitazone", "label": "CPR:5"}]}
{"sentText": "Measurement of Transport Activities of 3\u03b2Hydroxy\u03945bile Acids in Bile Salt Export Pump and Multidrug ResistanceAssociated Proteins Using LCMSMS", "relationMentions": [{"em1Text": "3\u03b2Hydroxy\u03945bile Acids", "em2Text": "Bile Salt Export Pump", "label": "CPR:9"}, {"em1Text": "3\u03b2Hydroxy\u03945bile Acids", "em2Text": "Multidrug ResistanceAssociated Proteins", "label": "CPR:9"}]}
{"sentText": "The present study demonstrated that human multidrug resistanceassociated protein 3 vesicles accepted conjugated 3\u03b2hydroxy\u03945bile acids along with common bile acids such as glycocholic acid and taurolithocholic acid 3sulfate", "relationMentions": [{"em1Text": "human multidrug resistanceassociated protein 3", "em2Text": "3\u03b2hydroxy\u03945bile acids", "label": "CPR:9"}, {"em1Text": "human multidrug resistanceassociated protein 3", "em2Text": "bile acids", "label": "CPR:9"}, {"em1Text": "human multidrug resistanceassociated protein 3", "em2Text": "glycocholic acid", "label": "CPR:9"}, {"em1Text": "human multidrug resistanceassociated protein 3", "em2Text": "taurolithocholic acid 3sulfate", "label": "CPR:9"}]}
{"sentText": "Upon nicotine preexposure brain acetylcholinesterase increased while monoamine oxidase MAO decreased", "relationMentions": [{"em1Text": "nicotine", "em2Text": "acetylcholinesterase", "label": "CPR:3"}, {"em1Text": "nicotine", "em2Text": "monoamine oxidase", "label": "CPR:4"}, {"em1Text": "nicotine", "em2Text": "MAO", "label": "CPR:4"}]}
{"sentText": "GlutathioneStransferase a phase II enzyme was inhibited by both arsenic and nicotine but no such inhibition was noted in arsenictreated animals preexposed to nicotine", "relationMentions": [{"em1Text": "GlutathioneStransferase", "em2Text": "arsenic", "label": "CPR:4"}, {"em1Text": "GlutathioneStransferase", "em2Text": "nicotine", "label": "CPR:4"}]}
{"sentText": "We developed a computational model of the hypothalamicpituitarygonadal HPG axis in female fathead minnows to predict doseresponse and timecourse DRTC behaviors for endocrine effects of the aromatase inhibitor fadrozole FAD", "relationMentions": [{"em1Text": "aromatase", "em2Text": "fadrozole", "label": "CPR:4"}, {"em1Text": "aromatase", "em2Text": "FAD", "label": "CPR:4"}]}
{"sentText": "A highly potent inhibition of the peroxidase catalytic reaction by NO SNO was seen in assays employing the coupled PrxTrx system", "relationMentions": [{"em1Text": "peroxidase", "em2Text": "NO", "label": "CPR:4"}, {"em1Text": "peroxidase", "em2Text": "SNO", "label": "CPR:4"}]}
{"sentText": "In this setting Snitrosocysteine 10 \u03bcm effectively blocked the Trx mediated regeneration of oxidized Prx1", "relationMentions": [{"em1Text": "Snitrosocysteine", "em2Text": "Trx", "label": "CPR:4"}, {"em1Text": "Snitrosocysteine", "em2Text": "oxidized Prx1", "label": "CPR:4"}]}
{"sentText": "CK significantly inhibited DMN induced increases in serum alanine aminotransferase ALT and aspartate aminotransferase AST activities fibrosis score and hepatic malondialdehyde and collagen content", "relationMentions": [{"em1Text": "DMN", "em2Text": "alanine aminotransferase", "label": "CPR:3"}, {"em1Text": "DMN", "em2Text": "ALT", "label": "CPR:3"}, {"em1Text": "DMN", "em2Text": "aspartate aminotransferase", "label": "CPR:3"}, {"em1Text": "DMN", "em2Text": "AST", "label": "CPR:3"}, {"em1Text": "DMN", "em2Text": "collagen", "label": "CPR:3"}]}
{"sentText": "Reverse transcription polymerase chain reaction RTPCR and western blot analyses revealed that CK inhibited DMN induced increases in matrix metalloproteinase13 MMP13 tissue inhibitor of metalloproteinase1 TIMP1 and tumor necrosis factor\u03b1 TNF\u03b1 mRNA and collagen type I and \u03b1smooth muscle actin protein", "relationMentions": [{"em1Text": "DMN", "em2Text": "matrix metalloproteinase13", "label": "CPR:3"}, {"em1Text": "DMN", "em2Text": "MMP13", "label": "CPR:3"}, {"em1Text": "DMN", "em2Text": "tissue inhibitor of metalloproteinase1", "label": "CPR:3"}, {"em1Text": "DMN", "em2Text": "TIMP1", "label": "CPR:3"}, {"em1Text": "DMN", "em2Text": "tumor necrosis factor\u03b1", "label": "CPR:3"}, {"em1Text": "DMN", "em2Text": "TNF\u03b1", "label": "CPR:3"}, {"em1Text": "DMN", "em2Text": "collagen type I", "label": "CPR:3"}, {"em1Text": "DMN", "em2Text": "\u03b1smooth muscle actin", "label": "CPR:3"}]}
{"sentText": "DMN induced cyclooxygenase2 COX2 expression and nuclear factorkappa B NF\u03baB activation was reduced by CK treatment", "relationMentions": [{"em1Text": "DMN", "em2Text": "nuclear factorkappa B", "label": "CPR:3"}, {"em1Text": "DMN", "em2Text": "NF\u03baB", "label": "CPR:3"}, {"em1Text": "DMN", "em2Text": "cyclooxygenase2", "label": "CPR:3"}, {"em1Text": "DMN", "em2Text": "COX2", "label": "CPR:3"}]}
{"sentText": "Extrinsic apoptotic pathway markers such as Fas levels and caspase8 activity increased as a result of CdTe QD exposure", "relationMentions": [{"em1Text": "Fas", "em2Text": "CdTe", "label": "CPR:3"}, {"em1Text": "caspase8", "em2Text": "CdTe", "label": "CPR:3"}]}
{"sentText": "Puerarin administration enhanced glutathione GSH activity glial cell linederived neurotrophic factor GDNF expression and PI3K Akt pathway activation which might ameliorate MPTP injectioninduced progressive elevation of reactive oxygen species ROS formation in mice", "relationMentions": [{"em1Text": "Puerarin", "em2Text": "glial cell linederived neurotrophic factor", "label": "CPR:3"}, {"em1Text": "Puerarin", "em2Text": "GDNF", "label": "CPR:3"}, {"em1Text": "Puerarin", "em2Text": "PI3K", "label": "CPR:3"}, {"em1Text": "Puerarin", "em2Text": "Akt", "label": "CPR:3"}]}
{"sentText": "In addition to the effect on ROS puerarin ameliorated MPTP reduced lysosomeassociated membrane protein type 2A Lamp 2A expression", "relationMentions": [{"em1Text": "puerarin", "em2Text": "Lamp 2A", "label": "CPR:4"}, {"em1Text": "MPTP", "em2Text": "lysosomeassociated membrane protein type 2A", "label": "CPR:4"}, {"em1Text": "MPTP", "em2Text": "Lamp 2A", "label": "CPR:4"}]}
{"sentText": "In addition to the effect on ROS puerarin ameliorated MPTP reduced lysosomeassociated membrane protein type 2A Lamp 2A expression", "relationMentions": [{"em1Text": "puerarin", "em2Text": "Lamp 2A", "label": "CPR:4"}, {"em1Text": "MPTP", "em2Text": "lysosomeassociated membrane protein type 2A", "label": "CPR:4"}, {"em1Text": "MPTP", "em2Text": "Lamp 2A", "label": "CPR:4"}]}
{"sentText": "Taken together our data demonstrate that puerarin attenuates MPTP induced dopaminergic neuronal degeneration via modulating GDNF expression PI3KAkt pathway and GSH activation which subsequently ameliorate MPTP induced ROS formation and decrease of Lamp 2A expression", "relationMentions": [{"em1Text": "puerarin", "em2Text": "Lamp 2A", "label": "CPR:4"}, {"em1Text": "MPTP", "em2Text": "Lamp 2A", "label": "CPR:4"}]}
{"sentText": "IPI926 is both a substrate and inhibitor IC50 = 19 \u00b5M of Pglycoprotein", "relationMentions": [{"em1Text": "IPI926", "em2Text": "Pglycoprotein", "label": "CPR:4"}, {"em1Text": "IPI926", "em2Text": "Pglycoprotein", "label": "CPR:9"}]}
{"sentText": "IPI926 is both a substrate and inhibitor IC50 = 19 \u00b5M of Pglycoprotein", "relationMentions": [{"em1Text": "IPI926", "em2Text": "Pglycoprotein", "label": "CPR:4"}, {"em1Text": "IPI926", "em2Text": "Pglycoprotein", "label": "CPR:9"}]}
{"sentText": "Oral lorcaserin BELVIQ \u00ae a selective serotonin 5HT2C receptor agonist is indicated in the US as an adjunct to diet and exercise in the chronic weight management of obese adults or overweight adults with at least one weightrelated comorbidity eg", "relationMentions": [{"em1Text": "lorcaserin", "em2Text": "5HT2C", "label": "CPR:5"}, {"em1Text": "BELVIQ", "em2Text": "5HT2C", "label": "CPR:5"}]}
{"sentText": "Design Synthesis Biological Evaluation and Docking Studies of SPhenylalanine Derivatives with a 2Cyanopyrrolidine Moiety as Potent Dipeptidyl Peptidase 4 Inhibitors", "relationMentions": [{"em1Text": "2Cyanopyrrolidine", "em2Text": "Dipeptidyl Peptidase 4", "label": "CPR:4"}, {"em1Text": "SPhenylalanine", "em2Text": "Dipeptidyl Peptidase 4", "label": "CPR:4"}]}
{"sentText": "Galangin decreased expression of proinflammatory cytokines such as tumor necrosis factor TNF\u03b1 interleukin IL6 IL1\u03b2 and IL8", "relationMentions": [{"em1Text": "Galangin", "em2Text": "cytokines", "label": "CPR:4"}, {"em1Text": "Galangin", "em2Text": "tumor necrosis factor TNF\u03b1", "label": "CPR:4"}, {"em1Text": "Galangin", "em2Text": "interleukin", "label": "CPR:4"}, {"em1Text": "Galangin", "em2Text": "IL6", "label": "CPR:4"}, {"em1Text": "Galangin", "em2Text": "IL1\u03b2", "label": "CPR:4"}, {"em1Text": "Galangin", "em2Text": "IL8", "label": "CPR:4"}]}
{"sentText": "Furthermore galangin attenuated IgE mediated passive cutaneous anaphylaxis and the expression of histamine receptor 1 at the inflamed tissue", "relationMentions": [{"em1Text": "galangin", "em2Text": "IgE", "label": "CPR:4"}, {"em1Text": "galangin", "em2Text": "histamine receptor 1", "label": "CPR:4"}]}
{"sentText": "Nobiletin attenuates metastasis via both ERK and PI3K Akt pathways in HGFtreated liver cancer HepG2 cells", "relationMentions": [{"em1Text": "Nobiletin", "em2Text": "ERK", "label": "CPR:4"}, {"em1Text": "Nobiletin", "em2Text": "PI3K", "label": "CPR:4"}, {"em1Text": "Nobiletin", "em2Text": "Akt", "label": "CPR:4"}]}
{"sentText": "In conclusion nobiletin attenuates HGF induced HepG2 cells metastasis involving both ERK and PI3K Akt pathways and are potentially useful as antimetastatic agents for the treatment of hepatoma", "relationMentions": [{"em1Text": "nobiletin", "em2Text": "HGF", "label": "CPR:4"}, {"em1Text": "nobiletin", "em2Text": "ERK", "label": "CPR:4"}, {"em1Text": "nobiletin", "em2Text": "PI3K", "label": "CPR:4"}, {"em1Text": "nobiletin", "em2Text": "Akt", "label": "CPR:4"}]}
{"sentText": "Furthermore nobiletin could inhibit HGF induced the membrane localization of phosphorylated cMet ERK2 and Akt but not phosphorylated JNK12 and p38", "relationMentions": [{"em1Text": "nobiletin", "em2Text": "HGF", "label": "CPR:4"}, {"em1Text": "nobiletin", "em2Text": "cMet", "label": "CPR:4"}, {"em1Text": "nobiletin", "em2Text": "ERK2", "label": "CPR:4"}, {"em1Text": "nobiletin", "em2Text": "Akt", "label": "CPR:4"}]}
{"sentText": "Next nobiletin significantly decreased the levels of phosphoERK2 and phosphoAkt in ERK2 or Akt siRNAtransfected cells concomitantly with a marked reduction on cell invasion and migration", "relationMentions": [{"em1Text": "nobiletin", "em2Text": "phosphoERK2", "label": "CPR:4"}, {"em1Text": "nobiletin", "em2Text": "phosphoAkt", "label": "CPR:4"}, {"em1Text": "nobiletin", "em2Text": "ERK2", "label": "CPR:4"}, {"em1Text": "nobiletin", "em2Text": "Akt", "label": "CPR:4"}]}
{"sentText": "Excess of cholesterol converted into 24OHC may upregulate ApoE synthesis which is a scavenger for A\u03b2 and Tau", "relationMentions": [{"em1Text": "cholesterol", "em2Text": "ApoE", "label": "CPR:3"}, {"em1Text": "24OHC", "em2Text": "ApoE", "label": "CPR:3"}]}
{"sentText": "Cholesterol also increases Amyloid \u03b2 A\u03b2 deposition and tau pathology", "relationMentions": [{"em1Text": "Cholesterol", "em2Text": "Amyloid \u03b2", "label": "CPR:4"}, {"em1Text": "Cholesterol", "em2Text": "A\u03b2", "label": "CPR:4"}, {"em1Text": "Cholesterol", "em2Text": "tau", "label": "CPR:4"}]}
{"sentText": "We have identified 3hydroxypyridin2thione 3HPT as a novel ZBG that is compatible with HDAC inhibition", "relationMentions": [{"em1Text": "3hydroxypyridin2thione", "em2Text": "HDAC", "label": "CPR:4"}, {"em1Text": "3HPT", "em2Text": "HDAC", "label": "CPR:4"}]}
{"sentText": "3HPT inhibits HDAC 6 and HDAC 8 with an IC50 of 681 and 3675 nM respectively", "relationMentions": [{"em1Text": "3HPT", "em2Text": "HDAC 6", "label": "CPR:4"}, {"em1Text": "3HPT", "em2Text": "HDAC 8", "label": "CPR:4"}]}
{"sentText": "Small molecules bearing hydroxamic acid as the zinc binding group ZBG have been the most effective histone deacetylase inhibitors HDAC i to date", "relationMentions": [{"em1Text": "zinc", "em2Text": "histone deacetylase", "label": "CPR:4"}, {"em1Text": "zinc", "em2Text": "HDAC", "label": "CPR:4"}]}
{"sentText": "Subsequent optimization led to several novel 3HPT based HDACi that are selective for HDAC 6 and HDAC 8", "relationMentions": [{"em1Text": "3HPT", "em2Text": "HDAC", "label": "CPR:4"}, {"em1Text": "3HPT", "em2Text": "HDAC 6", "label": "CPR:4"}, {"em1Text": "3HPT", "em2Text": "HDAC 8", "label": "CPR:4"}]}
{"sentText": "3Hydroxypyridin2thione as Novel Zinc Binding Group for Selective Histone Deacetylase Inhibition", "relationMentions": [{"em1Text": "3Hydroxypyridin2thione", "em2Text": "Histone Deacetylase", "label": "CPR:4"}, {"em1Text": "Zinc", "em2Text": "Histone Deacetylase", "label": "CPR:4"}]}
{"sentText": "Moreover curcumin could also downregulate the expression and activity of matrix metalloproteinase9 MMP9", "relationMentions": [{"em1Text": "curcumin", "em2Text": "matrix metalloproteinase9", "label": "CPR:4"}, {"em1Text": "curcumin", "em2Text": "MMP9", "label": "CPR:4"}]}
{"sentText": "Treatment with EVn50 or VB1 resulted in arresting the MDAMB435 and SMMC7721 cells at G2M phase which was further supported by observations of increased phosphorylation of Histone 3 at Ser10 phosphorylation of Cdk1 at Tyr15 expression of cyclin B1 and decreased expression of Cdc25c", "relationMentions": [{"em1Text": "EVn50", "em2Text": "Histone 3", "label": "CPR:3"}, {"em1Text": "EVn50", "em2Text": "Cdk1", "label": "CPR:3"}, {"em1Text": "EVn50", "em2Text": "cyclin B1", "label": "CPR:3"}, {"em1Text": "VB1", "em2Text": "Histone 3", "label": "CPR:3"}, {"em1Text": "VB1", "em2Text": "Cdk1", "label": "CPR:3"}, {"em1Text": "VB1", "em2Text": "cyclin B1", "label": "CPR:3"}, {"em1Text": "EVn50", "em2Text": "Cdc25c", "label": "CPR:4"}, {"em1Text": "VB1", "em2Text": "Cdc25c", "label": "CPR:4"}]}
{"sentText": "Treatment with EVn50 or VB1 resulted in arresting the MDAMB435 and SMMC7721 cells at G2M phase which was further supported by observations of increased phosphorylation of Histone 3 at Ser10 phosphorylation of Cdk1 at Tyr15 expression of cyclin B1 and decreased expression of Cdc25c", "relationMentions": [{"em1Text": "EVn50", "em2Text": "Histone 3", "label": "CPR:3"}, {"em1Text": "EVn50", "em2Text": "Cdk1", "label": "CPR:3"}, {"em1Text": "EVn50", "em2Text": "cyclin B1", "label": "CPR:3"}, {"em1Text": "VB1", "em2Text": "Histone 3", "label": "CPR:3"}, {"em1Text": "VB1", "em2Text": "Cdk1", "label": "CPR:3"}, {"em1Text": "VB1", "em2Text": "cyclin B1", "label": "CPR:3"}, {"em1Text": "EVn50", "em2Text": "Cdc25c", "label": "CPR:4"}, {"em1Text": "VB1", "em2Text": "Cdc25c", "label": "CPR:4"}]}
{"sentText": "Xanthohumol and 2hydroxychalcone induced apoptosis by Bcl2 downregulation", "relationMentions": [{"em1Text": "Xanthohumol", "em2Text": "Bcl2", "label": "CPR:4"}, {"em1Text": "2hydroxychalcone", "em2Text": "Bcl2", "label": "CPR:4"}]}
{"sentText": "Importantly 2hydroxychalcone and xanthohumol exerted more potent inhibitory effects on the proliferation MMP9 expression and invasive phenotype of MDAMB231 than chalcone", "relationMentions": [{"em1Text": "2hydroxychalcone", "em2Text": "MMP9", "label": "CPR:4"}, {"em1Text": "xanthohumol", "em2Text": "MMP9", "label": "CPR:4"}]}
{"sentText": "dAmino acid oxidase DAAO catalyzes the oxidation of damino acids including dserine a coagonist of the Nmethyldaspartate receptor", "relationMentions": [{"em1Text": "dserine", "em2Text": "Nmethyldaspartate receptor", "label": "CPR:5"}, {"em1Text": "dAmino acid oxidase", "em2Text": "dserine", "label": "CPR:9"}, {"em1Text": "DAAO", "em2Text": "dserine", "label": "CPR:9"}, {"em1Text": "dAmino acid oxidase", "em2Text": "damino acids", "label": "CPR:9"}, {"em1Text": "DAAO", "em2Text": "damino acids", "label": "CPR:9"}]}
{"sentText": "dAmino acid oxidase DAAO catalyzes the oxidation of damino acids including dserine a coagonist of the Nmethyldaspartate receptor", "relationMentions": [{"em1Text": "dserine", "em2Text": "Nmethyldaspartate receptor", "label": "CPR:5"}, {"em1Text": "dAmino acid oxidase", "em2Text": "dserine", "label": "CPR:9"}, {"em1Text": "DAAO", "em2Text": "dserine", "label": "CPR:9"}, {"em1Text": "dAmino acid oxidase", "em2Text": "damino acids", "label": "CPR:9"}, {"em1Text": "DAAO", "em2Text": "damino acids", "label": "CPR:9"}]}
{"sentText": "Among 12 parabens with linear alkyl chains ranging in length from C1 to C12 heptylparaben C7 and pentylparaben C5 showed the most potent ER\u03b1 and ER\u03b2 agonistic activity in the order of 107M and 108M respectively and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12", "relationMentions": [{"em1Text": "heptylparaben", "em2Text": "ER\u03b1", "label": "CPR:5"}, {"em1Text": "heptylparaben", "em2Text": "ER\u03b2", "label": "CPR:5"}, {"em1Text": "pentylparaben", "em2Text": "ER\u03b1", "label": "CPR:5"}, {"em1Text": "pentylparaben", "em2Text": "ER\u03b2", "label": "CPR:5"}, {"em1Text": "parabens", "em2Text": "ER\u03b1", "label": "CPR:5"}, {"em1Text": "parabens", "em2Text": "ER\u03b2", "label": "CPR:5"}, {"em1Text": "alkyl", "em2Text": "ER\u03b1", "label": "CPR:5"}, {"em1Text": "alkyl", "em2Text": "ER\u03b2", "label": "CPR:5"}]}
{"sentText": "Among 12 parabens with linear alkyl chains ranging in length from C1 to C12 heptylparaben C7 and pentylparaben C5 showed the most potent ER\u03b1 and ER\u03b2 agonistic activity in the order of 107M and 108M respectively and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12", "relationMentions": [{"em1Text": "heptylparaben", "em2Text": "ER\u03b1", "label": "CPR:5"}, {"em1Text": "heptylparaben", "em2Text": "ER\u03b2", "label": "CPR:5"}, {"em1Text": "pentylparaben", "em2Text": "ER\u03b1", "label": "CPR:5"}, {"em1Text": "pentylparaben", "em2Text": "ER\u03b2", "label": "CPR:5"}, {"em1Text": "parabens", "em2Text": "ER\u03b1", "label": "CPR:5"}, {"em1Text": "parabens", "em2Text": "ER\u03b2", "label": "CPR:5"}, {"em1Text": "alkyl", "em2Text": "ER\u03b1", "label": "CPR:5"}, {"em1Text": "alkyl", "em2Text": "ER\u03b2", "label": "CPR:5"}]}
{"sentText": "Most parabens showing estrogenic activity exhibited ER\u03b2 agonistic activity at lower concentrations than those inducing ER\u03b1 agonistic activity", "relationMentions": [{"em1Text": "parabens", "em2Text": "ER\u03b2", "label": "CPR:5"}, {"em1Text": "parabens", "em2Text": "ER\u03b1", "label": "CPR:5"}]}
{"sentText": "These results indicate that parabens are selective agonists for ER\u03b2 over ER\u03b1 their interactions with ER\u03b1\u03b2 are dependent on the size and bulkiness of the alkyl groups and they are metabolized by carboxylesterases leading to attenuation of their estrogenic activity", "relationMentions": [{"em1Text": "parabens", "em2Text": "ER\u03b2", "label": "CPR:5"}, {"em1Text": "parabens", "em2Text": "ER\u03b1", "label": "CPR:5"}, {"em1Text": "parabens", "em2Text": "carboxylesterases", "label": "CPR:9"}]}
{"sentText": "Fourteen of 17 parabens exhibited hER\u03b1 andor hER\u03b2 agonistic activity at concentrations of \u2a7d1\u00d7105M whereas none of the 17 parabens showed AR agonistic or antagonistic activity", "relationMentions": [{"em1Text": "parabens", "em2Text": "hER\u03b1", "label": "CPR:5"}, {"em1Text": "parabens", "em2Text": "hER\u03b2", "label": "CPR:5"}]}
{"sentText": "Wattakaka volubilis steroidal glycoside mixture WVSM and PPG 150\u03bcM significantly inhibited the COX2 and iNOS enzymes resulting in low levels of PGE2 and NO in LPSinduced RAW 2647 macrophage cells", "relationMentions": [{"em1Text": "steroidal glycoside", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "steroidal glycoside", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "PPG", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "PPG", "em2Text": "iNOS", "label": "CPR:4"}]}
{"sentText": "Wattakaka volubilis steroidal glycoside mixture WVSM and PPG 150\u03bcM significantly inhibited the COX2 and iNOS enzymes resulting in low levels of PGE2 and NO in LPSinduced RAW 2647 macrophage cells", "relationMentions": [{"em1Text": "steroidal glycoside", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "steroidal glycoside", "em2Text": "iNOS", "label": "CPR:4"}, {"em1Text": "PPG", "em2Text": "COX2", "label": "CPR:4"}, {"em1Text": "PPG", "em2Text": "iNOS", "label": "CPR:4"}]}
{"sentText": "Our data showed that chronic ethanol overactivated CYP2E1 but suppressed HO1 with concurrent hepatic oxidative damage which was partially normalized by quercetin 100mgkgbw", "relationMentions": [{"em1Text": "ethanol", "em2Text": "CYP2E1", "label": "CPR:3"}, {"em1Text": "ethanol", "em2Text": "HO1", "label": "CPR:4"}]}
{"sentText": "Ethanol stimulated 100mM CYP2E1 upregulation was suppressed by quercetin but further enhanced by HO1 inhibition with resultant heme accumulation", "relationMentions": [{"em1Text": "Ethanol", "em2Text": "CYP2E1", "label": "CPR:3"}, {"em1Text": "Ethanol", "em2Text": "HO1", "label": "CPR:4"}, {"em1Text": "CYP2E1", "em2Text": "quercetin", "label": "CPR:4"}, {"em1Text": "HO1", "em2Text": "heme", "label": "CPR:9"}]}
{"sentText": "Furthermore we detected that ICI treatment induced glycogen synthase kinase Gsk3\u03b2 Ser 9 phosphorylation which correlates with cyclin D1 nuclear localization", "relationMentions": [{"em1Text": "ICI", "em2Text": "glycogen synthase kinase", "label": "CPR:3"}, {"em1Text": "ICI", "em2Text": "Gsk3\u03b2", "label": "CPR:3"}]}
{"sentText": "Agonistic activity of ICI 182 780 on activation of GSK 3\u03b2 AKT pathway in the rat uterus during the estrous cycle", "relationMentions": [{"em1Text": "ICI 182 780", "em2Text": "AKT", "label": "CPR:3"}, {"em1Text": "ICI 182 780", "em2Text": "GSK 3\u03b2", "label": "CPR:5"}]}
{"sentText": "Both ICI treatments induced a significant decrease p001 in uterine estrogen receptor alpha ER\u03b1 content had no effect on uterine progesterone receptor PR protein expression and caused marked nuclear localization of cyclin D1 in both luminal and glandular uterine epithelium as compared to vehicletreated animals", "relationMentions": [{"em1Text": "ICI", "em2Text": "estrogen receptor alpha", "label": "CPR:4"}, {"em1Text": "ICI", "em2Text": "ER\u03b1", "label": "CPR:4"}]}
{"sentText": "Aminopropylindenes derived from Grundmanns ketone as a novel chemotype of oxidosqualene cyclase inhibitors", "relationMentions": [{"em1Text": "Aminopropylindenes", "em2Text": "oxidosqualene cyclase", "label": "CPR:4"}, {"em1Text": "Grundmanns ketone", "em2Text": "oxidosqualene cyclase", "label": "CPR:4"}]}
{"sentText": "A series of aminopropylindenes designed as mimics of a cationic high energy intermediate in the oxidosqualene cyclase1 OSC mediated cyclization of 23oxidosqualen to lanosterol was prepared from Grundmanns ketone", "relationMentions": [{"em1Text": "OSC", "em2Text": "23oxidosqualen", "label": "CPR:9"}, {"em1Text": "oxidosqualene cyclase1", "em2Text": "23oxidosqualen", "label": "CPR:9"}, {"em1Text": "OSC", "em2Text": "lanosterol", "label": "CPR:9"}, {"em1Text": "oxidosqualene cyclase1", "em2Text": "lanosterol", "label": "CPR:9"}]}
{"sentText": "A series of aminopropylindenes designed as mimics of a cationic high energy intermediate in the oxidosqualene cyclase1 OSC mediated cyclization of 23oxidosqualen to lanosterol was prepared from Grundmanns ketone", "relationMentions": [{"em1Text": "OSC", "em2Text": "23oxidosqualen", "label": "CPR:9"}, {"em1Text": "oxidosqualene cyclase1", "em2Text": "23oxidosqualen", "label": "CPR:9"}, {"em1Text": "OSC", "em2Text": "lanosterol", "label": "CPR:9"}, {"em1Text": "oxidosqualene cyclase1", "em2Text": "lanosterol", "label": "CPR:9"}]}
{"sentText": "Consistent with two glucose uptake pathways induced uptake of 2NBDG a fluorescent glucose derivative was decreased by inhibition of HCs or glucose transporter GLUT4 and blocked by dual blockade", "relationMentions": [{"em1Text": "glucose", "em2Text": "glucose transporter", "label": "CPR:9"}, {"em1Text": "glucose", "em2Text": "GLUT4", "label": "CPR:9"}, {"em1Text": "2NBDG", "em2Text": "glucose transporter", "label": "CPR:9"}, {"em1Text": "2NBDG", "em2Text": "GLUT4", "label": "CPR:9"}]}
{"sentText": "Consistent with two glucose uptake pathways induced uptake of 2NBDG a fluorescent glucose derivative was decreased by inhibition of HCs or glucose transporter GLUT4 and blocked by dual blockade", "relationMentions": [{"em1Text": "glucose", "em2Text": "glucose transporter", "label": "CPR:9"}, {"em1Text": "glucose", "em2Text": "GLUT4", "label": "CPR:9"}, {"em1Text": "2NBDG", "em2Text": "glucose transporter", "label": "CPR:9"}, {"em1Text": "2NBDG", "em2Text": "GLUT4", "label": "CPR:9"}]}
{"sentText": "Opening of Panx1 HCs during repetitive activation allows efflux of ATP influx of glucose and possibly Ca2 too which are required for potentiation of contraction", "relationMentions": [{"em1Text": "Panx1", "em2Text": "ATP", "label": "CPR:9"}, {"em1Text": "Panx1", "em2Text": "glucose", "label": "CPR:9"}, {"em1Text": "Panx1", "em2Text": "Ca2", "label": "CPR:9"}]}
{"sentText": "When dual angiogenic growth factors GFs such as plateletderived GF PDGF and vascular endothelial GF VEGF are encapsulated separately in the core and shell domains respectively the VEGF release rate is much greater than that of PDGF and the difference of the cumulative release percentage between the two GFs is about 30 on day 7 with LMW core PLGA and more than 45 with HMW core PLGA", "relationMentions": [{"em1Text": "VEGF", "em2Text": "PLGA", "label": "CPR:3"}, {"em1Text": "PDGF", "em2Text": "PLGA", "label": "CPR:3"}]}
{"sentText": "Potency switch between CHK1 and MK2 Discovery of imidazo12apyrazine and imidazo12cpyrimidine based kinase inhibitors", "relationMentions": [{"em1Text": "MK2", "em2Text": "imidazo12apyrazine", "label": "CPR:4"}, {"em1Text": "imidazo12apyrazine", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "CHK1", "em2Text": "imidazo12apyrazine", "label": "CPR:4"}, {"em1Text": "MK2", "em2Text": "imidazo12cpyrimidine", "label": "CPR:4"}, {"em1Text": "imidazo12cpyrimidine", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "CHK1", "em2Text": "imidazo12cpyrimidine", "label": "CPR:4"}]}
{"sentText": "Potency switch between CHK1 and MK2 Discovery of imidazo12apyrazine and imidazo12cpyrimidine based kinase inhibitors", "relationMentions": [{"em1Text": "MK2", "em2Text": "imidazo12apyrazine", "label": "CPR:4"}, {"em1Text": "imidazo12apyrazine", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "CHK1", "em2Text": "imidazo12apyrazine", "label": "CPR:4"}, {"em1Text": "MK2", "em2Text": "imidazo12cpyrimidine", "label": "CPR:4"}, {"em1Text": "imidazo12cpyrimidine", "em2Text": "kinase", "label": "CPR:4"}, {"em1Text": "CHK1", "em2Text": "imidazo12cpyrimidine", "label": "CPR:4"}]}
{"sentText": "A series of structurally novel aryl ureas was derived from optimization of the HTS lead as selective histamine H3 receptor H3R antagonists", "relationMentions": [{"em1Text": "aryl ureas", "em2Text": "histamine H3 receptor", "label": "CPR:6"}, {"em1Text": "aryl ureas", "em2Text": "H3R", "label": "CPR:6"}]}
{"sentText": "Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity Part I", "relationMentions": [{"em1Text": "aryl ureas", "em2Text": "histamine H3 receptor", "label": "CPR:6"}, {"em1Text": "aryl amides", "em2Text": "histamine H3 receptor", "label": "CPR:6"}]}
{"sentText": "In terms of the mechanisms we found that fatty acid amide hydrolase FAAH which degrades anandamide was upregulated after nerve injury at both ages so that this upregulation likely did not account for the agedependent differences", "relationMentions": [{"em1Text": "FAAH", "em2Text": "anandamide", "label": "CPR:9"}, {"em1Text": "fatty acid amide hydrolase", "em2Text": "anandamide", "label": "CPR:9"}]}
{"sentText": "However enzymes contributing to oxidative metabolism of anandamide namely cyclooxygenase1 and Cyp2D6 were increased in the brain of aged mice possibly enhancing the oxidative breakdown of anandamide", "relationMentions": [{"em1Text": "anandamide", "em2Text": "cyclooxygenase1", "label": "CPR:9"}, {"em1Text": "anandamide", "em2Text": "Cyp2D6", "label": "CPR:9"}]}
{"sentText": "The expression of ABCA1 and ABCG1 was induced by 24OHC as well as TO901317 and retinoic acid which are ligands of the nuclear receptors LXRRXR", "relationMentions": [{"em1Text": "ABCA1", "em2Text": "retinoic acid", "label": "CPR:3"}, {"em1Text": "ABCG1", "em2Text": "retinoic acid", "label": "CPR:3"}, {"em1Text": "ABCA1", "em2Text": "24OHC", "label": "CPR:3"}, {"em1Text": "ABCG1", "em2Text": "24OHC", "label": "CPR:3"}, {"em1Text": "ABCA1", "em2Text": "TO901317", "label": "CPR:3"}, {"em1Text": "ABCG1", "em2Text": "TO901317", "label": "CPR:3"}]}
{"sentText": "The expression of ABCA1 and ABCG1 was induced by 24OHC as well as TO901317 and retinoic acid which are ligands of the nuclear receptors LXRRXR", "relationMentions": [{"em1Text": "ABCA1", "em2Text": "retinoic acid", "label": "CPR:3"}, {"em1Text": "ABCG1", "em2Text": "retinoic acid", "label": "CPR:3"}, {"em1Text": "ABCA1", "em2Text": "24OHC", "label": "CPR:3"}, {"em1Text": "ABCG1", "em2Text": "24OHC", "label": "CPR:3"}, {"em1Text": "ABCA1", "em2Text": "TO901317", "label": "CPR:3"}, {"em1Text": "ABCG1", "em2Text": "TO901317", "label": "CPR:3"}]}
{"sentText": "To confirm the role of each transporter we analyzed HEK293 cells stably expressing human ABCA1 or ABCG1 we clearly observed 24OHC efflux in the presence of HDL whereas efflux in the presence of apolipoprotein AI was marginal", "relationMentions": [{"em1Text": "human ABCA1", "em2Text": "24OHC", "label": "CPR:9"}, {"em1Text": "ABCG1", "em2Text": "24OHC", "label": "CPR:9"}]}
{"sentText": "Because 24Shydroxycholesterol 24OHC produced by 24hydroxylase induces apoptosis of neuronal cells it is vital to eliminate it rapidly from cells", "relationMentions": [{"em1Text": "24Shydroxycholesterol", "em2Text": "24hydroxylase", "label": "CPR:9"}, {"em1Text": "24OHC", "em2Text": "24hydroxylase", "label": "CPR:9"}]}
{"sentText": "The selective CaMKII\u03b1 inhibitor KN62 reversed the blockade produced by ionomycin and Kdepolarization", "relationMentions": [{"em1Text": "CaMKII\u03b1", "em2Text": "KN62", "label": "CPR:4"}, {"em1Text": "CaMKII\u03b1", "em2Text": "ionomycin", "label": "CPR:4"}]}
{"sentText": "The Bcl2 Bax ratio increased and Mfn2 expression decreased in MIN6 cells after glucose stimulation", "relationMentions": [{"em1Text": "Bcl2", "em2Text": "glucose", "label": "CPR:3"}, {"em1Text": "Bax", "em2Text": "glucose", "label": "CPR:3"}, {"em1Text": "Mfn2", "em2Text": "glucose", "label": "CPR:4"}]}
{"sentText": "Additionally treatment with glucose iron showed a higher HO activity", "relationMentions": [{"em1Text": "glucose", "em2Text": "HO", "label": "CPR:3"}, {"em1Text": "iron", "em2Text": "HO", "label": "CPR:3"}]}
{"sentText": "Our study revealed that high glucose Fe concentrations in MIN6 cells induced an increase of the Bcl2 Bax ratio an indicator of increased cell apoptosis", "relationMentions": [{"em1Text": "glucose", "em2Text": "Bcl2", "label": "CPR:3"}, {"em1Text": "glucose", "em2Text": "Bax", "label": "CPR:3"}, {"em1Text": "Fe", "em2Text": "Bcl2", "label": "CPR:3"}, {"em1Text": "Fe", "em2Text": "Bax", "label": "CPR:3"}]}
{"sentText": "Our study revealed that high glucose Fe concentrations in MIN6 cells induced an increase of the Bcl2 Bax ratio an indicator of increased cell apoptosis", "relationMentions": [{"em1Text": "glucose", "em2Text": "Bcl2", "label": "CPR:3"}, {"em1Text": "glucose", "em2Text": "Bax", "label": "CPR:3"}, {"em1Text": "Fe", "em2Text": "Bcl2", "label": "CPR:3"}, {"em1Text": "Fe", "em2Text": "Bax", "label": "CPR:3"}]}
{"sentText": "Targeted disruption of the gene encoding the Nglycosyltransferase prlH abolished pyralomicin production and recombinant expression of PrlA confirms the activity of this enzyme as a sugar phosphate cyclase involved in the formation of the C7 cyclitol moiety", "relationMentions": [{"em1Text": "Nglycosyltransferase", "em2Text": "pyralomicin", "label": "CPR:9"}, {"em1Text": "prlH", "em2Text": "pyralomicin", "label": "CPR:9"}, {"em1Text": "PrlA", "em2Text": "C7", "label": "CPR:9"}, {"em1Text": "sugar phosphate cyclase", "em2Text": "C7", "label": "CPR:9"}, {"em1Text": "PrlA", "em2Text": "cyclitol", "label": "CPR:9"}, {"em1Text": "sugar phosphate cyclase", "em2Text": "cyclitol", "label": "CPR:9"}]}
{"sentText": "Targeted disruption of the gene encoding the Nglycosyltransferase prlH abolished pyralomicin production and recombinant expression of PrlA confirms the activity of this enzyme as a sugar phosphate cyclase involved in the formation of the C7 cyclitol moiety", "relationMentions": [{"em1Text": "Nglycosyltransferase", "em2Text": "pyralomicin", "label": "CPR:9"}, {"em1Text": "prlH", "em2Text": "pyralomicin", "label": "CPR:9"}, {"em1Text": "PrlA", "em2Text": "C7", "label": "CPR:9"}, {"em1Text": "sugar phosphate cyclase", "em2Text": "C7", "label": "CPR:9"}, {"em1Text": "PrlA", "em2Text": "cyclitol", "label": "CPR:9"}, {"em1Text": "sugar phosphate cyclase", "em2Text": "cyclitol", "label": "CPR:9"}]}
{"sentText": "This includes nonribosomal peptide synthetases NRPS and polyketide synthases PKS required for the formation of the benzopyranopyrrole core unit as well as a suite of tailoring enzymes eg four halogenases an Omethyltransferase and an Nglycosyltransferase necessary for further modifications of the core structure", "relationMentions": [{"em1Text": "nonribosomal peptide synthetases", "em2Text": "benzopyranopyrrole", "label": "CPR:9"}, {"em1Text": "NRPS", "em2Text": "benzopyranopyrrole", "label": "CPR:9"}, {"em1Text": "polyketide synthases", "em2Text": "benzopyranopyrrole", "label": "CPR:9"}, {"em1Text": "PKS", "em2Text": "benzopyranopyrrole", "label": "CPR:9"}, {"em1Text": "benzopyranopyrrole", "em2Text": "halogenases", "label": "CPR:9"}, {"em1Text": "benzopyranopyrrole", "em2Text": "Omethyltransferase", "label": "CPR:9"}, {"em1Text": "benzopyranopyrrole", "em2Text": "Nglycosyltransferase", "label": "CPR:9"}]}
{"sentText": "This includes nonribosomal peptide synthetases NRPS and polyketide synthases PKS required for the formation of the benzopyranopyrrole core unit as well as a suite of tailoring enzymes eg four halogenases an Omethyltransferase and an Nglycosyltransferase necessary for further modifications of the core structure", "relationMentions": [{"em1Text": "nonribosomal peptide synthetases", "em2Text": "benzopyranopyrrole", "label": "CPR:9"}, {"em1Text": "NRPS", "em2Text": "benzopyranopyrrole", "label": "CPR:9"}, {"em1Text": "polyketide synthases", "em2Text": "benzopyranopyrrole", "label": "CPR:9"}, {"em1Text": "PKS", "em2Text": "benzopyranopyrrole", "label": "CPR:9"}, {"em1Text": "benzopyranopyrrole", "em2Text": "halogenases", "label": "CPR:9"}, {"em1Text": "benzopyranopyrrole", "em2Text": "Omethyltransferase", "label": "CPR:9"}, {"em1Text": "benzopyranopyrrole", "em2Text": "Nglycosyltransferase", "label": "CPR:9"}]}
{"sentText": "The current study examined the bioactivation potential of ghrelin receptor inverse agonists 122chloro42H123triazol2ylbenzyl27diazaspiro35nonan7yl2imidazo21bthiazol6ylethanone 1 and 122chloro42H123triazol2ylbenzyl27diazaspiro35nonan7yl22methylimidazo21bthiazol6ylethanone 2 containing a fused imidazo21bthiazole motif in the core structure", "relationMentions": [{"em1Text": "ghrelin receptor", "em2Text": "122chloro42H123triazol2ylbenzyl27diazaspiro35nonan7yl22methylimidazo21bthiazol6ylethanone", "label": "CPR:5"}, {"em1Text": "ghrelin receptor", "em2Text": "imidazo21bthiazole", "label": "CPR:5"}, {"em1Text": "ghrelin receptor", "em2Text": "122chloro42H123triazol2ylbenzyl27diazaspiro35nonan7yl2imidazo21bthiazol6ylethanone", "label": "CPR:5"}]}
{"sentText": "In the current study we show that systematic modification of an aminoalkylindole scaffold identifies two new compounds with dual CB1R antagonist CB2R agonist activity", "relationMentions": [{"em1Text": "aminoalkylindole", "em2Text": "CB2R", "label": "CPR:5"}, {"em1Text": "aminoalkylindole", "em2Text": "CB1R", "label": "CPR:6"}]}
{"sentText": "Collectively these initial findings suggest that design and systematic modification of aminoalkylindoles such as 3 may lead to development of novel cannabinoid ligands with dual CB1R antagonist CB2R agonist activity with potential for use as treatments of alcohol abuse", "relationMentions": [{"em1Text": "aminoalkylindoles", "em2Text": "CB2R", "label": "CPR:5"}, {"em1Text": "aminoalkylindoles", "em2Text": "CB1R", "label": "CPR:6"}]}
{"sentText": "We have recently reported that a monohydroxylated metabolite of the synthetic aminoalkylindole cannabinoid JHW073 3 exhibits neutral antagonist activity at CB1Rs and thus may serve as a promising lead for the development of novel alcohol abuse therapies", "relationMentions": [{"em1Text": "aminoalkylindole", "em2Text": "CB1Rs", "label": "CPR:6"}, {"em1Text": "JHW073", "em2Text": "CB1Rs", "label": "CPR:6"}]}
{"sentText": "Protein levels of the glucose transporter GLUT4 involved in glucose transport via these two pathways were also increased", "relationMentions": [{"em1Text": "glucose", "em2Text": "glucose transporter", "label": "CPR:9"}, {"em1Text": "glucose", "em2Text": "GLUT4", "label": "CPR:9"}]}
{"sentText": "Puerarin stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG63 cells via ERdependent MEK ERK and PI3K Akt activation", "relationMentions": [{"em1Text": "Puerarin", "em2Text": "MEK", "label": "CPR:3"}, {"em1Text": "Puerarin", "em2Text": "ERK", "label": "CPR:3"}, {"em1Text": "Puerarin", "em2Text": "PI3K", "label": "CPR:3"}, {"em1Text": "Puerarin", "em2Text": "Akt", "label": "CPR:3"}]}
{"sentText": "Moreover we also demonstrate that puerarin functions at least partially through activation of MEK ERK and PI3K Akt signaling", "relationMentions": [{"em1Text": "puerarin", "em2Text": "MEK", "label": "CPR:3"}, {"em1Text": "puerarin", "em2Text": "ERK", "label": "CPR:3"}, {"em1Text": "puerarin", "em2Text": "PI3K", "label": "CPR:3"}, {"em1Text": "puerarin", "em2Text": "Akt", "label": "CPR:3"}]}
{"sentText": "RESULTS Pretreatment of ucOC 30ngml prevented LAinduced apoptosis in insulinstimulated endothelial cells effects were abolished by pretreatment with the phosphatidylinositol 3kinase PI3kinase inhibitor wortmannin", "relationMentions": [{"em1Text": "phosphatidylinositol 3kinase", "em2Text": "wortmannin", "label": "CPR:4"}, {"em1Text": "PI3kinase", "em2Text": "wortmannin", "label": "CPR:4"}]}
{"sentText": "The involvement of the various DA receptor subtypes in the motor effects of NOFQ and NOP receptor antagonists was evaluated pharmacologically using D1 D5 SCH23390 D2D3 raclopride amisulpride and D3 S33084 receptor antagonists and by using D2 receptor knockout mice", "relationMentions": [{"em1Text": "D1", "em2Text": "SCH23390", "label": "CPR:6"}, {"em1Text": "D5", "em2Text": "SCH23390", "label": "CPR:6"}, {"em1Text": "D2", "em2Text": "raclopride", "label": "CPR:6"}, {"em1Text": "D3", "em2Text": "raclopride", "label": "CPR:6"}, {"em1Text": "D2", "em2Text": "amisulpride", "label": "CPR:6"}, {"em1Text": "D3", "em2Text": "amisulpride", "label": "CPR:6"}, {"em1Text": "D3", "em2Text": "S33084", "label": "CPR:6"}]}
{"sentText": "The involvement of the various DA receptor subtypes in the motor effects of NOFQ and NOP receptor antagonists was evaluated pharmacologically using D1 D5 SCH23390 D2D3 raclopride amisulpride and D3 S33084 receptor antagonists and by using D2 receptor knockout mice", "relationMentions": [{"em1Text": "D1", "em2Text": "SCH23390", "label": "CPR:6"}, {"em1Text": "D5", "em2Text": "SCH23390", "label": "CPR:6"}, {"em1Text": "D2", "em2Text": "raclopride", "label": "CPR:6"}, {"em1Text": "D3", "em2Text": "raclopride", "label": "CPR:6"}, {"em1Text": "D2", "em2Text": "amisulpride", "label": "CPR:6"}, {"em1Text": "D3", "em2Text": "amisulpride", "label": "CPR:6"}, {"em1Text": "D3", "em2Text": "S33084", "label": "CPR:6"}]}
{"sentText": "Haloperidol promotes mTORC1dependent phosphorylation of ribosomal protein S6 via dopamine and cAMPregulated phosphoprotein of 32 kDa and inhibition of protein phosphatase1", "relationMentions": [{"em1Text": "Haloperidol", "em2Text": "ribosomal protein S6", "label": "CPR:3"}, {"em1Text": "Haloperidol", "em2Text": "protein phosphatase1", "label": "CPR:4"}]}
{"sentText": "This effect was prevented by rapamycin an inhibitor of the mammalian target of rapamycin complex 1 mTORC1 or by PF470867 a selective inhibitor of the p70 ribosomal S6 kinase 1 S6K1", "relationMentions": [{"em1Text": "rapamycin", "em2Text": "mammalian target of rapamycin complex 1", "label": "CPR:4"}, {"em1Text": "rapamycin", "em2Text": "mTORC1", "label": "CPR:4"}, {"em1Text": "PF470867", "em2Text": "p70 ribosomal S6 kinase 1", "label": "CPR:4"}, {"em1Text": "PF470867", "em2Text": "S6K1", "label": "CPR:4"}]}
{"sentText": "In line with this observation incubation of striatal slices with okadaic acid and calyculin A two inhibitors of PP1 increased Ser240244 phosphorylation", "relationMentions": [{"em1Text": "okadaic acid", "em2Text": "PP1", "label": "CPR:4"}, {"em1Text": "calyculin A", "em2Text": "PP1", "label": "CPR:4"}]}
{"sentText": "Rats intoxicated with Cd for 30 days significantly increased tissue malondialdehyde MDA levels and significantly decreased enzymatic antioxidants superoxide dismutase glutathione peroxidase and catalase in the frontal cortex tissue", "relationMentions": [{"em1Text": "Cd", "em2Text": "superoxide dismutase", "label": "CPR:4"}, {"em1Text": "Cd", "em2Text": "glutathione peroxidase", "label": "CPR:4"}, {"em1Text": "Cd", "em2Text": "catalase", "label": "CPR:4"}]}
{"sentText": "Simvastatin and lovastatin metabolized through CYP3A have the highest potency for drugdrug interaction with potent CYP3A inhibitors such as ritonavir or cobicistat boosted HIVPI or the hepatitis C virus HCV PI telaprevir or boceprevir and therefore their coadministration is contraindicated", "relationMentions": [{"em1Text": "CYP3A", "em2Text": "boceprevir", "label": "CPR:4"}, {"em1Text": "CYP3A", "em2Text": "ritonavir", "label": "CPR:4"}, {"em1Text": "CYP3A", "em2Text": "cobicistat", "label": "CPR:4"}, {"em1Text": "CYP3A", "em2Text": "telaprevir", "label": "CPR:4"}, {"em1Text": "Simvastatin", "em2Text": "CYP3A", "label": "CPR:9"}, {"em1Text": "lovastatin", "em2Text": "CYP3A", "label": "CPR:9"}]}
{"sentText": "Simvastatin and lovastatin metabolized through CYP3A have the highest potency for drugdrug interaction with potent CYP3A inhibitors such as ritonavir or cobicistat boosted HIVPI or the hepatitis C virus HCV PI telaprevir or boceprevir and therefore their coadministration is contraindicated", "relationMentions": [{"em1Text": "CYP3A", "em2Text": "boceprevir", "label": "CPR:4"}, {"em1Text": "CYP3A", "em2Text": "ritonavir", "label": "CPR:4"}, {"em1Text": "CYP3A", "em2Text": "cobicistat", "label": "CPR:4"}, {"em1Text": "CYP3A", "em2Text": "telaprevir", "label": "CPR:4"}, {"em1Text": "Simvastatin", "em2Text": "CYP3A", "label": "CPR:9"}, {"em1Text": "lovastatin", "em2Text": "CYP3A", "label": "CPR:9"}]}
{"sentText": "The HCVPIs boceprevir and telaprevir are both to different extents inhibitors of CYP3A", "relationMentions": [{"em1Text": "boceprevir", "em2Text": "CYP3A", "label": "CPR:4"}, {"em1Text": "telaprevir", "em2Text": "CYP3A", "label": "CPR:4"}]}
{"sentText": "Drugdrug interactions are dependent on statins pharmacokinetic profile simvastatin lovastatin and atorvastatin are metabolized through cytochrome P450 CYP 3A while the metabolism of the other statins is independent of this CYP", "relationMentions": [{"em1Text": "simvastatin", "em2Text": "cytochrome P450 CYP 3A", "label": "CPR:9"}, {"em1Text": "lovastatin", "em2Text": "cytochrome P450 CYP 3A", "label": "CPR:9"}, {"em1Text": "atorvastatin", "em2Text": "cytochrome P450 CYP 3A", "label": "CPR:9"}]}
{"sentText": "The limitation of SRF by diazepam was not prevented by inverse or partial agonists at the BDZ receptor including Ro 151788 and the beta CCs", "relationMentions": [{"em1Text": "BDZ receptor", "em2Text": "Ro 151788", "label": "CPR:5"}, {"em1Text": "BDZ receptor", "em2Text": "beta CCs", "label": "CPR:5"}]}
{"sentText": "In addition to effects on cell proliferation DHT increased the percentage of alkaline phosphatase ALP positive cells in all three bone cell systems tested and this effect was inhibited by antiandrogens", "relationMentions": [{"em1Text": "DHT", "em2Text": "alkaline phosphatase", "label": "CPR:3"}, {"em1Text": "DHT", "em2Text": "ALP", "label": "CPR:3"}]}
{"sentText": "We conclude that androgens can stimulate human and murine osteoblastic cell proliferation in vitro and induce expression of the osteoblastline differentiation marker ALP presumably by an androgen receptor mediated mechanism", "relationMentions": [{"em1Text": "androgens", "em2Text": "osteoblastline differentiation marker", "label": "CPR:3"}, {"em1Text": "androgens", "em2Text": "ALP", "label": "CPR:3"}]}
{"sentText": "Ibrutinib ImbruvicaR is a firstinclass potent orally administered covalent inhibitor of Brutons tyrosine kinase BTK that inhibits Bcell antigen receptor signalling downstream of BTK", "relationMentions": [{"em1Text": "Ibrutinib", "em2Text": "BTK", "label": "CPR:4"}, {"em1Text": "Ibrutinib", "em2Text": "Bcell antigen receptor", "label": "CPR:4"}, {"em1Text": "Ibrutinib", "em2Text": "Brutons tyrosine kinase", "label": "CPR:4"}, {"em1Text": "ImbruvicaR", "em2Text": "BTK", "label": "CPR:4"}, {"em1Text": "ImbruvicaR", "em2Text": "Bcell antigen receptor", "label": "CPR:4"}, {"em1Text": "ImbruvicaR", "em2Text": "Brutons tyrosine kinase", "label": "CPR:4"}]}
{"sentText": "Ibrutinib ImbruvicaR is a firstinclass potent orally administered covalent inhibitor of Brutons tyrosine kinase BTK that inhibits Bcell antigen receptor signalling downstream of BTK", "relationMentions": [{"em1Text": "Ibrutinib", "em2Text": "BTK", "label": "CPR:4"}, {"em1Text": "Ibrutinib", "em2Text": "Bcell antigen receptor", "label": "CPR:4"}, {"em1Text": "Ibrutinib", "em2Text": "Brutons tyrosine kinase", "label": "CPR:4"}, {"em1Text": "ImbruvicaR", "em2Text": "BTK", "label": "CPR:4"}, {"em1Text": "ImbruvicaR", "em2Text": "Bcell antigen receptor", "label": "CPR:4"}, {"em1Text": "ImbruvicaR", "em2Text": "Brutons tyrosine kinase", "label": "CPR:4"}]}
{"sentText": "To study the mechanism underlying this phenomenon the effects of the nonselective betaadrenoceptor antagonists propranolol no intrinsic sympathomimetic activity ISA alprenolol weak ISA and mepindolol strong ISA on lymphocyte beta 2adrenoceptor densityassessed by 125Iiodocyanopindolol ICYP bindingand plasma renin activity PRA were investigated in male healthy volunteers aged 2335 years", "relationMentions": [{"em1Text": "betaadrenoceptor", "em2Text": "propranolol", "label": "CPR:6"}, {"em1Text": "betaadrenoceptor", "em2Text": "alprenolol", "label": "CPR:6"}, {"em1Text": "betaadrenoceptor", "em2Text": "mepindolol", "label": "CPR:6"}]}
{"sentText": "Inhibition of 5lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5aminosalicylic acid", "relationMentions": [{"em1Text": "5lipoxygenase", "em2Text": "5aminosalicylic acid", "label": "CPR:4"}, {"em1Text": "5lipoxygenase", "em2Text": "sulfasalazine", "label": "CPR:4"}, {"em1Text": "5lipoxygenase", "em2Text": "arachidonic acid", "label": "CPR:9"}]}
{"sentText": "Interference with lipoxygenase enzymes rather than a steroid like inhibition of arachidonic acid release from intracellular phospholipids seems to be the mode of action", "relationMentions": [{"em1Text": "lipoxygenase", "em2Text": "steroid", "label": "CPR:4"}, {"em1Text": "lipoxygenase", "em2Text": "arachidonic acid", "label": "CPR:9"}]}
{"sentText": "In contrast serum alkaline phosphatase was elevated in animals dosed with 13cisRA or 4HPR but not in those dose with ROAc", "relationMentions": [{"em1Text": "alkaline phosphatase", "em2Text": "13cisRA", "label": "CPR:3"}, {"em1Text": "alkaline phosphatase", "em2Text": "4HPR", "label": "CPR:3"}]}
{"sentText": "The order of effect was 4HPR greater than ROAc greater than 13cisRA with increases in prothrombin times correlating with increases in hemorrhagic deaths", "relationMentions": [{"em1Text": "4HPR", "em2Text": "prothrombin", "label": "CPR:3"}, {"em1Text": "ROAc", "em2Text": "prothrombin", "label": "CPR:3"}, {"em1Text": "13cisRA", "em2Text": "prothrombin", "label": "CPR:3"}]}
{"sentText": "13cisRA and ROAc but not 4HPR caused a dosedependent reduction in plasma osteocalcin an effect that correlated with retinoidinduced bone effects", "relationMentions": [{"em1Text": "13cisRA", "em2Text": "osteocalcin", "label": "CPR:4"}, {"em1Text": "ROAc", "em2Text": "osteocalcin", "label": "CPR:4"}, {"em1Text": "4HPR", "em2Text": "osteocalcin", "label": "CPR:4"}]}
{"sentText": "In contrast to diethylcarbamazine piriprost U60257 69deepoxy69phenyliminodelta 68prostaglandin I1 which inhibits the formation of sulfidopeptide leuktrienes in RBL cells at the 5lipoxygenase step EC50 5 microM did not inhibit the leukotriene synthetase of these cells", "relationMentions": [{"em1Text": "diethylcarbamazine", "em2Text": "5lipoxygenase", "label": "CPR:4"}, {"em1Text": "diethylcarbamazine", "em2Text": "leukotriene synthetase", "label": "CPR:4"}, {"em1Text": "piriprost", "em2Text": "5lipoxygenase", "label": "CPR:4"}, {"em1Text": "U60257", "em2Text": "5lipoxygenase", "label": "CPR:4"}, {"em1Text": "69deepoxy69phenyliminodelta 68prostaglandin I1", "em2Text": "5lipoxygenase", "label": "CPR:4"}, {"em1Text": "sulfidopeptide leuktrienes", "em2Text": "5lipoxygenase", "label": "CPR:9"}]}
{"sentText": "In contrast to diethylcarbamazine piriprost U60257 69deepoxy69phenyliminodelta 68prostaglandin I1 which inhibits the formation of sulfidopeptide leuktrienes in RBL cells at the 5lipoxygenase step EC50 5 microM did not inhibit the leukotriene synthetase of these cells", "relationMentions": [{"em1Text": "diethylcarbamazine", "em2Text": "5lipoxygenase", "label": "CPR:4"}, {"em1Text": "diethylcarbamazine", "em2Text": "leukotriene synthetase", "label": "CPR:4"}, {"em1Text": "piriprost", "em2Text": "5lipoxygenase", "label": "CPR:4"}, {"em1Text": "U60257", "em2Text": "5lipoxygenase", "label": "CPR:4"}, {"em1Text": "69deepoxy69phenyliminodelta 68prostaglandin I1", "em2Text": "5lipoxygenase", "label": "CPR:4"}, {"em1Text": "sulfidopeptide leuktrienes", "em2Text": "5lipoxygenase", "label": "CPR:9"}]}
{"sentText": "Inhibition of the leukotriene synthetase of rat basophil leukemia cells by diethylcarbamazine and synergism between diethylcarbamazine and piriprost a 5lipoxygenase inhibitor", "relationMentions": [{"em1Text": "diethylcarbamazine", "em2Text": "5lipoxygenase", "label": "CPR:4"}, {"em1Text": "piriprost", "em2Text": "5lipoxygenase", "label": "CPR:4"}, {"em1Text": "leukotriene synthetase", "em2Text": "diethylcarbamazine", "label": "CPR:4"}]}
{"sentText": "Similar concentrations also inhibited the formation of leukotriene C4 LTC4 by LTC synthetase a detergentsolubilized cell free particulate enzyme from RBL cells which is capable of coupling LTA4 to glutathione", "relationMentions": [{"em1Text": "leukotriene C4", "em2Text": "LTC synthetase", "label": "CPR:9"}, {"em1Text": "LTC4", "em2Text": "LTC synthetase", "label": "CPR:9"}, {"em1Text": "LTC synthetase", "em2Text": "LTA4", "label": "CPR:9"}]}
{"sentText": "The test procedure was verified with respect to intestinal lactose hydrolysis by demonstrating a linear relationship between lactose lactulose excretion and log jejunal mucosal lactase activity by in vitro assay R2 = 095 in a further group of subjects", "relationMentions": [{"em1Text": "lactose", "em2Text": "lactase", "label": "CPR:9"}, {"em1Text": "lactulose", "em2Text": "lactase", "label": "CPR:9"}]}
{"sentText": "Differential lactose lactulose Lrhamnose absorption provides a noninvasive and sensitive index of small intestinal integrity of value for the interpretation of prolonged or otherwise complicated enteritis and the distinction of primary secondary intestinal lactase deficiency", "relationMentions": [{"em1Text": "lactose", "em2Text": "lactase", "label": "CPR:9"}, {"em1Text": "lactulose", "em2Text": "lactase", "label": "CPR:9"}, {"em1Text": "Lrhamnose", "em2Text": "lactase", "label": "CPR:9"}]}
{"sentText": "Xanthines are classical antagonists for adenosine receptors for many of their pharmacological actions may be due to blockade of adenosine receptors", "relationMentions": [{"em1Text": "Xanthines", "em2Text": "adenosine receptors", "label": "CPR:4"}, {"em1Text": "Xanthines", "em2Text": "adenosine receptors", "label": "CPR:6"}]}
{"sentText": "Xanthines are classical antagonists for adenosine receptors for many of their pharmacological actions may be due to blockade of adenosine receptors", "relationMentions": [{"em1Text": "Xanthines", "em2Text": "adenosine receptors", "label": "CPR:4"}, {"em1Text": "Xanthines", "em2Text": "adenosine receptors", "label": "CPR:6"}]}
{"sentText": "The inhibitory effect of gossypol and gossypol acetic acid upon testicular cytosolic LDHX was measured in vitro", "relationMentions": [{"em1Text": "gossypol", "em2Text": "LDHX", "label": "CPR:4"}, {"em1Text": "gossypol acetic acid", "em2Text": "LDHX", "label": "CPR:4"}]}
{"sentText": "Most reducing cofactors for the peroxidase protect PHS and prostacyclin synthase from inactivation by hydroperoxides", "relationMentions": [{"em1Text": "PHS", "em2Text": "hydroperoxides", "label": "CPR:4"}, {"em1Text": "prostacyclin synthase", "em2Text": "hydroperoxides", "label": "CPR:4"}]}
{"sentText": "Inactivation of prostaglandin H synthase and prostacyclin synthase by phenylbutazone", "relationMentions": [{"em1Text": "prostaglandin H synthase", "em2Text": "phenylbutazone", "label": "CPR:4"}, {"em1Text": "prostacyclin synthase", "em2Text": "phenylbutazone", "label": "CPR:4"}]}
{"sentText": "Staining was largely absent when substrate was omitted or after pretreatment with the irreversible SSAO inhibitor hydralazine and the slowly reversible inhibitor semicarbazide", "relationMentions": [{"em1Text": "SSAO", "em2Text": "hydralazine", "label": "CPR:4"}, {"em1Text": "SSAO", "em2Text": "semicarbazide", "label": "CPR:4"}]}
{"sentText": "Staining around the edges of the brown fat cells was observed with the SSAO substrates tyramine and benzylamine", "relationMentions": [{"em1Text": "SSAO", "em2Text": "tyramine", "label": "CPR:9"}, {"em1Text": "SSAO", "em2Text": "benzylamine", "label": "CPR:9"}]}
{"sentText": "This agent acts synergistically with many penicillins such as ampicillin carbenicillin and the like and with cephalosporins cefazolin cefamandole or cefoxitin to inhibit gramnegative bacilli probably on the basis of binding to different proteins needed for the production of the peptidoglycan of the bacterial cell wall", "relationMentions": [{"em1Text": "penicillins", "em2Text": "peptidoglycan", "label": "CPR:3"}, {"em1Text": "ampicillin", "em2Text": "peptidoglycan", "label": "CPR:3"}, {"em1Text": "carbenicillin", "em2Text": "peptidoglycan", "label": "CPR:3"}, {"em1Text": "cephalosporins", "em2Text": "peptidoglycan", "label": "CPR:3"}, {"em1Text": "cefazolin", "em2Text": "peptidoglycan", "label": "CPR:3"}, {"em1Text": "cefamandole", "em2Text": "peptidoglycan", "label": "CPR:3"}, {"em1Text": "cefoxitin", "em2Text": "peptidoglycan", "label": "CPR:3"}]}
{"sentText": "Since both TFP and W7 are potent inhibitors of calmodulin we investigated the possibility that inhibition of calmodulin was responsible for the loss of receptors", "relationMentions": [{"em1Text": "TFP", "em2Text": "calmodulin", "label": "CPR:4"}, {"em1Text": "W7", "em2Text": "calmodulin", "label": "CPR:4"}]}
{"sentText": "The binding of FHA HIS was inhibited on 3579 of the platelets by the histamine H1 receptor antagonists diphenhydramine and clemastine", "relationMentions": [{"em1Text": "FHA", "em2Text": "diphenhydramine", "label": "CPR:4"}, {"em1Text": "FHA", "em2Text": "clemastine", "label": "CPR:4"}, {"em1Text": "histamine H1 receptor", "em2Text": "diphenhydramine", "label": "CPR:6"}, {"em1Text": "histamine H1 receptor", "em2Text": "clemastine", "label": "CPR:6"}]}
{"sentText": "The binding of FHA HIS was inhibited on 3579 of the platelets by the histamine H1 receptor antagonists diphenhydramine and clemastine", "relationMentions": [{"em1Text": "FHA", "em2Text": "diphenhydramine", "label": "CPR:4"}, {"em1Text": "FHA", "em2Text": "clemastine", "label": "CPR:4"}, {"em1Text": "histamine H1 receptor", "em2Text": "diphenhydramine", "label": "CPR:6"}, {"em1Text": "histamine H1 receptor", "em2Text": "clemastine", "label": "CPR:6"}]}
{"sentText": "Triclosan inhibited both cyclooxygenase 1 and cyclooxygenase 2 with IC50 values of 43 microM and 227 microM respectively", "relationMentions": [{"em1Text": "Triclosan", "em2Text": "cyclooxygenase 1", "label": "CPR:4"}, {"em1Text": "Triclosan", "em2Text": "cyclooxygenase 2", "label": "CPR:4"}]}
{"sentText": "Hence triclosan has the ability to inhibit both the cyclooxygenase and lipoxygenase pathways of arachidonic acid metabolism with similar efficacy", "relationMentions": [{"em1Text": "triclosan", "em2Text": "cyclooxygenase", "label": "CPR:4"}, {"em1Text": "triclosan", "em2Text": "lipoxygenase", "label": "CPR:4"}, {"em1Text": "cyclooxygenase", "em2Text": "arachidonic acid", "label": "CPR:9"}, {"em1Text": "lipoxygenase", "em2Text": "arachidonic acid", "label": "CPR:9"}]}
{"sentText": "Hence triclosan has the ability to inhibit both the cyclooxygenase and lipoxygenase pathways of arachidonic acid metabolism with similar efficacy", "relationMentions": [{"em1Text": "triclosan", "em2Text": "cyclooxygenase", "label": "CPR:4"}, {"em1Text": "triclosan", "em2Text": "lipoxygenase", "label": "CPR:4"}, {"em1Text": "cyclooxygenase", "em2Text": "arachidonic acid", "label": "CPR:9"}, {"em1Text": "lipoxygenase", "em2Text": "arachidonic acid", "label": "CPR:9"}]}
{"sentText": "Cells propagated in medium containing N5methyltetrahydrofolate and homocysteine showed a substantial increase in MS activity which paralleled the increase in the intracellular concentration of MeCbl and the Cbl bound to the enzyme", "relationMentions": [{"em1Text": "N5methyltetrahydrofolate", "em2Text": "MS", "label": "CPR:3"}, {"em1Text": "homocysteine", "em2Text": "MS", "label": "CPR:3"}]}
{"sentText": "These findings suggest that some of the deleterious effects of consumption of endophyteinfected tall fescue which contains several ergot alkaloids including ergovaline may be due to D2 dopamine receptor activation", "relationMentions": [{"em1Text": "ergot alkaloids", "em2Text": "D2 dopamine receptor", "label": "CPR:3"}, {"em1Text": "ergovaline", "em2Text": "D2 dopamine receptor", "label": "CPR:3"}]}
{"sentText": "Ergot alkaloids were also effective in inhibiting VIP stimulated cyclic AMP production with EC50 values for ergovaline ergonovine alphaergocryptine ergotamine and dopamine of 8 2 47 2 28 2 2 1 and 8 1 nM respectively", "relationMentions": [{"em1Text": "Ergot alkaloids", "em2Text": "VIP", "label": "CPR:4"}, {"em1Text": "VIP", "em2Text": "ergovaline", "label": "CPR:4"}, {"em1Text": "VIP", "em2Text": "ergonovine", "label": "CPR:4"}, {"em1Text": "VIP", "em2Text": "alphaergocryptine", "label": "CPR:4"}, {"em1Text": "VIP", "em2Text": "ergotamine", "label": "CPR:4"}, {"em1Text": "VIP", "em2Text": "dopamine", "label": "CPR:4"}, {"em1Text": "VIP", "em2Text": "cyclic AMP", "label": "CPR:9"}]}
{"sentText": "Ergovaline inhibition of radioligand binding to the D2 dopamine receptor and ergot alkaloid inhibition of vasoactive intestinal peptide VIP stimulated cyclic AMP production in GH4ZR7 cells stably transfected with a rat D2 dopamine receptor were evaluated", "relationMentions": [{"em1Text": "ergot alkaloid", "em2Text": "vasoactive intestinal peptide", "label": "CPR:4"}, {"em1Text": "ergot alkaloid", "em2Text": "VIP", "label": "CPR:4"}, {"em1Text": "vasoactive intestinal peptide", "em2Text": "cyclic AMP", "label": "CPR:9"}, {"em1Text": "VIP", "em2Text": "cyclic AMP", "label": "CPR:9"}]}
{"sentText": "Ergovaline inhibition of radioligand binding to the D2 dopamine receptor and ergot alkaloid inhibition of vasoactive intestinal peptide VIP stimulated cyclic AMP production in GH4ZR7 cells stably transfected with a rat D2 dopamine receptor were evaluated", "relationMentions": [{"em1Text": "ergot alkaloid", "em2Text": "vasoactive intestinal peptide", "label": "CPR:4"}, {"em1Text": "ergot alkaloid", "em2Text": "VIP", "label": "CPR:4"}, {"em1Text": "vasoactive intestinal peptide", "em2Text": "cyclic AMP", "label": "CPR:9"}, {"em1Text": "VIP", "em2Text": "cyclic AMP", "label": "CPR:9"}]}
{"sentText": "Incubation of rat aortic membranes with the irreversible alpha 1Badrenoceptor antagonist chloroethylclonidine CEC 10 microM did not change the KD of 3Hprazosin binding in comparison to untreated membranes but reduced by 88 the total number of binding sites Bmax", "relationMentions": [{"em1Text": "alpha 1Badrenoceptor", "em2Text": "chloroethylclonidine", "label": "CPR:6"}, {"em1Text": "alpha 1Badrenoceptor", "em2Text": "CEC", "label": "CPR:6"}]}
{"sentText": "Furthermore the phosphorylation of myosin light chain produced by norepinephrine was greater than that produced by clonidine", "relationMentions": [{"em1Text": "myosin light chain", "em2Text": "norepinephrine", "label": "CPR:3"}, {"em1Text": "myosin light chain", "em2Text": "clonidine", "label": "CPR:3"}]}
{"sentText": "The present study utilized blood from normal volunteers and 125Ifibrinogen in a dilute whole blood clot assay to determine the relative concentrations of lysine analogues required for inhibition of clot lysis induced by exogenous tPA AMCA 006 mM and EACA 06 mM were effective in prolonging clot lysis if 1 whole blood clots were formed and then exposed to a lysine analogue and exogenous tPA or if 2 whole blood clots were formed in the presence of exogenous tPA and a lysine analogue", "relationMentions": [{"em1Text": "tPA", "em2Text": "AMCA", "label": "CPR:4"}, {"em1Text": "tPA", "em2Text": "EACA", "label": "CPR:4"}, {"em1Text": "lysine", "em2Text": "tPA", "label": "CPR:4"}]}
{"sentText": "The goal of the present study was to compare the effects of three potent reference renin inhibitors remikiren CGP 38560A and enalkiren in sodiumdepleted normotensive squirrel monkeys", "relationMentions": [{"em1Text": "renin", "em2Text": "remikiren", "label": "CPR:4"}, {"em1Text": "renin", "em2Text": "CGP 38560A", "label": "CPR:4"}, {"em1Text": "renin", "em2Text": "enalkiren", "label": "CPR:4"}]}
{"sentText": "One possible explanation is that in our model remikiren in contrast to CGP 38560A and enalkiren is able to inhibit renin in a functionally important extraplasmatic compartment", "relationMentions": [{"em1Text": "remikiren", "em2Text": "renin", "label": "CPR:4"}, {"em1Text": "CGP 38560A", "em2Text": "renin", "label": "CPR:4"}, {"em1Text": "enalkiren", "em2Text": "renin", "label": "CPR:4"}]}
{"sentText": "RESULTS Nedocromil sodium inhibited the chemotactic response toward FMLP and NAF IL8 of GMCSF primed eosinophils approximately 60 inhibitory concentration of 50 IC50 approximately 1 to 10 nmolL whereas these responses of IL3 primed eosinophils was completely inhibited IC50 approximately 1 nmolL", "relationMentions": [{"em1Text": "Nedocromil sodium", "em2Text": "IL3", "label": "CPR:4"}, {"em1Text": "Nedocromil sodium", "em2Text": "NAF", "label": "CPR:4"}, {"em1Text": "Nedocromil sodium", "em2Text": "IL8", "label": "CPR:4"}, {"em1Text": "Nedocromil sodium", "em2Text": "GMCSF", "label": "CPR:4"}]}
{"sentText": "Glutathioneindependent prostaglandin D synthase prostaglandinH2 Disomerase 5Z13E15S9 alpha11 alphaepidioxy15hydroxyprosta513dienoate Disomerase EC 53992 is an enzyme responsible for biosynthesis of prostaglandin D2 in the central nervous system", "relationMentions": [{"em1Text": "prostaglandinH2 Disomerase", "em2Text": "prostaglandin D2", "label": "CPR:9"}, {"em1Text": "5Z13E15S9 alpha11 alphaepidioxy15hydroxyprosta513dienoate Disomerase", "em2Text": "prostaglandin D2", "label": "CPR:9"}, {"em1Text": "EC 53992", "em2Text": "prostaglandin D2", "label": "CPR:9"}, {"em1Text": "prostaglandin D synthase", "em2Text": "prostaglandin D2", "label": "CPR:9"}]}
{"sentText": "Kainateevoked currents showed partial desensitization that was reduced on incubation with concanavalin A conA but not cyclothiazide and were attenuated by the non NmethylDaspartate NMDA receptor antagonist CNQX 6cyano7nitroquinoxalinedione", "relationMentions": [{"em1Text": "NmethylDaspartate NMDA receptor", "em2Text": "CNQX", "label": "CPR:6"}, {"em1Text": "NmethylDaspartate NMDA receptor", "em2Text": "6cyano7nitroquinoxalinedione", "label": "CPR:6"}]}
{"sentText": "One group of experimental animals was treated with 5lipoxygenase 5LO inhibitor diethylcarbamazine DEC Sigma St Louis Missouri 50 mgkg iv", "relationMentions": [{"em1Text": "5lipoxygenase", "em2Text": "diethylcarbamazine", "label": "CPR:4"}, {"em1Text": "5LO", "em2Text": "diethylcarbamazine", "label": "CPR:4"}, {"em1Text": "5lipoxygenase", "em2Text": "DEC", "label": "CPR:4"}, {"em1Text": "5LO", "em2Text": "DEC", "label": "CPR:4"}]}
{"sentText": "One group of experimental animals was treated with 5lipoxygenase 5LO inhibitor diethylcarbamazine DEC Sigma St Louis Missouri 50 mgkg iv", "relationMentions": [{"em1Text": "5lipoxygenase", "em2Text": "diethylcarbamazine", "label": "CPR:4"}, {"em1Text": "5LO", "em2Text": "diethylcarbamazine", "label": "CPR:4"}, {"em1Text": "5lipoxygenase", "em2Text": "DEC", "label": "CPR:4"}, {"em1Text": "5LO", "em2Text": "DEC", "label": "CPR:4"}]}
{"sentText": "Expressions of insulin and PC3 but not PC2 are coordinately regulated by glucose consistent with the important role of PC3 in regulating proinsulin processing", "relationMentions": [{"em1Text": "insulin", "em2Text": "glucose", "label": "CPR:3"}, {"em1Text": "PC3", "em2Text": "glucose", "label": "CPR:3"}]}
{"sentText": "The present results suggest that the action of DMI in this animal model is unlikely to be directly related to a reduction in betaadrenoceptors but may be related to a reduction in frontal cortical 5HT2A receptors", "relationMentions": [{"em1Text": "DMI", "em2Text": "betaadrenoceptors", "label": "CPR:4"}, {"em1Text": "DMI", "em2Text": "5HT2A", "label": "CPR:4"}]}
{"sentText": "We thus speculated that activation of PGHS1 might be a mechanism by which minoxidil 24diamino6piperidinopyrimidine3oxyde stimulates hair growth in vivo", "relationMentions": [{"em1Text": "PGHS1", "em2Text": "minoxidil", "label": "CPR:3"}, {"em1Text": "PGHS1", "em2Text": "24diamino6piperidinopyrimidine3oxyde", "label": "CPR:3"}]}
{"sentText": "This study was designed to determine the gastroprotective properties of cinitapride CNT a novel prokinetic benzamide derivative agonist of 5HT4 and 5HT1 receptors and 5HT2 antagonist on mucosal injury produced by 50 vv ethanol", "relationMentions": [{"em1Text": "cinitapride", "em2Text": "5HT4", "label": "CPR:5"}, {"em1Text": "cinitapride", "em2Text": "5HT1", "label": "CPR:5"}, {"em1Text": "benzamide", "em2Text": "5HT4", "label": "CPR:5"}, {"em1Text": "benzamide", "em2Text": "5HT1", "label": "CPR:5"}, {"em1Text": "CNT", "em2Text": "5HT4", "label": "CPR:5"}, {"em1Text": "CNT", "em2Text": "5HT1", "label": "CPR:5"}, {"em1Text": "cinitapride", "em2Text": "5HT2", "label": "CPR:6"}, {"em1Text": "benzamide", "em2Text": "5HT2", "label": "CPR:6"}, {"em1Text": "CNT", "em2Text": "5HT2", "label": "CPR:6"}]}
{"sentText": "This study was designed to determine the gastroprotective properties of cinitapride CNT a novel prokinetic benzamide derivative agonist of 5HT4 and 5HT1 receptors and 5HT2 antagonist on mucosal injury produced by 50 vv ethanol", "relationMentions": [{"em1Text": "cinitapride", "em2Text": "5HT4", "label": "CPR:5"}, {"em1Text": "cinitapride", "em2Text": "5HT1", "label": "CPR:5"}, {"em1Text": "benzamide", "em2Text": "5HT4", "label": "CPR:5"}, {"em1Text": "benzamide", "em2Text": "5HT1", "label": "CPR:5"}, {"em1Text": "CNT", "em2Text": "5HT4", "label": "CPR:5"}, {"em1Text": "CNT", "em2Text": "5HT1", "label": "CPR:5"}, {"em1Text": "cinitapride", "em2Text": "5HT2", "label": "CPR:6"}, {"em1Text": "benzamide", "em2Text": "5HT2", "label": "CPR:6"}, {"em1Text": "CNT", "em2Text": "5HT2", "label": "CPR:6"}]}
{"sentText": "Here we report that alendronate is a potent inhibitor of the proteintyrosinephosphatasemeg1 PTPmeg1", "relationMentions": [{"em1Text": "alendronate", "em2Text": "proteintyrosinephosphatasemeg1", "label": "CPR:4"}, {"em1Text": "alendronate", "em2Text": "PTPmeg1", "label": "CPR:4"}]}
{"sentText": "Among the other bisphosphonates studied alendronate was more potent and selective for PTPmeg1", "relationMentions": [{"em1Text": "bisphosphonates", "em2Text": "PTPmeg1", "label": "CPR:4"}, {"em1Text": "alendronate", "em2Text": "PTPmeg1", "label": "CPR:4"}]}
{"sentText": "The hydrolysis of fluorescein diphosphate by PTP epsilon and PTPmeg1 was sensitive to alendronate with IC50 values of less than 1 microM PTPsigma however under the same conditions was inhibited by only 50 with 141 microM alendronate", "relationMentions": [{"em1Text": "alendronate", "em2Text": "PTPsigma", "label": "CPR:4"}, {"em1Text": "diphosphate", "em2Text": "PTP epsilon", "label": "CPR:9"}, {"em1Text": "diphosphate", "em2Text": "PTPmeg1", "label": "CPR:9"}]}
{"sentText": "Alendronate inhibited PTPmeg1 with an IC50 value of 23 microM PTPsigma with an IC50 value of 2 microM and did not inhibit PTP epsilon at concentrations up to 1 mM", "relationMentions": [{"em1Text": "Alendronate", "em2Text": "PTPmeg1", "label": "CPR:4"}, {"em1Text": "Alendronate", "em2Text": "PTPsigma", "label": "CPR:4"}]}
{"sentText": "PTP inhibition by hisphosphonates or vanadate was diminished by the metal chelating agent EDTA or by the reducing agent dithiothreitol suggesting that a metal ion and the oxidation of a cysteine residue are required for full inhibition", "relationMentions": [{"em1Text": "PTP", "em2Text": "hisphosphonates", "label": "CPR:4"}, {"em1Text": "PTP", "em2Text": "vanadate", "label": "CPR:4"}]}
{"sentText": "1616dimethylPGE2 and two putative EP1 antagonists AH6809 and SC19220 did not show any significant binding to this receptor", "relationMentions": [{"em1Text": "EP1", "em2Text": "AH6809", "label": "CPR:6"}, {"em1Text": "EP1", "em2Text": "SC19220", "label": "CPR:6"}]}
{"sentText": "Monoamine uptake inhibitors structurally analogous to cocaine cocaethylene CFT betaCIT CPT cocaine norcocaine and benztropine also produced this rapid pressor response whereas structurally unrelated uptake inhibitors with diverse monoamine transporter selectivities BTCP indatraline GBR 12935 mazindol nomifensine and zimeldine either did not produce a rapid pressor response or produced only a small pressor response", "relationMentions": [{"em1Text": "monoamine transporter", "em2Text": "BTCP", "label": "CPR:4"}, {"em1Text": "monoamine transporter", "em2Text": "indatraline", "label": "CPR:4"}, {"em1Text": "monoamine transporter", "em2Text": "GBR 12935", "label": "CPR:4"}, {"em1Text": "monoamine transporter", "em2Text": "mazindol", "label": "CPR:4"}, {"em1Text": "monoamine transporter", "em2Text": "nomifensine", "label": "CPR:4"}, {"em1Text": "monoamine transporter", "em2Text": "zimeldine", "label": "CPR:4"}]}
{"sentText": "At nonconvulsant doses the sodium channel blockers acetylprocainamide dibucaine dyclonine prilocaine proparacaine quinidine and tetracaine produced a small pressor response or no increase in BP", "relationMentions": [{"em1Text": "sodium channel", "em2Text": "acetylprocainamide", "label": "CPR:4"}, {"em1Text": "sodium channel", "em2Text": "dibucaine", "label": "CPR:4"}, {"em1Text": "sodium channel", "em2Text": "dyclonine", "label": "CPR:4"}, {"em1Text": "sodium channel", "em2Text": "prilocaine", "label": "CPR:4"}, {"em1Text": "sodium channel", "em2Text": "proparacaine", "label": "CPR:4"}, {"em1Text": "sodium channel", "em2Text": "quinidine", "label": "CPR:4"}, {"em1Text": "sodium channel", "em2Text": "tetracaine", "label": "CPR:4"}]}
{"sentText": "In conclusion these findings indicate that 3HSR 142948A is a new potent antagonist radioligand which recognizes with high affinity both neurotensin NT1 and NT2 receptors and represents thus an excellent tool to study neurotensin receptors in the rat brain", "relationMentions": [{"em1Text": "3HSR 142948A", "em2Text": "neurotensin NT1", "label": "CPR:6"}, {"em1Text": "3HSR 142948A", "em2Text": "NT2 receptors", "label": "CPR:6"}]}
{"sentText": "The present study describes the characterization of the binding properties and autoradiographic distribution of a new nonpeptide antagonist of neurotensin receptors 3HSR 142948A 2526dimethoxyphenyl14N3dimethylaminopropylNmethyl carbamoyl2isopropylphenyl1Hpyrazole3carbonylaminoad amantane2carboxylic acid hydrochloride in the rat brain", "relationMentions": [{"em1Text": "neurotensin receptors", "em2Text": "3HSR 142948A", "label": "CPR:6"}, {"em1Text": "neurotensin receptors", "em2Text": "2526dimethoxyphenyl14N3dimethylaminopropylNmethyl carbamoyl2isopropylphenyl1Hpyrazole3carbonylaminoad amantane2carboxylic acid hydrochloride", "label": "CPR:6"}]}
{"sentText": "Dihydropyridines DHPs block Ltype Ca2 channels more potently at depolarized membrane potentials consistent with high affinity binding to the inactivated state", "relationMentions": [{"em1Text": "Dihydropyridines", "em2Text": "Ltype Ca2 channels", "label": "CPR:4"}, {"em1Text": "DHPs", "em2Text": "Ltype Ca2 channels", "label": "CPR:4"}]}
{"sentText": "Nisoldipine a DHP antagonist blocks the smooth muscle channel more potently than the cardiac one a phenomenon observed not only in native channels but also in expressed channels", "relationMentions": [{"em1Text": "Nisoldipine", "em2Text": "smooth muscle channel", "label": "CPR:4"}, {"em1Text": "DHP", "em2Text": "smooth muscle channel", "label": "CPR:4"}]}
{"sentText": "System y cationic amino acid transport is mediated by proteins encoded by a family of genes Cat1 Cat2 and Cat3", "relationMentions": [{"em1Text": "System y", "em2Text": "amino acid", "label": "CPR:9"}, {"em1Text": "amino acid", "em2Text": "Cat1", "label": "CPR:9"}, {"em1Text": "amino acid", "em2Text": "Cat2", "label": "CPR:9"}, {"em1Text": "amino acid", "em2Text": "Cat3", "label": "CPR:9"}]}
{"sentText": "Lintitript markedly increased postprandial plasma CCK release P0001 while distinctly reducing postprandial PP levels P001 as compared to placebo", "relationMentions": [{"em1Text": "Lintitript", "em2Text": "CCK", "label": "CPR:3"}, {"em1Text": "Lintitript", "em2Text": "PP", "label": "CPR:4"}]}
{"sentText": "The observed inhibition on IFNgamma GMCSF and IL3 mRNA was blocked by the selective beta2AR antagonist ICI 118551 106 M and by timolol 106 M a nonselective antagonist", "relationMentions": [{"em1Text": "IFNgamma", "em2Text": "ICI 118551", "label": "CPR:3"}, {"em1Text": "GMCSF", "em2Text": "ICI 118551", "label": "CPR:3"}, {"em1Text": "IL3", "em2Text": "ICI 118551", "label": "CPR:3"}, {"em1Text": "IFNgamma", "em2Text": "timolol", "label": "CPR:3"}, {"em1Text": "GMCSF", "em2Text": "timolol", "label": "CPR:3"}, {"em1Text": "IL3", "em2Text": "timolol", "label": "CPR:3"}, {"em1Text": "beta2AR", "em2Text": "ICI 118551", "label": "CPR:6"}, {"em1Text": "beta2AR", "em2Text": "timolol", "label": "CPR:6"}]}
{"sentText": "The observed inhibition on IFNgamma GMCSF and IL3 mRNA was blocked by the selective beta2AR antagonist ICI 118551 106 M and by timolol 106 M a nonselective antagonist", "relationMentions": [{"em1Text": "IFNgamma", "em2Text": "ICI 118551", "label": "CPR:3"}, {"em1Text": "GMCSF", "em2Text": "ICI 118551", "label": "CPR:3"}, {"em1Text": "IL3", "em2Text": "ICI 118551", "label": "CPR:3"}, {"em1Text": "IFNgamma", "em2Text": "timolol", "label": "CPR:3"}, {"em1Text": "GMCSF", "em2Text": "timolol", "label": "CPR:3"}, {"em1Text": "IL3", "em2Text": "timolol", "label": "CPR:3"}, {"em1Text": "beta2AR", "em2Text": "ICI 118551", "label": "CPR:6"}, {"em1Text": "beta2AR", "em2Text": "timolol", "label": "CPR:6"}]}
{"sentText": "Concanavalin A Con Ainduced IFNgamma GMCSF and IL3 mRNAs are dosedependently inhibited by the nonselective betaAR agonist isoproterenol and by the selective beta2AR agonist fenoterol", "relationMentions": [{"em1Text": "IFNgamma", "em2Text": "isoproterenol", "label": "CPR:4"}, {"em1Text": "GMCSF", "em2Text": "isoproterenol", "label": "CPR:4"}, {"em1Text": "IL3", "em2Text": "isoproterenol", "label": "CPR:4"}, {"em1Text": "IFNgamma", "em2Text": "fenoterol", "label": "CPR:4"}, {"em1Text": "GMCSF", "em2Text": "fenoterol", "label": "CPR:4"}, {"em1Text": "IL3", "em2Text": "fenoterol", "label": "CPR:4"}, {"em1Text": "betaAR", "em2Text": "isoproterenol", "label": "CPR:5"}, {"em1Text": "beta2AR", "em2Text": "fenoterol", "label": "CPR:5"}]}
{"sentText": "Concanavalin A Con Ainduced IFNgamma GMCSF and IL3 mRNAs are dosedependently inhibited by the nonselective betaAR agonist isoproterenol and by the selective beta2AR agonist fenoterol", "relationMentions": [{"em1Text": "IFNgamma", "em2Text": "isoproterenol", "label": "CPR:4"}, {"em1Text": "GMCSF", "em2Text": "isoproterenol", "label": "CPR:4"}, {"em1Text": "IL3", "em2Text": "isoproterenol", "label": "CPR:4"}, {"em1Text": "IFNgamma", "em2Text": "fenoterol", "label": "CPR:4"}, {"em1Text": "GMCSF", "em2Text": "fenoterol", "label": "CPR:4"}, {"em1Text": "IL3", "em2Text": "fenoterol", "label": "CPR:4"}, {"em1Text": "betaAR", "em2Text": "isoproterenol", "label": "CPR:5"}, {"em1Text": "beta2AR", "em2Text": "fenoterol", "label": "CPR:5"}]}
{"sentText": "These results indicate that carbetocin is a partial agonistantagonist to the oxytocin receptor while the two metabolites carbetocin metabolite I and carbetocin metabolite II are pure antagonists", "relationMentions": [{"em1Text": "carbetocin", "em2Text": "oxytocin receptor", "label": "CPR:5"}, {"em1Text": "carbetocin", "em2Text": "oxytocin receptor", "label": "CPR:6"}]}
{"sentText": "These results indicate that carbetocin is a partial agonistantagonist to the oxytocin receptor while the two metabolites carbetocin metabolite I and carbetocin metabolite II are pure antagonists", "relationMentions": [{"em1Text": "carbetocin", "em2Text": "oxytocin receptor", "label": "CPR:5"}, {"em1Text": "carbetocin", "em2Text": "oxytocin receptor", "label": "CPR:6"}]}
{"sentText": "Here we present the crystal structure of the dimeric catalytic domain residues 117424 of human phenylalanine hydroxylase hPheOH cocrystallized with various potent and wellknown catechol inhibitors and refined at a resolution of 20 A", "relationMentions": [{"em1Text": "human phenylalanine hydroxylase", "em2Text": "catechol", "label": "CPR:4"}, {"em1Text": "hPheOH", "em2Text": "catechol", "label": "CPR:4"}]}
